<html lang="en"><head><!-- Shady DOM styles for custom-style --><!-- Shady DOM styles for dom-template --><!-- Shady DOM styles for dom-repeat --><!-- Shady DOM styles for array-selector --><!-- Shady DOM styles for dom-if --><!-- Shady DOM styles for state-modifier --><style scope="state-modifier">a[inherit].state-modifier {
  color: inherit;
}</style><!-- Shady DOM styles for browser-ui --><!-- Shady DOM styles for outlined-text-field --><style scope="outlined-text-field">outlined-text-field {
  display: flex;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
  flex-direction: column;
}

outlined-text-field span.outlined-text-field {
  display: flex;
  flex-direction: row;
  align-items: center;
}

outlined-text-field input.outlined-text-field {
  height: 40px;
  padding: 0 33px 0 16px;
  
  border-color: #b0b3b6;
  border-width: 1px;
  border-style: solid;
  
  border-radius: 8px;
  caret-color: #3c78e0;
  color: #6a6c71;
  font-size: 14px;
  flex-grow: 1;
}

outlined-text-field[orig] input.outlined-text-field {
  border-color: #e5e5e5;
  
  border-radius: 0;
}

outlined-text-field[dense] input.outlined-text-field {
  height: 32px;
}

outlined-text-field[uppercase] input.outlined-text-field {
  text-transform: uppercase;
}

outlined-text-field:not([wizard-focused]):hover input.outlined-text-field {
  border-color: #737375;
  color: #414447;
}

outlined-text-field:not([wizard-focused]):focus-within input.outlined-text-field,outlined-text-field[wizard-focused] input.outlined-text-field {
  border-color: #3574e0;
  caret-color: #80a5f1;
}

outlined-text-field[wizard-focused] input.outlined-text-field {
  border-width: 2px;
}

outlined-text-field input.outlined-text-field::placeholder {
  color: #65686c;
}

outlined-text-field[uppercase] input.outlined-text-field::placeholder {
  text-transform: none;
}</style><!-- Shady DOM styles for mat-keyword-editor --><!-- Shady DOM styles for mat-chips-input --><!-- Shady DOM styles for mat-input-chip --><!-- Shady DOM styles for pat-dialog --><style scope="pat-dialog">pat-dialog {
  background: white;
  position: absolute;
  border-radius: 8px;
  
  box-shadow: 0 24px 38px 3px rgb(0 0 0 / 14%),
              0 9px 46px 8px rgb(0 0 0 / 12%),
              0 11px 15px -7px rgb(0 0 0 / 20%);
  z-index: 1;
  display: flex;
  flex-direction: column;
}

pat-dialog:not([open]) {
  display: none;
}</style><!-- Shady DOM styles for mat-tabs --><!-- Shady DOM styles for filter-chip --><style scope="filter-chip">filter-chip {
  align-items: center;
  background-color: #fff;
  border-color: #dadce0;
  border-radius: 8px;
  border-style: solid;
  border-width: 1px;
  color: #606368;
  cursor: pointer;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-size: 14px;
  font-weight: 500;
  height: 32px;
  letter-spacing: 0.2px;
  padding: 0 16px;
  user-select: none;
  display: inline-flex;
  white-space: nowrap;
}

filter-chip[disabled] {
  background-color: #e8e8e8;
  border-color: #e8e8e8;
  color: #a9abad;
  cursor: auto;
}

filter-chip svg.filter-chip {
  visibility: collapse;
  font-size: 18px;
  width: 0;
  height: 18px;
}

filter-chip[selected] svg.filter-chip {
  visibility: visible;
  margin: 0 8px;
  width: 18px;
}

filter-chip[selected] svg.filter-chip path.filter-chip {
  fill: #4577d1;
}

filter-chip:not([disabled]):hover {
  background-color: #f7f8f8;
  border-color: #d7d9dc;
  color: #454649;
}

filter-chip:not([disabled]):hover:active {
  background-color: #eff0f0;
  border-color: #d2d5d8;
  color: #222326;
}

filter-chip:not([disabled]):focus {
  background-color: #e7e8e8;
  border-color: #232528;
  color: #202124;
}

filter-chip:not([disabled])[selected] {
  background-color: #e9f0fd;
  border-color: #e9f0fd;
  color: #4577d1;
  padding-left: 0;
}

filter-chip:not([disabled]):focus[selected] {
  background-color: #d5e1fb;
  border-color: #d5e1fb;
  color: #2550a0;
}

filter-chip:not([disabled]):hover[selected] {
  box-shadow: rgba(0, 0, 0, 0.2) 0px 3px 1px -2px,
    rgba(0, 0, 0, 0.14) 0px 2px 2px 0px, rgba(0, 0, 0, 0.12) 0px 1px 5px 0px;
}

filter-chip:not([disabled]):hover:active[selected] {
  background-color: #abc8f2;
  border-color: #abc8f2;
  color: #2a54a3;
}</style><!-- Shady DOM styles for figure-callout --><style scope="figure-callout">figure-callout:not([filenames=""]) a.figure-callout {
  cursor: zoom-in;
  text-decoration: underline;
  text-decoration-color: #ddd;
}</style><!-- Shady DOM styles for mat-button --><style scope="mat-button-0">.mat-button-0 {
  ;
  align-items: center;
  border-radius: 4px;
  color: hsl(217 4% 39%); 
  cursor: pointer;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-size: 14px;
  font-weight: 500;
  height: 36px;
  letter-spacing: 0.2px;
  padding: 0 8px;
  user-select: none;
  display: inline-flex;
  white-space: nowrap;
}

.mat-button-0[filled] {
  background-color: hsl(217 73% 54%); 
  color: white;
}

.mat-button-0[filled]:hover {
  background-color: hsl(217 60% 47%);
}

.mat-button-0[filled]:focus {
  background-color: hsl(217 59% 44%);
}

.mat-button-0[filled]:active {
  background-color: hsl(217 59% 45%);
}

.mat-button-0[filled][disabled] {
  background-color: hsl(217 2% 90%); 
  color: hsl(217 1% 65%);
}</style><!-- Shady DOM styles for search-term-wizard --><style scope="search-term-wizard">search-term-wizard:not([open]) {
  display: none;
}

search-term-wizard .header.search-term-wizard {
  border-bottom: 1px solid #e5e5e5;
  padding: 24px;
  padding-bottom: 0;
}

search-term-wizard .title.search-term-wizard {
  color: #3c4043;
  font-family: Google Sans,Roboto,Arial,sans-serif;
  font-size: 22px;
  user-select: none;
  margin: 0 48px;
}

search-term-wizard #panels.search-term-wizard > *.search-term-wizard:not([selected]) {
  display: none;
}</style><!-- Shady DOM styles for outlined-textarea --><style scope="outlined-textarea">outlined-textarea {
  display: flex;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
  flex-direction: row;
  
  position: relative;
}

outlined-textarea span.outlined-textarea {
  display: flex;
  flex-direction: column;
  flex-grow: 1;
  justify-content: center;
}

outlined-textarea span.right-button-container.outlined-textarea {
  position: absolute;
  right: 0;
  height: 100%;
}

outlined-textarea textarea.outlined-textarea {
  padding: 16px 16px 0 16px;
  border-color: #b0b3b6;
  border-width: 1px;
  border-style: solid;
  border-radius: 8px;
  caret-color: #3c78e0;
  color: #6a6c71;
  font-size: 14px;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
  resize: none;
}

outlined-textarea[dense] textarea.outlined-textarea {
  padding: 8px;
}

outlined-textarea[has-icon] textarea.outlined-textarea {
  padding-right: 38px;
}

outlined-textarea[orig] textarea.outlined-textarea {
  border-color: #e5e5e5;
  
  border-radius: 0;
}

outlined-textarea:not([rows]) textarea.outlined-textarea {
  height: 40px;
}

outlined-textarea textarea.resizable.outlined-textarea {
  resize: vertical;
}

outlined-textarea textarea.outlined-textarea:focus,outlined-textarea[wizard-focused] textarea.outlined-textarea,outlined-textarea textarea.outlined-textarea:focus:hover {
  border-color: #3574e0 !important;
  
  outline: none !important;
}

outlined-textarea textarea.outlined-textarea:hover {
  border-color: #202124;
  color: #414447;
}

outlined-textarea.hasValue textarea.outlined-textarea {
  border-color: #888d91;
  color: #45474a;
}

outlined-textarea #helperText.outlined-textarea {
  color: #6a6c71;
  font-size: 12px;
  letter-spacing: 0.3px;
  margin-left: 17px;
  margin-top: 6px;
  user-select: none;
}

outlined-textarea:not([helper-text]) #helperText.outlined-textarea {
  display: none;
}

outlined-textarea[error] textarea.outlined-textarea {
  border-color: #cb4b3d;
  caret-color: #ca493a;
  color: #3d4043;
}

outlined-textarea textarea.outlined-textarea::placeholder {
  font-size: 14px;
  font-weight: 400;
}

outlined-textarea:not([error]):not([disabled]) textarea.outlined-textarea::placeholder {
  color: #6a6c71;
}

outlined-textarea[error] textarea.outlined-textarea::placeholder {
  color: #c84132;
}

outlined-textarea[error] #helperText.outlined-textarea {
  color: #cd5648;
}

outlined-textarea[error] textarea.outlined-textarea:focus {
  border-color: #c84031;
  border-width: 2px;
  outline: none !important;
}

outlined-textarea[error]:not([disabled]) textarea.outlined-textarea:hover {
  border-color: #97231b;
}

outlined-textarea[error]:not([disabled]) textarea.outlined-textarea:hover::placeholder,outlined-textarea[error]:not([disabled]) textarea.outlined-textarea:hover + #helperText.outlined-textarea {
  color: #a94945;
}

outlined-textarea[disabled] textarea.outlined-textarea {
  border-color: #e9e9e9;
  color: #b5b6b8;
}

outlined-textarea[disabled] #helperText.outlined-textarea {
  color: #c4c6c7;
}

outlined-textarea[error][disabled] {
  opacity: 50%;
}

outlined-textarea[error][disabled] textarea.outlined-textarea {
  border-color: #cb4b3d;
  caret-color: #ca493a;
}

outlined-textarea[error][disabled] #helperText.outlined-textarea,outlined-textarea[error][disabled] textarea.outlined-textarea {
  color: #a94945;
}

outlined-textarea[error][disabled] textarea.outlined-textarea::placeholder {
  color: #c84132;
}</style><!-- Shady DOM styles for chemistry-search-term-wizard --><style scope="chemistry-search-term-wizard">chemistry-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
}

chemistry-search-term-wizard > span.chemistry-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

chemistry-search-term-wizard .suggestions.chemistry-search-term-wizard {
  margin-top: 4px;
}

chemistry-search-term-wizard > span.chemistry-search-term-wizard svg.chemistry-search-term-wizard {
  margin-right: 24px;
}

chemistry-search-term-wizard path.chemistry-search-term-wizard {
  fill: #5f6368;
}

chemistry-search-term-wizard .help.chemistry-search-term-wizard {
  margin-left: 12px;
  margin-right: 0;
  cursor: pointer;
}

chemistry-search-term-wizard outlined-text-field.chemistry-search-term-wizard {
  flex-grow: 1;
}

chemistry-search-term-wizard mat-button.chemistry-search-term-wizard {
  margin-left: 48px;
}

chemistry-search-term-wizard filter-chip.chemistry-search-term-wizard {
  margin-right: 4px;
}

chemistry-search-term-wizard outlined-textarea.chemistry-search-term-wizard {
  flex-grow: 1;
}

chemistry-search-term-wizard outlined-text-field[batchMode].chemistry-search-term-wizard {
  display: none;
}

chemistry-search-term-wizard outlined-textarea.chemistry-search-term-wizard:not([batchMode]) {
  display: none;
}</style><!-- Shady DOM styles for text-search-term-wizard --><style scope="text-search-term-wizard">text-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
}

text-search-term-wizard > span.text-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

text-search-term-wizard > span.text-search-term-wizard svg.text-search-term-wizard {
  margin-right: 24px;
}

text-search-term-wizard path.text-search-term-wizard {
  fill: #5f6368;
}

text-search-term-wizard outlined-text-field.text-search-term-wizard {
  flex-grow: 1;
}

text-search-term-wizard mat-button.text-search-term-wizard {
  margin-left: 48px;
}

text-search-term-wizard filter-chip.text-search-term-wizard {
  margin-right: 4px;
}</style><!-- Shady DOM styles for classification-wizard --><style scope="classification-wizard">classification-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
  max-width: 674px;
}

classification-wizard > span.classification-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

classification-wizard .suggestions.classification-wizard {
  margin-top: 4px;
}

classification-wizard > span.classification-wizard svg.classification-wizard {
  margin-right: 24px;
}

classification-wizard path.classification-wizard {
  fill: #5f6368;
}

classification-wizard outlined-text-field.classification-wizard {
  flex-grow: 1;
}

classification-wizard mat-button.classification-wizard {
  margin-left: 48px;
}

classification-wizard filter-chip.classification-wizard {
  margin-right: 4px;
}

classification-wizard .no-matches.classification-wizard {
  margin-left: 64px;
}

classification-wizard .table-container.classification-wizard {
  max-height: 300px;
  overflow: scroll;
  margin-top: 8px;
}

classification-wizard .table-container.classification-wizard::-webkit-scrollbar {
  -webkit-appearance: none;
  width: 10px;
}

classification-wizard .table-container.classification-wizard::-webkit-scrollbar-thumb {
  border-radius: 5px;
  background-color: #5f636880;
  -webkit-box-shadow: 0 0 1px rgba(255,255,255,.5);
}

classification-wizard table.classification-wizard {
  margin-left: 51px;
  max-width: 575px;
}

classification-wizard tr.classification-wizard {
  margin-top: 4px;
}

classification-wizard tr.classification-wizard suggestive-chip.classification-wizard {
  margin-right: 8px;
}

classification-wizard #spinner.classification-wizard {
  justify-content: space-around;
  margin-left: 48px;
  transform: scale(0.5);
}</style><!-- Shady DOM styles for suggestive-chip --><!-- Shady DOM styles for mat-checkbox --><!-- Shady DOM styles for measure-search-term-wizard --><style scope="measure-search-term-wizard">measure-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
  max-width: 674px;
}

measure-search-term-wizard > span.measure-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

measure-search-term-wizard .suggestions.measure-search-term-wizard {
  margin-top: 4px;
}

measure-search-term-wizard > span.measure-search-term-wizard svg.measure-search-term-wizard {
  margin-right: 24px;
}

measure-search-term-wizard path.measure-search-term-wizard {
  fill: #5f6368;
}

measure-search-term-wizard outlined-text-field.measure-search-term-wizard {
  flex-grow: 1;
}

measure-search-term-wizard mat-button.measure-search-term-wizard {
  margin-left: 48px;
}

measure-search-term-wizard filter-chip.measure-search-term-wizard {
  margin-right: 4px;
}</style><!-- Shady DOM styles for numerical-search-term-wizard --><style scope="numerical-search-term-wizard">numerical-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
  max-width: 674px;
}

numerical-search-term-wizard > span.numerical-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

numerical-search-term-wizard .suggestions.numerical-search-term-wizard {
  margin-top: 4px;
}

numerical-search-term-wizard > span.numerical-search-term-wizard svg.numerical-search-term-wizard {
  margin-right: 24px;
}

numerical-search-term-wizard path.numerical-search-term-wizard {
  fill: #5f6368;
}

numerical-search-term-wizard outlined-text-field.numerical-search-term-wizard,numerical-search-term-wizard outlined-textarea.numerical-search-term-wizard {
  flex-grow: 1;
}

numerical-search-term-wizard mat-button.numerical-search-term-wizard {
  margin-left: 48px;
}

numerical-search-term-wizard filter-chip.numerical-search-term-wizard {
  margin-right: 4px;
}

numerical-search-term-wizard #spinner.numerical-search-term-wizard {
  justify-content: space-around;
  margin-left: 48px;
  transform: scale(0.5);
}

numerical-search-term-wizard #suggestions.numerical-search-term-wizard {
  margin-left: 58px;
  display: flex;
  flex-direction: column;
  align-items: flex-start;
}

numerical-search-term-wizard .suggestion.numerical-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
}

numerical-search-term-wizard .suggestion.numerical-search-term-wizard mat-checkbox.numerical-search-term-wizard {
  margin-right: 8px;
}</style><!-- Shady DOM styles for text-button --><style scope="text-button">text-button {
  align-items: center;
  border-radius: 4px;
  cursor: pointer;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-size: 14px;
  font-weight: 500;
  height: 36px;
  letter-spacing: .25px;
  margin: 6px 0;
  padding: 0 8px;
  user-select: none;
  display: inline-flex;
  white-space: nowrap;
  line-height: 36px;
  text-decoration: none;
  text-transform: none;
  color: #5f6368;
}

text-button:hover {
  background-color: #f8f9fa;
}

text-button:active {
  background-color: #d5e2fa;
}

text-button[selected] {
  background-color: #e8f0fe;
  color: #1967d2;
}

text-button[selected]:active {
  background-color: #d2e3fc;
}</style><!-- Shady DOM styles for mat-spinner --><!-- Shady DOM styles for requery-tile --><style scope="requery-tile">requery-tile {
  display: flex;
  justify-content: space-between;
  align-items: center;
  box-sizing: border-box;
  min-height: 40px;
  padding: 8px 12px 8px 8px;
  gap: 8px;

  border-radius: 16px;
  background: #f7f8f9;
  color: #1f1f1f;
}

requery-tile:hover {
  background: #d7d8d9;
}

requery-tile > [slot="image"] {
  flex-shrink: 0;

  border-radius: 8px;

  background: #fff;
}

.label.requery-tile {
  flex-grow: 999;

  font: 16px/20px "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
}

.search-icon.requery-tile {
  flex-shrink: 0;

  width: 24px;
  height: 24px;
  background-image: url('https://fonts.gstatic.com/s/i/short-term/release/googlesymbols/search/default/24px.svg');
}</style><!-- Shady DOM styles for s-more-inline --><style scope="s-more-inline">s-more-inline {
  display: block;
  margin-top: 24px;
  padding: 16px;
  padding-top: 0;
  position: relative;

  line-height: 18px;
  text-overflow: ellipsis;
  white-space: nowrap;
  cursor: pointer;
}

hr.s-more-inline {
  background-color: #dadce0;
  margin-top: 18px;
  position: absolute;
  border: 0;
  height: 1px;
  left: 0;
  width: 100%;
}

.button.s-more-inline {
  display: flex;
  align-items: center;
  justify-content: center;

  position: relative; 
  margin: 0 auto;

  font: 400 14px Roboto, arial, sans-serif;
  height: 36px;
  width: 300px;
  border-radius: 18px;
  background-color: #f1f3f4;
}

.button.s-more-inline:hover {
  background-color: #d8d7dc;
}

.button.s-more-inline > [slot] {
  padding-right: 8px;
}

.expand.s-more-inline {
  display: inline-block;
  width: 20px;
  height: 20px;
}

.expand.less.s-more-inline {
  background-image: url('https://fonts.gstatic.com/s/i/short-term/release/googlesymbols/expand_less/default/20px.svg');
}

.expand.more.s-more-inline {
  background-image: url('https://fonts.gstatic.com/s/i/short-term/release/googlesymbols/expand_more/default/20px.svg');
}</style><!-- Shady DOM styles for workspace-ui-search --><!-- Shady DOM styles for keyword-wizard --><style scope="keyword-wizard">keyword-wizard {
  display: inline-block;
}

iron-icon.keyword-wizard {
  height: 20px;
    width: 20px;
    color: #999;
    cursor: pointer;
}

iron-icon[active].keyword-wizard {
  color: #4285f4 !important;
}

iron-icon.keyword-wizard:hover {
  color: #ccc;
}

#wizardIcon.keyword-wizard {
  padding-left: 1px;
    height: 16px;
    width: 16px;
    margin: 4px 1px 1px 1px;
}

#wizard.keyword-wizard {
  padding: 0;
    left: 0;
    top: 37px;
    position: absolute;
    background-color: white;
    z-index: 2;
    overflow: hidden;
}

.wizard-header.keyword-wizard {
  display: block;
    width: 100%;
    color: #737373;
    text-transform: uppercase;
    font-size: 13px;
    margin: 16px 0 6px 12px;
}

.filter-chips.keyword-wizard {
  margin-left: 20px;
}

.chip.keyword-wizard {
  background-color: #ebebeb;
    color: #6a6a6a;
    display: inline-block;
    font-size: 13px;
    font-family: inherit;
    border-radius: 12px;
    padding: 6px 12px;
}

.chip.keyword-wizard:hover {
  cursor: pointer;
}

.chip[selected].keyword-wizard {
  background-color: #4285f4;
    color: white;
}

.input-label.keyword-wizard {
  display: inline-block;
    font-size: 13px;
    font-family: inherit;
}

.keyword-input.keyword-wizard {
  display: inline-block;
    border-top: 0;
    border-left: 0;
    border-right: 0;
    border-bottom: 1px solid #dfe1e5;
    padding: 3px;
}

.keyword-input.keyword-wizard::placeholder {
  font-style: italic;
}

.keyword-input.keyword-wizard:hover,.keyword-input.keyword-wizard:focus {
  border-color: #4284f4;
    border-width: 1px;
    outline: none;
}

.cpc-field.keyword-wizard {
  display: inline-block;
    margin: 6px 0 0 24px;
}

#checkboxCPC.keyword-wizard:hover {
  cursor: pointer;
}

.checkbox-label.keyword-wizard {
  font-size: 13px;
    font-style: italic;
    color: #737373;
}

.chemistry-field.keyword-wizard {
  display: block;
}

#inputChem.input-batch.keyword-wizard {
  height: 150px;
    border: 1px solid #dfe1e5;
    padding: 6px;
}

#inputChem.keyword-wizard {
  resize: none;
    height: 15px;
    vertical-align: text-top;
    font-size: 13px;
    font-family: inherit;
    padding: 2px;
}

.chem-type-label.keyword-wizard {
  display: inline;
    font-size: 13px;
    margin-left: 12px;
    margin-right: 4px;
}

#chemType.keyword-wizard {
  border-top: 0;
    border-left: 0;
    border-right: 0;
    border-bottom: 1px solid #dfe1e5;
    margin: 6px;
    padding: 2px;
    outline: none;
    font-family: inherit;
    font-size: 13px;
}

.import.keyword-wizard {
  font-size: 13px;
    font-family: inherit;
}

.import-text.keyword-wizard {
  vertical-align: middle;
    display: inline-block;
}

.import-button.keyword-wizard {
  margin: 6px 0 0 24px;
}

.import-button.keyword-wizard button.keyword-wizard {
  border: 0;
    border-radius: 4px;
    padding: 6px 12px;
    font-family: inherit;
    background-color: #4284f4;
    color: white;
}

.import-button.keyword-wizard button.keyword-wizard:hover {
  cursor: pointer;
    background-color: #4284f4;
    color: white;
}

.wizard-buttons.keyword-wizard {
  float: right;
    padding: 12px;
}

.wizard-buttons.keyword-wizard button.keyword-wizard {
  border: 0;
    border-radius: 4px;
    padding: 6px 12px;
    margin: 2px;
    font-family: inherit;
    background-color: #4284f4;
    color: white;
}

.wizard-buttons.keyword-wizard button.keyword-wizard:hover {
  cursor: pointer;
}

@media screen and (max-width: 700px) {
#wizard.keyword-wizard {
  width: 275px;
}

.chip.keyword-wizard {
  margin: 4px 2px;
}

.keyword-input.keyword-wizard {
  width: 82%;
      margin: 4px 12px 12px 24px;
}

.search-within.keyword-wizard .input-label.keyword-wizard {
  display: none;
}

.cpc-field.keyword-wizard .keyword-input.keyword-wizard {
  width: 225px;
      margin: 12px 0 6px 0;
}

.find-patents.keyword-wizard .input-label.keyword-wizard {
  display: none;
}

.search-by.keyword-wizard .input-label.keyword-wizard {
  width: 55px;
      margin-left: 24px;
}

.search-by.keyword-wizard .keyword-input.keyword-wizard {
  margin-top: 6px;
}

#inputChem.keyword-wizard {
  width: 82%;
      padding: 2px;
      margin: 8px 12px 12px 24px;
}

#inputChem.input-batch.keyword-wizard {
  width: 220px;
      padding: 4px;
}

#chemType.keyword-wizard {
  width: 150px;
}

.import-text.keyword-wizard {
  margin: 6px 12px 6px 24px;
      width: 220px;
}

iron-icon.help-header.keyword-wizard {
  display: none;
}

}

@media screen and (min-width: 700px) {
#wizard.keyword-wizard {
  width: 540px;
}

.chip.keyword-wizard {
  margin: 0 2px;
}

.cpc-field.keyword-wizard .keyword-input.keyword-wizard {
  width: 240px;
      margin: 12px 16px 6px 6px;
}

.cpc-inputs.keyword-wizard {
  display: inline;
}

.find-patents.keyword-wizard .keyword-input.keyword-wizard {
  width: 53%;
      margin: 4px 10px;
}

.cpc-field.keyword-wizard .keyword-input.keyword-wizard::placeholder,#inputAnd.keyword-wizard::placeholder,#inputExact.keyword-wizard::placeholder,#inputOr.keyword-wizard::placeholder,#inputMinus.keyword-wizard::placeholder {
  color: white;
}

.find-patents.keyword-wizard .input-label.keyword-wizard {
  width: 35%;
      margin-left: 24px;
}

.search-by.keyword-wizard .keyword-input.keyword-wizard {
  width: 42%;
      margin: 6px 4px;
}

.search-by.keyword-wizard .input-label.keyword-wizard {
  width: 55px;
      margin-left: 24px;
}

#inputChem.keyword-wizard {
  width: 290px;
      margin: 2px 12px 2px 6px;
}

#inputChem.input-batch.keyword-wizard {
  width: 280px;
      padding: 6px;
}

.import-text.keyword-wizard {
  margin: 6px 12px;
      width: 415px;
}

#chemType.keyword-wizard {
  width: 105px;
}

iron-icon.keyword-wizard:hover.help-header {
  cursor: default;
}

iron-icon.help-header.keyword-wizard {
  height: 16px;
      padding: 0 2px 2px 2px;
      color: #a3a3a3;
}

.help.keyword-wizard p.keyword-wizard {
  margin: 0 0 8px 0
}

.help.keyword-wizard .q.keyword-wizard {
  font-family: monospace;
      color: #0b8043;
      white-space: nowrap;
}

.help.keyword-wizard {
  z-index: 4;
      position: absolute;
      right: 10px;
      padding: 12px;
      border-radius: 2px;
      border: 1px solid #e0e0e0;
      box-shadow: 0 2px 2px 0 rgba(0, 0, 0, 0.2), 0 6px 10px 0 rgba(0, 0, 0, 0.3);
      background: white;
      font-size: 13px;
      line-height: 20px;
      width: 450px;
      max-height: 400px;
      overflow: auto;
}

#withinHelp.keyword-wizard {
  top: 75px;
}

#chemHelp.keyword-wizard {
  top: 0;
}

#searchBooleanHelp.keyword-wizard {
  top: 140px;
}

}</style><!-- Shady DOM styles for bottom-bar --><style scope="bottom-bar">.fixed.bottom-bar {
  display: block;
  position: fixed;
  height: 46px;
  bottom: 0;
}

.fixed[medium].bottom-bar {
  height: 280px;
}

.fixed[large].bottom-bar {
  height: 480px;
}

.shadow.bottom-bar {
  background: white;
  padding: 16px;
  border-radius: 8px 8px 0px 0px;
  box-shadow: 0px 8px 10px 1px rgba(0,0,0,.14), 0px 3px 14px 2px rgba(0,0,0,.12), 0px 5px 5px -3px rgba(0,0,0,.2);
}

.oneline.bottom-bar {
  white-space: nowrap;
  overflow: hidden;
  text-overflow: ellipsis;
  cursor: pointer;
}

.button.bottom-bar {
  cursor: pointer;
}

.buttonAlign.bottom-bar {
  margin-top: -4px;
}

.header.bottom-bar {
  height: 30px;
  font-family: 'Google Sans';
  font-size: 18px;
  padding-bottom: 8px;
}

.list.bottom-bar {
  overflow-y: auto;
  line-height: 20px;
}

.definition.bottom-bar {
  padding: 0px 0px 4px 0px;
  cursor: pointer;
}

[medium].bottom-bar .content.bottom-bar {
  height: 230px;
}

[large].bottom-bar .content.bottom-bar {
  height: 430px;
}

[medium].bottom-bar .content.bottom-bar .list.bottom-bar {
  height: 200px;
}

[large].bottom-bar .content.bottom-bar .list.bottom-bar {
  height: 400px;
}

[hidden].bottom-bar {
  display: none;
}

.label.bottom-bar {
  font-family: 'Google Sans';
  font-size: 12px;
  line-height: 16px;
  font-weight: 400;
  padding: 6px 0px 4px 0px;
  color: #1f1f1f;
}

[pad].bottom-bar {
  margin-left: 16px;
}

.layout.vertical.bottom-bar {
  display: flex;
  flex-direction: column;
}

.layout.horizontal.bottom-bar {
  display: flex;
  flex-direction: row;
}

.flex.bottom-bar {
  flex: 1;
  flex-basis: 0.000000001px;
}

.layout.start.bottom-bar {
  align-items: flex-start;
}

.layout.center.bottom-bar {
  align-items: center;
}

.layout.end.bottom-bar {
  align-items: flex-end;
}

.flex-2.bottom-bar {
  flex: 2;
}

.flex-3.bottom-bar {
  flex: 3;
}

.flex-4.bottom-bar {
  flex: 4;
}

.flex-5.bottom-bar {
  flex: 5;
}

.flex-6.bottom-bar {
  flex: 6;
}

.flex-7.bottom-bar {
  flex: 7;
}

.flex-8.bottom-bar {
  flex: 8;
}

.flex-9.bottom-bar {
  flex: 9;
}

.flex-10.bottom-bar {
  flex: 10;
}

.flex-11.bottom-bar {
  flex: 11;
}

.flex-12.bottom-bar {
  flex: 12;
}</style><!-- Shady DOM styles for landscape-link --><!-- Shady DOM styles for landscape-summary-box --><!-- Shady DOM styles for search-state --><!-- Shady DOM styles for iron-overlay-backdrop --><!-- Shady DOM styles for opaque-animation --><!-- Shady DOM styles for iron-dropdown --><!-- Shady DOM styles for iron-meta --><!-- Shady DOM styles for iron-icon --><style scope="iron-icon-0">.iron-icon-0 {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;-ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;-ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
        position: relative;

        vertical-align: middle;

        fill: currentcolor;
        stroke: none;

        width: 24px;
        height: 24px;;
}

.iron-icon-0[hidden] {
  display: none;
}</style><!-- Shady DOM styles for iron-iconset-svg --><!-- Shady DOM styles for iron-list --><!-- Shady DOM styles for paper-icon-item --><!-- Shady DOM styles for paper-item-body --><!-- Shady DOM styles for paper-item --><!-- Shady DOM styles for dropdown-menu --><!-- Shady DOM styles for chips-input --><!-- Shady DOM styles for input-chip --><!-- Shady DOM styles for keyword-editor --><!-- Shady DOM styles for paper-ripple --><!-- Shady DOM styles for paper-button --><!-- Shady DOM styles for date-editor --><!-- Shady DOM styles for metadata-editor --><!-- Shady DOM styles for restrict-editor --><!-- Shady DOM styles for overlay-tooltip --><style scope="overlay-tooltip">overlay-tooltip {
  display: none;
        color: #fff;
        background-color: #000;
        padding: 10px 12px;
        border-radius: 3px;
        font-size: 13px;
        font-weight: normal;
        line-height: normal;
        position: fixed;
        z-index: 100;
}

#arrow.overlay-tooltip {
  width: 0;
        height: 0;
        border-style: solid;
        border-width: 0 6px 8px 6px;
        border-color: transparent transparent #000 transparent;
        position: absolute;
        top: -8px;
        left: calc(50% - 6px);
}</style><!-- Shady DOM styles for query-renderer --><!-- Shady DOM styles for result-nav --><style scope="result-nav">result-nav {
  display: block;
        white-space: nowrap;
        padding: 0 30px;
        line-height: 30px;
        height: 30px;
        margin-top: 17px;
        font-weight: 500;
        font-size: 15px;
}

state-modifier.result-nav {
  color: #333;
}

state-modifier[disabled].result-nav {
  pointer-events: none;
        color: #ccc;
}</style><!-- Shady DOM styles for raw-html --><!-- Shady DOM styles for paper-material --><style scope="paper-material-0">.paper-material-0 {
  display: block;
        position: relative;
}

.paper-material-0[elevation="1"] {
  box-shadow: 0 2px 2px 0 rgba(0, 0, 0, 0.14),
                    0 1px 5px 0 rgba(0, 0, 0, 0.12),
                    0 3px 1px -2px rgba(0, 0, 0, 0.2);
}

.paper-material-0[elevation="2"] {
  box-shadow: 0 4px 5px 0 rgba(0, 0, 0, 0.14),
                    0 1px 10px 0 rgba(0, 0, 0, 0.12),
                    0 2px 4px -1px rgba(0, 0, 0, 0.4);
}

.paper-material-0[elevation="3"] {
  box-shadow: 0 6px 10px 0 rgba(0, 0, 0, 0.14),
                    0 1px 18px 0 rgba(0, 0, 0, 0.12),
                    0 3px 5px -1px rgba(0, 0, 0, 0.4);
}

.paper-material-0[elevation="4"] {
  box-shadow: 0 8px 10px 1px rgba(0, 0, 0, 0.14),
                    0 3px 14px 2px rgba(0, 0, 0, 0.12),
                    0 5px 5px -3px rgba(0, 0, 0, 0.4);
}

.paper-material-0[elevation="5"] {
  box-shadow: 0 16px 24px 2px rgba(0, 0, 0, 0.14),
                    0  6px 30px 5px rgba(0, 0, 0, 0.12),
                    0  8px 10px -5px rgba(0, 0, 0, 0.4);
}

.paper-material-0[animated] {
  transition: box-shadow 0.28s cubic-bezier(0.4, 0, 0.2, 1);
}

.paper-material-0 {
  ;
}</style><!-- Shady DOM styles for search-box --><style scope="search-box">.layout.horizontal.search-box,.layout.vertical.search-box {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-box {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-box {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-box {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-box {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-box {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-box,.layout.center-center.search-box {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-box,.layout.center-center.search-box {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-box {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-box {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-box {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.inputbox.search-box {
  border: 1px solid #ccc;
        padding: 0 12px;
        background: white;
}

.inputbox[focused].search-box {
  border: 1px solid #4285f4 !important;
}

.inputbox.search-box:hover {
  border: 1px solid #999;
}

#searchInput.search-box {
  font-family: inherit;
        font-size: 16px;
        padding: 8px 0;
        outline: none;
        border-right: none;
        width: 100%;
        margin-right: 0;
        border: 0;
}

#searchButton.search-box {
  cursor: pointer;
        background-color: #4285f4;
        border: none;
        color: #fff;
        vertical-align: top;
        width: 70px;
        height: 37px;
        outline: none;
}

.suggest-bg.search-box {
  display: inline-block;
        min-width: 0;
        white-space: nowrap;
}

#suggestMenu.search-box {
  position: absolute;
        margin-top: 38px;
        width: 100%;
        background: white;
        z-index: 1;
}

#suggestMenu.search-box .row.search-box {
  font-size: 13px;
        line-height: 28px;
        white-space: nowrap;
        overflow: hidden;
        text-overflow: ellipsis;
        padding: 4px 2px;
        cursor: pointer;
}

.row[selected].search-box {
  background: rgba(0, 0, 0, 0.05);
}

.suggest-icon.search-box {
  height: 20px;
        width: 20px;
        padding: 0 12px 0 6px;
        transition: transform .15s linear;
        transform: scale(1);
}

.suggest-icon[hide].search-box {
  transform: scale(0);
}

#corpora.search-box {
  padding: 6px 0;
        user-select: none;
}

#corpora.search-box iron-icon.search-box {
  height: 20px;
        width: 20px;
        color: #ccc;
        cursor: pointer;
}

#corpora.search-box iron-icon[active].search-box {
  color: #4285f4 !important;
}

#corpora.search-box iron-icon.search-box:hover {
  color: #999;
}</style><!-- Shady DOM styles for iron-media-query --><!-- Shady DOM styles for paper-header-panel --><!-- Shady DOM styles for iron-a11y-announcer --><style scope="iron-a11y-announcer">iron-a11y-announcer {
  display: inline-block;
        position: fixed;
        clip: rect(0px,0px,0px,0px);
}</style><!-- Shady DOM styles for iron-autogrow-textarea --><!-- Shady DOM styles for iron-input --><!-- Shady DOM styles for paper-input-char-counter --><!-- Shady DOM styles for paper-input-container --><!-- Shady DOM styles for paper-input-error --><!-- Shady DOM styles for paper-input --><!-- Shady DOM styles for paper-textarea --><!-- Shady DOM styles for paper-toast --><style scope="paper-toast-0">.paper-toast-0 {
  display: block;
        position: fixed;
        background-color: #323232;
        color: #f1f1f1;
        min-height: 48px;
        min-width: 288px;
        padding: 16px 24px;
        box-sizing: border-box;
        box-shadow: 0 2px 5px 0 rgba(0, 0, 0, 0.26);
        border-radius: 2px;
        margin: 12px;
        font-size: 14px;
        cursor: default;
        -webkit-transition: -webkit-transform 0.3s, opacity 0.3s;
        transition: transform 0.3s, opacity 0.3s;
        opacity: 0;
        -webkit-transform: translateY(100px);
        transform: translateY(100px);font-family: 'Roboto', 'Noto', sans-serif;
        -webkit-font-smoothing: antialiased;
}

.paper-toast-0.capsule {
  border-radius: 24px;
}

.paper-toast-0.fit-bottom {
  width: 100%;
        min-width: 0;
        border-radius: 0;
        margin: 0;
}

.paper-toast-0.paper-toast-open {
  opacity: 1;
        -webkit-transform: translateY(0px);
        transform: translateY(0px);
}</style><!-- Shady DOM styles for paper-toolbar --><!-- Shady DOM styles for search-footer --><style scope="search-footer">#footer.search-footer {
  font-size: 13px;
        margin-top: 10px;
        background: #fafafa;
        padding: 20px 10px;
        align-items: center;
        border-top: 1px solid #ebebeb;
}

#footer.search-footer .links.search-footer > *.search-footer {
  display: inline-block;
        margin: 0 12px;
}

.layout.horizontal.search-footer,.layout.vertical.search-footer {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-footer {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-footer {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-footer {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-footer {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-footer {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-footer,.layout.center-center.search-footer {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-footer,.layout.center-center.search-footer {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-footer {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-footer {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-footer {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.search-footer {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.search-footer,.layout.center-center.search-footer {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.search-footer {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.search-footer {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.search-footer {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.search-footer,.layout.center-center.search-footer {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.search-footer {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.search-footer {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.search-footer {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.search-footer {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.search-footer {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.search-footer {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.search-footer {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.search-footer {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.search-footer {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.search-footer {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.search-footer {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.search-footer {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.search-footer {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}</style><!-- Shady DOM styles for search-header --><style scope="search-header">search-header {
  display: block;
}

.lockup-logo.search-header,.lockup-text.search-header {
  display: inline-block;
}

.lockup-logo.search-header {
  width: 74px;
        height: 24px;
        background-image: url('https://www.gstatic.com/images/branding/googlelogo/1x/googlelogo_color_74x24dp.png');
        background-size: 74px 24px;
}

.lockup-text.search-header {
  font-family: "Product Sans", Arial, Helvetica, sans-serif;

        
        font-size: 22.1px;

        
        text-rendering: optimizeLegibility;

        
        position: relative;
        top: -6px;
        left: -5px;

        
        -webkit-font-smoothing: antialiased;
        -moz-osx-font-smoothing: grayscale;
}

.lockup-brand.search-header {
  opacity: 0.54;
}

@media (-webkit-min-device-pixel-ratio: 1.5), (min-resolution: 144dpi) {
.lockup-logo.search-header {
  background-image: url('https://www.gstatic.com/images/branding/googlelogo/2x/googlelogo_color_74x24dp.png');
}

.lockup-text.search-header {
  font-size: 21.3px;
          left: -7px;
}

}

header.search-header {
  background-color: #fafafa;
        border-bottom: 1px solid #ebebeb;
        color: #333;
        height: 60px;
        width: 100%;
        z-index: 1;
        display: block;
}

[latestStyle].search-header header.search-header {
  background-color: transparent;
}

.headerpad.search-header {
  margin-left: 16px;
}

[wide].search-header .headerpad.search-header {
  margin-left: 32px;
}

.leftheader.search-header {
  width: 322px;
}

header.search-header h1.search-header {
  display: none;
}

header.search-header h1.search-header state-modifier.search-header {
  color: #777;
        text-decoration: none;
        display: inline-block;
}

[wide].search-header header.search-header h1.search-header {
  box-sizing: border-box;
        margin: 0;
        padding: 20px 0 10px;
        font-size: 20px;
        font-weight: 400;
        white-space: nowrap;
        display: block;
}

search-box.search-header {
  height: 37px;
        padding: 0 16px;
        width: 900px;
        align-self: center;
}

.layout.horizontal.search-header,.layout.vertical.search-header {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-header {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-header {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-header {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-header {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-header {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-header,.layout.center-center.search-header {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-header,.layout.center-center.search-header {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-header {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-header {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-header {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.search-header {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.search-header,.layout.center-center.search-header {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.search-header {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.search-header {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.search-header {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.search-header,.layout.center-center.search-header {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.search-header {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.search-header {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.search-header {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.search-header {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.search-header {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.search-header {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.search-header {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.search-header {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.search-header {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.search-header {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.search-header {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.search-header {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.search-header {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}</style><!-- Shady DOM styles for search-ui --><style scope="search-ui-0">.search-ui-0 paper-button.search-ui {
  display: inline-block;
        text-align: center;
        font-family: inherit;
}

.search-ui-0 .layout.horizontal.search-ui,.search-ui-0 .layout.vertical.search-ui {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.search-ui-0 .layout.inline.search-ui {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.search-ui-0 .layout.horizontal.search-ui {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.search-ui-0 .layout.vertical.search-ui {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.search-ui-0 .layout.wrap.search-ui {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.search-ui-0 .layout.no-wrap.search-ui {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.search-ui-0 .layout.center.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.search-ui-0 .layout.center-justified.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.search-ui-0 .flex.search-ui {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.search-ui-0 .flex-auto.search-ui {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.search-ui-0 .flex-none.search-ui {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.search-ui-0 .layout.start.search-ui {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.search-ui-0 .layout.center.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.search-ui-0 .layout.end.search-ui {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.search-ui-0 .layout.baseline.search-ui {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.search-ui-0 .layout.start-justified.search-ui {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.search-ui-0 .layout.center-justified.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.search-ui-0 .layout.end-justified.search-ui {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.search-ui-0 .layout.around-justified.search-ui {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.search-ui-0 .layout.justified.search-ui {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.search-ui-0 .self-start.search-ui {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.search-ui-0 .self-center.search-ui {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.search-ui-0 .self-end.search-ui {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.search-ui-0 .self-stretch.search-ui {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.search-ui-0 .self-baseline.search-ui {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.search-ui-0 .layout.start-aligned.search-ui {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.search-ui-0 .layout.end-aligned.search-ui {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.search-ui-0 .layout.center-aligned.search-ui {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.search-ui-0 .layout.between-aligned.search-ui {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.search-ui-0 .layout.around-aligned.search-ui {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

.search-ui-0 {
  display: block;
        min-width: 350px;
        height: 100%;
}

.search-ui-0 #content.search-ui {
  height: 100%;
}

.search-ui-0 #leftBarOverflow.search-ui {
  padding-right: 16px;
}

.search-ui-0 [wide].search-ui #leftBarOverflow.search-ui {
  overflow: auto;
}

.search-ui-0 #leftBar.search-ui {
  box-sizing: border-box;
        color: #666;
        font-size: 13px;
        padding: 16px 0 16px 16px;
        border-bottom: 1px solid #e5e5e5;
}

.search-ui-0 [wide].search-ui #leftBar.search-ui {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;

        -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
        position: relative;
        width: 350px;
        margin-bottom: 0;
        padding-bottom: 0;
        border-bottom: none;
}

@media print {
.search-ui-0 #leftBar.search-ui {
  display: none !important;
}

}

.search-ui-0 #leftBar.search-ui h3.search-ui {
  text-transform: uppercase;
        font-size: 13px;
        font-weight: normal;
        margin-top: 6px;
        margin-bottom: 6px;
        cursor: default;
        display: inline-block;
        color: #a3a3a3;
}

.search-ui-0 #closeButton.search-ui {
  position: absolute;
        right: 0;
}

.search-ui-0 #searchTermsHeader.search-ui {
  position: relative;
}

.search-ui-0 #searchTermsQ.search-ui iron-icon.search-ui {
  height: 16px;
        padding: 0 2px 2px 2px;
        color: #a3a3a3;
}

.search-ui-0 #searchTermsHeader.search-ui:hover iron-icon.search-ui {
  color: #4285f4;
}

.search-ui-0 #closeLeftBar.search-ui {
  height: 16px;
        width: 16px;
        padding: 0 0 8px 0;
        cursor: pointer;
}

.search-ui-0 #compactQuery.search-ui iron-icon.search-ui {
  height: 20px;
}

.search-ui-0 #backToResultsButton.search-ui {
  color: #fff;
        background: #4285f4;
        margin-top: 20px;
        text-align: center;
}

.search-ui-0 #main.search-ui {
  display: block;
        min-height: calc(100vh - 127px);
}

@media print {
.search-ui-0 [wide].search-ui main.search-ui {
  margin-left: 0;
}

}</style><!-- Shady DOM styles for import-list --><!-- Shady DOM styles for iron-request --><!-- Shady DOM styles for iron-ajax --><!-- Shady DOM styles for paper-dialog --><!-- Shady DOM styles for coverage-stats --><!-- Shady DOM styles for iron-image --><!-- Shady DOM styles for iron-selector --><!-- Shady DOM styles for paper-card --><!-- Shady DOM styles for paper-checkbox --><!-- Shady DOM styles for landing-page --><!-- Shady DOM styles for remote-fetch --><!-- Shady DOM styles for paper-spinner --><style scope="paper-spinner-0">.paper-spinner-0 {
  display: inline-block;
        position: relative;
        width: 28px;
        height: 28px;
}

.paper-spinner-0 #spinnerContainer.paper-spinner {
  width: 100%;
        height: 100%;

        
        direction: ltr;
}

.paper-spinner-0 #spinnerContainer.active.paper-spinner {
  -webkit-animation: container-rotate-paper-spinner-0 1568ms linear infinite;
        animation: container-rotate-paper-spinner-0 1568ms linear infinite;
}

@-webkit-keyframes container-rotate-paper-spinner-0 {
to {
  -webkit-transform: rotate(360deg)
}

}

@keyframes container-rotate-paper-spinner-0 {
to {
  transform: rotate(360deg)
}

}

.paper-spinner-0 .spinner-layer.paper-spinner {
  position: absolute;
        width: 100%;
        height: 100%;
        opacity: 0;
        white-space: nowrap;
        color: #4285f4;
}

.paper-spinner-0 .layer-1.paper-spinner {
  color: #4285f4;
}

.paper-spinner-0 .layer-2.paper-spinner {
  color: #db4437;
}

.paper-spinner-0 .layer-3.paper-spinner {
  color: #f4b400;
}

.paper-spinner-0 .layer-4.paper-spinner {
  color: #0f9d58;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0;
        -webkit-animation-duration: 5332ms;
        -webkit-animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        -webkit-animation-iteration-count: infinite;
        animation-name: fill-unfill-rotate-paper-spinner-0;
        animation-duration: 5332ms;
        animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        animation-iteration-count: infinite;
        opacity: 1;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-1.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-1-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-1-fade-in-out-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-2.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-2-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-2-fade-in-out-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-3.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-3-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-3-fade-in-out-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-4.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-4-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-4-fade-in-out-paper-spinner-0;
}

@-webkit-keyframes fill-unfill-rotate-paper-spinner-0 {
12.5% {
  -webkit-transform: rotate(135deg)
}

25% {
  -webkit-transform: rotate(270deg)
}

37.5% {
  -webkit-transform: rotate(405deg)
}

50% {
  -webkit-transform: rotate(540deg)
}

62.5% {
  -webkit-transform: rotate(675deg)
}

75% {
  -webkit-transform: rotate(810deg)
}

87.5% {
  -webkit-transform: rotate(945deg)
}

to {
  -webkit-transform: rotate(1080deg)
}

}

@keyframes fill-unfill-rotate-paper-spinner-0 {
12.5% {
  transform: rotate(135deg)
}

25% {
  transform: rotate(270deg)
}

37.5% {
  transform: rotate(405deg)
}

50% {
  transform: rotate(540deg)
}

62.5% {
  transform: rotate(675deg)
}

75% {
  transform: rotate(810deg)
}

87.5% {
  transform: rotate(945deg)
}

to {
  transform: rotate(1080deg)
}

}

@-webkit-keyframes layer-1-fade-in-out-paper-spinner-0 {
0% {
  opacity: 1
}

25% {
  opacity: 1
}

26% {
  opacity: 0
}

89% {
  opacity: 0
}

90% {
  opacity: 1
}

to {
  opacity: 1
}

}

@keyframes layer-1-fade-in-out-paper-spinner-0 {
0% {
  opacity: 1
}

25% {
  opacity: 1
}

26% {
  opacity: 0
}

89% {
  opacity: 0
}

90% {
  opacity: 1
}

to {
  opacity: 1
}

}

@-webkit-keyframes layer-2-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

15% {
  opacity: 0
}

25% {
  opacity: 1
}

50% {
  opacity: 1
}

51% {
  opacity: 0
}

to {
  opacity: 0
}

}

@keyframes layer-2-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

15% {
  opacity: 0
}

25% {
  opacity: 1
}

50% {
  opacity: 1
}

51% {
  opacity: 0
}

to {
  opacity: 0
}

}

@-webkit-keyframes layer-3-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

40% {
  opacity: 0
}

50% {
  opacity: 1
}

75% {
  opacity: 1
}

76% {
  opacity: 0
}

to {
  opacity: 0
}

}

@keyframes layer-3-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

40% {
  opacity: 0
}

50% {
  opacity: 1
}

75% {
  opacity: 1
}

76% {
  opacity: 0
}

to {
  opacity: 0
}

}

@-webkit-keyframes layer-4-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

65% {
  opacity: 0
}

75% {
  opacity: 1
}

90% {
  opacity: 1
}

to {
  opacity: 0
}

}

@keyframes layer-4-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

65% {
  opacity: 0
}

75% {
  opacity: 1
}

90% {
  opacity: 1
}

to {
  opacity: 0
}

}

.paper-spinner-0 .circle-clipper.paper-spinner {
  display: inline-block;
        position: relative;
        width: 50%;
        height: 100%;
        overflow: hidden;
}

.paper-spinner-0 .spinner-layer.paper-spinner::after {
  left: 45%;
        width: 10%;
        border-top-style: solid;
}

.paper-spinner-0 .spinner-layer.paper-spinner::after,.paper-spinner-0 .circle-clipper.paper-spinner::after {
  content: '';
        box-sizing: border-box;
        position: absolute;
        top: 0;
        border-width: 3px;
        border-radius: 50%;
}

.paper-spinner-0 .circle-clipper.paper-spinner::after {
  bottom: 0;
        width: 200%;
        border-style: solid;
        border-bottom-color: transparent !important;
}

.paper-spinner-0 .circle-clipper.left.paper-spinner::after {
  left: 0;
        border-right-color: transparent !important;
        -webkit-transform: rotate(129deg);
        transform: rotate(129deg);
}

.paper-spinner-0 .circle-clipper.right.paper-spinner::after {
  left: -100%;
        border-left-color: transparent !important;
        -webkit-transform: rotate(-129deg);
        transform: rotate(-129deg);
}

.paper-spinner-0 .active.paper-spinner .gap-patch.paper-spinner::after,.paper-spinner-0 .active.paper-spinner .circle-clipper.paper-spinner::after {
  -webkit-animation-duration: 1333ms;
        -webkit-animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        -webkit-animation-iteration-count: infinite;
        animation-duration: 1333ms;
        animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        animation-iteration-count: infinite;
}

.paper-spinner-0 .active.paper-spinner .circle-clipper.left.paper-spinner::after {
  -webkit-animation-name: left-spin-paper-spinner-0;
        animation-name: left-spin-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .circle-clipper.right.paper-spinner::after {
  -webkit-animation-name: right-spin-paper-spinner-0;
        animation-name: right-spin-paper-spinner-0;
}

@-webkit-keyframes left-spin-paper-spinner-0 {
0% {
  -webkit-transform: rotate(130deg)
}

50% {
  -webkit-transform: rotate(-5deg)
}

to {
  -webkit-transform: rotate(130deg)
}

}

@keyframes left-spin-paper-spinner-0 {
0% {
  transform: rotate(130deg)
}

50% {
  transform: rotate(-5deg)
}

to {
  transform: rotate(130deg)
}

}

@-webkit-keyframes right-spin-paper-spinner-0 {
0% {
  -webkit-transform: rotate(-130deg)
}

50% {
  -webkit-transform: rotate(5deg)
}

to {
  -webkit-transform: rotate(-130deg)
}

}

@keyframes right-spin-paper-spinner-0 {
0% {
  transform: rotate(-130deg)
}

50% {
  transform: rotate(5deg)
}

to {
  transform: rotate(-130deg)
}

}

.paper-spinner-0 #spinnerContainer.cooldown.paper-spinner {
  -webkit-animation: container-rotate-paper-spinner-0 1568ms linear infinite, fade-out-paper-spinner-0 400ms cubic-bezier(0.4, 0.0, 0.2, 1);
        animation: container-rotate-paper-spinner-0 1568ms linear infinite, fade-out-paper-spinner-0 400ms cubic-bezier(0.4, 0.0, 0.2, 1);
}

@-webkit-keyframes fade-out-paper-spinner-0 {
0% {
  opacity: 1
}

to {
  opacity: 0
}

}

@keyframes fade-out-paper-spinner-0 {
0% {
  opacity: 1
}

to {
  opacity: 0
}

}</style><!-- Shady DOM styles for paper-spinner-lite --><!-- Shady DOM styles for concept-card --><!-- Shady DOM styles for concept-mention --><style scope="concept-mention">.block.concept-mention {
  display: block;
}

[hidden].concept-mention {
  display: none !important;
}

.invisible.concept-mention {
  visibility: hidden !important;
}

.relative.concept-mention {
  position: relative;
}

.fit.concept-mention {
  position: absolute;
        top: 0;
        right: 0;
        bottom: 0;
        left: 0;
}

body.fullbleed.concept-mention {
  margin: 0;
        height: 100vh;
}

.scroll.concept-mention {
  -webkit-overflow-scrolling: touch;
        overflow: auto;
}

.fixed-bottom.concept-mention,.fixed-left.concept-mention,.fixed-right.concept-mention,.fixed-top.concept-mention {
  position: fixed;
}

.fixed-top.concept-mention {
  top: 0;
        left: 0;
        right: 0;
}

.fixed-right.concept-mention {
  top: 0;
        right: 0;
        bottom: 0;
}

.fixed-bottom.concept-mention {
  right: 0;
        bottom: 0;
        left: 0;
}

.fixed-left.concept-mention {
  top: 0;
        bottom: 0;
        left: 0;
}

#target.concept-mention:hover {
  background-color: #e8f0fe;
}

#target[noicon].concept-mention {
  padding: 1px;
}

#target.concept-mention:hover[noicon] {
  border: 1px solid #e8f0fe;
        padding: 0;
}

#target.concept-mention {
  display: inline-block;
}

.inline-icon.concept-mention {
  cursor: pointer;
        height: 12px;
        width: 12px;
        padding-left: 4px;
        color: #5e6368;
}

concept-card.concept-mention {
  z-index: 1;
        position: absolute;
}</style><!-- Shady DOM styles for fterm-concept-card --><!-- Shady DOM styles for fterm-concept-mention --><!-- Shady DOM styles for paper-fab --><!-- Shady DOM styles for paper-icon-button --><!-- Shady DOM styles for paper-icon-button-light --><!-- Shady DOM styles for classification-tree --><style scope="classification-tree">.layout.horizontal.classification-tree,.layout.vertical.classification-tree {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.classification-tree {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.classification-tree {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.classification-tree {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.classification-tree {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.classification-tree {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.classification-tree,.layout.center-center.classification-tree {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.classification-tree,.layout.center-center.classification-tree {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.classification-tree {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.classification-tree {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.classification-tree {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

classification-tree {
  display: block;
        line-height: 20px;
}

.wrap.classification-tree {
  padding: 6px 12px;
}

.wrap.classification-tree:hover {
  background: #fafafa;
}

.description.classification-tree {
  padding-left: 4px;
}

iron-icon.classification-tree {
  color: #eaeaea;
}

.code[first].classification-tree {
  font-weight: 500;
}

.code[additional].classification-tree {
  font-style: italic;
}</style><!-- Shady DOM styles for classification-viewer --><style scope="classification-viewer">.table.classification-viewer {
  border: 1px solid #eaeaea;
        display: block;
}

.more.classification-viewer {
  padding: 6px 12px;
        cursor: pointer;
        font-style: italic;
        color: #aaa;
}

.more.classification-viewer:hover {
  background: #fafafa;
}

.chip.classification-viewer {
  display: inline-block;
        padding: 4px 6px;
        border-radius: 2px;
}

.chip[additional].classification-viewer {
  font-style: italic;
}</style><!-- Shady DOM styles for image-carousel --><style scope="image-carousel">image-carousel {
  display: block;
}

.thumbnails.image-carousel {
  display: block;
        background-color: transparent;
        padding: 7px;
        white-space: nowrap;
        overflow: auto;
        font-size: 0;
}

.thumbnails.image-carousel img.image-carousel {
  margin-right: 7px;
        cursor: zoom-in;
}

.thumbnails.image-carousel img[selected].image-carousel {
  outline: solid 3px #4285f4;
}

.thumbnails.image-carousel img.image-carousel:last-of-type {
  margin-right: 0;
}</style><!-- Shady DOM styles for image-viewer --><!-- Shady DOM styles for patent-result --><style scope="patent-result">#wrapper.patent-result {
  padding: 20px;
        max-width: 1050px;
        outline: 0;
}

.scroll-target.patent-result:before {
  display: block;
        content: '';
        visibility: hidden;
}

h1.patent-result {
  font-weight: 500;
        font-size: 20px;
        margin: 0 0 20px 0;
}

h3.patent-result {
  font-size: 15px;
        font-weight: 500;
        margin: 28px 0 18px 0;
}

dl.patent-result {
  line-height: 1.5;
        font-size: 0;
}

dt.patent-result,dd.patent-result {
  display: inline;
        font-size: 13px;
        margin: 0;
}

dt.patent-result {
  font-weight: 500;
        color: #000;
}

dt.patent-result::after {
  content: ': ';
}

dd.patent-result {
  color: #aaa;
}

dd.patent-result ~ dd.patent-result::before {
  content: ', ';
}

dt.patent-result + dd.patent-result::before {
  content: '';
}

dd.patent-result ~ dt.patent-result::before {
  display: block;
        content: '';
        margin-top: 8px;
}

dd.patent-result core-icon.patent-result {
  width: 14px;
        height: 14px;
        vertical-align: top;
        color: inherit;
}

.table.patent-result {
  display: table;
        border-collapse: collapse;
        border-spacing: 0;
        border: 1px solid #eaeaea;
        width: 100%;
        box-sizing: border-box;
}

.tr.patent-result {
  display: table-row;
        border-bottom: 1px solid #eaeaea;
}

.th.patent-result,.td.patent-result {
  display: table-cell;
        padding: 10px 12px;
}

.thead.patent-result {
  display: table-header-group;
}

.tbody.patent-result {
  display: table-row-group;
}

.th.patent-result {
  text-align: left;
        white-space: nowrap;
        background-color: #fafafa;
        color: #757575;
}

.td.patent-result {
  vertical-align: top;
}

.td.patent-result > p.patent-result {
  margin-top: 0;
}

.nowrap.patent-result {
  white-space: nowrap;
}

.knowledge-card.patent-result {
  border: 1px solid #e5e5e5;
        border-radius: 2px;
}

.knowledge-card.patent-result > header.patent-result {
  -webkit-font-smoothing: antialiased;
        -moz-osx-font-smoothing: grayscale;
        background: #4285f4;
        color: #fff;
        padding: 20px 12px;
}

.knowledge-card.patent-result > header.patent-result state-modifier.patent-result,.knowledge-card.patent-result > header.patent-result a.patent-result {
  color: inherit;
        margin: 0 12px 0 0;
        display: inline-block;
}

.knowledge-card.patent-result > header.patent-result h2.patent-result,.knowledge-card.patent-result > header.patent-result .tagline.patent-result {
  margin: 0;
        font-weight: normal;
        padding-top: 4px;
}

.knowledge-card.patent-result > header.patent-result h2.patent-result {
  font-size: 20px;
}

.knowledge-card.patent-result .knowledge-card-action-bar.patent-result {
  background: #3367d6;
        padding: 10px 12px;
        margin: 20px -12px -20px;
}

.knowledge-card.patent-result .knowledge-card-action-bar.patent-result core-icon.patent-result {
  margin-right: 12px;
        width: 24px;
        height: 24px;
}

.knowledge-card.patent-result dl.patent-result {
  padding: 16px 12px;
}

.knowledge-card.patent-result hr.patent-result {
  border: none;
        height: 1px;
        background: #e5e5e5;
        margin: 0;
}

.main-link.patent-result {
  margin: 14px;
        font-weight: 500;
}

.footer.patent-result h3.patent-result state-modifier.patent-result,.footer.patent-result h3.patent-result a.patent-result {
  float: right;
        font-weight: 400;
        font-size: 13px;
        line-height: 24px;
}

.footer.patent-result dl.patent-result {
  margin-left: 30px;
}

.footer.patent-result > ul.patent-result > li.patent-result {
  margin-bottom: 8px;
}

h3.patent-result .righthead.patent-result {
  color: #aaa;
        font-weight: 400;
        font-size: 13px;
        cursor: help;
}

.tooltip-hint.patent-result {
  border-bottom: 1px dotted #ccc;
}

[marginRight].patent-result {
  margin-right: 60px;
}

.flex-width.patent-result {
  min-width: 0;
        word-break: break-word;
}

.responsive-table.patent-result {
  width: 100%;
        overflow-x: auto;
        overflow-y: hidden;
}

.layout.horizontal.patent-result,.layout.vertical.patent-result {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.patent-result {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.patent-result {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.patent-result {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.patent-result {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.patent-result {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.patent-result,.layout.center-center.patent-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.patent-result,.layout.center-center.patent-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.patent-result {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.patent-result {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.patent-result {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.patent-result {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.patent-result,.layout.center-center.patent-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.patent-result {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.patent-result {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.patent-result {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.patent-result,.layout.center-center.patent-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.patent-result {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.patent-result {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.patent-result {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.patent-result {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.patent-result {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.patent-result {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.patent-result {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.patent-result {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.patent-result {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.patent-result {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.patent-result {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.patent-result {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.patent-result {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

.flex.patent-result,.flex-1.patent-result {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-2.patent-result {
  -ms-flex: 2;
        -webkit-flex: 2;
        flex: 2;
}

.flex-3.patent-result {
  -ms-flex: 3;
        -webkit-flex: 3;
        flex: 3;
}

.flex-4.patent-result {
  -ms-flex: 4;
        -webkit-flex: 4;
        flex: 4;
}

.flex-5.patent-result {
  -ms-flex: 5;
        -webkit-flex: 5;
        flex: 5;
}

.flex-6.patent-result {
  -ms-flex: 6;
        -webkit-flex: 6;
        flex: 6;
}

.flex-7.patent-result {
  -ms-flex: 7;
        -webkit-flex: 7;
        flex: 7;
}

.flex-8.patent-result {
  -ms-flex: 8;
        -webkit-flex: 8;
        flex: 8;
}

.flex-9.patent-result {
  -ms-flex: 9;
        -webkit-flex: 9;
        flex: 9;
}

.flex-10.patent-result {
  -ms-flex: 10;
        -webkit-flex: 10;
        flex: 10;
}

.flex-11.patent-result {
  -ms-flex: 11;
        -webkit-flex: 11;
        flex: 11;
}

.flex-12.patent-result {
  -ms-flex: 12;
        -webkit-flex: 12;
        flex: 12;
}

@media print {
#text.patent-result {
  flex-direction: column-reverse !important;
}

}

patent-result-ref-list.patent-result {
  width: 100%;
}

patent-result-ref-list.patent-result + patent-result-ref-list.patent-result {
  margin-left: 10px;
}

[narrow].patent-result {
  flex-direction: column-reverse !important;
}

.famheader.patent-result {
  text-align: left;
        white-space: nowrap;
        background-color: #fafafa;
        color: #757575;
}

.collapse.patent-result {
  color: #616161;
        font-size: 13px;
        cursor: pointer;
}

#imageDrag.patent-result {
  position: fixed;
        cursor: col-resize;
}

#imageDrag.patent-result div.patent-result {
  width: 4px;
        height: 100%;
        margin: 0 4px;
        background: #eee;
}

#imageDrag.patent-result:hover {
  background: #eee;
}

#imageDrag.patent-result:hover div.patent-result {
  background: #ccc;
}

.imageWrapper.patent-result {
  position: fixed;
        top: 60px;
        background: white;
        margin-left: 12px;
}

#notices.patent-result {
  padding: 20px;
}

#figures.patent-result {
  background: #efefef;
}

.headerButton.patent-result {
  color: #3c80f6;
        cursor: pointer;
        display: inline-block;
        padding: 0 14px;
        line-height: 27px;
}

.headerButton.patent-result iron-icon.patent-result {
  width: 16px;
        height: 16px;
}

.tr.conceptDomain.patent-result {
  display: table-row;
}

.responsive-grid.patent-result {
  display: grid;
        gap: 8px;
        grid-template-columns: none;
}</style><!-- Shady DOM styles for family-viewer --><!-- Shady DOM styles for app-row --><!-- Shady DOM styles for application-timeline --><style scope="application-timeline">.layout.horizontal.application-timeline,.layout.vertical.application-timeline {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.application-timeline {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.application-timeline {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.application-timeline {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.application-timeline {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.application-timeline {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.application-timeline,.layout.center-center.application-timeline {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.application-timeline,.layout.center-center.application-timeline {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.application-timeline {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.application-timeline {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.application-timeline {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.wrap.application-timeline {
  padding: 16px 12px;
}

.event.application-timeline {
  padding: 3px 0;
}

[date].application-timeline {
  color: #5f6368;
        font-size: 13px;
        padding: 3px 0;
        width: 70px;
        line-height: 16px;
}

[critical].application-timeline [date].application-timeline {
  color: #202124;
        font-weight: 500;
        line-height: 18px;
}

.line.application-timeline {
  margin: 9px 6px;
        border-radius: 4px;
        background: #dadce0;
        width: 4px;
        height: 4px;
}

.dot.application-timeline {
  margin: 3px 0;
        border-radius: 4px;
        background: #dadce0;
        width: 4px;
        height: 4px;
        display: inline-block;
}

[critical].application-timeline .line.application-timeline {
  background: #4285f4;
}

[current].application-timeline .line.application-timeline {
  background: #81c995;
}

[current][critical].application-timeline .line.application-timeline {
  background: #81c995;
}

.title.application-timeline {
  font-size: 13px;
        padding: 3px 0;
        line-height: 16px;
}

.title-text.application-timeline {
  color: #5f6368;
}

.description-item.application-timeline {
  font-size: 12px;
        padding: 6px 0;
        max-width: 300px;
}

#legal.application-timeline {
  height: 14px;
        width: 14px;
        padding: 0 3px 1px 3px;
        vertical-align: text-bottom;
}

#icon.application-timeline {
  height: 12px;
        width: 12px;
        padding: 0 3px 3px 3px;
        vertical-align: text-bottom;
}

.unknown.application-timeline {
  font-style: italic;
}

.not_active.application-timeline {
  text-decoration: line-through;
}

.active.application-timeline {
  font-weight: 500;
}

#cc[this].application-timeline {
  color: #202124 !important;
        text-decoration: underline;
}

#cc[this].not_active.application-timeline {
  text-decoration: line-through underline;
}

hr.application-timeline {
  border: none;
        height: 1px;
        background: #e5e5e5;
        margin: 10px 0 16px 0;
}

.header.application-timeline {
  font-size: 13px;
        line-height: 20px;
        font-weight: 500;
        color: #202124;
        padding-bottom: 8px;
}

.block.application-timeline {
  padding: 0 6px 0 0;
}

.year.application-timeline {
  color: #5f6368;
        font-size: 13px;
        font-weight: 500;
        padding: 3px 1px;
        width: 70px;
}

.expand.application-timeline {
  cursor: pointer;
        padding: 6px 0 3px 0;
}</style><!-- Shady DOM styles for patent-text --><style scope="patent-text">.layout.horizontal.patent-text,.layout.vertical.patent-text {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.patent-text {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.patent-text {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.patent-text {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.patent-text {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.patent-text {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.patent-text,.layout.center-center.patent-text {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.patent-text,.layout.center-center.patent-text {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.patent-text {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.patent-text {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.patent-text {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.patent-text {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.patent-text,.layout.center-center.patent-text {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.patent-text {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.patent-text {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.patent-text {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.patent-text,.layout.center-center.patent-text {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.patent-text {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.patent-text {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.patent-text {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.patent-text {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.patent-text {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.patent-text {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.patent-text {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.patent-text {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.patent-text {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.patent-text {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.patent-text {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.patent-text {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.patent-text {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

patent-text {
  display: block;
}

#text.patent-text {
  line-height: 20px;
        min-width: 0;
}

#margin.patent-text {
  width: 16px;
}

#createHighlight.patent-text {
  position: relative;
        width: 16px;
        height: 16px;
        cursor: pointer;
}

.notranslate.patent-text > .google-src-text.patent-text {
  display: none;
}

.notranslate.patent-text:hover,mark.patent-text {
  background-color: #fbfcae;
}

.description-paragraph.patent-text {
  margin-block-start: 1em;
        margin-block-end: 1em;
}

.claim-text.patent-text {
  margin: 14px 0 0 20px;
}

.claim-dependent.patent-text {
  margin-left: 40px;
        color: #888;
}

[hide-claims].patent-text .claim-dependent.patent-text .claim-text.patent-text {
  height: 0;
        width: 0;
        visibility: hidden;
}

[hide-claims].patent-text .claim-dependent.patent-text .claim.patent-text:after {
  content: "…"
}

.patent-full-image.patent-text {
  max-width: 100%;
        height: auto;
}

.small-patent-image.patent-text {
  display: inline;
}

ul.patent-text {
  padding: 0 0 0 50px;
}

li.patent-text {
  list-style-type: none;
        position: relative;
}

ol.claims.patent-text li.patent-text {
  list-style-type: decimal;
        font-weight: bold;
}

ol.claims.patent-text li.patent-text > *.patent-text {
  font-weight: normal;
}

li.patent-text > para-num.patent-text {
  position: absolute;
        left: -45px;
        color: #888;
}

mark.patent-text {
  background: #fff59d;
}

mark.searchText.patent-text {
  background: #80deea;
}

.searchTextHeader.patent-text {
  font-weight: 500;
}

pre.patent-text {
  white-space: pre-wrap;
}

heading.patent-text {
  display: block;
        font-weight: 500;
        font-size: 13px;
}

#comment.patent-text {
  width: 16px;
        height: 16px;
}

[has-search][no-results].patent-text {
  display: none;
}

.highlight.patent-text {
  background-color: #fef7e0;
}</style><!-- Shady DOM styles for para-num --><!-- Shady DOM styles for result-container --><style scope="result-container">paper-spinner.result-container {
  position: absolute;
        
        top: calc(50%  + 56px - 16px);
        left: calc(50% + 175px - 16px);
}</style><!-- Shady DOM styles for scholar-result --><!-- Shady DOM styles for search-result --><style scope="search-result">.layout.horizontal.search-result,.layout.vertical.search-result {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-result {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-result {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-result {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-result {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-result {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-result,.layout.center-center.search-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-result,.layout.center-center.search-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-result {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-result {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-result {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.search-result {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.search-result,.layout.center-center.search-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.search-result {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.search-result {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.search-result {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.search-result,.layout.center-center.search-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.search-result {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.search-result {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.search-result {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.search-result {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.search-result {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.search-result {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.search-result {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.search-result {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.search-result {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.search-result {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.search-result {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.search-result {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.search-result {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

search-result {
  display: block;
        font-size: 13px;
}

#mainContainer.search-result {
  min-height: calc(100vh - 127px);
        color: #333;
}

#compactQuery.search-result {
  padding: 18px 20px 10px 20px;
        cursor: pointer;
}

#compactQuery.search-result > span.search-result {
  padding: 0 14px 0 0;
}

#compactQuery.search-result iron-icon.search-result {
  padding-right: 6px;
        height: 16px;
        width: 16px;
}</style><!-- Shady DOM styles for webdoc-result --><!-- Shady DOM styles for iron-pages --><!-- Shady DOM styles for paper-tab --><!-- Shady DOM styles for paper-tabs --><!-- Shady DOM styles for debug-info --><!-- Shady DOM styles for search-paging --><!-- Shady DOM styles for search-result-item --><!-- Shady DOM styles for search-result-image --><!-- Shady DOM styles for search-result-entities --><!-- Shady DOM styles for search-result-measures --><!-- Shady DOM styles for search-results --><!-- Shady DOM styles for summary-box --><!-- Shady DOM styles for timeline-page --><!-- Shady DOM styles for iron-localstorage --><!-- Shady DOM styles for search-app --><style scope="search-app">search-app {
  display: block;
        height: 100%;
}

#toast.search-app {
  min-height: 64px;
        min-width: 742px;
}</style><style>body {transition: opacity ease-in 0.2s; } 
body[unresolved] {opacity: 0; display: block; overflow: hidden; position: relative; } 
</style>
    <title>JP2004508052A - 
  Test system for identifying and characterizing compounds and uses thereof
 
      - Google Patents</title>

    <meta name="viewport" content="width=device-width, initial-scale=1">
    <meta charset="UTF-8">
    <meta name="referrer" content="origin-when-crossorigin">
    <link rel="canonical" href="https://patents.google.com/patent/JP2004508052A/en">
    <meta name="description" content="
   
    The present invention relates to test systems based on transmembrane receptors from helminths and arthropods, for identifying and characterizing substances that act on helminths, arthropods or have an effect on calcium metabolism in organisms and / or cells. Regarding its use. The invention further relates to the use of specific ligands in the present test system, and their use as anthelmintics or arthropodidic actives.
   
 
   ">
    <meta name="DC.type" content="patent">
    <meta name="DC.title" content="
  Test system for identifying and characterizing compounds and uses thereof
 
     ">
    <meta name="DC.date" content="2001-08-24" scheme="dateSubmitted">
    <meta name="DC.description" content="
   
    The present invention relates to test systems based on transmembrane receptors from helminths and arthropods, for identifying and characterizing substances that act on helminths, arthropods or have an effect on calcium metabolism in organisms and / or cells. Regarding its use. The invention further relates to the use of specific ligands in the present test system, and their use as anthelmintics or arthropodidic actives.
   
 
   ">
    <meta name="citation_patent_application_number" content="JP:2002525836A">
    <meta name="citation_pdf_url" content="https://patentimages.storage.googleapis.com/ff/34/e0/248773ea2fc764/JP2004508052A.pdf">
    <meta name="citation_patent_publication_number" content="JP:2004508052:A">
    <meta name="DC.date" content="2004-03-18">
    <meta name="DC.contributor" content="ゲオルク・フォン・ザムゾン−ヒンメルシュトイェルナ" scheme="inventor">
    <meta name="DC.contributor" content="アヒム・ハルダー" scheme="inventor">
    <meta name="DC.contributor" content="フランク・ヴンダーリヒ" scheme="inventor">
    <meta name="DC.contributor" content="ハンス−ペーター・シュミット−ヴレデ" scheme="inventor">
    <meta name="DC.contributor" content="ベアテ・ゼーガー" scheme="inventor">
    <meta name="DC.contributor" content="Bayer AG" scheme="assignee">
    <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto:400,400italic,500,500italic,700">
    <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Product+Sans">
    <link rel="stylesheet" href="https://fonts.googleapis.com/css2?family=Google+Sans:wght@400;500;700">

    <style>
      body { transition: none; }
    </style>

    <script src="https://apis.google.com/_/scs/abc-static/_/js/k=gapi.lb.en.IKZeRvoAYNY.O/m=client/rt=j/sv=1/d=1/ed=1/am=AAAQ/rs=AHpOoo-SMWTzMRJrTty6iE5dL_aWGYOnuw/cb=gapi.loaded_0?le=scs" async=""></script><script>
      window.version = 'patent-search.search_20240531_RC00';

      function sendFeedback() {
        userfeedback.api.startFeedback({
          'productId': '713680',
          'bucket': 'patent-search-web',
          'productVersion': window.version,
        });
      }

      window.experiments = {};
      window.experiments.patentCountries = "ae,ag,al,am,ao,ap,ar,at,au,aw,az,ba,bb,bd,be,bf,bg,bh,bj,bn,bo,br,bw,bx,by,bz,ca,cf,cg,ch,ci,cl,cm,cn,co,cr,cs,cu,cy,cz,dd,de,dj,dk,dm,do,dz,ea,ec,ee,eg,em,ep,es,fi,fr,ga,gb,gc,gd,ge,gh,gm,gn,gq,gr,gt,gw,hk,hn,hr,hu,ib,id,ie,il,in,ir,is,it,jo,jp,ke,kg,kh,km,kn,kp,kr,kw,kz,la,lc,li,lk,lr,ls,lt,lu,lv,ly,ma,mc,md,me,mg,mk,ml,mn,mo,mr,mt,mw,mx,my,mz,na,ne,ng,ni,nl,no,nz,oa,om,pa,pe,pg,ph,pl,pt,py,qa,ro,rs,ru,rw,sa,sc,sd,se,sg,si,sk,sl,sm,sn,st,su,sv,sy,sz,td,tg,th,tj,tm,tn,tr,tt,tw,tz,ua,ug,us,uy,uz,vc,ve,vn,wo,yu,za,zm,zw";
      
      
      window.experiments.keywordWizard = true;
      
      
      
      window.experiments.definitions = true;

      window.Polymer = {
        dom: 'shady',
        lazyRegister: true,
      };
    </script>

    <script src="//www.gstatic.com/patent-search/frontend/patent-search.search_20240531_RC00/scs/compiled_dir/webcomponentsjs/webcomponents-lite.min.js"></script>
    <style>[hidden]:not([style-scope]):not(.style-scope) {
  display: none !important;
}

</style><style></style><style></style><style></style><style></style><link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto:400,300,300italic,400italic,500,500italic,700,700italic"><link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto+Mono:400,700"><style></style><style></style><style>
  html, body {
    min-width: 100%;
    width: 100%;
    min-height: 100%;
    height: 100%;
  }

  body {
    background-color: #fff;
    font-family: 'Roboto', sans-serif;
    color: #333;
    margin: 0;
    padding: 0;
    /*
     * Turn off https://github.com/WICG/ScrollAnchoring/blob/master/explainer.md
     * https://memegen.googleplex.com/5230756293246976
     */
    overflow-anchor: none;
  }

  body h1, body h2, body h3 {
    -webkit-font-smoothing: antialiased;
    -moz-osx-font-smoothing: grayscale;
  }

  body a:link {
    color: #3c80f6;
    text-decoration: none;
  }

  body a:visited {
    color: #3c80f6;
  }

  body a[open-result]:visited {
    color: #7e57c2;
  }

  /* For Firefox */
  a:link {
    color: #3c80f6;
    text-decoration: none;
  }

  a:visited {
    color: #3c80f6;
  }

  a[open-result]:visited {
    color: #7e57c2;
  }

  ::selection , body ::selection {
    background-color: #c6dafc;
    color: #333;
  }
</style><link rel="import" href="//www.gstatic.com/patent-search/frontend/patent-search.search_20240531_RC00/scs/compiled_dir/search-app-vulcanized.html">
  <style>[hidden] { display: none !important; }</style><script type="text/javascript" charset="UTF-8" src="https://apis.google.com/js/client.js" gapi_processed="true"></script></head>
  <body>
    <script src="//www.gstatic.com/patent-search/frontend/patent-search.search_20240531_RC00/scs/compiled_dir/search-app-vulcanized.js"></script><span style="font-size: 13px; white-space: pre-wrap; display: inline-block; position: absolute; left: -99999px; top: -99999px; max-width: 217px;"></span><span style="font-size: 13px; white-space: pre-wrap; display: inline-block; position: absolute; left: -99999px; top: -99999px; max-width: 217px;"></span>
    <search-app>
    
    <remote-fetch class="style-scope search-app"></remote-fetch>
    <search-state class="style-scope search-app"></search-state>
    <browser-ui class="style-scope search-app"></browser-ui>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    
      <search-result id="result" class="style-scope search-app">
    
    
    <search-ui mode="result" class="style-scope search-result x-scope search-ui-0">
    
    
    
    <div id="content" class="style-scope search-ui" wide="">
      <search-header show-search="" class="style-scope search-ui">
    
    
    <div class="style-scope search-header" wide="">
      <header class="style-scope search-header">
        <div class="layout horizontal headerpad style-scope search-header">
          <div class="layout horizontal leftheader style-scope search-header">
            <h1 class="style-scope search-header">
              <state-modifier inherit="" act="{&quot;type&quot;: &quot;HOME&quot;}" class="style-scope search-header"><a id="link" href="#" class="style-scope state-modifier" inherit="">
                <div class="lockup style-scope search-header">
                  <span class="lockup-logo style-scope search-header"></span>
                  <span class="lockup-text style-scope search-header">
                    <span class="lockup-brand style-scope search-header">&nbsp;Patents</span>
                  </span>
                </div>
              </a></state-modifier>
            </h1>
          </div>
          
            <search-box class="style-scope search-header">
    
    <div class="layout horizontal style-scope search-box" style="position: relative;">
      <div class="inputbox flex layout horizontal style-scope search-box">
        <div class="suggest-bg flex style-scope search-box">
          <input name="q" id="searchInput" data-proto="SEARCH_INPUT" autocomplete="off" class="style-scope search-box">
        </div>
        <div id="corpora" class="style-scope search-box">
          <iron-icon icon="icons:lightbulb-outline" id="patentIcon" class="style-scope search-box x-scope iron-icon-0" active=""><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M9 21c0 .55.45 1 1 1h4c.55 0 1-.45 1-1v-1H9v1zm3-19C8.14 2 5 5.14 5 9c0 2.38 1.19 4.47 3 5.74V17c0 .55.45 1 1 1h6c.55 0 1-.45 1-1v-2.26c1.81-1.27 3-3.36 3-5.74 0-3.86-3.14-7-7-7zm2.85 11.1l-.85.6V16h-4v-2.3l-.85-.6C7.8 12.16 7 10.63 7 9c0-2.76 2.24-5 5-5s5 2.24 5 5c0 1.63-.8 3.16-2.15 4.1z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
          <overlay-tooltip positioning-target="#patentIcon" direction="bottom" class="style-scope search-box" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Include patents
    </div>
  </overlay-tooltip>
          <iron-icon icon="social:school" id="nplIcon" class="style-scope search-box x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M5 13.18v4L12 21l7-3.82v-4L12 17l-7-3.82zM12 3L1 9l11 6 9-4.91V17h2V9L12 3z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
          <overlay-tooltip positioning-target="#nplIcon" direction="bottom" class="style-scope search-box" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Include non-patent literature
    </div>
  </overlay-tooltip>
          <keyword-wizard id="wizardIcon" class="style-scope search-box">


<div id="wizardContainer" class="style-scope keyword-wizard">
  <iron-icon icon="image:tune" id="wizardIcon" class="style-scope keyword-wizard x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M3 17v2h6v-2H3zM3 5v2h10V5H3zm10 16v-2h8v-2h-8v-2h-2v6h2zM7 9v2H3v2h4v2h2V9H7zm14 4v-2H11v2h10zm-6-4h2V7h4V5h-4V3h-2v6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
  <paper-material elevation="2" id="wizard" class="style-scope keyword-wizard x-scope paper-material-0" hidden="">
    
    

    
    
    <div class="search-within style-scope keyword-wizard">
      <span class="wizard-header style-scope keyword-wizard">
        Search within
        <iron-icon icon="icons:help-outline" class="help-header style-scope keyword-wizard x-scope iron-icon-0" id="within"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </span>
      
      <div class="help style-scope keyword-wizard" id="withinHelp" hidden="">
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Search within the title, abstract, claims, or full patent document</b>: You can
          restrict your search to a specific field using field names.</p>
        <p class="style-scope keyword-wizard">Use <span class="q style-scope keyword-wizard">TI=</span> to search in the title, <span class="q style-scope keyword-wizard">AB=</span> for the
          abstract, <span class="q style-scope keyword-wizard">CL=</span> for the claims, or <span class="q style-scope keyword-wizard">TAC=</span> for
          all three. For example, <span class="q style-scope keyword-wizard">TI=(safety belt)</span>.
        </p>
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Search by Cooperative Patent Classifications (CPCs)</b>: These are commonly used to
          represent ideas in place of keywords, and can also be entered in a search term box. If
          you're searching for<span class="q style-scope keyword-wizard">seat belts</span>, you could also search for
          <span class="q style-scope keyword-wizard">B60R22/00</span> to retrieve documents that mention safety belts or body
          harnesses. <span class="q style-scope keyword-wizard">CPC=B60R22</span> will match documents with exactly this CPC,
          <span class="q style-scope keyword-wizard">CPC=B60R22/low</span> matches documents with this CPC or a child
          classification of this CPC.
        </p>
          <a href="https://support.google.com/faqs/answer/7049475" target="_blank" class="style-scope keyword-wizard">Learn More</a>
      </div>
      <div class="filter-chips style-scope keyword-wizard">
        <span class="chip style-scope keyword-wizard" id="title" selected="">Title</span>
        <span class="chip style-scope keyword-wizard" id="abstract" selected="">Abstract</span>
        <span class="chip style-scope keyword-wizard" id="claims" selected="">Claims</span>
        <span class="chip style-scope keyword-wizard" id="fullDoc" selected="">Full Document</span>
      </div>
      
      <div class="cpc-field style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputCPC" class="style-scope keyword-wizard">or CPC</label></span>
        <div class="cpc-inputs style-scope keyword-wizard">
          <input class="keyword-input style-scope keyword-wizard" id="inputCPC" placeholder="Or search with CPC">
          <input type="checkbox" id="childCPC" checked="" class="style-scope keyword-wizard">
          <label class="checkbox-label style-scope keyword-wizard" for="childCPC">
            Include child classifications
          </label>
        </div>
      </div>
    </div>
    
    <div class="find-patents style-scope keyword-wizard">
      <span class="wizard-header style-scope keyword-wizard">
        Find patents
        <iron-icon class="help-header style-scope keyword-wizard x-scope iron-icon-0" icon="icons:help-outline" id="searchBoolean"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </span>
      
      <div class="help style-scope keyword-wizard" id="searchBooleanHelp" hidden="">
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Keywords and boolean syntax (USPTO or EPO format)</b>:
          <span class="q style-scope keyword-wizard">seat belt</span> searches these two words, or their plurals and close
          synonyms. <span class="q style-scope keyword-wizard">"seat belt"</span> searches this exact phrase, in order.
          <span class="q style-scope keyword-wizard">-seat -belt</span> searches for documents not containing either word.
        </p>
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">For searches using boolean logic</b>, the default operator is
          <span class="q style-scope keyword-wizard">AND</span> with left associativity. <i class="style-scope keyword-wizard">Note:</i> this means
          <span class="q style-scope keyword-wizard">safety OR seat belt</span> is searched as <span class="q style-scope keyword-wizard">(safety OR seat)
          AND belt</span>. Each word automatically includes plurals and close synonyms. Adjacent
          words that are implicitly ANDed together, such as <span class="q style-scope keyword-wizard">(safety belt)</span>,
          are treated as a phrase when generating synonyms.
        </p>
        <a href="https://support.google.com/faqs/answer/7049475" target="_blank" class="style-scope keyword-wizard">Learn More</a>
      </div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputAnd" class="style-scope keyword-wizard">with ALL of the words</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputAnd" placeholder="with ALL of the words">
      </div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputExact" class="style-scope keyword-wizard">with the EXACT PHRASE</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputExact" placeholder="with the EXACT PHRASE"></div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputOr" class="style-scope keyword-wizard">with AT LEAST ONE of the words</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputOr" placeholder="with AT LEAST ONE of the words"></div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputMinus" class="style-scope keyword-wizard">WITHOUT the words</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputMinus" placeholder="WITHOUT the words"></div>
    </div>
    <div class="search-by style-scope keyword-wizard">
      <div class="wizard-header style-scope keyword-wizard">
          Search by
          <iron-icon icon="icons:help-outline" class="help-header style-scope keyword-wizard x-scope iron-icon-0" id="chem"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </div>
      
      <div class="help style-scope keyword-wizard" id="chemHelp" hidden="">
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Chemistry searches</b> match terms (trade names, IUPAC names, etc.
          extracted from the entire document, and processed from .MOL files.)
        </p>
        <p class="style-scope keyword-wizard">Substructure (use <span class="q style-scope keyword-wizard">SSS=</span>) and similarity (use
          <span class="q style-scope keyword-wizard">~</span>) searches are limited to one per search at the top-level
          <span class="q style-scope keyword-wizard">AND</span> condition. Exact searches can be used multiple times throughout
          the search query.
        </p>
        <p class="style-scope keyword-wizard">Searching by SMILES or InChi key requires no special syntax. To search by SMARTS, use
          <span class="q style-scope keyword-wizard">SMARTS=</span>.
        </p>
        <p class="style-scope keyword-wizard">To search for multiple molecules, select "Batch" in the "Type" menu. Enter multiple
          molecules separated by whitespace or by comma.
        </p>
        <a href="https://support.google.com/faqs/answer/7049475" target="_blank" class="style-scope keyword-wizard">Learn More</a>
      </div>
      
      <div class="chemistry-field style-scope keyword-wizard">
          <span class="input-label style-scope keyword-wizard"><label for="inputChem" class="style-scope keyword-wizard">Chemistry</label></span>
          <span class="chem-type-label style-scope keyword-wizard"><label for="chemType" hidden="" class="style-scope keyword-wizard">Type</label></span>
          <select id="chemType" class="style-scope keyword-wizard">
            <option value="identical" class="style-scope keyword-wizard">Identical</option>
            <option value="substructure" class="style-scope keyword-wizard">Substructure</option>
            <option value="smarts" class="style-scope keyword-wizard">SMARTS</option>
            <option value="similarity" class="style-scope keyword-wizard">Similarity</option>
            <option value="batch" class="style-scope keyword-wizard">Batch</option>
          </select>
          <textarea class="keyword-input style-scope keyword-wizard" id="inputChem" placeholder="Trade name, SMILES, InChiKey"></textarea>
      </div>
      <div class="import style-scope keyword-wizard">
        <div class="wizard-header style-scope keyword-wizard">
          Patent numbers
        </div>
        <span class="import-button style-scope keyword-wizard">
          <a href="https://patents.google.com/import" class="style-scope keyword-wizard"><button class="style-scope keyword-wizard">Import</button></a>
        </span>
        <p class="import-text style-scope keyword-wizard">
          Search specific patents by importing a CSV or list of patent publication or application numbers.
        </p>
      </div>
    </div>
    
    <div class="wizard-buttons style-scope keyword-wizard">
      <button type="reset" class="style-scope keyword-wizard">Close</button>
      <button type="button" autofocus="" class="style-scope keyword-wizard">Add</button>
    </div>
  
  </paper-material>
</div>
</keyword-wizard>
          <overlay-tooltip positioning-target="#wizardIcon" direction="bottom" class="style-scope search-box" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Display advanced search options
    </div>
  </overlay-tooltip>
        </div>
      </div>
      <paper-material id="suggestMenu" class="style-scope search-box x-scope paper-material-0" elevation="1" hidden="">
    
    

    
        <template is="dom-repeat" class="style-scope search-box"></template>
        <div class="row style-scope search-box" hidden="">
          <iron-icon class="suggest-icon style-scope search-box x-scope iron-icon-0" icon="error"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M12 2C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm1 15h-2v-2h2v2zm0-4h-2V7h2v6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Sorry, we couldn't find this patent number.
        </div>
        <div class="row style-scope search-box" hidden="">
          <iron-icon class="suggest-icon style-scope search-box x-scope iron-icon-0" icon="error"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M12 2C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm1 15h-2v-2h2v2zm0-4h-2V7h2v6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> 
        </div>
      
  </paper-material>
      <button id="searchButton" class="style-scope search-box"><iron-icon class="style-scope search-box x-scope iron-icon-0" icon="search"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M15.5 14h-.79l-.28-.27C15.41 12.59 16 11.11 16 9.5 16 5.91 13.09 3 9.5 3S3 5.91 3 9.5 5.91 16 9.5 16c1.61 0 3.09-.59 4.23-1.57l.27.28v.79l5 4.99L20.49 19l-4.99-5zm-6 0C7.01 14 5 11.99 5 9.5S7.01 5 9.5 5 14 7.01 14 9.5 11.99 14 9.5 14z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></button>
    </div>
  </search-box>
          <template is="dom-if" class="style-scope search-header"></template>
          <div class="flex style-scope search-header"></div>
          
            <div id="header-container" class="style-scope search-header">
              <result-nav class="style-scope search-header">
    
    <div class="style-scope result-nav" hidden="">
      <state-modifier id="current" act="{&quot;type&quot;: &quot;BACK_TO_RESULTS&quot;}" inherit="" class="style-scope result-nav"><a id="link" href="#" class="style-scope state-modifier" inherit=""><span class="style-scope result-nav"></span> of
      <template is="dom-if" class="style-scope result-nav"></template>
      0<template is="dom-if" class="style-scope result-nav"></template></a></state-modifier>
      <state-modifier id="prevResult" inherit="" act="{&quot;type&quot;: &quot;NAV_RESULT&quot;, &quot;result&quot;: &quot;$id&quot;, &quot;page&quot;: $page}" class="style-scope result-nav" disabled=""><a id="link" href="#" class="style-scope state-modifier" inherit="">
        <iron-icon icon="chevron-left" class="style-scope result-nav x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M15.41 7.41L14 6l-6 6 6 6 1.41-1.41L10.83 12z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </a></state-modifier><state-modifier id="nextResult" inherit="" act="{&quot;type&quot;: &quot;NAV_RESULT&quot;, &quot;result&quot;: &quot;$id&quot;, &quot;page&quot;: $page}" class="style-scope result-nav" disabled=""><a id="link" href="#" class="style-scope state-modifier" inherit="">
        <iron-icon icon="chevron-right" class="style-scope result-nav x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M10 6L8.59 7.41 13.17 12l-4.58 4.59L10 18l6-6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </a></state-modifier>
      <overlay-tooltip positioning-target="#prevResult" direction="bottom" arrow="" class="style-scope result-nav" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip"></div>
    <div class="style-scope overlay-tooltip">
      Previous result
    </div>
  </overlay-tooltip>
      <overlay-tooltip positioning-target="#nextResult" direction="bottom" arrow="" class="style-scope result-nav" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip"></div>
    <div class="style-scope overlay-tooltip">
      Next result
    </div>
  </overlay-tooltip>
    </div>
  </result-nav>
            </div>
          <template is="dom-if" class="style-scope search-header"></template>
        </div>
      </header>
    </div>
  </search-header>

      <div class="layout horizontal style-scope search-ui">
        <template is="dom-if" class="style-scope search-ui"></template>

        <div id="main" class="style-scope search-ui">
          <search-term-wizard class="style-scope search-ui"><pat-dialog open="" class="style-scope search-term-wizard">
  <span class="header style-scope search-term-wizard">
    <span class="title style-scope search-term-wizard">Search tools</span>
    <span id="language" class="style-scope search-term-wizard">
      <text-button id="textButton" selected="" class="style-scope search-term-wizard">Text
</text-button>
      <text-button id="classificationButton" class="style-scope search-term-wizard">Classification
</text-button>
      <text-button id="chemistryButton" class="style-scope search-term-wizard">Chemistry
</text-button>
      <text-button id="measureButton" class="style-scope search-term-wizard">Measure
</text-button>
      <text-button id="numbersButton" class="style-scope search-term-wizard">Numbers
</text-button>
    </span>
  </span>
  <span id="panels" class="style-scope search-term-wizard">
    <text-search-term-wizard id="textPanel" class="style-scope search-term-wizard" selected=""><span class="style-scope text-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope text-search-term-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope text-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="textField" placeholder="Type a concept you want to search for here" class="style-scope text-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Type a concept you want to search for here">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope text-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope text-search-term-wizard">
    <path d="M8 18.025h8v-2.1H8Zm0-4h8v-2.1H8ZM6.075 22.2q-.95 0-1.612-.662-.663-.663-.663-1.613V4.075q0-.95.663-1.613.662-.662 1.612-.662h8L20.2 7.925v12q0 .95-.662 1.613-.663.662-1.613.662Zm6.85-13.125v-5h-6.85v15.85h11.85V9.075Zm-6.85-5v5-5 15.85-15.85Z" class="style-scope text-search-term-wizard"></path>
  </svg>
  <filter-chip id="fullDocuments" selected="" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Full documents</filter-chip>
  <filter-chip id="title" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Title</filter-chip>
  <filter-chip id="abstract" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Abstract</filter-chip>
  <filter-chip id="claims" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Claims</filter-chip>
</span>
<span class="style-scope text-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope text-search-term-wizard">
    <path d="M16 16.925q2.05 0 3.488-1.437Q20.925 14.05 20.925 12t-1.437-3.488Q18.05 7.075 16 7.075q-.625 0-1.2.15t-1.075.425q.7.925 1.087 2.025.388 1.1.388 2.325t-.388 2.325q-.387 1.1-1.087 2.025.5.275 1.075.425.575.15 1.2.15Zm-4-2.075q.45-.575.688-1.313.237-.737.237-1.537 0-.8-.237-1.538Q12.45 9.725 12 9.15q-.45.575-.688 1.312-.237.738-.237 1.538t.237 1.537q.238.738.688 1.313Zm-4 2.075q.625 0 1.2-.15t1.075-.425q-.7-.925-1.087-2.025Q8.8 13.225 8.8 12t.388-2.325q.387-1.1 1.087-2.025-.5-.275-1.075-.425-.575-.15-1.2-.15-2.05 0-3.487 1.437Q3.075 9.95 3.075 12t1.438 3.488Q5.95 16.925 8 16.925ZM8 19.2q-3 0-5.1-2.1Q.8 15 .8 12q0-3 2.1-5.1Q5 4.8 8 4.8q1.125 0 2.137.312 1.013.313 1.863.913.85-.6 1.863-.913Q14.875 4.8 16 4.8q3 0 5.1 2.1Q23.2 9 23.2 12q0 3-2.1 5.1-2.1 2.1-5.1 2.1-1.125 0-2.137-.313-1.013-.312-1.863-.912-.85.6-1.863.912Q9.125 19.2 8 19.2Z" class="style-scope text-search-term-wizard"></path>
  </svg>
  <filter-chip id="all" selected="" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
All</filter-chip>
  <filter-chip id="any" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Any</filter-chip>
  <filter-chip id="exact" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Exact</filter-chip>
  <filter-chip id="not" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Not</filter-chip>
</span>
<span class="style-scope text-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope text-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope text-search-term-wizard">Add AND condition</span></mat-button></span></text-search-term-wizard>
    <classification-wizard id="classificationPanel" class="style-scope search-term-wizard"><span class="style-scope classification-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope classification-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope classification-wizard"></path>
  </svg>
  <outlined-text-field id="textField" placeholder="Enter a CPC here" uppercase="" class="style-scope classification-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Enter a CPC here">
  
</span>
</outlined-text-field>
</span>
<template is="dom-if" class="style-scope classification-wizard"></template>
<template is="dom-if" class="style-scope classification-wizard"></template>
<template is="dom-if" class="style-scope classification-wizard"></template>
<span class="style-scope classification-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope classification-wizard">
    <path d="M16 16.925q2.05 0 3.488-1.437Q20.925 14.05 20.925 12t-1.437-3.488Q18.05 7.075 16 7.075q-.625 0-1.2.15t-1.075.425q.7.925 1.087 2.025.388 1.1.388 2.325t-.388 2.325q-.387 1.1-1.087 2.025.5.275 1.075.425.575.15 1.2.15Zm-4-2.075q.45-.575.688-1.313.237-.737.237-1.537 0-.8-.237-1.538Q12.45 9.725 12 9.15q-.45.575-.688 1.312-.237.738-.237 1.538t.237 1.537q.238.738.688 1.313Zm-4 2.075q.625 0 1.2-.15t1.075-.425q-.7-.925-1.087-2.025Q8.8 13.225 8.8 12t.388-2.325q.387-1.1 1.087-2.025-.5-.275-1.075-.425-.575-.15-1.2-.15-2.05 0-3.487 1.437Q3.075 9.95 3.075 12t1.438 3.488Q5.95 16.925 8 16.925ZM8 19.2q-3 0-5.1-2.1Q.8 15 .8 12q0-3 2.1-5.1Q5 4.8 8 4.8q1.125 0 2.137.312 1.013.313 1.863.913.85-.6 1.863-.913Q14.875 4.8 16 4.8q3 0 5.1 2.1Q23.2 9 23.2 12q0 3-2.1 5.1-2.1 2.1-5.1 2.1-1.125 0-2.137-.313-1.013-.312-1.863-.912-.85.6-1.863.912Q9.125 19.2 8 19.2Z" class="style-scope classification-wizard"></path>
  </svg>
  <filter-chip id="notExact" class="style-scope classification-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>

    These CPCs and their children
  </filter-chip>
  <filter-chip selected="" id="exact" class="style-scope classification-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>

    These exact CPCs
  </filter-chip>
</span>
<span class="style-scope classification-wizard">
  <mat-button id="button" filled="" class="style-scope classification-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope classification-wizard">Add AND condition</span></mat-button>
</span></classification-wizard>
    <chemistry-search-term-wizard id="chemistryPanel" class="style-scope search-term-wizard"><span class="style-scope chemistry-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope chemistry-search-term-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope chemistry-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="textField" placeholder="Trade name, SMILES, InChI Key" class="style-scope chemistry-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Trade name, SMILES, InChI Key">
  
</span>
</outlined-text-field>
  <outlined-textarea id="textArea" placeholder="Enter multiple SMILES or InChI Keys, one per line" rows="4" class="style-scope chemistry-search-term-wizard"><span class="style-scope outlined-textarea">
  <textarea id="textarea" autocomplete="off" autocorrect="off" spellcheck="false" tabindex="0" aria-disabled="false" wrap="soft" class="style-scope outlined-textarea" rows="4" placeholder="Enter multiple SMILES or InChI Keys, one per line">  </textarea>
  <div id="helperText" class="style-scope outlined-textarea"> </div>
</span>
<span class="right-button-container style-scope outlined-textarea">
  
</span>
</outlined-textarea>
  <a href="https://support.google.com/faqs/answer/7049475#zippy=%2Csearching-by-chemistry" target="_blank" class="style-scope chemistry-search-term-wizard">
    <svg class="help style-scope chemistry-search-term-wizard" xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49">
      <path d="M11.95 18q.525 0 .888-.363.362-.362.362-.887t-.362-.887q-.363-.363-.888-.363t-.888.363q-.362.362-.362.887t.362.887q.363.363.888.363Zm-.9-3.85h1.85q0-.825.188-1.3.187-.475 1.062-1.3.65-.65 1.025-1.238.375-.587.375-1.412 0-1.4-1.025-2.15T12.1 6q-1.425 0-2.312.75-.888.75-1.238 1.8l1.65.65q.125-.45.563-.975Q11.2 7.7 12.1 7.7q.8 0 1.2.437.4.438.4.963 0 .5-.3.937-.3.438-.75.813-1.1.975-1.35 1.475-.25.5-.25 1.825ZM12 22q-2.075 0-3.9-.788-1.825-.787-3.175-2.137-1.35-1.35-2.137-3.175Q2 14.075 2 12t.788-3.9q.787-1.825 2.137-3.175 1.35-1.35 3.175-2.138Q9.925 2 12 2t3.9.787q1.825.788 3.175 2.138 1.35 1.35 2.137 3.175Q22 9.925 22 12t-.788 3.9q-.787 1.825-2.137 3.175-1.35 1.35-3.175 2.137Q14.075 22 12 22Zm0-2q3.35 0 5.675-2.325Q20 15.35 20 12q0-3.35-2.325-5.675Q15.35 4 12 4 8.65 4 6.325 6.325 4 8.65 4 12q0 3.35 2.325 5.675Q8.65 20 12 20Zm0-8Z" class="style-scope chemistry-search-term-wizard"></path>
    </svg>
  </a>
</span>
<span id="chemQuantifiers" class="style-scope chemistry-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope chemistry-search-term-wizard">
    <path d="M5 21.2q-1.4 0-2-1.25-.6-1.25.3-2.325l5.5-6.7V5.15h-.825q-.475 0-.8-.338Q6.85 4.475 6.85 4q0-.475.325-.813.325-.337.8-.337h8.05q.475 0 .8.337.325.338.325.813 0 .475-.325.812-.325.338-.8.338H15.2v5.775l5.5 6.7q.9 1.075.3 2.325-.6 1.25-2 1.25Zm2.15-3.275h9.7l-3.275-3.85h-3.15Zm-2 1h13.7l-5.925-7.2V5.15h-1.85v6.575Zm6.85-6.9Z" class="style-scope chemistry-search-term-wizard"></path>
  </svg>
  <filter-chip id="exact" selected="" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Exact</filter-chip>
  <filter-chip id="exactBatch" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Exact Batch</filter-chip>
  <filter-chip id="similar" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Similar</filter-chip>
  <filter-chip id="substructure" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Substructure</filter-chip>
  <filter-chip id="smarts" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Substructure (SMARTS)</filter-chip>
</span>
<span id="location" class="style-scope chemistry-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope chemistry-search-term-wizard">
    <path d="M8 18.025h8v-2.1H8Zm0-4h8v-2.1H8ZM6.075 22.2q-.95 0-1.612-.662-.663-.663-.663-1.613V4.075q0-.95.663-1.613.662-.662 1.612-.662h8L20.2 7.925v12q0 .95-.662 1.613-.663.662-1.613.662Zm6.85-13.125v-5h-6.85v15.85h11.85V9.075Zm-6.85-5v5-5 15.85-15.85Z" class="style-scope chemistry-search-term-wizard"></path>
  </svg>
  <filter-chip id="fullDocuments" selected="" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Full documents</filter-chip>
  <filter-chip id="claims" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Claims only</filter-chip>
</span>
<span class="style-scope chemistry-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope chemistry-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope chemistry-search-term-wizard">Add AND condition</span></mat-button>
</span>
</chemistry-search-term-wizard>
    <measure-search-term-wizard id="measurePanel" class="style-scope search-term-wizard"><span class="style-scope measure-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope measure-search-term-wizard">
    <path d="M4.1 18.15q-.95 0-1.612-.663-.663-.662-.663-1.612v-7.75q0-.95.663-1.613Q3.15 5.85 4.1 5.85h15.8q.95 0 1.613.662.662.663.662 1.613v7.75q0 .95-.662 1.612-.663.663-1.613.663Zm0-2.275h15.8v-7.75H17V12h-2V8.125h-2V12h-2V8.125H9V12H7V8.125H4.1v7.75ZM7 12h2Zm4 0h2Zm4 0h2Zm-3 0Z" class="style-scope measure-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="measureExpression" placeholder="1.5 mm, 20 ft, 400-500 fahrenheit, 800 MHz, 0.01-100 mol" class="style-scope measure-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="1.5 mm, 20 ft, 400-500 fahrenheit, 800 MHz, 0.01-100 mol">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope measure-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope measure-search-term-wizard">
    <path d="M3.875 20.15V8.85h4.25v11.3Zm6 0V3.85h4.25v16.3Zm6 0v-7.3h4.25v7.3Z" class="style-scope measure-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="context" placeholder="activity, wavelength, embossing depth, absorption" class="style-scope measure-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="activity, wavelength, embossing depth, absorption">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope measure-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope measure-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope measure-search-term-wizard">Add AND condition</span></mat-button>
</span>
</measure-search-term-wizard>
    <numerical-search-term-wizard id="numericalPanel" class="style-scope search-term-wizard"><span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <outlined-textarea id="batch" placeholder="Enter multiple Patent Application and Publication Numbers, one per line" rows="4" class="style-scope numerical-search-term-wizard"><span class="style-scope outlined-textarea">
  <textarea id="textarea" autocomplete="off" autocorrect="off" spellcheck="false" tabindex="0" aria-disabled="false" wrap="soft" class="style-scope outlined-textarea" rows="4" placeholder="Enter multiple Patent Application and Publication Numbers, one per line">  </textarea>
  <div id="helperText" class="style-scope outlined-textarea"> </div>
</span>
<span class="right-button-container style-scope outlined-textarea">
  
</span>
</outlined-textarea>
</span>
<template is="dom-if" class="style-scope numerical-search-term-wizard"></template>
<template is="dom-if" class="style-scope numerical-search-term-wizard"></template>
<span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="m10.825 23.45-1.6-1.625L10.9 20.15H8q-.35.9-1.162 1.488-.813.587-1.838.587-1.35 0-2.287-.937-.938-.938-.938-2.288 0-1.025.588-1.837Q2.95 16.35 3.85 16V8q-.9-.35-1.487-1.163Q1.775 6.025 1.775 5q0-1.35.938-2.288Q3.65 1.775 5 1.775q1.025 0 1.838.587Q7.65 2.95 8 3.85h2.9L9.225 2.175l1.6-1.625L15.275 5l-4.45 4.45-1.6-1.625L10.9 6.15H8q-.25.65-.725 1.125T6.15 8v8q.65.25 1.125.725T8 17.85h2.9l-1.675-1.675 1.6-1.625 4.45 4.45ZM19 22.225q-1.35 0-2.287-.937-.938-.938-.938-2.288 0-1.05.588-1.863.587-.812 1.487-1.137V8q-.9-.325-1.487-1.137-.588-.813-.588-1.863 0-1.35.938-2.288.937-.937 2.287-.937 1.35 0 2.288.937.937.938.937 2.288 0 1.05-.587 1.863Q21.05 7.675 20.15 8v8q.9.35 1.488 1.163.587.812.587 1.837 0 1.35-.937 2.288-.938.937-2.288.937ZM5 19.95q.4 0 .675-.275T5.95 19q0-.4-.275-.675T5 18.05q-.4 0-.675.275T4.05 19q0 .4.275.675T5 19.95Zm14 0q.4 0 .675-.275T19.95 19q0-.4-.275-.675T19 18.05q-.4 0-.675.275T18.05 19q0 .4.275.675t.675.275Zm-14-14q.4 0 .675-.275T5.95 5q0-.4-.275-.675T5 4.05q-.4 0-.675.275T4.05 5q0 .4.275.675T5 5.95Zm14 0q.4 0 .675-.275T19.95 5q0-.4-.275-.675T19 4.05q-.4 0-.675.275T18.05 5q0 .4.275.675T19 5.95ZM5 19Zm14 0ZM5 5Zm14 0Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <filter-chip id="applicationNumbers" class="style-scope numerical-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Application Numbers</filter-chip>
  <filter-chip id="publicationNumbers" class="style-scope numerical-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Publication Numbers</filter-chip>
  <filter-chip id="either" selected="" class="style-scope numerical-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Either</filter-chip>
</span>
<span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="M12 22.2q-2.1 0-3.962-.8-1.863-.8-3.25-2.175Q3.4 17.85 2.6 15.988 1.8 14.125 1.8 12t.8-3.988q.8-1.862 2.188-3.237Q6.175 3.4 8.038 2.6 9.9 1.8 12 1.8q2.125 0 3.988.8 1.862.8 3.237 2.175Q20.6 6.15 21.4 8.012q.8 1.863.8 3.988t-.8 3.988q-.8 1.862-2.175 3.237Q17.85 20.6 15.988 21.4q-1.863.8-3.988.8Zm-1-2.325v-1.95q-.8 0-1.387-.575-.588-.575-.588-1.4v-.975L4.275 10.2q-.075.45-.137.9-.063.45-.063.9 0 3 1.975 5.25T11 19.875Zm6.85-2.525q.5-.55.888-1.175.387-.625.65-1.313.262-.687.4-1.412.137-.725.137-1.45 0-2.425-1.338-4.438-1.337-2.012-3.612-2.887v.375q0 .825-.587 1.4-.588.575-1.388.575h-2v2q0 .4-.287.687-.288.288-.688.288h-2v2h5.95q.425 0 .713.287.287.288.287.688v2.975h1q.65 0 1.163.387.512.388.712 1.013Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="countryFilter" placeholder="Restrict search to these countries" class="style-scope numerical-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Restrict search to these countries">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="M2.85 18.225V15.95h6.3v2.275Zm0-5.075v-2.3h12.3v2.3Zm0-5.1V5.775h18.3V8.05Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="countryOrder" placeholder="Prefer results from these countries in this order" class="style-scope numerical-search-term-wizard" value="US, EP, WO, JP, CN"><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Prefer results from these countries in this order">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope numerical-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope numerical-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope numerical-search-term-wizard">Add AND condition</span></mat-button>
</span>
</numerical-search-term-wizard>
  </span>

</pat-dialog>
</search-term-wizard>
          
      <div content="" class="style-scope search-result">
        <div id="mainContainer" class="vertical layout style-scope search-result">
          <template is="dom-if" class="style-scope search-result"></template>
          <result-container class="style-scope search-result">
    

    <paper-spinner class="style-scope result-container x-scope paper-spinner-0" aria-hidden="true" hidden=""><div id="spinnerContainer" class="  style-scope paper-spinner"><div class="spinner-layer layer-1 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div><div class="spinner-layer layer-2 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div><div class="spinner-layer layer-3 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div><div class="spinner-layer layer-4 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div></div></paper-spinner>
    
      <patent-result class="style-scope result-container">
    
    
    <div class="layout horizontal style-scope patent-result">
      <div style="width: 1200px; height: auto; overflow: auto;" class="style-scope patent-result">
        <div id="wrapper" tabindex="0" class="style-scope patent-result">
          <result-tags class="style-scope patent-result"></result-tags>
          <h1 id="title" class="scroll-target style-scope patent-result">
            
  Test system for identifying and characterizing compounds and uses thereof
 
     </h1>
          <div class="horizontal layout style-scope patent-result">
            
            <div class="flex-3 style-scope patent-result" style="margin-top:-20px;overflow:hidden;" marginright="">
              <section id="abstract" class="style-scope patent-result">
                <h3 class="layout horizontal style-scope patent-result">
                  <div class="flex style-scope patent-result">Abstract</div>
                  <div class="righthead style-scope patent-result">translated from Japanese</div>
                </h3>
                <patent-text name="abstract" class="style-scope patent-result" style="padding-top: 0px;">
    
    
    <template is="dom-if" restamp="" class="style-scope patent-text"></template>
    <overlay-tooltip id="tooltip" class="style-scope patent-text" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
    </div>
  </overlay-tooltip>
    <div class="layout horizontal style-scope patent-text">
      <section id="text" class="flex style-scope patent-text"><abstract mxw-id="PA54922587" lang="EN" load-source="google" class="style-scope patent-text">
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">本発明は、蠕虫及び節足動物由来の膜貫通受容体に基づく試験システム、蠕虫、節足動物に作用するかあるいは生物及び／又は細胞のカルシウム代謝に対する効果を有する物質を同定しかつ特徴付けるためのその使用に関する。さらに本発明は本試験システムにおける特異的なリガンドの使用、及び駆虫薬又は殺節足動物活性物質としてのその使用に関する。</span>The present invention relates to test systems based on transmembrane receptors from helminths and arthropods, for identifying and characterizing substances that act on helminths, arthropods or have an effect on calcium metabolism in organisms and / or cells. Regarding its use. The invention further relates to the use of specific ligands in the present test system, and their use as anthelmintics or arthropodidic actives.</span>
  </p>
</abstract>
  </section>
      <div id="margin" class="style-scope patent-text">
        <div id="createHighlight" style="top: 0px;" class="style-scope patent-text" hidden="">
          <iron-icon id="comment" icon="editor:insert-comment" class="style-scope patent-text x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 2H4c-1.1 0-2 .9-2 2v12c0 1.1.9 2 2 2h14l4 4V4c0-1.1-.9-2-2-2zm-2 12H6v-2h12v2zm0-3H6V9h12v2zm0-3H6V6h12v2z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        </div>
      </div>
    </div>
  </patent-text>
              </section>
              
              
                <section id="thumbnails" class="style-scope patent-result">
                  <h3 class="style-scope patent-result">Images (<span class="style-scope patent-result">20</span>)</h3>
                  <image-carousel id="figures" class="style-scope patent-result">
    
    
      <div class="thumbnails style-scope image-carousel">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/99/3a/78/5f57de369b7f18/2004508052-4.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/6e/a6/5e/b12d8ca92659ff/2004508052-5.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/06/e0/df/91d65bf04613d5/2004508052-6.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/61/cb/a8/7e5dfffebaebdb/2004508052-7.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/15/6b/d3/7219c76e2a5e67/2004508052-8.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/ad/80/fc/ea6eac7f1a3381/2004508052-9.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/33/41/82/fc64a46cf96ca6/2004508052-10.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/0d/d7/3d/565da1ddd09807/2004508052-11.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/58/e9/23/c01c3ca2e9b50d/2004508052-12.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/9d/3a/a8/f8b7e2dfe4f07f/2004508052-13.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/08/f1/78/b55d84ba04cc03/2004508052-14.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/31/c5/bc/6ba8abf3eaf977/2004508052-15.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/de/0b/93/0bd13d4693226d/2004508052-16.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/54/bf/a8/ed70b8b33f49d6/2004508052-17.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/e3/4a/59/37cf1271df9d19/2004508052-18.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/21/35/d8/04a29a7c66a5ad/2004508052-19.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/7a/e7/7b/f2bbfcc4f584f2/2004508052-20.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/27/17/09/d9b0d099eb9ef7/2004508052-21.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/df/b4/a3/0885745fdfb30a/2004508052-22.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/b4/4c/42/65f474834c3be0/2004508052-23.png">
        <template is="dom-repeat" as="img" class="style-scope image-carousel"></template>
      </div>
    <template is="dom-if" class="style-scope image-carousel"></template>
  </image-carousel>
                </section>
              <template is="dom-if" class="style-scope patent-result"></template>
              
              <section id="classifications" class="style-scope patent-result">
                <h3 class="layout horizontal style-scope patent-result">
                  <div class="flex style-scope patent-result">Classifications</div>
                  <div id="machineClassifiedWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">machine-classified</div>
                  <div id="machineClassifiedCPCWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">cpc-machine-classified</div>
                  <div id="machineClassifiedFtermWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">fterm-machine-classified</div>
                  <div class="style-scope patent-result" hidden="">&nbsp;</div>
                  <div id="familyClassifiedFtermWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">fterm-family-classified</div>
                </h3>
                <overlay-tooltip positioning-target="#machineClassifiedWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The classifications are assigned by a computer and are not a legal conclusion. <br class="style-scope patent-result"> Google has not performed a legal analysis and makes no representation as to the accuracy of the classifications listed.
    </div>
  </overlay-tooltip>
                <overlay-tooltip positioning-target="#machineClassifiedCPCWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The CPC classifications are assigned by a computer and are not a legal conclusion. <br class="style-scope patent-result"> Google has not performed a legal analysis and makes no representation as to the accuracy of the classifications listed.
    </div>
  </overlay-tooltip>
                <overlay-tooltip positioning-target="#familyClassifiedFtermWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The F-term classifications are assigned based on a patent family member containing these classification codes.
    </div>
  </overlay-tooltip>
                <overlay-tooltip positioning-target="#machineClassifiedFtermWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The F-term classifications are assigned by a computer and are not a legal conclusion. <br class="style-scope patent-result"> Google has not performed a legal analysis and makes no representation as to the accuracy of the classifications listed.
    </div>
  </overlay-tooltip>
                <classification-viewer class="style-scope patent-result">
    
    <div class="table style-scope classification-viewer">
      
        <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G"><a id="link" href="#" class="style-scope state-modifier">G</a></state-modifier>
                  <span class="description style-scope classification-tree">PHYSICS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01"><a id="link" href="#" class="style-scope state-modifier">G01</a></state-modifier>
                  <span class="description style-scope classification-tree">MEASURING; TESTING</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N"><a id="link" href="#" class="style-scope state-modifier">G01N</a></state-modifier>
                  <span class="description style-scope classification-tree">INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N33/00"><a id="link" href="#" class="style-scope state-modifier">G01N33/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N33/48"><a id="link" href="#" class="style-scope state-modifier">G01N33/48</a></state-modifier>
                  <span class="description style-scope classification-tree">Biological material, e.g. blood, urine; Haemocytometers</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N33/50"><a id="link" href="#" class="style-scope state-modifier">G01N33/50</a></state-modifier>
                  <span class="description style-scope classification-tree">Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N33/5005"><a id="link" href="#" class="style-scope state-modifier">G01N33/5005</a></state-modifier>
                  <span class="description style-scope classification-tree">Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N33/5008"><a id="link" href="#" class="style-scope state-modifier">G01N33/5008</a></state-modifier>
                  <span class="description style-scope classification-tree">Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" first="true" data-cpc="G01N33/502"><a id="link" href="#" class="style-scope state-modifier">G01N33/502</a></state-modifier>
                  <span class="description style-scope classification-tree">Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
      <template is="dom-repeat" class="style-scope classification-viewer"></template>
      
      <div class="style-scope classification-viewer">
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A"><a id="link" href="#" class="style-scope state-modifier">A</a></state-modifier>
                  <span class="description style-scope classification-tree">HUMAN NECESSITIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61"><a id="link" href="#" class="style-scope state-modifier">A61</a></state-modifier>
                  <span class="description style-scope classification-tree">MEDICAL OR VETERINARY SCIENCE; HYGIENE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P"><a id="link" href="#" class="style-scope state-modifier">A61P</a></state-modifier>
                  <span class="description style-scope classification-tree">SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P33/00"><a id="link" href="#" class="style-scope state-modifier">A61P33/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Antiparasitic agents</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P33/10"><a id="link" href="#" class="style-scope state-modifier">A61P33/10</a></state-modifier>
                  <span class="description style-scope classification-tree">Anthelmintics</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07"><a id="link" href="#" class="style-scope state-modifier">C07</a></state-modifier>
                  <span class="description style-scope classification-tree">ORGANIC CHEMISTRY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07K"><a id="link" href="#" class="style-scope state-modifier">C07K</a></state-modifier>
                  <span class="description style-scope classification-tree">PEPTIDES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07K14/00"><a id="link" href="#" class="style-scope state-modifier">C07K14/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07K14/435"><a id="link" href="#" class="style-scope state-modifier">C07K14/435</a></state-modifier>
                  <span class="description style-scope classification-tree">Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07K14/43504"><a id="link" href="#" class="style-scope state-modifier">C07K14/43504</a></state-modifier>
                  <span class="description style-scope classification-tree">Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07K14/43536"><a id="link" href="#" class="style-scope state-modifier">C07K14/43536</a></state-modifier>
                  <span class="description style-scope classification-tree">Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07K14/4354"><a id="link" href="#" class="style-scope state-modifier">C07K14/4354</a></state-modifier>
                  <span class="description style-scope classification-tree">Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms from nematodes</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07"><a id="link" href="#" class="style-scope state-modifier">C07</a></state-modifier>
                  <span class="description style-scope classification-tree">ORGANIC CHEMISTRY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07K"><a id="link" href="#" class="style-scope state-modifier">C07K</a></state-modifier>
                  <span class="description style-scope classification-tree">PEPTIDES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07K14/00"><a id="link" href="#" class="style-scope state-modifier">C07K14/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07K14/435"><a id="link" href="#" class="style-scope state-modifier">C07K14/435</a></state-modifier>
                  <span class="description style-scope classification-tree">Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07K14/705"><a id="link" href="#" class="style-scope state-modifier">C07K14/705</a></state-modifier>
                  <span class="description style-scope classification-tree">Receptors; Cell surface antigens; Cell surface determinants</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07"><a id="link" href="#" class="style-scope state-modifier">C07</a></state-modifier>
                  <span class="description style-scope classification-tree">ORGANIC CHEMISTRY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07K"><a id="link" href="#" class="style-scope state-modifier">C07K</a></state-modifier>
                  <span class="description style-scope classification-tree">PEPTIDES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07K14/00"><a id="link" href="#" class="style-scope state-modifier">C07K14/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07K14/435"><a id="link" href="#" class="style-scope state-modifier">C07K14/435</a></state-modifier>
                  <span class="description style-scope classification-tree">Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07K14/705"><a id="link" href="#" class="style-scope state-modifier">C07K14/705</a></state-modifier>
                  <span class="description style-scope classification-tree">Receptors; Cell surface antigens; Cell surface determinants</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07K14/72"><a id="link" href="#" class="style-scope state-modifier">C07K14/72</a></state-modifier>
                  <span class="description style-scope classification-tree">Receptors; Cell surface antigens; Cell surface determinants for hormones</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07K14/723"><a id="link" href="#" class="style-scope state-modifier">C07K14/723</a></state-modifier>
                  <span class="description style-scope classification-tree">G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12"><a id="link" href="#" class="style-scope state-modifier">C12</a></state-modifier>
                  <span class="description style-scope classification-tree">BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12Q"><a id="link" href="#" class="style-scope state-modifier">C12Q</a></state-modifier>
                  <span class="description style-scope classification-tree">MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12Q1/00"><a id="link" href="#" class="style-scope state-modifier">C12Q1/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12Q1/68"><a id="link" href="#" class="style-scope state-modifier">C12Q1/68</a></state-modifier>
                  <span class="description style-scope classification-tree">Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12Q1/6876"><a id="link" href="#" class="style-scope state-modifier">C12Q1/6876</a></state-modifier>
                  <span class="description style-scope classification-tree">Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12Q1/6888"><a id="link" href="#" class="style-scope state-modifier">C12Q1/6888</a></state-modifier>
                  <span class="description style-scope classification-tree">Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G"><a id="link" href="#" class="style-scope state-modifier">G</a></state-modifier>
                  <span class="description style-scope classification-tree">PHYSICS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01"><a id="link" href="#" class="style-scope state-modifier">G01</a></state-modifier>
                  <span class="description style-scope classification-tree">MEASURING; TESTING</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N"><a id="link" href="#" class="style-scope state-modifier">G01N</a></state-modifier>
                  <span class="description style-scope classification-tree">INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N33/00"><a id="link" href="#" class="style-scope state-modifier">G01N33/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N33/48"><a id="link" href="#" class="style-scope state-modifier">G01N33/48</a></state-modifier>
                  <span class="description style-scope classification-tree">Biological material, e.g. blood, urine; Haemocytometers</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N33/50"><a id="link" href="#" class="style-scope state-modifier">G01N33/50</a></state-modifier>
                  <span class="description style-scope classification-tree">Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N33/5005"><a id="link" href="#" class="style-scope state-modifier">G01N33/5005</a></state-modifier>
                  <span class="description style-scope classification-tree">Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N33/5008"><a id="link" href="#" class="style-scope state-modifier">G01N33/5008</a></state-modifier>
                  <span class="description style-scope classification-tree">Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G"><a id="link" href="#" class="style-scope state-modifier">G</a></state-modifier>
                  <span class="description style-scope classification-tree">PHYSICS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01"><a id="link" href="#" class="style-scope state-modifier">G01</a></state-modifier>
                  <span class="description style-scope classification-tree">MEASURING; TESTING</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N"><a id="link" href="#" class="style-scope state-modifier">G01N</a></state-modifier>
                  <span class="description style-scope classification-tree">INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N33/00"><a id="link" href="#" class="style-scope state-modifier">G01N33/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N33/48"><a id="link" href="#" class="style-scope state-modifier">G01N33/48</a></state-modifier>
                  <span class="description style-scope classification-tree">Biological material, e.g. blood, urine; Haemocytometers</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N33/50"><a id="link" href="#" class="style-scope state-modifier">G01N33/50</a></state-modifier>
                  <span class="description style-scope classification-tree">Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N33/5005"><a id="link" href="#" class="style-scope state-modifier">G01N33/5005</a></state-modifier>
                  <span class="description style-scope classification-tree">Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N33/5008"><a id="link" href="#" class="style-scope state-modifier">G01N33/5008</a></state-modifier>
                  <span class="description style-scope classification-tree">Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N33/5014"><a id="link" href="#" class="style-scope state-modifier">G01N33/5014</a></state-modifier>
                  <span class="description style-scope classification-tree">Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G"><a id="link" href="#" class="style-scope state-modifier">G</a></state-modifier>
                  <span class="description style-scope classification-tree">PHYSICS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01"><a id="link" href="#" class="style-scope state-modifier">G01</a></state-modifier>
                  <span class="description style-scope classification-tree">MEASURING; TESTING</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N"><a id="link" href="#" class="style-scope state-modifier">G01N</a></state-modifier>
                  <span class="description style-scope classification-tree">INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N33/00"><a id="link" href="#" class="style-scope state-modifier">G01N33/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N33/48"><a id="link" href="#" class="style-scope state-modifier">G01N33/48</a></state-modifier>
                  <span class="description style-scope classification-tree">Biological material, e.g. blood, urine; Haemocytometers</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N33/50"><a id="link" href="#" class="style-scope state-modifier">G01N33/50</a></state-modifier>
                  <span class="description style-scope classification-tree">Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N33/5005"><a id="link" href="#" class="style-scope state-modifier">G01N33/5005</a></state-modifier>
                  <span class="description style-scope classification-tree">Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N33/5008"><a id="link" href="#" class="style-scope state-modifier">G01N33/5008</a></state-modifier>
                  <span class="description style-scope classification-tree">Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N33/5082"><a id="link" href="#" class="style-scope state-modifier">G01N33/5082</a></state-modifier>
                  <span class="description style-scope classification-tree">Supracellular entities, e.g. tissue, organisms</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N33/5085"><a id="link" href="#" class="style-scope state-modifier">G01N33/5085</a></state-modifier>
                  <span class="description style-scope classification-tree">Supracellular entities, e.g. tissue, organisms of invertebrates</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G"><a id="link" href="#" class="style-scope state-modifier">G</a></state-modifier>
                  <span class="description style-scope classification-tree">PHYSICS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01"><a id="link" href="#" class="style-scope state-modifier">G01</a></state-modifier>
                  <span class="description style-scope classification-tree">MEASURING; TESTING</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N"><a id="link" href="#" class="style-scope state-modifier">G01N</a></state-modifier>
                  <span class="description style-scope classification-tree">INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N33/00"><a id="link" href="#" class="style-scope state-modifier">G01N33/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N33/48"><a id="link" href="#" class="style-scope state-modifier">G01N33/48</a></state-modifier>
                  <span class="description style-scope classification-tree">Biological material, e.g. blood, urine; Haemocytometers</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N33/50"><a id="link" href="#" class="style-scope state-modifier">G01N33/50</a></state-modifier>
                  <span class="description style-scope classification-tree">Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N33/53"><a id="link" href="#" class="style-scope state-modifier">G01N33/53</a></state-modifier>
                  <span class="description style-scope classification-tree">Immunoassay; Biospecific binding assay; Materials therefor</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N33/5308"><a id="link" href="#" class="style-scope state-modifier">G01N33/5308</a></state-modifier>
                  <span class="description style-scope classification-tree">Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G"><a id="link" href="#" class="style-scope state-modifier">G</a></state-modifier>
                  <span class="description style-scope classification-tree">PHYSICS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01"><a id="link" href="#" class="style-scope state-modifier">G01</a></state-modifier>
                  <span class="description style-scope classification-tree">MEASURING; TESTING</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N"><a id="link" href="#" class="style-scope state-modifier">G01N</a></state-modifier>
                  <span class="description style-scope classification-tree">INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N33/00"><a id="link" href="#" class="style-scope state-modifier">G01N33/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N33/48"><a id="link" href="#" class="style-scope state-modifier">G01N33/48</a></state-modifier>
                  <span class="description style-scope classification-tree">Biological material, e.g. blood, urine; Haemocytometers</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N33/50"><a id="link" href="#" class="style-scope state-modifier">G01N33/50</a></state-modifier>
                  <span class="description style-scope classification-tree">Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N33/68"><a id="link" href="#" class="style-scope state-modifier">G01N33/68</a></state-modifier>
                  <span class="description style-scope classification-tree">Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N33/6872"><a id="link" href="#" class="style-scope state-modifier">G01N33/6872</a></state-modifier>
                  <span class="description style-scope classification-tree">Intracellular protein regulatory factors and their receptors, e.g. including ion channels</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G"><a id="link" href="#" class="style-scope state-modifier">G</a></state-modifier>
                  <span class="description style-scope classification-tree">PHYSICS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01"><a id="link" href="#" class="style-scope state-modifier">G01</a></state-modifier>
                  <span class="description style-scope classification-tree">MEASURING; TESTING</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N"><a id="link" href="#" class="style-scope state-modifier">G01N</a></state-modifier>
                  <span class="description style-scope classification-tree">INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N2333/00"><a id="link" href="#" class="style-scope state-modifier">G01N2333/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Assays involving biological materials from specific organisms or of a specific nature</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N2333/435"><a id="link" href="#" class="style-scope state-modifier">G01N2333/435</a></state-modifier>
                  <span class="description style-scope classification-tree">Assays involving biological materials from specific organisms or of a specific nature from animals; from humans</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N2333/43504"><a id="link" href="#" class="style-scope state-modifier">G01N2333/43504</a></state-modifier>
                  <span class="description style-scope classification-tree">Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N2333/43526"><a id="link" href="#" class="style-scope state-modifier">G01N2333/43526</a></state-modifier>
                  <span class="description style-scope classification-tree">Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates from worms</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" additional="true" data-cpc="G01N2333/4353"><a id="link" href="#" class="style-scope state-modifier">G01N2333/4353</a></state-modifier>
                  <span class="description style-scope classification-tree">Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates from worms from nematodes</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G"><a id="link" href="#" class="style-scope state-modifier">G</a></state-modifier>
                  <span class="description style-scope classification-tree">PHYSICS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01"><a id="link" href="#" class="style-scope state-modifier">G01</a></state-modifier>
                  <span class="description style-scope classification-tree">MEASURING; TESTING</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N"><a id="link" href="#" class="style-scope state-modifier">G01N</a></state-modifier>
                  <span class="description style-scope classification-tree">INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N2333/00"><a id="link" href="#" class="style-scope state-modifier">G01N2333/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Assays involving biological materials from specific organisms or of a specific nature</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N2333/435"><a id="link" href="#" class="style-scope state-modifier">G01N2333/435</a></state-modifier>
                  <span class="description style-scope classification-tree">Assays involving biological materials from specific organisms or of a specific nature from animals; from humans</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N2333/46"><a id="link" href="#" class="style-scope state-modifier">G01N2333/46</a></state-modifier>
                  <span class="description style-scope classification-tree">Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N2333/47"><a id="link" href="#" class="style-scope state-modifier">G01N2333/47</a></state-modifier>
                  <span class="description style-scope classification-tree">Assays involving proteins of known structure or function as defined in the subgroups</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N2333/4701"><a id="link" href="#" class="style-scope state-modifier">G01N2333/4701</a></state-modifier>
                  <span class="description style-scope classification-tree">Details</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" additional="true" data-cpc="G01N2333/4719"><a id="link" href="#" class="style-scope state-modifier">G01N2333/4719</a></state-modifier>
                  <span class="description style-scope classification-tree">G-proteins</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G"><a id="link" href="#" class="style-scope state-modifier">G</a></state-modifier>
                  <span class="description style-scope classification-tree">PHYSICS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01"><a id="link" href="#" class="style-scope state-modifier">G01</a></state-modifier>
                  <span class="description style-scope classification-tree">MEASURING; TESTING</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N"><a id="link" href="#" class="style-scope state-modifier">G01N</a></state-modifier>
                  <span class="description style-scope classification-tree">INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N2333/00"><a id="link" href="#" class="style-scope state-modifier">G01N2333/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Assays involving biological materials from specific organisms or of a specific nature</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N2333/435"><a id="link" href="#" class="style-scope state-modifier">G01N2333/435</a></state-modifier>
                  <span class="description style-scope classification-tree">Assays involving biological materials from specific organisms or of a specific nature from animals; from humans</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" additional="true" data-cpc="G01N2333/705"><a id="link" href="#" class="style-scope state-modifier">G01N2333/705</a></state-modifier>
                  <span class="description style-scope classification-tree">Assays involving receptors, cell surface antigens or cell surface determinants</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        <template is="dom-repeat" class="style-scope classification-viewer"></template>
        <div class="more style-scope classification-viewer" style="" hidden="">View 13 more classifications</div>
        <div class="more style-scope classification-viewer">Hide more classifications</div>
      </div>
      <template is="dom-if" class="style-scope classification-viewer"></template>
    </div>
  </classification-viewer>
              </section>
              
              <template is="dom-if" class="style-scope patent-result"></template>
              
              <template is="dom-if" class="style-scope patent-result"></template>
              
              
                <section class="style-scope patent-result">
                  <h3 class="layout horizontal style-scope patent-result">
                    <div class="flex style-scope patent-result">Landscapes</div>
                  </h3>
                  <div class="responsive-grid style-scope patent-result">
                    
                      <landscape-link class="style-scope patent-result"><state-modifier act="{&quot;type&quot;:&quot;QUERY_SET_TERM&quot;,&quot;term&quot;:&quot;$term&quot;,&quot;origin&quot;:&quot;LANDSCAPE_LINK&quot;}" class="style-scope landscape-link" data-term="Health &amp; Medical Sciences"><a id="link" href="#" class="style-scope state-modifier">
  <requery-tile class="area style-scope landscape-link">
<span class="label style-scope requery-tile">
    Health &amp; Medical Sciences
  </span>
<span class="search-icon style-scope requery-tile"></span>
</requery-tile>
</a></state-modifier>
</landscape-link>
                    
                      <landscape-link class="style-scope patent-result"><state-modifier act="{&quot;type&quot;:&quot;QUERY_SET_TERM&quot;,&quot;term&quot;:&quot;$term&quot;,&quot;origin&quot;:&quot;LANDSCAPE_LINK&quot;}" class="style-scope landscape-link" data-term="Life Sciences &amp; Earth Sciences"><a id="link" href="#" class="style-scope state-modifier">
  <requery-tile class="area style-scope landscape-link">
<span class="label style-scope requery-tile">
    Life Sciences &amp; Earth Sciences
  </span>
<span class="search-icon style-scope requery-tile"></span>
</requery-tile>
</a></state-modifier>
</landscape-link>
                    <template is="dom-repeat" class="style-scope patent-result"></template>
                  </div>
                  <s-more-inline class="style-scope patent-result"><hr aria-hidden="true" class="style-scope s-more-inline">

<div class="button style-scope s-more-inline">
  <span slot="expand_text" class="style-scope patent-result">Show more</span>
  <span class="expand more style-scope s-more-inline"></span>
</div>
<div class="button style-scope s-more-inline" hidden="">
  <span slot="collapse_text" class="style-scope patent-result">Show less</span>
  <span class="expand less style-scope s-more-inline"></span>
</div>
</s-more-inline>
                </section>
              <template is="dom-if" class="style-scope patent-result"></template>
            </div>
            <div class="flex-2 style-scope patent-result">
              <section class="knowledge-card style-scope patent-result">
                <header class="style-scope patent-result">
                  <h2 id="pubnum" class="style-scope patent-result">JP2004508052A</h2>
                  <p class="tagline style-scope patent-result">Japan</p>
                  <overlay-tooltip positioning-target="#pubnum" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                    <div style="max-width: 300px;" class="style-scope patent-result">Published unexamined patent application (based on international application)</div>
                  
    </div>
  </overlay-tooltip>

                  <div class="knowledge-card-action-bar style-scope patent-result">
                    <a target="_blank" class="style-scope patent-result" href="https://patentimages.storage.googleapis.com/ff/34/e0/248773ea2fc764/JP2004508052A.pdf"><iron-icon icon="description" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Download PDF</a>
                    <state-modifier inherit="" act="{&quot;type&quot;: &quot;QUERY_FIND_PRIOR_ART&quot;, &quot;keywords&quot;: $keywords, &quot;before&quot;: &quot;$before&quot;}" class="style-scope patent-result" data-keywords="[&quot;receptor&quot;,&quot;spp&quot;,&quot;cells&quot;,&quot;transmembrane receptor&quot;,&quot;protein&quot;]" data-before="20000907"><a id="link" href="#" class="style-scope state-modifier" inherit="">
                      <iron-icon icon="find-in-page" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 19.59V8l-6-6H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c.45 0 .85-.15 1.19-.4l-4.43-4.43c-.8.52-1.74.83-2.76.83-2.76 0-5-2.24-5-5s2.24-5 5-5 5 2.24 5 5c0 1.02-.31 1.96-.83 2.75L20 19.59zM9 13c0 1.66 1.34 3 3 3s3-1.34 3-3-1.34-3-3-3-3 1.34-3 3z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Find Prior Art
                    </a></state-modifier>
                    <state-modifier inherit="" act="{&quot;type&quot;: &quot;QUERY_SIMILAR_DOCUMENTS&quot;, &quot;id&quot;: &quot;$id&quot;}" class="style-scope patent-result" data-id="patent/JP2004508052A"><a id="link" href="#" class="style-scope state-modifier" inherit="">
                      <iron-icon icon="editor:functions" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M18 4H6v2l6.5 6L6 18v2h12v-3h-7l5-5-5-5h7z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Similar
                    </a></state-modifier>
                  </div>
                </header>

                <dl class="important-people style-scope patent-result">
                  
                    <dt class="style-scope patent-result">Other languages</dt>
                    <dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP2004508052A/ja"><a id="link" href="#" class="style-scope state-modifier">Japanese</a></state-modifier></dd><template is="dom-repeat" strip-whitespace="" class="style-scope patent-result"></template>
                  <template is="dom-if" class="style-scope patent-result"></template>
                  
                  <dt class="style-scope patent-result">Inventor</dt>
                  <dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="ゲオルク・フォン・ザムゾン−ヒンメルシュトイェルナ"><a id="link" href="#" class="style-scope state-modifier">ゲオルク・フォン・ザムゾン−ヒンメルシュトイェルナ</a></state-modifier></dd><dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="アヒム・ハルダー"><a id="link" href="#" class="style-scope state-modifier">アヒム・ハルダー</a></state-modifier></dd><dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="フランク・ヴンダーリヒ"><a id="link" href="#" class="style-scope state-modifier">フランク・ヴンダーリヒ</a></state-modifier></dd><dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="ハンス−ペーター・シュミット−ヴレデ"><a id="link" href="#" class="style-scope state-modifier">ハンス−ペーター・シュミット−ヴレデ</a></state-modifier></dd><dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="ベアテ・ゼーガー"><a id="link" href="#" class="style-scope state-modifier">ベアテ・ゼーガー</a></state-modifier></dd><template is="dom-repeat" strip-whitespace="" class="style-scope patent-result"></template>
                  <template is="dom-if" class="style-scope patent-result"></template>

                  
                  <dt class="style-scope patent-result">
                    <span class="tooltip-hint style-scope patent-result" id="assigneeWarning">Current Assignee</span>
                    <overlay-tooltip positioning-target="#assigneeWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                      The listed assignees may be inaccurate.<br class="style-scope patent-result">
                      Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.
                    
    </div>
  </overlay-tooltip>
                  </dt>
                  <dd class="style-scope patent-result">
                    
    Bayer AG
  
                  </dd><template is="dom-repeat" strip-whitespace="" class="style-scope patent-result"></template>
                  <template is="dom-if" class="style-scope patent-result"></template>
                </dl>

                <hr class="style-scope patent-result">

                <application-timeline class="style-scope patent-result">
    
    
    <div class="wrap style-scope application-timeline">
      <div class="header style-scope application-timeline">Worldwide applications</div>
      <div class="event style-scope application-timeline">
        
          <span class="block style-scope application-timeline">
            <span class="year style-scope application-timeline">2001</span>
            <span class="dot style-scope application-timeline"></span>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/WO2002020830A2/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">WO</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: PCT/EP2001/009771</div>
                <div class="style-scope application-timeline">Filing date: 2001-08-24</div>
                <div class="style-scope application-timeline">Legal status: Application Discontinuation</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/CA2421248A1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">CA</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: CA002421248A</div>
                <div class="style-scope application-timeline">Filing date: 2001-08-24</div>
                <div class="style-scope application-timeline">Legal status: Abandoned</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/EP1317562A2/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">EP</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: EP01974211A</div>
                <div class="style-scope application-timeline">Filing date: 2001-08-24</div>
                <div class="style-scope application-timeline">Legal status: Withdrawn</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/CN1543508A/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline">CN</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: CNA01818524XA</div>
                <div class="style-scope application-timeline">Filing date: 2001-08-24</div>
                <div class="style-scope application-timeline">Legal status: Pending</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/AU2001293789A1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">AU</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: AU2001293789A</div>
                <div class="style-scope application-timeline">Filing date: 2001-08-24</div>
                <div class="style-scope application-timeline">Legal status: Abandoned</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/NZ524533A/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="unknown style-scope application-timeline">NZ</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: NZ524533A</div>
                <div class="style-scope application-timeline">Filing date: 2001-08-24</div>
                <div class="style-scope application-timeline">Legal status: </div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/JP2004508052A/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline" this="">JP</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: JP2002525836A</div>
                <div class="style-scope application-timeline">Filing date: 2001-08-24</div>
                <div class="style-scope application-timeline">Legal status: Withdrawn</div>
              
    </div>
  </overlay-tooltip>
            <template is="dom-repeat" class="style-scope application-timeline"></template>
          </span>
        <template is="dom-repeat" class="style-scope application-timeline"></template>
      </div>
      <hr class="style-scope application-timeline">
      <div class="header style-scope application-timeline">Application JP2002525836A events <iron-icon id="legal" icon="icons:help-outline" class="style-scope application-timeline x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        <overlay-tooltip positioning-target="#legal" direction="right" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
          <div style="max-width: 300px;" class="style-scope application-timeline">
            A timeline of key events for this patent application, including priority claims, publications, legal status, reassignments, and litigation.<br class="style-scope application-timeline"><br class="style-scope application-timeline">
            Google has not performed a legal analysis and makes no representation as to the accuracy or completeness of the events listed.
          </div>
        
    </div>
  </overlay-tooltip>
      </div>
      <div class="event layout horizontal style-scope application-timeline"><div date="" class="external-priority style-scope application-timeline">2000-10-30</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/DE10053785A1/en"><a id="link" href="#" class="style-scope state-modifier"><span class="title-text style-scope application-timeline">Priority claimed from DE10053785A</span></a></state-modifier><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline" critical=""><div date="" class="filed style-scope application-timeline">2001-08-24</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_ASSIGNEE&quot;, &quot;assignee&quot;: &quot;$assignee&quot;}" class="style-scope application-timeline" data-assignee="Bayer AG"><a id="link" href="#" class="style-scope state-modifier"><span class="title-text style-scope application-timeline">Application filed by Bayer AG</span></a></state-modifier><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline" critical=""><div date="" class="publication style-scope application-timeline">2004-03-18</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/JP2004508052A/en"><a id="link" href="#" class="style-scope state-modifier"><span class="title-text style-scope application-timeline">Publication of JP2004508052A</span></a></state-modifier><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline" current="" critical=""><div date="" class="legal-status style-scope application-timeline">Status</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><span class="title-text style-scope application-timeline">Withdrawn</span><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><template is="dom-repeat" strip-whitespace="" class="style-scope application-timeline"></template>
      <template is="dom-if" class="style-scope application-timeline"></template>
    </div>
  </application-timeline>
                <hr class="style-scope patent-result">

                <dl class="links style-scope patent-result">
                  <dt class="style-scope patent-result">Info</dt>

                  
                  <dd class="style-scope patent-result"><a href="#patentCitations" class="style-scope patent-result">Patent citations (2)</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#citedBy" class="style-scope patent-result">Cited by (5)</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#legalEvents" class="style-scope patent-result">Legal events</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#similarDocuments" class="style-scope patent-result">Similar documents</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#relatedApplications" class="style-scope patent-result">Priority and Related Applications</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  <dt class="style-scope patent-result">External links</dt>

                  <dd class="style-scope patent-result"><a target="_blank" class="style-scope patent-result" href="https://worldwide.espacenet.com/publicationDetails/biblio?CC=JP&amp;NR=2004508052A&amp;KC=A&amp;FT=D">Espacenet</a></dd><dd class="style-scope patent-result"><a target="_blank" class="style-scope patent-result" href="https://globaldossier.uspto.gov/#/result/publication/JP/2004508052/1">Global Dossier</a></dd><dd class="style-scope patent-result"><a target="_blank" class="style-scope patent-result" href="https://patents.stackexchange.com/questions/tagged/JP2004508052A">Discuss</a></dd><template is="dom-repeat" strip-whitespace="" class="style-scope patent-result"></template>
                </dl>
              </section>
            </div>
          </div>

          <div id="text" class="horizontal layout style-scope patent-result">
            <div class="flex flex-width style-scope patent-result" marginright="">
              <section id="description" class="style-scope patent-result">
                <h3 class="layout horizontal style-scope patent-result">
                  <div class="flex style-scope patent-result">Description</div>
                  <div class="righthead style-scope patent-result">translated from Japanese</div>
                </h3>
                <patent-text name="description" id="descriptionText" class="style-scope patent-result" style="padding-top: 0px;">
    
    
    <template is="dom-if" restamp="" class="style-scope patent-text"></template>
    <overlay-tooltip id="tooltip" class="style-scope patent-text" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
    </div>
  </overlay-tooltip>
    <div class="layout horizontal style-scope patent-text">
      <section id="text" class="flex style-scope patent-text"><description mxw-id="PDES19076269" lang="EN" load-source="google" class="style-scope patent-text">
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">【０００１】<br class="style-scope patent-text">
本発明は、蠕虫（ｈｅｌｍｉｎｔｈ）及び節足動物由来の膜貫通受容体に基づく試験システムに関し、並びに蠕虫、節足動物にて作用する又は生物宿主細胞のカルシウムバランスに作用する物質を同定および特徴付けるための本試験システムの使用に関する。さらに本発明は、本試験システムにおける特異的なリガンドの使用、及び駆虫又は殺節足動物活性物質としての該リガンドの使用に関する。<br class="style-scope patent-text">
【０００２】<br class="style-scope patent-text">
寄生蠕虫及び節足動物は、ヒト及び動物の健康上重大な問題である。農業の分野だけでみても、このような寄生虫により引き起こされる損害を退治又は防止するためにかかる費用は、全世界合計で年間７０億ドイツマルクを超える（１９９７年の統計）。多くの活性物質のクラスに属する数多くの活性物質が、主に蠕虫によって引き起こされる内因的寄生虫病（ｅｎｄｏｐａｒａｓｉｔｏｓｅｓ）及び主として節足動物によって引き起こされる外因的寄生虫病（ｅｃｔｏｐａｒａｓｉｔｏｓｅｓ）を処置するために利用されている。ここ２０年の間に、門（ｐｈｙｌｕｍ）内の多数の寄生生物種（例えば、蠕虫）に対し、または様々な動物学的門（ｚｏｏｌｏｇｉｃａｌ ｐｈｙｌａ）（例えば、蠕虫及び昆虫）の範囲にまで拡張したとしても、非常に良好な作用を同時に示す活性物質の重要性が特に増大している。とりわけ前者には広範なスペクトルを有する駆虫薬、例えばベンズイミダゾール又はイミダゾチアゾールなどが挙げられ、後者としては大環状ラクトンが挙げられる。<br class="style-scope patent-text">
【０００３】<br class="style-scope patent-text">
前回、新規の、広範な活性を有する活性物質の群が市場に出まわったのは、約２０年前のことで、それは大環状ラクトンであった。しかしながら、多くの内因的寄生虫及び外因的寄生虫種は、活性物質の個々のクラス及び幾つかの場合には同時に様々なクラスに対する耐性を獲得している。従って、駆虫活性を有する新規物質を開発する必要性が継続し、緊急性が増大している。<br class="style-scope patent-text">
【０００４】<br class="style-scope patent-text">
現在有効な活性物質の、数少ない有望な新しい群には、多数の特許の対象である環状デプシペプチド （ＷＯ ９３／１９０５３， ＥＰ ６２６ ３７６， ＷＯ ９４／１９３３４， ＷＯ ９５／０７２７２， ＥＰ ６２６ ３７５， ＥＰ ６５７ １７１， ＥＰ ６５７ １７２， ＥＰ ６５７ １７３） が含まれ、活性が調査されている （Ｃｏｎｄｅｒら、１９９５； Ｍａｒｔｉｎら、１９９６； Ｓａｓａｋｉら、１９９２； Ｔｅｒａｄａ Ｍ １９９２； Ｓａｍｓｏｎ−Ｈｉｍｍｅｌｓｔｊｅｒｎａら、２０００）。<br class="style-scope patent-text">
【０００５】<br class="style-scope patent-text">
この群の活性物質の１つの代表、ＰＦ １０２２Ａ （シクロ（−Ｄ−Ｌａｃ−Ｌ−ＭｅＬｅｕ−Ｄ−ＰｈＬａｃ−Ｌ−ＭｅＬｅｕ−）<sub class="style-scope patent-text">２</sub>）の作用機構を解明すべく、既に多くの研究が記載されている （参照として、ＤＥ−Ａ−１９７ ０４ ０２４中の該当箇所の情報）。これらには、環状デプシペプチドに対して特異的な結合タンパク質やヒツジ寄生虫Ｈａｅｍｏｎｃｈｕｓ ｃｏｎｔｏｒｔｕｓ （ＤＥ−Ａ−１９７ ０４ ０２４）由来のタンパク質をコードしているＤＮＡ配列を同定し、かつ特徴づけることが記載された。本発明の範囲として、ＨＣ１１０−Ｒと称される上記タンパク質の機能的相互作用、特に環状デプシペプチドの更なる代表としてのリガンドＢＡＹ ４４−４４００ （ｃｙｃｌｏ（−Ｄ−Ｌａｃ−Ｌ−ＭｅＬｅｕ−Ｄ−ｐ−モルホリニル−ＰｈＬａｃ−Ｌ−ＭｅＬｅｕ−）との機能的相互作用、を記載する。この目的のために、先の出願ＤＥ−Ａ−１９７ ０４ ０２４に記載の配列番号２に基づき、ＨＣ１１０−Ｒを発現する組換え真核細胞系を構築した。<br class="style-scope patent-text">
【０００６】<br class="style-scope patent-text">
従って本発明は、特に蠕虫及び節足動物の、好ましくは線虫及びダニ類由来の、特に好ましくは毛様線虫（Ｔｒｉｃｈｏｓｔｒｏｎｇｙｌｉｄａｅ）由来の、さらにより好ましくはＨａｅｍｏｎｃｈｕｓ ｓｐｐ．由来の膜貫通受容体に、とりわけＨ． ｃｏｎｔｏｒｔｕｓ由来の受容体ＨＣ１１０−Ｒに基づき、被験化合物の高速大量処理（ハイスループットスクリーニング検定；ＨＴＳ検定）が可能な試験システムを提供することを目的とする。<br class="style-scope patent-text">
【０００７】<br class="style-scope patent-text">
相同タンパク質は、文献ＤＥ−Ａ−１９７ ０４ ０２４（本文献の教示は本出願に包含される）に記載の配列番号２に示す配列と、少なくとも２０個、好ましくは少なくとも２５個、特に好ましくは３０個の連続したアミノ酸、さらにとりわけ好ましくはその全長にわたって、少なくとも７０％、好ましくは８０％、特に好ましくは９０％、より好ましくは９５％同一であるタンパク質とする。<br class="style-scope patent-text">
【０００８】<br class="style-scope patent-text">
アミノ酸配列の同一性は、標準設定のＧＣＧプログラムパッケージ、バージョン９．１のＧＡＰプログラムを用いて決定することが好ましい （Ｄｅｖｅｒｅｕｘら、１９８４）。<br class="style-scope patent-text">
【０００９】<br class="style-scope patent-text">
本目的は、ＧＰＣ受容体の少なくとも１つの生物学的活性を発揮するポリペプチドを提供することによって、並びにこれらポリペプチドを得る方法を提供することによって、並びに殺線虫活性及び殺節足動物活性を有する化合物の同定方法を提供することによって、達成される。<br class="style-scope patent-text">
【００１０】<br class="style-scope patent-text">
組換え微生物に基づく試験システムは、製薬的に活性な物質を同定するために多くの場で既に用いられており、また特に寄生虫遺伝子を組換え発現する微生物も使用されている （Ｋｌｅｉｎ ａｎｄ Ｇｅａｒｙ １９９７）。しかしながら、これまで、寄生虫膜貫通受容体を、標的として真核生物中にて組換え機能性タンパク質として用いたシステムは開示されていない。本発明中に記載する試験システムは、ハイ−スループット−スクリーニング（ＨＴＳ）又は超−ＨＴＳにて受容体の新規クラスを同定するのに用いることができる。<br class="style-scope patent-text">
【００１１】<br class="style-scope patent-text">
線虫由来の受容体を組換え発現させることは通常困難である。従って、線虫由来のＧタンパク共役受容体（ＧＰＣＲ）を、その機能特性（例えば、インヒビターに対する感受性）が天然受容体の特性に対応するような様式で発現させることは、今のところ一般に不可能である。<br class="style-scope patent-text">
【００１２】<br class="style-scope patent-text">
真核生物系における、蠕虫、特に線虫由来の、及び節足動物由来の受容体の機能的発現は、例えば新規の駆虫薬又は殺節足動物薬を探索するのに、実用上、非常に重要である。<br class="style-scope patent-text">
【００１３】<br class="style-scope patent-text">
従って、本発明はさらに、膜貫通受容体、特に線虫及び節足動物由来のＧＰＣ受容体を発現させる可能な方法を提供することを目的とし、これを踏まえて、殺線虫活性及び殺節足動物活性を有する新規物質を同定することができる試験システムを開発することに基づく。<br class="style-scope patent-text">
【００１４】<br class="style-scope patent-text">
従って、本発明は特に、蠕虫及び節足動物由来、好ましくは線虫及びダニ類由来、特に好ましくは毛様線虫由来、さらにより非常に好ましくは捻転胃虫由来、及び最も好ましくは寄生線虫Ｈ． ｃｏｎｔｏｒｔｕｓ由来のオーファンＧタンパク共役受容体を、殺線虫活性物質の効率的な探索のための標的タンパク質として発現させること、及び使用することに関する。<br class="style-scope patent-text">
【００１５】<br class="style-scope patent-text">
この受容体を、胃腸線虫Ｈ． ｃｏｎｔｏｒｔｕｓから得られたｃＤＮＡライブラリーにて同定した。そのｃＤＮＡは、１１０ｋＤａサイズの線虫の膜貫通タンパク質であって、ＨＣ１１０−Ｒと称される膜貫通タンパク質をコードしている。このタンパク質は、Ｇタンパク共役受容体（ＧＰＣＲ）のセクレチンファミリーに属しており、ラトロフィリン（ｌａｔｒｏｐｈｉｌｉｎ）と高い類似性を示す（図５）。<br class="style-scope patent-text">
【００１６】<br class="style-scope patent-text">
<u class="style-scope patent-text">標的としてのＨＣ１１０−Ｒ受容体</u> <br class="style-scope patent-text">
ＧＰＣＲラトロフィリンは、哺乳類の脳から独自に単離された。ラトロフィリンは分子量２１０ｋＤａであり、第一の膜貫通セグメントの１８残基上流で翻訳後開裂を受け、その結果、２つの非共有結合サブユニットから構成される。ｐ１２０サブユニットはＮ末端の親水性細胞外タンパク質を含み、ｐ８５サブユニットは７回膜貫通ドメインとラトロフィリンの細胞内Ｃ末端領域とを含み、ＧＰＣＲに対して異常に大きい。２つの近似した相同体、ラトロフィリン−２及びラトロフィリン−３が最近同定された（図６も参照のこと）。後者は、ラトロフィリン−１と同様に脳内で優先的に発現されるのに対し、ラトロフィリン−２は、優先的に哺乳類の胎盤、腎臓、脾臓、卵巣、心臓及び肺に偏在して発現される （Ｉｃｈｔｃｈｅｎｋｏら、１９９９； Ｓｕｇｉｔａら、１９９８）。<br class="style-scope patent-text">
【００１７】<br class="style-scope patent-text">
ＨＣ１１０−Ｒはラトロフィリン２１０ｋＤａの半分の大きさしかないが、配列の類似性は機能的な類似性にも及んでいる。両受容体に対する内因性リガンドは未だに知られていないが、ラトロフィリンとＨＣ１１０−Ｒはいずれも、人工リガンドα−ＬＴＸ（α−ラトロトキシン）により影響を受けることが知られている。<br class="style-scope patent-text">
【００１８】<br class="style-scope patent-text">
例えば、ＨＥＫ−２９３細胞をラトロフィリンで一過的にトランスフェクトする場合、放射性の<sup class="style-scope patent-text">４５</sup>Ｃａ<sup class="style-scope patent-text">２＋</sup>を用いる実験計画により示すことができるように、α−ＬＴＸの添加により外部Ｃａ<sup class="style-scope patent-text">２＋</sup>の流入を引き起こす。さらにα−ＬＴＸは、ＨＣ１１０−Ｒで一過的にトランスフェクションしたＨＥＫ−２９３細胞においても、Ｃａ<sup class="style-scope patent-text">２＋</sup>流入を引き起こし、これは例えばＣａ<sup class="style-scope patent-text">２＋</sup>イメージングにより観察できる）（図１０及び１１も参照のこと）。<br class="style-scope patent-text">
【００１９】<br class="style-scope patent-text">
しかしながら、このＣａ<sup class="style-scope patent-text">２＋</sup>流入は非常に複雑である。ＨＣ１１０−Ｒが、Ｃ末端に緑色蛍光タンパク質（ＧＦＰ）を結合した構築物の形である場合、流入は二相的である。即ち１つの変化は約３分後に、別のもう１つの変化は約２２分後に見られる。しかしながら、ＨＣ１１０−Ｒの前にＮ末端のＭｙｃ−Ｈｉｓタグのみある場合、主の流入は、α−ＬＴＸを添加した約２〜３分後にのみ観察される。この理由についてはまだ分かっていないが、α−ＬＴＸ添加に対する応答は、以下の説明によって示されるように特異的である：<br class="style-scope patent-text">
１．Ｃａ<sup class="style-scope patent-text">２＋</sup>流入は、トランスフェクトしていない細胞及びマウスβ<sub class="style-scope patent-text">２</sub>−アドレナリン作動性受容体で一過的にトランスフェクションした細胞では観察されない。<br class="style-scope patent-text">
２．［Ｃａ<sup class="style-scope patent-text">２＋</sup>］<sub class="style-scope patent-text">ｉ</sub>の変化はα−ＬＴＸの投与量に依存する（図１０）。<br class="style-scope patent-text">
３．二相的な変化には、ニフェジピンに対するそれらの感受性から明らかなように、Ｃｄ<sup class="style-scope patent-text">２＋</sup>によってブロックされ得るＣａ<sup class="style-scope patent-text">２＋</sup>チャネル、特にＬタイプのチャネルを介して起きるＣａ<sup class="style-scope patent-text">２＋</sup>流入であることが必要である。<br class="style-scope patent-text">
【００２０】<br class="style-scope patent-text">
α−ＬＴＸとＨＣ１１０−Ｒとの相互作用及びシグナル伝達の正確なメカニズムには、さらに説明が必要である。ラトロフィリン−１の例については、α−ＬＴＸによって引き起こされるＨＥＫ−２９３細胞中へのＣａ<sup class="style-scope patent-text">２＋</sup>流入に、単一の膜貫通ドメインのみが必要であることを証明することが可能である （Ｋｒａｓｐｅｒｎｏｖら、１９９９）。<br class="style-scope patent-text">
【００２１】<br class="style-scope patent-text">
本明細書に記載されたシステムにおいてニフェジピンがα−ＬＴＸの効果をブロックするという事実は、本システムは、新規の特異的なカルシウムチャネル遮断物質（ブロッカー）を同定するのにも適当であることを示している。ニフェジピンは、カルシウムチャネルアゴニスト及びアンタゴニストのクラスに属し、それらはカルシウムチャネルの特定の部位に対する結合、例えばＬタイプのチャネルに対する結合に基づいて、分類される。カルシウムチャネル遮断物質の主要な３つのクラス（Ｌタイプ）には、ベンジルアセトニトリル（ｂｅｎｚｙｌａｃｅｔｏｎｉｔｒｉｌｅ）（例えば、ベラパミル（ｖｅｒａｐａｍｉｌ）， ＷＯ ９１／０２４９７）、ベンゾチアゼピノン （例えば、ジルチアゼム）、及び１，４−ジヒドロピリジン誘導体（例えば、ニフェジピン、ニバルジピン（ｎｉｖａｌｄｉｐｉｎｅ）、ニモジピン、ニカルジピン、イスラジピン、アムロジピン、ニトレンジピン、フェロジピン又はニソルジピン）がある （Ｂａｃｏｎら、１９８９； ＷＯ ９０／０９７９２）。Ｌ−タイプカルシウムチャネル遮断物質の別のクラスには、１，３−ジホスホナート、例えばベルフォソジルが含まれる。<br class="style-scope patent-text">
【００２２】<br class="style-scope patent-text">
従って本発明はまた、新規カルシウムチャネル遮断物質を同定するための、α−ＬＴＸ結合膜貫通受容体の使用に関する。７回ラセン膜貫通受容体はこの目的の使用に特に好ましく、Ｇタンパク結合受容体であることが特に好ましい。セクレチンファミリーの膜貫通受容体の使用は特に非常に好ましい。最も好ましいのは、配列番号２に示されるＨＣ１１０−Ｒ受容体、及びそれと７０％、好ましくは８０％、特に好ましくは９０％、そして非常に好ましくは９５％相同的である受容体タンパク質の使用である。<br class="style-scope patent-text">
【００２３】<br class="style-scope patent-text">
入手可能なデータは、さらに、ＨＣ１１０−Ｒが新規駆虫薬デプシペプチドＢＡＹ４４−４４００の標的であることを示している。ＢＡＹ４４−４４００は、ＨＣ１１０−ＲでトランスフェクションしたＨＥＫ−２９３細胞においてα−ＬＴＸによるシグナル伝達を妨害する（図１２）。この妨害は、他のデプシペプチド、例えばビューヴァリシン（ｂｅａｕｖｅｒｉｃｉｎ）、エニアチン（ｅｎｎｉａｔｉｎ）などに典型的なように、ＢＡＹ４４−４４００のイオン透過活性から生じ得る（Ｇｅβｎｅｒら、１９９６）。しかしながら、ＢＡＹ４４−４４００は非トランスフェクト細胞では何の変化も引き起こさない。さらに、ＢＡＹ４４−４４００は、マウスβ<sub class="style-scope patent-text">２</sub>アドレナリン作動性受容体を用いてトランスフェクションしたＨＥＫ−２９３細胞を介するイソプロテレノール誘導性シグナル伝達を妨害しない。加えて、ＢＡＹ４４−４４００は、α−ＬＴＸのアンタゴニストとして作用するが、それ単独ではＨＣ１１０−ＲでトランスフェクションしたＨＥＫ−２９３細胞中のＣａ<sup class="style-scope patent-text">２＋</sup>濃度に影響を及ぼさない。<br class="style-scope patent-text">
【００２４】<br class="style-scope patent-text">
ＨＣ１１０−Ｒタンパク質<br class="style-scope patent-text">
ＤＥ １９７ ０４ ０２４ Ａ１に記載の膜タンパク質は、駆虫薬活性物質 ＰＦ１０２２Ａの可能性のある標的タンパク質であると同定された。寄生線虫Ｈａｅｍｏｎｃｈｕｓ ｃｏｎｔｏｒｔｕｓのλＺＡＰＩＩ ｃＤＮＡ発現ライブラリーを調製し、ＰＦ１０２２ＡとＫＬＨ （キーホール リンペットヘモシアニン）とのコンジュゲート ＰＦ１０２２Ａ−ＫＬＨおよびこのコンジュゲートに対するポリクローナル抗体を用いてｃＤＮＡライブラリーをスクリーニングすることにより、可能性のある標的タンパク質を同定した（実施例１を参照のこと）。非増殖組換えクローン約１．５×１０<sup class="style-scope patent-text">６</sup>の試験により、Ｈ． ｃｏｎｔｏｒｔｕｓ由来の３．６ｋｂ ｍＲＮＡとハイブリダイズする３０３６ｂｐ長のｃＤＮＡクローンが明らかとなった（実施例２も参照のこと）。ＲＡＣＥ ＰＣＲ法を用いて、３’末端及び５’末端を補完した（実施例４）。最終的に、３５３９ｂｐ長のｃＤＮＡを得、これをＨＣ１１０−Ｒと称した。このｃＤＮＡは、ＡＴＧ<sup class="style-scope patent-text">１００</sup>で始まるオープンリーディングフレームを有する９８６アミノ酸（１１０ｋＤａ）をコードしている（図２）。この開始コドンは、翻訳を最適に開始させるためのコザック配列に囲まれている。このタンパク質の導かれた分子量を、インビトロにて転写されたＨＣ１１０−Ｒ ＲＮＡのインビトロ翻訳により確認した。<br class="style-scope patent-text">
【００２５】<br class="style-scope patent-text">
ＨＣ１１０−Ｒタンパク質のアミノ酸配列は特定の構造を幾つか示す。このタンパク質の細胞外Ｎ末端部分は、全部で５３５残基から成る。このＮ末端には、２１アミノ酸長のシグナルペプチド及び１８位の開裂部位が含まれる。その次に、レクチン様配列（ＡＡ ２２−２１５）及び１４４位のセリンが唯一割り込んで存在しているいわゆる「Ｔｈｒ ストレッチ」 （ＡＡ １２８−１４７） がある。この「Ｔｈｒ ストレッチ」の下流には、構造 ＣＸ<sub class="style-scope patent-text">９</sub>ＷＸ<sub class="style-scope patent-text">１２</sub>ＣＸ<sub class="style-scope patent-text">９</sub>ＷＸＣＸ<sub class="style-scope patent-text">５</sub>ＷＸ<sub class="style-scope patent-text">９</sub>ＣＸ<sub class="style-scope patent-text">３</sub>Ｗ （ＡＡ １６６−２２１） を有するシステイン豊富（リッチ）モチーフがある。さらに、ＨＣ１１０−Ｒタンパク質は、５３６残基と７７２残基の間に７回疎水性ラセン膜貫通ドメインを含んでいる。この膜貫通領域のすぐ上流に、構造ＣＸＷＷＸ<sub class="style-scope patent-text">６</sub>ＷＸ<sub class="style-scope patent-text">４</sub>ＣＸ<sub class="style-scope patent-text">１１</sub>ＣＸＣ （ＡＡ ４７８−５２４）の４−Ｃｙｓ領域がさらに存在する。膜貫通領域に、残基５８７−５９７， ６５４−６７３及び７４３−７４９を含む３つの細胞外ループと、３つの細胞内ループ （５５９−５６９位， ６２７−６３６位， ６９６−７２４位）がある。Ｃ末端は、２１４残基長（２４ ｋＤａ）であり、プロリン リッチ部分（ＡＡ ８４５−８６１）やＰＥＳＴ領域（ＡＡ ９１５−９３３）を含む。最後に、誘導された細胞内ドメイン中に、さらに残基２６、４９９及び８６２の３個の推定Ｎ−グリコシル化部位、並びに１４個の推定リン酸エステル化部位がある（図６も参照のこと）。<br class="style-scope patent-text">
【００２６】<br class="style-scope patent-text">
データベース分析により、ＨＣ１１０−Ｒタンパク質は、線虫 Ｃａｅｎｏｒｈａｂｄｉｔｉｓ ｅｌｅｇａｎｓのゲノムクローンＢ０４５７（ジーンバンク<sup class="style-scope patent-text">ＴＭ</sup>アクセッションナンバーＺ５４３０６）から得られる未知の膜貫通タンパク質（１００１４ ＡＡ）と４８％同一で、７８％類似していることが明らかとなった（図３も参照のこと）。<br class="style-scope patent-text">
【００２７】<br class="style-scope patent-text">
本明細書にて用いる用語「同一性」は、いわゆるアライメントにて一致する配列部位の数を表す。これはアライメント長の百分率として示される。<br class="style-scope patent-text">
【００２８】<br class="style-scope patent-text">
本明細書中で用いられる用語「類似性」は、類似性計量に基づく配列の類似性であり、言い換えると、例えばバリンをスレオニン又はロイシンと仮定して、どの程度類似しているかの尺度である。<br class="style-scope patent-text">
【００２９】<br class="style-scope patent-text">
本明細書中で用いられる用語「相同的」は、進化上の関係を意味する、言い換えると、２つの相同タンパク質が共通の祖先配列から派生したものであるかどうかを意味する。この用語は、通常、相同配列の方がより類似している又はアライメントにおける一致部位が非相同配列よりも多いという事実は別にして、同一性又は類似性と何らかの関係がある必要はない。<br class="style-scope patent-text">
【００３０】<br class="style-scope patent-text">
２つの配列の比較によって、例えばレクチン様配列、「Ｔｈｒ ストレッチ」、Ｃｙｓモチーフ及びＰＥＳＴ配列など、両方のタンパク質に共通する特徴が示される。膜貫通領域で最も高い同一性が見出される（６２％）のに対し、Ｎ末端領域（４４％）及びＣ末端領域（５０％） における同一性はそれほど顕著ではない。<br class="style-scope patent-text">
【００３１】<br class="style-scope patent-text">
さらに、ＨＣ１１０−Ｒタンパク質は、７回ラセンＧタンパク共役膜貫通受容体（ＧＰＣＲ）、特にセクレチンサブファミリーに対して２０〜３０％の同一性を有する。７回膜貫通ドメインの比較により、構造及び配列に関してセクレチンサブファミリーの種々のＧＰＣＲとＨＣ１１０−Ｒとの間に高い同一性及び類似性が示される（図４）。<br class="style-scope patent-text">
【００３２】<br class="style-scope patent-text">
セクレチンサブファミリーのメンバーであるラトロフィリン、哺乳類、例えばヒト由来（ジーンバンク<sup class="style-scope patent-text">ＴＭ</sup>アクセッションナンバー： Ｅ１３６０６９０）、ウシ由来（例えば、Ｇ４１６０２１、Ｇ４１６０５３及びＧ４１８５８０４）、及びラット由来 （Ｕ７８１０５又はＵ７２４８７）は、他のセクレチン受容体よりも、ＨＣ１１０−Ｒに対して幾分高い同一性を示す。特に、膜貫通領域の同一性は４５〜４８％を示す。ＨＣ１１０−Ｒ及び１４６６アミノ酸のラット ラトロフィリン−１ ＧＰＣＲ（Ｕ７８１０５）は、例えば、膜貫通領域の前にレクチンドメイン、システイン豊富ドメイン及び保存的な４−Ｃｙｓモチーフがあるなど共通の特徴を示す。後者は、ラトロフィリン及び他の巨大セクレチンＧＰＣＲのタンパク質分解部位であることが最近示された。比較すると、ＨＣ１１０−ＲのＮ末端は、ラトロフィリンのオルファクトメジン領域及びＰｒｏ／Ｔｈｒ領域を含まないが、ラトロフィリンはその代わり、ＨＣ１１０−Ｒの「Ｔｈｒ ストレッチ」を有しない。<br class="style-scope patent-text">
【００３３】<br class="style-scope patent-text">
従って、本出願はさらに、駆虫活性を有する物質を同定するための、蠕虫由来の７回膜貫通ドメインを有するＧタンパク共役膜貫通受容体の使用に関する。本発明に基づき、セクレチンサブファミリーが有し得る膜貫通受容体の使用が好ましい。<br class="style-scope patent-text">
【００３４】<br class="style-scope patent-text">
<u class="style-scope patent-text">細胞での局在</u> <br class="style-scope patent-text">
一過性トランスフェクション実験は、種々の哺乳類細胞系、例えばＣＯＳ−７細胞又はＨＥＫ−２９３細胞において、ＨＣ１１０−Ｒ−ＧＦＰ融合タンパク質を用いて行なった（図７）。Ｈ． ｃｏｎｔｏｒｔｕｓ細胞系がまだ確立されていないため、非相同的発現を選択した。<br class="style-scope patent-text">
【００３５】<br class="style-scope patent-text">
パシフィック・クラゲＡｅｑｕｏｒｅａ ｖｉｃｔｏｒｉａ由来の緑色蛍光タンパク質（ＧＦＰ）は、生細胞においてタンパク質の場所を特定するために用いることができる（図８を参照のこと）。ＧＦＰは、一過性トランスフェクト又は安定なトランスフェクトの頻度を示すためのインビボレポーターとして細胞レベルで、及びタンパク質の局在を特定するために細胞下レベルで用いられる。野生型ＧＦＰは、ＵＶライト（３６０〜４００ｎｍ； 最大３９５ｎｍ）又は青色ライト（４４０〜４８０ｎｍ； 最大４７５ｎｍ）による励起後に最大５０９ｎｍの緑色光を発する、２３８アミノ酸から構成される２７ｋＤａのモノマーであり、外来物質又は補因子を必要としない（Ｃｈａｌｆｉｅら，　１９９４）。したがって、ＧＦＰは蛍光顕微鏡により直接インビボ検出でき、かつその蛍光特徴は融合タンパク質の一部であっても本質的に変わることはない。ＥＧＦＰ（増強ＧＦＰ）は、野生型ＧＦＰの遺伝的変異体であり、哺乳動物細胞のトランスフェクトに用いられる （Ｙａｎｇら、１９９６）。ＥＧＦＰの最大励起は、Ｓｅｒ<sup class="style-scope patent-text">６５</sup>をＴｈｒに置換することで唯一の４９０ｎｍのピークに移動した。ベクターｐＥＧＦＰ−Ｃ１ （ジーンバンクアクセッションナンバー： Ｕ５５７６３） 及びｐＥＧＦＰ−Ｎ３ （ジーンバンクアクセッションナンバー： Ｕ５５７６２） ［クローンテック， Ｐａｌｏ Ａｌｔｏ， ＣＡ， Ｕ．Ｓ．Ａ．］ は、強力な構成性ＣＭＶプロモーターの退治下にＥＧＦＰを発現し、ＥＧＦＰのＮ末端及びＣ末端のそれぞれに別のタンパク質を融合させるために用いることができる。<br class="style-scope patent-text">
【００３６】<br class="style-scope patent-text">
安定な細胞系は、全ての細胞が所望のタンパク質を恒常的に発現し、局在化した後も所望のタンパク質を単離できる点で、一過性発現よりも有利である。蛍光顕微鏡又はウェスタンブロットの助けによってタンパク質を検出するために、所望のタンパク質に対する抗体が必要であるか、または、実際のタンパク質のＣ末端にＭｙｃ又はＨｉｓタグを正しいリーディングフレームで融合させる発現ベクターを選択することが適当であり、大抵の場合、モノクローナル抗体であっても、それに対する抗体を購入することができる。<br class="style-scope patent-text">
【００３７】<br class="style-scope patent-text">
同様に、本発明は、ＨＣ １１０−Ｒ受容体及び可能であればそれと相同的なタンパク質を安定に発現する細胞に関する。<br class="style-scope patent-text">
【００３８】<br class="style-scope patent-text">
<u class="style-scope patent-text">ＨＣ１１０−Ｒタンパク質に対するα−ラトロトキシンの効果</u> <br class="style-scope patent-text">
ＨＣ１１０−Ｒとラトロフィリンとの間の類似性をさらに実証するため、及び組換え的に発現したＨＣ１１０−Ｒの機能を試験するため、ＨＥＫ−２９３細胞を、ＨＣ１１０−Ｒ−ＧＦＰ融合タンパク質を用いて一過的にトランスフェクト及び安定にトランスフェクトし、α−ラトロトキシン（α−ＬＴＲ）を用いて刺激した。<br class="style-scope patent-text">
【００３９】<br class="style-scope patent-text">
α−ラトロトキシンは、クロゴケグモ（Ｌａｔｒｏｄｅｃｔｕｓ ｍａｃｔａｎｓ）毒から単離し得るシナプス前神経毒である。脊椎動物の中枢神経系に対するその毒性は知られており、［Ｃａ<sup class="style-scope patent-text">２＋</sup>］<sub class="style-scope patent-text">ｉ</sub>を増大させ、神経伝達物質の非退治型のエキソサイトーシスを刺激することで神経の脱分極を引き起こす。このように、α−ラトロトキシンの効果は、少なくとも部分的にラトロフィリンにより媒介されることも明らかとなった。さらに、α−ラトロトキシンの毒性は、ＧＴＰ結合タンパク質と共役する受容体（ＧＰＣＲ）と相互作用するその能力に拠るものであると推定される。これらの受容体は、通常、内因性ホルモン又は神経ペプチドの効果を媒介する （Ｈｏｌｚ及びＨａｂｅｎｅｒ １９９８）。<br class="style-scope patent-text">
【００４０】<br class="style-scope patent-text">
トランスフェクションしたＨＥＫ−２９３細胞のα−ＬＴＸに対する応答を試験するため、本発明では、この細胞中に存在するＣａ<sup class="style-scope patent-text">２＋</sup> 即ち［Ｃａ<sup class="style-scope patent-text">２＋</sup>］<sub class="style-scope patent-text">ｉ</sub>の変化を測定することによる、いわゆるＣａ<sup class="style-scope patent-text">２＋</sup>イメージング技術を用いた （実施例２４、及び図９、１０及び１１を参照）。<br class="style-scope patent-text">
【００４１】<br class="style-scope patent-text">
α−ＬＲＸは、［Ｃａ<sup class="style-scope patent-text">２＋</sup>］<sub class="style-scope patent-text">ｉ</sub>の二相的な増大を引き起こす。７５ｎＭの濃度で、α−ＬＴＸは、まず、α−ＬＴＸの添加から２分後に僅か５±０．２ｎｍの非常に小さな増大を生じ、２２分後に約２２０±１４．９ｎＭ Ｃａ<sup class="style-scope patent-text">２＋</sup>の大きい遅延型の増大を生じる。α−ＬＴＸの濃度が増加（７．５ ｎＭ〜１２０ ｎＭ）するにつれ、最初の増大は大きくなり、第二の増大は小さくなる。１２０ｎＭのα−ＬＴＸ濃度で、第一の増大値は約１３５±１３．６ｎＭ Ｃａ<sup class="style-scope patent-text">２＋</sup>に達するが、一方で第二の増大値は約５０±７．１ｎＭ Ｃａ<sup class="style-scope patent-text">２＋</sup>にまで落ち込む。９０ｎＭ及び１２０ｎＭのα−ＬＴＸを用いる同じプロファイルでは飽和を示す。<br class="style-scope patent-text">
【００４２】<br class="style-scope patent-text">
Ｎ末端ＧＦＰタグＨＣ１１０−Ｒ構築物を用いてＨＥＫ−２９３細胞をトランスフェクトし、それをα−ＬＴＸ ７５ｎＭで刺激すると、第二のピークが僅かに低下する。また、ＨＣ１１０−Ｒタンパク質をＮ末端ＧＦＰタグを用いて提供した場合、最終的に、α−ＬＴＸに対する応答がほんの僅か減少した。従って、ＧＦＰタグのＮ−又はＣ−末端への結合は、ＨＣ１１０−Ｒによるα−ＬＴＸ結合及び次のシグナル伝達に対する影響を無視できると考えられる。<br class="style-scope patent-text">
【００４３】<br class="style-scope patent-text">
トランスフェクトしていない、又はＧＦＰを用いて単に一過的にトランスフェクションした細胞は、α−ＬＴＸに対して応答を示さない。Ｃ末端ＧＦＰタグを有する他のＧタンパク共役受容体、例えばマウスβ<sub class="style-scope patent-text">２</sub>アドレナリン作動性受容体、又はヒト ムスカリン性Ｈ１アセチルコリン受容体を用いてＨＥＫ−２９３細胞を一過的にトランスフェクションした場合に、濃度７５ｎＭのα−ＬＴＸにより引き起こされる［Ｃａ<sup class="style-scope patent-text">２＋</sup>］<sub class="style-scope patent-text">ｉ</sub>の増大は、ほんの僅かである（２０分後に約４０±１０．４）か、又はゼロである。<br class="style-scope patent-text">
【００４４】<br class="style-scope patent-text">
α−ＬＴＸにより引き起こされる［Ｃａ<sup class="style-scope patent-text">２＋</sup>］<sub class="style-scope patent-text">ｉ</sub>の増大は、細胞外Ｃａ<sup class="style-scope patent-text">２＋</sup>の流入と細胞内Ｃａ<sup class="style-scope patent-text">２＋</sup>の流出の両方につながり得る。α−ＬＴＸを添加する前又は後に、細胞外Ｃａ<sup class="style-scope patent-text">２＋</sup>を２ｍＭ ＥＧＴＡを用いて除去した場合、ＨＣ１１０−Ｒ−ＧＦＰ融合タンパク質を発現するＨＥＫ−２９３細胞の［Ｃａ<sup class="style-scope patent-text">２＋</sup>］<sub class="style-scope patent-text">ｉ</sub>にはほんの僅かな増大が表れる。このことから、α−ＬＴＸは主に、細胞外Ｃａ<sup class="style-scope patent-text">２＋</sup>の流入を引き起こすことが明らかである。このＣａ<sup class="style-scope patent-text">２＋</sup>流入は、単純拡散に基づくものではなく、原形質膜のＣａ<sup class="style-scope patent-text">２＋</sup>チャネルの力により生じる。<br class="style-scope patent-text">
【００４５】<br class="style-scope patent-text">
１５μＭのニフェジピンは、［Ｃａ<sup class="style-scope patent-text">２＋</sup>］<sub class="style-scope patent-text">ｉ</sub>のα−ＬＴＸ誘導性の増大を有意に低下させるに十分であることから、Ｃａ<sup class="style-scope patent-text">２＋</sup>流入に関与するＣａ<sup class="style-scope patent-text">２＋</sup>チャネルの大部分はＬタイプである。さらに、第一の増大が完全に阻害され、第二の増大は２６７±１２．７ｎＭから３０±５．４ｎＭにまで落ち込む。<br class="style-scope patent-text">
【００４６】<br class="style-scope patent-text">
また、Ｃ末端Ｍｙｃ／Ｈｉｓタグを有するＨＣ１１０−Ｒ受容体を発現する安定な又は一過性のＨＥＫ−２９３細胞系は、α−ＬＴＸに用量依存的に応答する（図１０を参照のこと）。７．５ｎＭのα−ＬＴＸでは、この場合でも同様に、α−ＬＴＸ−誘導性のＣａ<sup class="style-scope patent-text">２＋</sup>流入を生じさせるには少なすぎる。しかしながら、さらに２５ｎＭ α−ＬＴＸは、僅か２分後に［Ｃａ<sup class="style-scope patent-text">２＋</sup>］<sub class="style-scope patent-text">ｉ</sub>を１３０±３８．０ｎＭにまで増大させるのに十分である。７５ｎＭ α−ＬＴＸを添加することで２９６±９１．５ ｎＭのＣａ<sup class="style-scope patent-text">２＋</sup>流入が生じる、これはα−ＬＴＸ添加２分後に同様に非常に増大し、たった２７分後にもとのＣａ<sup class="style-scope patent-text">２＋</sup>含有量に戻る。このＣａ<sup class="style-scope patent-text">２＋</sup>シグナルは、シグナルの高さ及びそのプロファイルについて、同じα−ＬＴＸ濃度（７５ｎＭ）のＨＣ１１０−Ｒ−ＧＦＰトランスフェクトＨＥＫ２９３細胞の第二の遅延型のＣａ<sup class="style-scope patent-text">２＋</sup>ピークに似ているが、その応答は（また、高濃度（９０ｎＭ及び１２０ｎＭ）のＨＣ１１０−Ｒ−ＧＦＰトランスフェクト細胞について同様に）α−ＬＴＸ添加後すぐに起こる。<br class="style-scope patent-text">
【００４７】<br class="style-scope patent-text">
従って、本発明は同様に、線虫由来のセクレチン（ｓｅｋｒｅｔｉｎ）ファミリーの膜貫通受容体のアゴニストとしての、α−ＬＴＸの使用に関する。α−ＬＴＸは、配列番号２に示すＨＣ１１０−Ｒ受容体、及びそれと７０％、好ましくは８０％、特に好ましくは９０％、さらにとりわけ非常に好ましくは９５％相同的である受容体タンパク質のアゴニストとして用いることが好ましい。<br class="style-scope patent-text">
【００４８】<br class="style-scope patent-text">
同様に、本発明は殺線虫剤としてのα−ＬＴＸの使用に関する。<br class="style-scope patent-text">
【００４９】<br class="style-scope patent-text">
同様に、本発明は、殺線虫活性又は殺節足動物活性を有する化合物、膜貫通受容体のアゴニスト又はアンタゴニストとして活性である可能性のある化合物を同定する方法における、α−ＬＴＸの使用に関する。<br class="style-scope patent-text">
【００５０】<br class="style-scope patent-text">
同様に、本発明は、カルシウムチャネルをブロックする化合物を同定する方法における、α−ＬＴＸの使用に関する。<br class="style-scope patent-text">
【００５１】<br class="style-scope patent-text">
<u class="style-scope patent-text">α−ＬＴＸの作用に対するＢＡＹ ４４−４４００の効果</u> <br class="style-scope patent-text">
ＰＦ１０２２Ａは、具体的な種に依存して、１００〜８００ｎｇ／ｍＬの濃度範囲で線虫に対してその効果を発揮する （Ｔｅｒａｄａ， １９９２） 。ＨＣ１１０−ＲとＰＦ１０２２Ａとの間の何らかの可能性のある相互作用、及びＨＣ１１０−Ｒにより媒介されるシグナル伝達を、各場合において調べるため、ＰＦ１０２２Ａの容易に可溶化する誘導体であるＢＡＹ４４−４４００を、ＦＵＲＡ−２をローディングし、ＨＣ１１０−Ｒ−ＧＦＰでトランスフェクションしたＨＥＫ−２９３細胞における、以下のＣａ<sup class="style-scope patent-text">２＋</sup>イメージング実験に用いた。<br class="style-scope patent-text">
【００５２】<br class="style-scope patent-text">
４００ｎｇ／ｍＬの濃度では、細胞を活性物質で９０分間プレインキュベーションしても、非常に有効な殺線虫剤 ＢＡＹ４４−４４００及び事実上効果のない鏡像体ＰＦ１０２２−００１のいずれも、ＨＣ１１０−Ｒ−ＧＦＰでトランスフェクションしたＨＥＫ２９３細胞においてＣａ<sup class="style-scope patent-text">２＋</sup>応答を引き起こさない。これとは対照的に、両物質は、程度は異なるが、α−ＬＴＸに依存してシグナル伝達に影響を及ぼす（図１２及び１４）。４ｎｇ／ｍＬのＢＡＹ４４−４４００の存在下では、α−ＬＴＸは、１４分後に最大４４±６．０ｎＭ Ｃａ<sup class="style-scope patent-text">２＋</sup>の小さいＣａ<sup class="style-scope patent-text">２＋</sup>増大のみを誘導する（図１２）。しかしながら、ＰＦ１０２２−００１の存在下では、α−ＬＴＸは、６分後に１０３±１１．５ｎＭ Ｃａ<sup class="style-scope patent-text">２＋</sup>のより大きな増大を引き起こす（図１０Ｂ）。別の方法では、細胞を４ｎｇ／ｍＬ又は４００ｎｇ／ｍＬのＢＡＹ４４−４４００及びＰＦ１０２２Ａと９０分間プレインキュベーションし、次いで活性物質を除去したのち、細胞をα−ＬＴＸで刺激した。ＰＦ１０２２ＡとプレインキュベーションしたＨＥＫ−２９３細胞は、α−ＬＴＸに対する応答において有意な変化はなかった。ＢＡＹ４４−４４００のみが、α−ＬＴＸに対する細胞の感受性に影響を及ぼした。濃度４ｎｇ／ｍＬのＢＡＹ４４−４４００において、α−ＬＴＸは、安定なＣａ<sup class="style-scope patent-text">２＋</sup>レベルに達する１９分前に、Ｃａ<sup class="style-scope patent-text">２＋</sup>増大（９５±２０．５ ｎＭ Ｃａ<sup class="style-scope patent-text">２＋</sup>）を誘導した。４００ｎｇ／ｍＬのＢＡＹ４４−４４００では、α−ＬＴＸは、約６５±７．５ｎＭ Ｃａ<sup class="style-scope patent-text">２＋</sup>だけＣａ<sup class="style-scope patent-text">２＋</sup>濃度の増大をもたらした。さらに、この小さな増大は１２分移動した。<br class="style-scope patent-text">
【００５３】<br class="style-scope patent-text">
これらの結果の特異性を確認するため、さらに、内因性の天然Ｍ１−Ｒに対する１ｍＭカルバコールの効果を、非トランスフェクトＨＥＫ−２９３細胞において測定した。４００ｎｇ／ｍＬのＢＡＹ４４−４４００の存在は、細胞の応答に変化を及ぼさなかった。ＨＥＫ−２９３細胞において、内因性の天然β<sub class="style-scope patent-text">２</sub>−Ｒの、又はニコチンコリン作動性受容体の、イソプロテレノール及びアレコリンにより誘導された刺激はいずれも、ＢＡＹ４４−４４００によって何ら影響を受けなかった。<br class="style-scope patent-text">
【００５４】<br class="style-scope patent-text">
最後に、本発明の範囲内である、Ｃ末端にＧＦＰを伴って提供されるＨＣ１１０−Ｒタンパク質を一過的にまたは安定に発現するＨＥＫ−２９３細胞におけるＨＣ１１０−Ｒタンパク質に対する、ＰＦ１０２２Ａ変異体のより可溶性の変異体であるＢＡＹ４４−４４００の効果を、Ｃａ<sup class="style-scope patent-text">２＋</sup>イメージングにより調べた。ＨＥＫ−２９３細胞を４００ｎｇ／ｍＬのＢＡＹ４４−４４００のみとインキュベートすると、細胞は、細胞内のＣａ<sup class="style-scope patent-text">２＋</sup>濃度における変化とは類似しない様式で５０分間応答した。しかしながら、ＢＡＹ４４−４４００の効果はα−ＬＴＸの存在下で認められる。７５ｎＭ α−ＬＴＸを加える前に、細胞をＢＡＹ４４−４４００と６分間インキュベートすることで、Ｃａ<sup class="style-scope patent-text">２＋</sup>濃度に対するα−ＬＴＸの効果が低下する。［Ｃａ<sup class="style-scope patent-text">２＋</sup>］<sub class="style-scope patent-text">ｉ</sub>における最初の小さな増大は見られず、第二の増大はα−ＬＴＸを加えた１５分後に８５％にまで低下する。α−ＬＴＸに対する応答は、細胞をＦＵＲＡで３０分間処理する前に、ＢＡＹ４４−４４００と６０分間プレインキュベーションした場合、さらに強力なものとなる。Ｃａ<sup class="style-scope patent-text">２＋</sup>の最初の増大は全く見られず、７０ｎＭ ［Ｃａ<sup class="style-scope patent-text">２＋</sup>］<sub class="style-scope patent-text">ｉ</sub>の非常に小さな第二の増大が、７５ｎＭ α−ＬＴＸを加えた３０分後に見られるのみである。<br class="style-scope patent-text">
【００５５】<br class="style-scope patent-text">
α−ＬＴＸの作用に対するＢＡＹ４４−４４００の特異的な効果を示すため、２つの対照実験を行なった。最初に、ＨＥＫ−２９３細胞を、Ｃ末端にＧＦＰタグを伴って提供されるマウスβ<sub class="style-scope patent-text">２</sub>−アドレナリン作動性受容体で一過的にトランスフェクト又は安定にトランスフェクトして、イソプロテレノールをリガンドとして用いた。<br class="style-scope patent-text">
【００５６】<br class="style-scope patent-text">
実際に、イソプロテレノールも有意なＣａ<sup class="style-scope patent-text">２＋</sup>応答を引き起こす：イソプロテレノールを添加した後すぐに、Ｃａ<sup class="style-scope patent-text">２＋</sup>の増大のみが表れる。しかしながら、この増大はＢＡＹ４４−４４００の影響を受けない。<br class="style-scope patent-text">
【００５７】<br class="style-scope patent-text">
さらに、ＢＡＹ４４−４４００とＨＣ１１０−Ｒとの間の相互作用の特異性は、リガンドとしてＢＡＹ４４−４４００の部位を占める光学対掌体によって示される。駆虫活性が１００倍弱いＰＦ１０２２Ａ誘導体、ＰＦ１０２２−００１：シクロ（−Ｌ−Ｌａｃ−Ｄ−ＭｅＬｅｕ−Ｌ−ＰｈＬａｃ−Ｄ−Ｍｅ−Ｌｅｕ−）<sub class="style-scope patent-text">２</sub> （光学対掌体とも称する） を４００ｎｇ／ｍＬ用いて、細胞を９０分間前処理した後、７５ｎＭ α−ＬＴＸを添加した６分後に、僅か１１０ｎＭ Ｃａ<sup class="style-scope patent-text">２＋</sup>の増大が表れた、これは５９％にまで低下したことを意味する。４ｎｇ／ｍＬの光学対掌体を、７５ｎＭ α−ＬＴＸを添加する６分前に加えた場合、α−ＬＴＸを添加してすぐに６７ｎＭ ［Ｃａ<sup class="style-scope patent-text">２＋</sup>］<sub class="style-scope patent-text">ｉ</sub>の増大がみられる。光学対掌体の濃度を増加した場合、増大は２０ｎＭ Ｃａ<sup class="style-scope patent-text">２＋</sup>にまで低下する。<br class="style-scope patent-text">
【００５８】<br class="style-scope patent-text">
本明細書中にて用いられる用語「ポリペプチド」は、通常、ペプチド、オリゴペプチド又はオリゴマーと称される短いアミノ酸鎖と、通常タンパク質と称される長いアミノ酸鎖との両方を意味する。これには、天然のプロセス、例えば翻訳後プロセッシングによるか、あるいは最先端の化学的方法によるかのいずれかによって修飾され得るアミノ酸鎖が含まれる。このような修飾は、ポリペプチドの様々な部位で、かつ１つ以上が生じ得る、例えばペプチド骨格（バックボーン）で、アミノ酸側鎖で、アミノ末端宿主カルボキシ末端で生じ得る。これらには、例えばアセチル化、アシル化、ＡＤＰリボシル化、アミド化、フラビン、ヘム部分、ヌクレオチド若しくはヌクレオチド誘導体、脂質若しくは脂質誘導体またはホスファチジルイノシトールとの共有結合、環化、ジスルフィド架橋形成、ジメチル化、シスチン形成、ホルミル化、γ−カルボキシル化、グリコシル化、ヒドロキシル化、ヨウ素化、メチル化、ミリストイル化、酸化、タンパク質加水分解プロセッシング、リン酸化、セレノイル化及びｔＲＮＡ媒介のアミノ酸付加が包含される。<br class="style-scope patent-text">
【００５９】<br class="style-scope patent-text">
ポリペプチドは、本発明に基づいて、「成熟」タンパク質の形態において、又は大きなタンパク質（例えば、融合タンパク質）の一部として用いることができる。これには、さらに分泌配列又は「リーダー」配列、プロ配列（ｐｒｏ−ｓｅｑｕｅｎｃｅｓ）、簡単な精製を可能にする配列（例えば複数のヒスチジン残基）、又はさらなる安定化アミノ酸が包含され得る。<br class="style-scope patent-text">
【００６０】<br class="style-scope patent-text">
相同タンパク質又は相同ポリペプチドは、文献ＤＥ−Ａ−１９７ ０４ ０２４（本文献の教示は本出願に包含される）に記載の配列番号２に示す配列と少なくとも７０％、好ましくは８０％、特に好ましくは９０％、とりわけ非常に好ましくは９５％一致し、少なくとも２０個、好ましくは少なくとも２５個、特に好ましくは少なくとも３０個の連続アミノ酸、とりわけ非常に好ましくはその完全長を有するタンパク質又はポリペプチドとする。<br class="style-scope patent-text">
【００６１】<br class="style-scope patent-text">
本発明のポリペプチドの使用によれば、ポリペプチドは完全な受容体を表す必要はなく、少なくとも完全な受容体の生物学的活性を有してさえいれば、その単なる断片であって良い。さらに、ポリペプチドはＨ． ｃｏｎｔｏｒｔｕｓの膜貫通受容体から得られるものである必要もない。蠕虫又はさらに節足動物の別の種の膜貫通受容体に対応するポリペプチドあるいはその受容体の生物学的活性を発揮することさえできればその断片でさえ、本発明に従うものとする。<br class="style-scope patent-text">
【００６２】<br class="style-scope patent-text">
本発明のポリペプチドの使用に関して、ポリペプチドは、完全なＧＰＣ受容体の生物学的活性を少なくとも１つを発揮しさえすれば、天然のＧＰＣ受容体の対応する領域と比較して欠失又はアミノ酸置換を有していて良い。保存的な置換が好ましい。このような保存的置換には、１つのアミノ酸が以下の群由来の別のアミノ酸に置換された変異体を包含する：<br class="style-scope patent-text">
１．小さい脂肪族、無極性又は僅かに極性のある残基： Ａｌａ， Ｓｅｒ， Ｔｈｒ， Ｐｒｏ 及びＧｌｙ；<br class="style-scope patent-text">
２．極性、負に帯電している残基及びそのアミド： Ａｓｐ， Ａｓｎ， Ｇｌｕ及びＧｌｎ；<br class="style-scope patent-text">
３．極性、正に帯電している残基： Ｈｉｓ， Ａｒｇ及びＬｙｓ；<br class="style-scope patent-text">
４．大きな脂肪族、無極性残基： Ｍｅｔ， Ｌｅｕ， Ｉｌｅ， Ｖａｌ 及びＣｙｓ； 並びに<br class="style-scope patent-text">
５．芳香族残基： Ｐｈｅ， Ｔｙｒ及びＴｒｐ。<br class="style-scope patent-text">
【００６３】<br class="style-scope patent-text">
以下のリストは、好ましい保存的置換を示す：<br class="style-scope patent-text">
</span></span></p><div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/04/4c/a0/92d3e6f2c972b2/2004508052-99.png" class="style-scope patent-text"><img he="177" id="000002" wi="151" file="2004508052.tif" img-format="tif" img-content="drawing" width="604" height="708" alt="Figure 2004508052" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/04/4c/a0/92d3e6f2c972b2/2004508052-99.png"></a></div>
【００６４】<br class="style-scope patent-text">
上記の配列、及びＤＥ−Ａ−１９７ ０４ ０２４の配列番号１及び配列番号３に記載の配列は、蠕虫又は節足動物中の機能的に類似の膜貫通受容体の構造に関与するポリペプチドをコードする遺伝子を見い出すのにも用いることができる。本発明に基づく機能的に類似の受容体とは、本明細書中に記載のポリペプチドとアミノ酸配列が異なっていても、本質的に同じ生物学的機能を有しているポリペプチドを包含する受容体を意味する。<br class="style-scope patent-text">
【００６５】<br class="style-scope patent-text">
本明細書にて用いる用語「本質的に同じ生物学的機能」とは、機能することが可能なＧタンパク共役７回ラセン膜貫通受容体、特にセクレチンサブファミリーの受容体、の構造における関与、又はＨ． ｃｏｎｔｏｒｔｕｓ由来のＨＣ１１０−Ｒ受容体に相当する機能を意味する。該機能には、該受容体の上記の特性、例えばアゴニストとしてのα−ＬＴＸ又はα−ＬＴＸのアンタゴニストとしてのニフェジピンに対する感受性も、また含まれる。<br class="style-scope patent-text">
【００６６】<br class="style-scope patent-text">
本明細書にて用いる用語「ハイブリダイズ」は、１本鎖の核酸分子が相補鎖と塩基対を形成するプロセスを表す。本明細書中に記載の情報の配列から出発することで、例えば、Ｈ． ｃｏｎｔｏｒｔｕｓ以外の他の線虫由来、及び節足動物由来の、ＧＰＣ受容体の生物学的活性を有するポリペプチドをコードするＤＮＡ断片を単離できる。<br class="style-scope patent-text">
【００６７】<br class="style-scope patent-text">
適当なプローブに関して、アミノ末端及びカルボキシ末端のｃＤＮＡ部分が好ましい。ハイブリダイゼーション条件は、他の生物に由来する類似性の低い配列を検出することもできるように選ばれる。ストリンジェンシーの低いハイブリダイゼーション条件は、以下のようなものでよい：例えば、ハイブリダイゼーション溶液として６×ＳＳＣ／０％ ホルムアミド中、４０〜５５℃でハイブリダイゼーションを行なう。２回目の洗浄工程の条件は試験しなければならない、例えば、まず５０℃にて２×ＳＳＣで行ない、次いでそのシグナルの強度を評価する。次いで、洗浄条件に変更を加える。<br class="style-scope patent-text">
【００６８】<br class="style-scope patent-text">
適当なハイブリダイゼーション条件を、以下に例示として示す：<br class="style-scope patent-text">
ハイブリダイゼーション溶液：６×ＳＳＣ／０％ ホルムアミド、好ましいハイブリダイゼーション溶液：６×ＳＳＣ／０％ ホルムアミド<br class="style-scope patent-text">
ハイブリダイゼーション温度：３４℃、好ましいハイブリダイゼーション温度：４２℃<br class="style-scope patent-text">
１回目の洗浄工程：４０℃にて２×ＳＳＣ<br class="style-scope patent-text">
２回目の洗浄工程：４５℃にて２×ＳＳＣ；好ましい２回目の洗浄工程：５５℃にて０．６×ＳＳＣ：特に好ましい２回目の洗浄工程：６５℃にて０．３×ＳＳＣ。<br class="style-scope patent-text">
【００６９】<br class="style-scope patent-text">
ハイブリダイゼーション条件は、以下の式により適宜計算する：<br class="style-scope patent-text">
融解温度Ｔｍ＝８１．５℃＋１６．６ ｌｏｇ［ｃ（Ｎａ<sup class="style-scope patent-text">＋</sup>）］＋０．４１（％Ｇ＋Ｃ））−５００／ｎ<br class="style-scope patent-text">
（Ｌｏｔｔｓｐｅｉｃｈ ａｎｄ Ｚｏｒｂａｓ　１９９８）。<br class="style-scope patent-text">
【００７０】<br class="style-scope patent-text">
式中、ｃは濃度であり、ｎは塩基対のハイブリダイズする配列部分の長さである。５００／ｎの項は１００ｂｐを超える配列について除外される。最大のストリンジェンシーの洗浄は、Ｔｍより５〜１５℃低い温度で、１５ｍＭ Ｎａ＋のイオン強度（０．１×ＳＳＣに相当する）である。ハイブリダイゼーションにＲＮＡプローブを用いる場合、溶解温度は１０〜１５℃高くなる。<br class="style-scope patent-text">
【００７１】<br class="style-scope patent-text">
殺線虫活性及び殺節足動活性を有する化合物を同定するための本発明の方法に用いるポリペプチドは、ＤＥ−Ａ−１９７ ０４ ０２４に記載の配列番号１及び配列番号３に記載の核酸によりコードされる。<br class="style-scope patent-text">
【００７２】<br class="style-scope patent-text">
また、本発明の方法に含まれるものとしては、少なくとも２０個、好ましくは少なくとも１００個、特に好ましくは少なくとも５００個の連続したヌクレオチド、及びとりわけより好ましくは完全長にわたって、配列番号１又は配列番号３に示される配列と少なくとも７０％、好ましくは８０％、特に好ましくは９０％、とりわけより好ましくは９５％一致するのものが挙げられる。<br class="style-scope patent-text">
【００７３】<br class="style-scope patent-text">
同様に、本発明に記載の核酸は、遺伝子組換え無脊椎動物を作製するのに用いることができる。後者は、本発明の受容体又は野生型とは異なるその変異体の発現に基づく試験システムにおいて用いることができる。これには、他の遺伝子又は遺伝子退治配列（例えば、プロモーター）の修飾が、そのために本発明の受容体またはその変異体の発現における変化を引き起こす、全ての遺伝子組換え無脊椎動物も含まれる。<br class="style-scope patent-text">
【００７４】<br class="style-scope patent-text">
遺伝子組換え無脊椎動物の作製は、例えば、Ｄｒｏｓｏｐｈｉｌａ ｍｅｌａｎｏｇａｓｔｅｒにおいてはＰ因子介在の遺伝子導入によって、又はＣａｅｎｏｒｈａｂｄｉｔｉｓ ｅｌｅｇａｎｓにおいてはトランスポゾン介在の遺伝子導入によって行なわれる（例えばＴｃ１、Ｐｌａｓｔｅｒｋ １９９６）。<br class="style-scope patent-text">
【００７５】<br class="style-scope patent-text">
従って、本発明は、本発明の少なくとも１つの核酸を含む遺伝子組換え無脊椎動物、好ましくはＤｒｏｓｏｐｈｉｌａ ｍｅｌａｎｏｇａｓｔｅｒ またはＣａｅｎｏｒｈａｂｄｉｔｉｓ ｅｌｅｇａｎｓの種の遺伝子組換え無脊椎動物、及びその遺伝子組換え体の子孫にも関する。遺伝子組換え無脊椎動物は、本発明に基づく受容体を野生型とは異なる形態で含んでいることが好ましい。<br class="style-scope patent-text">
【００７６】<br class="style-scope patent-text">
本発明の核酸は、慣用の方法で作製することができる。例えば、核酸分子の完全な化学合成が可能である。さらに、本発明の配列のごく短い１片だけを化学的に合成し、そのようなオリゴヌクレオチドを放射活性又は蛍光染色によって標識することもできる。標識したオリゴヌクレオチドは、線虫ｍＲＮＡ又は昆虫ｍＲＮＡを出発物質として作製したｃＤＮＡライブラリーをスクリーニングするのに用いることができる。この標識したオリゴヌクレオチドにハイブリダイズするクローンを、関連するＤＮＡから単離するために選択する。単離したＤＮＡを特徴付けした後、本発明の核酸を簡単な方法により得る。<br class="style-scope patent-text">
【００７７】<br class="style-scope patent-text">
また、本発明に基づく核酸は、化学合成したオリゴヌクレオチドを用いるＰＣＲ法により作製することもできる。<br class="style-scope patent-text">
【００７８】<br class="style-scope patent-text">
本明細書にて用いる用語「オリゴヌクレオチド」は、１０〜５０ヌクレオチド、好ましくは１５〜３０ヌクレオチドからなるＤＮＡ分子を意味する。それらは、例えば、化学合成でき、プローブとして用いることができる。<br class="style-scope patent-text">
【００７９】<br class="style-scope patent-text">
本発明に基づく核酸は、コード領域近傍に天然に存在する調節領域の単離と特徴付けのために用いることができる。<br class="style-scope patent-text">
【００８０】<br class="style-scope patent-text">
同様に、本発明の方法により、本発明にしたがって使用される核酸又は本発明にしたがって使用されるＤＮＡ構築物を含むベクターを使用する。使用し得るベクターは、分子生物学の実験室で用いられる、全てのファージ、プラスミド、ファージミド、ファスミド、コスミド、ＹＡＣ、ＢＡＣ、人工染色体又は粒子銃に適した粒子である。<br class="style-scope patent-text">
【００８１】<br class="style-scope patent-text">
好ましいベクターには、植物細胞用のｐＢＩＮおよびその誘導体、酵母細胞用のｐＦＬ６１、細菌細胞用のｐＢＬＵＥＳＣＲＩＰＴベクター、ファージ用のλＺＡＰ（Ｓｔｒａｔａｇｅｎｅ製）がある。<br class="style-scope patent-text">
【００８２】<br class="style-scope patent-text">
種々のベクターが用いられ、多くの構築物が本発明の範囲内で作製される。同様に、本発明は細胞系の一過性または安定な形質転換およびＨＣ１１０−Ｒ受容体の安定な発現のために用いるベクターに関する。<br class="style-scope patent-text">
【００８３】<br class="style-scope patent-text">
Ｎ末端ＥＧＦＰタグを有する融合タンパク質（ＥＧＦＰ−ＨＣ１１０−Ｒ）又はＣ末端ＥＧＦＰタグを有する融合タンパク質（ＨＣ１１０−Ｒ−ＥＧＦＰ）を発現するＥＧＦＰ構築物を、真核生物細胞における一過性発現のために作製した。同様に、本発明は、これらのベクター及び慣用のＧＦＰベクターによってコードされるポリペプチド、およびレッドシフト変異体及びブルーシフト変異体に関する。<br class="style-scope patent-text">
【００８４】<br class="style-scope patent-text">
更なる構築物、ベクターｐＭｙｃ６ｘＨｉｓは安定な発現に用いることができ、同様に本発明はそれらに関する。ベクターｐＭｙｃ６ｘＨｉｓは、制限酵素ＮｈｉＩとＳｆｉＩでの２重消化した後、末端を平滑化し、ベクターを再びライゲーションすることによって、ベクターｐＳｅｃＴａｇＡ［Ｉｎｖｉｔｒｏｇｅｎ， Ｌｅｅｋ， ＮＬ］から得られる。<br class="style-scope patent-text">
【００８５】<br class="style-scope patent-text">
さらに、本発明は本発明にしたがって用いられる核酸、又は本発明にしたがって用いられるベクターを含む宿主細胞に関する。<br class="style-scope patent-text">
【００８６】<br class="style-scope patent-text">
本発明は特に、ＨＣ１１０−Ｒ−Ｍｙｃ／Ｈｉｓを用いて安定に形質転換したＨＥＫ−２９３細胞系（３８ １２４ Ｂｒａｕｎｓｃｈｗｅｉｇ、Ｍａｓｃｈｅｒｏｄｅｒ Ｗｅｇ １ｂ、Ｍｉｃｒｏｏｒｇａｎｉｓｍｅｎ ｕｎｄ Ｚｅｌｌｋｕｌｔｕｒｅｎ ＧｍｂＨから国際寄託当局 ＤＳＭＺ−Ｄｅｕｔｓｃｈｅ Ｓａｍｍｌｕｎｇに、ナンバーＤＳＭ ＡＣＣ２４６４として寄託した）に関する。<br class="style-scope patent-text">
【００８７】<br class="style-scope patent-text">
本発明は同様に、本発明にしたがって用いられる核酸または本発明にしたがって用いられるベクター、及び細胞がＣａ<sup class="style-scope patent-text">２＋</sup>の存在下で発光する発光タンパク質、エクオリンを発現することを可能にするベクターを含む宿主細胞に関する。対応する宿主細胞は、Ｃａ<sup class="style-scope patent-text">２＋</sup>濃度の変化、即ち、例えばＨＣ１１０−Ｒに対する物質の効果を、エクオリン指示薬の助けを借りて追跡することが可能である。本発明は特に、エクオリンを発現することが可能で、３８ １２４ Ｂｒａｕｎｓｃｈｗｅｉｇ、Ｍａｓｃｈｅｒｏｄｅｒ Ｗｅｇ １ｂ、Ｍｉｃｒｏｏｒｇａｎｉｓｍｅｎ ｕｎｄ Ｚｅｌｌｋｕｌｔｕｒｅｎ ＧｍｂＨから国際寄託当局 ＤＳＭＺ−Ｄｅｕｔｓｃｈｅ Ｓａｍｍｌｕｎｇに、ナンバーＤＳＭ ＡＣＣ２４６５として寄託されたＨＣ１１０−Ｒ−Ｍｙｃ／Ｈｉｓによって安定に形質転換したＨＥＫ−２９３細胞系に関する。<br class="style-scope patent-text">
【００８８】<br class="style-scope patent-text">
本明細書にて用いる用語「宿主細胞」は、本発明の核酸を天然では含まない細胞に関する。<br class="style-scope patent-text">
【００８９】<br class="style-scope patent-text">
適切且つ好ましい宿主細胞は、酵母、哺乳動物、両生類、昆虫又は植物細胞などの真核生物細胞である。好ましい真核生物宿主細胞には、ＨＥＫ−２９３、Ｓｃｈｎｅｉｄｅｒ Ｓ２、Ｓｐｏｄｏｐｔｅｒａ Ｓｆ９、Ｋｃ、ＣＨＯ、ＨｅｐＧ−２、Ｋ１、ＣＯＳ−１、ＣＯＳ−７、ＨｅＬａ、Ｃ１２７、３Ｔ３又はＢＨＫ細胞があり、特にアフリカツメガエル（ｘｅｎｏｐｕｓ ｏｏｃｙｔｅｓ）及びＨＥＫ−２９３又はＣＯＳ−７細胞がとりわけ好ましい。<br class="style-scope patent-text">
【００９０】<br class="style-scope patent-text">
同様に、本発明は、蠕虫由来の、特に好ましくは線形動物門、とりわけ好ましくは毛様線虫科由来の、とりわけさらに好ましくは捻転胃虫属由来の、及び最も好ましくはＨａｅｍｏｎｃｈｕｓ ｃｏｎｔｏｒｔｕｓ由来のＤＮＡの検出のための、出願番号ＤＥ−Ａ−１９７ ０４ ０２４に記載の配列番号２に対応するＤＮＡの使用に関する。<br class="style-scope patent-text">
【００９１】<br class="style-scope patent-text">
さらに、本発明は上記のＤＮＡ配列の領域又はその相補鎖に対応するオリゴヌクレオチド、及びそれとハイブリダイズすることが可能なオリゴヌクレオチドに関する。本発明は、それらのオリゴヌクレオチド又はその一部の、<br class="style-scope patent-text">
ａ）　ノーザンブロット分析又はサザンブロット分析におけるプローブ、<br class="style-scope patent-text">
ｂ） 上記の蠕虫を検出するための診断方法におけるＰＣＲプライマー（ここに、該ＰＣＲプライマーとＰＣＲ技術を利用して、関連する蠕虫のＤＮＡを特異的に増幅し、同定する）<br class="style-scope patent-text">
としての使用に関する。<br class="style-scope patent-text">
【００９２】<br class="style-scope patent-text">
さらに、本発明は、好ましくは線形動物門の、特に好ましくは毛様線虫科の、さらにより好ましくは捻転胃虫属の、及び最も好ましくはＨａｅｍｏｎｃｈｕｓ ｃｏｎｔｏｒｔｕｓの蠕虫を検出する方法であって、上記オリゴヌクレオチドは該生物由来のＤＮＡ配列と特異的にハイブリダイズし、次いでＰＣＲ技術により増幅される方法に関する。<br class="style-scope patent-text">
【００９３】<br class="style-scope patent-text">
既述生物の検出は、例えば<br class="style-scope patent-text">
ａ）　本発明のＨＣ１１０−ＲをコードするＤＮＡまたはその相補鎖、またはその５’若しくは３’隣接領域とハイブリダイズするオリゴヌクレオチドプローブ又はプライマーを提供し、<br class="style-scope patent-text">
ｂ）　該オリゴヌクレオチドプローブ又はプライマーを、適当に調製したＤＮＡ含有試料と接触させ、<br class="style-scope patent-text">
ｃ）　該オリゴヌクレオチド又はプライマーのハイブリダイゼーションを（例えば、ポリメラーゼ連鎖反応を用いて）検出し、<br class="style-scope patent-text">
ｄ）　検出したＨＣ１１０−Ｒ遺伝子の配列を決定し、そして、<br class="style-scope patent-text">
ｅ）　この配列と本発明に記載のＤＮＡ配列、好ましくは出願番号ＤＥ−Ａ−１９７ ０４ ０２４に記載の配列番号２の配列とを比較する、<br class="style-scope patent-text">
ことによって行なうことができる。<br class="style-scope patent-text">
【００９４】<br class="style-scope patent-text">
同様に、本発明は、好ましくは線形動物門の、特に好ましくは毛様線虫科の、さらにより好ましくは捻転胃虫属の、及び最も好ましくはＨａｅｍｏｎｃｈｕｓ ｃｏｎｔｏｒｔｕｓの蠕虫を検出する診断試験キットに関し、キットは、上記系統の群から種を検出する方法に用いることができる上記オリゴヌクレオチドを特に利用する。<br class="style-scope patent-text">
【００９５】<br class="style-scope patent-text">
同様に、本発明は上記の診断試験キットに関し、この試験キットに利用できるオリゴヌクレオチドは検出可能なマーカーと共に提供される。そのような検出可能なマーカーには、特に酵素、酵素基質、補酵素、酵素阻害物質、蛍光マーカー、発色団、発光マーカー及び放射性同位体が挙げられる。<br class="style-scope patent-text">
【００９６】<br class="style-scope patent-text">
さらに、本発明は、蠕虫、好ましくは線形動物門、特に好ましくは毛様線虫科、さらにより好ましくは捻転胃虫属及び最も好ましくはＨａｅｍｏｎｃｈｕｓ ｃｏｎｔｏｒｔｕｓ由来の、上記ＨＣ１１０−Ｒポリペプチドまたはその断片、またはそれらと７０％、好ましくは８０％、特に好ましくは９０％及びよりさらに好ましくは９５％相同な受容体タンパク質の、少なくとも１つのＨＣ１１０−Ｒポリペプチド又はその断片、またはそれらと７０％、好ましくは８０％、特に好ましくは９０％及びよりさらに好ましくは９５％相同な受容体タンパク質を含有するワクチンを生産するための使用に関する。この場合、このワクチンは、上記ＨＣ１１０−Ｒタンパク質に特異的な免疫応答を誘発できる。<br class="style-scope patent-text">
【００９７】<br class="style-scope patent-text">
好ましい態様において、ワクチンは、抗原決定基、例えば出願番号ＤＥ−Ａ−１９７ ０４ ０２４に記載の配列番号２のアミノ酸配列を有するポリペプチドの一個の決定基、又は上記ＤＮＡ又はその断片によりコードされるポリペプチドの一個の決定基を含んでいる。<br class="style-scope patent-text">
【００９８】<br class="style-scope patent-text">
さらに本発明は、本発明にしたがって用いられるポリペプチドを生産する方法に関する。周知の核酸によりコードされているポリペプチドは、その核酸を含む宿主細胞を好ましい条件下にて培養することによって製造することができる。次いで、所望のポリペプチドは、従来法により細胞又は培地から単離できる。また、そのポリペプチドをインビトロの系で製造することもできる。<br class="style-scope patent-text">
【００９９】<br class="style-scope patent-text">
本発明の核酸を用いて宿主細胞によって合成させた本発明に記載のポリペプチドを単離する迅速な方法は、例えば実施例に記載のように、単純な方法で融合パートナーをアフィニティー精製することができる融合タンパク質の発現によって開始される。融合パートナーは、例えばグルタチオンＳトランスフェラーゼが挙げられる。次いで、その融合タンパク質をグルタチオンアフィニティーカラムにて精製できる。融合パートナーは、例えば融合パートナーと精製される本発明ポリペプチドとの間のリンカーでの、部分的なタンパク質加水分解開裂により除去できる。このリンカーは、トリプシンによる開裂のための部位を規定するアルギニンやリシン残基などの標的アミノ酸を含むよう設計することができる。そのようなリンカーは、オリゴヌクレオチドを用いる標準的なクローニング法を用いることによって作製することができる。もう１つの可能な方法は、ヒスチジン融合タンパク質の使用と、Ｎｉ<sup class="style-scope patent-text">２＋</sup>タロン（Ｔａｌｏｎ）カラム上でのその精製に基づく。<br class="style-scope patent-text">
【０１００】<br class="style-scope patent-text">
さらに可能な精製法としては、調製用電気泳動法、ＦＰＬＣ、ＨＰＬＣ（例えば、ゲルろ過カラム、逆相カラム又は微疎水性（ｓｌｉｇｈｔｌｙ ｈｙｄｒｏｐｈｏｂｉｃ）カラムを用いる）、ゲルろ過、区別的精製（ｄｉｆｆｅｒｅｎｔｉａｌ ｐｒｅｃｉｐｉｔａｔｉｏｎ）、イオン交換クロマトグラフィー及びアフィニティークロマトグラフィーに基づく。<br class="style-scope patent-text">
【０１０１】<br class="style-scope patent-text">
受容体様タンパク質キナーゼは膜タンパク質であるため、この精製法においては、例えば、本ポリペプチドの２次構造及び３次構造に僅かにしか又は全く影響を及ぼさない界面活性剤、例えば非イオン性界面活性剤を用いて、界面活性剤抽出を行なうことが好ましい。<br class="style-scope patent-text">
【０１０２】<br class="style-scope patent-text">
本発明にしたがって使用されるポリペプチドの精製には、本発明の核酸を発現する宿主細胞から出発する膜の単離が含まれ得る。そのような細胞は、ＨＣ１１０−Ｒ遺伝子を元来発現する細胞由来の膜と比較して、少なくとも１０倍、好ましくは少なくとも１００倍、さらにより好ましくは少なくとも１０００倍の量で膜区画に見られるポリペプチド量に十分なコピー数のポリペプチドを発現する細胞であることが好ましい。<br class="style-scope patent-text">
【０１０３】<br class="style-scope patent-text">
本明細書中で用いる用語「単離又は精製」は、ポリペプチドを他のタンパク質又は細胞若しくは組織の他の巨大分子から分離することを意味する。ポリペプチドを含む本発明の組成物は、宿主細胞由来の調製物と比較して、タンパク質量が少なくとも１０倍、特に好ましくは少なくとも１００倍豊富であることが好ましい。<br class="style-scope patent-text">
【０１０４】<br class="style-scope patent-text">
また、本発明のポリペプチドは、該ポリペプチドに結合する抗体を用いれば、融合パートナーを用いることなくアフィニティー精製できる。<br class="style-scope patent-text">
【０１０５】<br class="style-scope patent-text">
さらに、本発明は上記ポリペプチド又は受容体と特異的に結合する抗体に関する。そのような抗体は慣用の方法により精製される。例えば、そのような抗体は、実質的な免疫担当宿主に、Ｈ． ｃｏｎｔｏｒｔｕｓ由来のＨＣ１１０−Ｒ受容体のような本発明の膜貫通受容体、又はその断片の、抗体産生に十分な量を注射し、次いでその抗体を単離することにより製造しうる。さらに、それ自体が周知である方法にて、モノクローナル抗体を産生する不死化細胞系を得ることができる。抗体は、検出試薬を用いて適当に標識化できる。そのような標識試薬の好ましい例としては、酵素、放射標識エレメント、蛍光化学物質、又はビオチンがある。完全抗体に代えて、所望の特異的な結合特性を有する断片を用いることもまた可能である。<br class="style-scope patent-text">
【０１０６】<br class="style-scope patent-text">
本明細書にて用いる用語「アゴニスト」は、膜貫通受容体を活性化する分子を意味する。<br class="style-scope patent-text">
【０１０７】<br class="style-scope patent-text">
本明細書にて用いる用語「アンタゴニスト」はアゴニストの結合部位にてアゴニストに取って代わるかアゴニストの機能を阻害する分子を表す。<br class="style-scope patent-text">
【０１０８】<br class="style-scope patent-text">
本明細書にて用いる用語「モジュレータ」はアゴニスト及びアンタゴニストの総称である。モジュレーターは、本発明に記載のポリペプチドと結合する小さい有機化合物分子、ペプチド又は抗体であっても良い。さらにモジュレーターは、ある分子に結合する小さな有機化合物分子、ペプチドまたは抗体であって、その分子が今度は本発明のポリペプチドに結合することによりその生物学的活性に影響を与えるものであってよい。モジュレーターは、天然の基質及びリガンドの模擬物であっても良い。<br class="style-scope patent-text">
【０１０９】<br class="style-scope patent-text">
モジュレーターは、小さな有機化合物であることが好ましい。<br class="style-scope patent-text">
【０１１０】<br class="style-scope patent-text">
ポリペプチドに対するモジュレーターの結合は、それらで処置した蠕虫又は節足動物の細胞のプロセスを変え、死に至らしめ得る。<br class="style-scope patent-text">
【０１１１】<br class="style-scope patent-text">
従って、本発明はさらに、駆虫剤及び殺節足動物剤としてのポリペプチドのモジュレーターの使用にも及ぶ。<br class="style-scope patent-text">
【０１１２】<br class="style-scope patent-text">
同様に、本発明は、特に、駆虫剤としてのα−ＬＴＸの使用に関する。<br class="style-scope patent-text">
【０１１３】<br class="style-scope patent-text">
また、本発明の方法における核酸又はポリペプチドの本発明に従う使用は、本発明の受容体と結合する化合物を見出すことを可能にする。同様に、後者は駆虫剤として、例えば植物については殺線虫剤として、又は動物については駆虫活性物質として用いることができる。例えば、核酸を含み、その対応する受容体又はポリペプチドを発現する宿主細胞、或いはその遺伝子産物を、宿主細胞、受容体又は個々のポリペプチドと少なくとも１つの化合物とが相互作用できる条件下で、化合物又は化合物の混合物と接触させる。<br class="style-scope patent-text">
【０１１４】<br class="style-scope patent-text">
本発明は、蠕虫又は節足動物由来の膜貫通受容体、好ましくはセクレチンサブファミリーのＧＰＣＲ、特に好ましくはＨ． ｃｏｎｔｏｒｔｕｓ由来の受容体ＨＣ１１０−Ｒと結合し、配列がそれらと７０％、好ましくは８０％、特に好ましくは９０％、さらにより好ましくは９５％一致する受容体と結合する、殺線虫活性物質を同定するために適当な方法に、特に関する。しかしながら、本方法は、本明細書に記載の種以外の種由来のＨＣ１１０−Ｒ相同受容体を用いて実施することもできる。本発明のＨＣ１１０−Ｒ以外の受容体を用いる方法は、本発明に完全に包含される。<br class="style-scope patent-text">
【０１１５】<br class="style-scope patent-text">
本発明に記載の方法には、ハイスループットスクリーニング（例えば、ハイスループットスクリーニング（ＨＴＳ）及び超ハイスループットスクリーニング（ＵＨＴＳ））が含まれる。この目的のために、本発明の核酸及び／又は本発明に記載のポリペプチドを含む宿主細胞及び無細胞調製物の両方を使用することができる。<br class="style-scope patent-text">
【０１１６】<br class="style-scope patent-text">
<u class="style-scope patent-text">無細胞試験システム</u> <br class="style-scope patent-text">
化合物及び天然抽出物を試験することを目的とする多くの試験システムは、与えられた期間に試験する物質の数を最大にするため、ハイスループット用に設計される。無細胞操作に基づく試験システムは、精製した又は半精製したタンパク質を必要とする。これらは、標的タンパク質に対するある物質の効果の可能性を主として検出することを目的とする「初期の」試験に適当である。<br class="style-scope patent-text">
【０１１７】<br class="style-scope patent-text">
細胞毒性などの効果は、これらインビトロの系では、通常無視する。この試験システムは、物質の阻害または抑制効果と刺激効果の両方をさらに試験する。物質の効果は、一連の濃度依存試験により確認することができる。被験物質を含まない対照混合物は、その効果を評価するために用いることができる。<br class="style-scope patent-text">
【０１１８】<br class="style-scope patent-text">
<u class="style-scope patent-text">細胞ベース試験システム</u> <br class="style-scope patent-text">
ＨＣ１１０−Ｒ及び相同受容体の活性を調節する物質を同定するための、細胞ベースの試験システムの開発は、本発明によって利用可能なＨＣ１１０−Ｒ受容体で安定にトランスフェクションした細胞系により開発が可能であるが、本発明に基づいて同定することができる他の種由来の対応する相同受容体によっても開発することができる。<br class="style-scope patent-text">
【０１１９】<br class="style-scope patent-text">
同様に、本発明はカルシウムチャネル遮断物質として有効なその他の化合物の同定を可能にする。<br class="style-scope patent-text">
【０１２０】<br class="style-scope patent-text">
モジュレーターは、合成反応混合物（例えば、インビトロ翻訳の産物）または細胞を構成する物質、例えば、膜又は本ポリペプチドを含む他の任意の調製物）をアゴニスト及びアンタゴニストであり得る候補分子の存在下又は非存在下にて、本ポリペプチドの標識した基質又はリガンドと共にインキュベートすることによって見い出すことができる。本発明のポリペプチドの活性を増大又は低下させる候補分子の能力は、標識したリガンドの結合を増大又は低下させることあるいは標識した基質の変換を増大又は低下させることから明らかとなる。十分に結合し且つ本発明のポリペプチドの活性を増大させる分子がアゴニストである。十分に結合するが本発明に記載のポリペプチドの生物学的活性を引き起こさない分子が、おそらく良いアンタゴニストである。<br class="style-scope patent-text">
【０１２１】<br class="style-scope patent-text">
<u class="style-scope patent-text">シンチレーション近接アッセイ（ＳＰＡ）</u> <br class="style-scope patent-text">
ＨＣ１１０−Ｒ及びそれと相同な受容体タンパク質の活性を調節する物質を同定するための１つの可能性として、シンチレーション近接アッセイ（ＳＰＡ）と呼ばれるものがある（ＥＰ−Ａ−０１５ ４７３）。この試験システムは、放射能標識したリガンド（例えば、小さな有機分子又は第二の放射能標識したタンパク質分子）と受容体（例えば、ＨＣ１１０−Ｒ）との相互作用を利用するものである。この場合、受容体を、シンチレーティング分子と共に提供される微粒子又はビーズと結合させる。放射能の減衰の間に、球形のシンチレーティング物質は放射性マーカーの素粒子により励起され、検出可能な光子を発する。シグナルを発するようリガンドにより放射された粒子のみが、受容体又はＨＣ１１０−Ｒと結合したリガンドにより発せられるものとなるよう、試験条件を最適化する。<br class="style-scope patent-text">
【０１２２】<br class="style-scope patent-text">
１つの可能な態様では、ＨＣ１１０−Ｒを、被験物質との相互作用または結合を伴う又は伴わずにビーズと結合させる。さらに、この場合、ＨＣ１１０−Ｒ受容体の断片を用いることも可能であろう。放射能標識したリガンドは、例えば、標識したα−ＬＴＸ、ニフェジピン又は標識したデプシペプチドであって良い。結合性リガンドを、固定化したＨＣ１１０−Ｒ受容体と結合させる場合、このリガンドは、それ自体を接触部分の領域に結合させるために、固定化したＨＣ１１０−Ｒと標識化リガンドとの間に存在する相互作用を阻害又は破壊する必要があるであろう。次いで、標識したＨＣ１１０−Ｒ受容体とのうまく結合したものを、閃光で検出することができる。同様に、固定化した標識化リガンドと固定化していない標識化リガンドとの間の複合体は、被験物質の結合により破壊され、閃光で検出できる強度に減衰する。次いで、その試験システムは補助的な阻害システムに対応する<br class="style-scope patent-text">
【０１２３】<br class="style-scope patent-text">
<u class="style-scope patent-text">２ハイブリッドシステム</u> <br class="style-scope patent-text">
全細胞に基づく試験システムの別の例としては、２ハイブリッドシステムと呼ばれるものがある。その具体的な例としては、相互作用トラップと呼ばれるものがある。これには、酵母における相互作用するタンパク質を遺伝的に選択することが関係する（例えば、Ｇｙｕｒｉｓら、１９９３を参照のこと）。この試験システムは、検出可能なシグナルを生じる相互作用の成功を通じて、２つのタンパク質の相互作用を検出し、そして描写するよう設計される。<br class="style-scope patent-text">
【０１２４】<br class="style-scope patent-text">
そのような試験システムは、大量の被験物質を所定の期間内に試験するのにも応用できる。<br class="style-scope patent-text">
【０１２５】<br class="style-scope patent-text">
このシステムは、２つのベクター、即ち「おとり」ベクターと「餌食」ベクターの構築に基づく。本発明のＨＣ１１０−Ｒ又はその断片をコードする遺伝子をおとりベクター中にクローニングした後、ＤＮＡ結合タンパク質であるＬｅｘＡタンパク質との融合タンパク質として発現させる。ＨＣ１１０−Ｒ相互作用パートナー、例えばα−ＬＴＸをコードする第２の遺伝子を、餌食ベクター中にクローニングし、Ｂ４２餌食タンパク質との融合タンパク質として発現させる。両ベクターは、ｌａｃＺ又はＨＩＳ２レポーター遺伝子の５’側にＬｅｘＡ結合ＤＮＡのコピーを含むＳａｃｃｈａｒｏｍｙｃｅｓ ｃｅｒｅｖｉｓｉａｅ宿主に存在する。この２つの融合タンパク質の間で相互作用が起こると、受容体遺伝子の転写が活性化される。被験物質の存在により、この相互作用が阻害又は破壊されると、この２つの融合タンパク質はもはや相互作用できず、レポーター遺伝子産物も産生されない。<br class="style-scope patent-text">
【０１２６】<br class="style-scope patent-text">
<u class="style-scope patent-text">置換試験</u> <br class="style-scope patent-text">
本発明に記載のポリペプチドのモジュレーターを見つけることができる別の方法の例としては置換試験があり、これは、この目的に適した条件下にて、本発明のポリペプチドと可能性のあるモジュレーターとを、本発明のポリペプチドと結合することが知られている分子、例えば天然の基質若しくはリガンド、又は基質若しくはリガンド模擬体と、共に合わせる試験である。α−ＬＴＸは、本発明の方法に従って、この試験に好ましく使用される。<br class="style-scope patent-text">
【０１２７】<br class="style-scope patent-text">
既知の分析システム、例えば、Ｂｉａｃｏｒｅ ＡＢ， Ｕｐｐｓａｌａ， Ｓｗｅｄｅｎのシステムは、完全なＨＣ１１０−Ｒタンパク質、またはＨＣ１１０−ＲのＮ−宿主Ｃ末端欠失変異体、インビトロ突然変異誘発又は他の既知の方法により改変されたＨＣ１１０−Ｒ分子のその他の変異体を用いる、分子相互作用試験に用いることができる。これには、１つに<br class="style-scope patent-text">
（ｉ）　ＨＣ１１０−Ｒ受容体又はその断片を、既知の化学的方法（アミン、チオール、アルデヒドを介したカップリング）により結合させること、又はバイオチップへのアフィニティー結合（例えば、ストレプトアビジン−ビオチン， ＩＭＡＣ）させること、あるいはもう１つに、<br class="style-scope patent-text">
（ｉｉ）α−ＬＴＸ又は別のモジュレーター、例えばＢＡＹ４４−４４００又は他の可能性のあるリガンドを、（ｉ）に記載したようにそのチップに結合させることが必要である。<br class="style-scope patent-text">
【０１２８】<br class="style-scope patent-text">
固定化した分子と、溶液中に存在するリガンド（ＨＣ１１０−Ｒタンパク質又は任意のモジュレーター、例えばＢＡＹ４４−４４００など）との結合を、物理的に測定する。Ｂｉａｃｏｒｅ Ｉｎｓｔｒｕｍｅｎｔにて、金の薄層を有するセンサーチップ上にリガンドを固定化する。分析物の溶液は、チップ上のマイクロフローセルによって拡散する。固定化されたリガンドに分析物が結合することにより、その表面の局所的な濃度が増大し、その媒体付近の金層の屈折率が徐々に増大する。これは、金属中の自由電子（プラズモン）と器具から発せられる光子との間の相互作用に対する効果である。この物理的変化は、チップ上の分子の質量及び数に比例し、そのリガンド−分析物間の結合をリアルタイムで記録し、みかけの結合／解離定数を決定することが可能である （Ｆｉｖａｓｈら、１９９８）。結合の特異性は、競合実験により立証する。<br class="style-scope patent-text">
【０１２９】<br class="style-scope patent-text">
さらに、対応する測定を、リガンドの結合に重要なＨＣ１１０−Ｒタンパク質ドメインを決定するために、及び新規の、これまで開示されていないＨＣ１１０−Ｒのリガンドを同定するために用いる。<br class="style-scope patent-text">
【０１３０】<br class="style-scope patent-text">
<u class="style-scope patent-text">カルシウムイメージング</u> <br class="style-scope patent-text">
カルシウムイメージング又はシグナリングは、ＨＣ１１０−Ｒと相互作用する物質を検出するもう１つの方法と考えられる（例えば、図１１及び１０を参照のこと）。これには、細胞内カルシウムレベルの変化を検出可能にするよう補助するカルシウム指示薬の使用が必要である。カルシウム指示薬をローディングしたＨＣ１１０−Ｒ発現細胞をこの方法に用いる。ＨＣ１１０−Ｒアゴニストにより引き起こされるカルシウム流入が存在する場合、または細胞内カルシウムの放出が存在する場合、指示薬のカルシウム取り込みの関数として、ＵＶ照射下で吸光度の変化が現れる。アンタゴニストは、このシステムでは、アゴニスト（例えば、α−ＬＴＸ）により誘導されるカルシウムシグナルを完全に又は部分的に抑制することによって同定することができる。この目的に好ましい可能なカルシウム指示薬には、Ｆｕｒａ−２（Ｓｉｇｍｅ）又はＩｎｄｏ−１ （ｍｏｌｅｃｕｌａｒ ｐｒｏｂｅｓ）がある。<br class="style-scope patent-text">
【０１３１】<br class="style-scope patent-text">
さらに、カルシウム指示薬は可視光により励起され、その蛍光特性が、カルシウム取り込みに依存して検出可能な形で変化する。指示薬Ｆｌｕｏ−３及びＦｌｕｏ−４は、カルシウム親和性が高い。Ｆｌｕｏ−４は、強い蛍光シグナルを有し、ＨＥＫ−２９３細胞の場合のように、細胞を低濃度でのみ用いる試験システムにおける測定に特に好ましい。さらに、指示薬として、Ｒｈｏｄ−２、ｘ−Ｒｈｏｄ−１、Ｆｌｕｏ−５Ｎ、Ｆｌｕｏ−５Ｆ、Ｍａｇ−Ｆｌｕｏ−４、Ｒｈｏｄ−５Ｆ、Ｒｈｏｄ−５Ｎ、Ｙ−Ｒｈｏｄ−５Ｎ、Ｍａｇ−Ｒｈｏｄ−２、Ｍａｇ−Ｘ−Ｒｈｏｄ−１、カルシウムグリーン−１及び−２、カルシウムグリーン−５Ｎ、オレゴングリーン４８８ ＢＡＰＴＡ−１、オレゴングリーン４８８ ＢＡＰＴＡ−２及び−５Ｎ、Ｆｕｒａレッド、カルセイン（ｃａｌｃｅｉｎ）などがある。<br class="style-scope patent-text">
【０１３２】<br class="style-scope patent-text">
カルシウム指示薬を細胞にローディングする別法として、標的細胞における発光タンパク質の組換え発現がある。そして、これらの発光タンパク質は、カルシウムイオンと複合体を形成すると、光を発するように応答する。すでに多くの研究や試験システムによく用いられている発光タンパク質として、エクオリンがある。標的タンパク質をエクオリンと同時に発現する細胞は、まず初めに、この試験方法において発光団セレンテラジンと共にローディングする。細胞により形成されるアポエクオリンは、セレンテラジンおよび二酸化炭素と複合体を形成する。続いてカルシウムも細胞に入り、この複合体と結合すると、二酸化炭素を放出し青色の光（最大発光約４６６ｎｍ）を発する。この場合の光の発光は、細胞内存在するカルシウムの濃度と相関する。<br class="style-scope patent-text">
【０１３３】<br class="style-scope patent-text">
このように、本発明は同様に、ＨＣ１１０−Ｒ、その断片、又は他の生物由来の類似タンパク質の使用に関し、該受容体の機能又は該受容体に対するモジュレーターの結合が、エクオリン又は同様の発光タンパク質により媒介される光シグナルにより検出される。<br class="style-scope patent-text">
【０１３４】<br class="style-scope patent-text">
また、この方法において、本発明の核酸を含む宿主細胞又は遺伝子導入無脊椎動物を使用することによって、受容体の発現に変化を及ぼす物質を見い出すことができる。そのような物質もまた、価値ある駆虫薬を示し得る。<br class="style-scope patent-text">
【０１３５】<br class="style-scope patent-text">
したがって、本発明の方法により見出される活性物質は、動物の害虫、特に農場、森林、倉庫において発生する昆虫、クモ及び線虫の退治、材料の保護、及び衛生部門に好ましい。本発明の方法により見出される活性物質は、線虫及びクモを退治するのに特に好ましい。上記の害虫には、以下のものが含まれる。<br class="style-scope patent-text">
【０１３６】<br class="style-scope patent-text">
Ｉｓｏｐｏｄａ目に属するもの、例えば、Ｏｎｉｓｃｕｓ ａｓｅｌｌｕｓ， Ａｒｍａｄｉｌｌｉｄｉｕｍ ｖｕｌｇａｒｅ， Ｐｏｒｃｅｌｌｉｏ ｓｃａｂｅｒ。<br class="style-scope patent-text">
Ｄｉｐｌｏｐｏｄａ目に属するもの、例えば、Ｂｌａｎｉｕｌｕｓ ｇｕｔｔｕｌａｔｕｓ。<br class="style-scope patent-text">
Ｃｈｉｌｏｐｏｄａ目に属するもの、例えば、Ｇｅｏｐｈｉｌｕｓ ｃａｒｐｏｐｈａｇｕｓ， Ｓｃｕｔｉｇｅｒａ ｓｐｐ．。<br class="style-scope patent-text">
Ｓｙｍｐｈｙｌａ目に属するもの、例えば、Ｓｃｕｔｉｇｅｒｅｌｌａ ｉｍｍａｃｕｌａｔａ。<br class="style-scope patent-text">
Ｔｈｙｓａｎｕｒａ目に属するもの、例えば、Ｌｅｐｉｓｍａ ｓａｃｃｈａｒｉｎａ。<br class="style-scope patent-text">
Ｃｏｌｌｅｍｂｏｌａ目に属するもの、例えば、Ｏｎｙｃｈｉｕｒｕｓ ａｒｍａｔｕｓ。<br class="style-scope patent-text">
Ｏｒｔｈｏｐｔｅｒａ目に属するもの、例えば、Ａｃｈｅｔａ ｄｏｍｅｓｔｉｃｕｓ， Ｇｒｙｌｌｏｔａｌｐａ ｓｐｐ．， Ｌｏｃｕｓｔａ ｍｉｇｒａｔｏｒｉａ ｍｉｇｒａｔｏｒｉｏｉｄｅｓ， Ｍｅｌａｎｏｐｌｕｓ ｓｐｐ．， Ｓｃｈｉｓｔｏｃｅｒｃａ ｇｒｅｇａｒｉａ。<br class="style-scope patent-text">
Ｂｌａｔｔａｒｉａ目に属するもの、例えば、Ｂｌａｔｔａ ｏｒｉｅｎｔａｌｉｓ， Ｐｅｒｉｐｌａｎｅｔａ ａｍｅｒｉｃａｎａ， Ｌｅｕｃｏｐｈａｅａ ｍａｄｅｒａｅ， Ｂｌａｔｔｅｌｌａ ｇｅｒｍａｎｉｃａ。<br class="style-scope patent-text">
Ｄｅｒｍａｐｔｅｒａ目に属するもの、例えば、Ｆｏｒｆｉｃｕｌａ ａｕｒｉｃｕｌａｒｉａ。<br class="style-scope patent-text">
Ｉｓｏｐｔｅｒａ目に属するもの、例えば、Ｒｅｔｉｃｕｌｉｔｅｒｍｅｓ ｓｐｐ．。<br class="style-scope patent-text">
Ｐｈｔｈｉｒａｐｔｅｒａ目に属するもの、例えば、Ｐｅｄｉｃｕｌｕｓ ｈｕｍａｎｕｓ ｃｏｒｐｏｒｉｓ， Ｈａｅｍａｔｏｐｉｎｕｓ ｓｐｐ．， Ｌｉｎｏｇｎａｔｈｕｓ ｓｐｐ．， Ｔｒｉｃｈｏｄｅｃｔｅｓ ｓｐｐ．， Ｄａｍａｌｉｎｉａ ｓｐｐ．。<br class="style-scope patent-text">
Ｔｈｙｓａｎｏｐｔｅｒａ目に属するもの、例えば、Ｈｅｒｃｉｎｏｔｈｒｉｐｓ ｆｅｍｏｒａｌｉｓ， Ｔｈｒｉｐｓ ｔａｂａｃｉ， Ｔｈｒｉｐｓ ｐａｌｍｉ， Ｆｒａｎｋｌｉｎｅｌｌａ ａｃｃｉｄｅｎｔａｌｉｓ。<br class="style-scope patent-text">
Ｈｅｔｅｒｏｐｔｅｒａ目に属するもの、例えば、Ｅｕｒｙｇａｓｔｅｒ ｓｐｐ．， Ｄｙｓｄｅｒｃｕｓ ｉｎｔｅｒｍｅｄｉｕｓ， Ｐｉｅｓｍａ ｑｕａｄｒａｔａ， Ｃｉｍｅｘ ｌｅｃｔｕｌａｒｉｕｓ， Ｒｈｏｄｎｉｕｓ ｐｒｏｌｉｘｕｓ， Ｔｒｉａｔｏｍａ ｓｐｐ。<br class="style-scope patent-text">
【０１３７】<br class="style-scope patent-text">
Ｈｏｍｏｐｔｅｒａ目に属するもの、例えば、Ａｌｅｕｒｏｄｅｓ ｂｒａｓｓｉｃａｅ， Ｂｅｍｉｓｉａ ｔａｂａｃｉ， Ｔｒｉａｌｅｕｒｏｄｅｓ ｖａｐｏｒａｒｉｏｒｕｍ， Ａｐｈｉｓ ｇｏｓｓｙｐｉｉ， Ｂｒｅｖｉｃｏｒｙｎｅ ｂｒａｓｓｉｃａｅ， Ｃｒｙｐｔｏｍｙｚｕｓ ｒｉｂｉｓ， Ａｐｈｉｓ ｆａｂａｅ， Ａｐｈｉｓ ｐｏｍｉ， Ｅｒｉｏｓｏｍａ ｌａｎｉｇｅｒｕｍ， Ｈｙａｌｏｐｔｅｒｕｓ ａｒｕｎｄｉｎｉｓ， Ｐｈｙｌｌｏｘｅｒａ ｖａｓｔａｔｒｉｘ， Ｐｅｍｐｈｉｇｕｓ ｓｐｐ．， Ｍａｃｒｏｓｉｐｈｕｍ ａｖｅｎａｅ， Ｍｙｚｕｓ ｓｐｐ．， Ｐｈｏｒｏｄｏｎ ｈｕｍｕｌｉ， Ｒｈｏｐａｌｏｓｉｐｈｕｍ ｐａｄｉ， Ｅｍｐｏａｓｃａ ｓｐｐ．， Ｅｕｓｃｅｌｉｓ ｂｉｌｏｂａｔｕｓ， Ｎｅｐｈｏｔｅｔｔｉｘ ｃｉｎｃｔｉｃｅｐｓ， Ｌｅｃａｎｉｕｍ ｃｏｒｎｉ， Ｓａｉｓｓｅｔｉａ ｏｌｅａｅ， Ｌａｏｄｅｌｐｈａｘ ｓｔｒｉａｔｅｌｌｕｓ， Ｎｉｌａｐａｒｖａｔａ ｌｕｇｅｎｓ， Ａｏｎｉｄｉｅｌｌａ ａｕｒａｎｔｉｉ， Ａｓｐｉｄｉｏｔｕｓ ｈｅｄｅｒａｅ， Ｐｓｅｕｄｏｃｏｃｃｕｓ ｓｐｐ．， Ｐｓｙｌｌａ ｓｐｐ。<br class="style-scope patent-text">
【０１３８】<br class="style-scope patent-text">
Ｌｅｐｉｄｏｐｔｅｒａ目に属するもの、例えば、Ｐｅｃｔｉｎｏｐｈｏｒａ ｇｏｓｓｙｐｉｅｌｌａ， Ｂｕｐａｌｕｓ ｐｉｎｉａｒｉｕｓ， Ｃｈｅｉｍａｔｏｂｉａ ｂｒｕｍａｔａ， Ｌｉｔｈｏｃｏｌｌｅｔｉｓ ｂｌａｎｃａｒｄｅｌｌａ， Ｈｙｐｏｎｏｍｅｕｔａ ｐａｄｅｌｌａ， Ｐｌｕｔｅｌｌａ ｘｙｌｏｓｔｅｌｌａ， Ｍａｌａｃｏｓｏｍａ ｎｅｕｓｔｒｉａ， Ｅｕｐｒｏｃｔｉｓ ｃｈｒｙｓｏｒｒｈｏｅａ， Ｌｙｍａｎｔｒｉａ ｓｐｐ．， Ｂｕｃｃｕｌａｔｒｉｘ ｔｈｕｒｂｅｒｉｅｌｌａ， Ｐｈｙｌｌｏｃｎｉｓｔｉｓ ｃｉｔｒｅｌｌａ， Ａｇｒｏｔｉｓ ｓｐｐ．， Ｅｕｘｏａ ｓｐｐ．， Ｆｅｌｔｉａ ｓｐｐ．， Ｅａｒｉａｓ ｉｎｓｕｌａｎａ， Ｈｅｌｉｏｔｈｉｓ ｓｐｐ．， Ｍａｍｅｓｔｒａ ｂｒａｓｓｉｃａｅ， Ｐａｎｏｌｉｓ ｆｌａｍｍｅａ， Ｓｐｏｄｏｐｔｅｒａ ｓｐｐ．， Ｔｒｉｃｈｏｐｌｕｓｉａ ｎｉ， Ｃａｒｐｏｃａｐｓａ ｐｏｍｏｎｅｌｌａ， Ｐｉｅｒｉｓ ｓｐｐ．， Ｃｈｉｌｏ ｓｐｐ．， Ｐｙｒａｕｓｔａ ｎｕｂｉｌａｌｉｓ， Ｅｐｈｅｓｔｉａ ｋｕｅｈｎｉｅｌｌａ， Ｇａｌｌｅｒｉａ ｍｅｌｌｏｎｅｌｌａ， Ｔｉｎｅｏｌａ ｂｉｓｓｅｌｌｉｅｌｌａ， Ｔｉｎｅａ ｐｅｌｌｉｏｎｅｌｌａ， Ｈｏｆｍａｎｎｏｐｈｉｌａ ｐｓｅｕｄｏｓｐｒｅｔｅｌｌａ， Ｃａｃｏｅｃｉａ ｐｏｄａｎａ， Ｃａｐｕａ ｒｅｔｉｃｕｌａｎａ， Ｃｈｏｒｉｓｔｏｎｅｕｒａ ｆｕｍｉｆｅｒａｎａ， Ｃｌｙｓｉａ ａｍｂｉｇｕｅｌｌａ， Ｈｏｍｏｎａ ｍａｇｎａｎｉｍａ， Ｔｏｒｔｒｉｘ ｖｉｒｉｄａｎａ， Ｃｎａｐｈａｌｏｃｅｒｕｓ ｓｐｐ．， Ｏｕｌｅｍａ ｏｒｙｚａｅ。<br class="style-scope patent-text">
Ｃｏｌｅｏｐｔｅｒａ目に属するもの、例えば、Ａｎｏｂｉｕｍ ｐｕｎｃｔａｔｕｍ， Ｒｈｉｚｏｐｅｒｔｈａ ｄｏｍｉｎｉｃａ， Ｂｒｕｃｈｉｄｉｕｓ ｏｂｔｅｃｔｕｓ， Ａｃａｎｔｈｏｓｃｅｌｉｄｅｓ ｏｂｔｅｃｔｕｓ， Ｈｙｌｏｔｒｕｐｅｓ ｂａｊｕｌｕｓ， Ａｇｅｌａｓｔｉｃａ ａｌｎｉ， Ｌｅｐｔｉｎｏｔａｒｓａ ｄｅｃｅｍｌｉｎｅａｔａ， Ｐｈａｅｄｏｎ ｃｏｃｈｌｅａｒｉａｅ， Ｄｉａｂｒｏｔｉｃａ ｓｐｐ．， Ｐｓｙｌｌｉｏｄｅｓ ｃｈｒｙｓｏｃｅｐｈａｌａ， Ｅｐｉｌａｃｈｎａ ｖａｒｉｖｅｓｔｉｓ， Ａｔｏｍａｒｉａ ｓｐｐ．， Ｏｒｙｚａｅｐｈｉｌｕｓ ｓｕｒｉｎａｍｅｎｓｉｓ， Ａｎｔｈｏｎｏｍｕｓ ｓｐｐ．， Ｓｉｔｏｐｈｉｌｕｓ ｓｐｐ．， Ｏｔｉｏｒｒｈｙｎｃｈｕｓ ｓｕｌｃａｔｕｓ， Ｃｏｓｍｏｐｏｌｉｔｅｓ ｓｏｒｄｉｄｕｓ， Ｃｅｕｔｈｏｒｒｈｙｎｃｈｕｓ ａｓｓｉｍｉｌｉｓ， Ｈｙｐｅｒａ ｐｏｓｔｉｃａ， Ｄｅｒｍｅｓｔｅｓ ｓｐｐ．， Ｔｒｏｇｏｄｅｒｍａ ｓｐｐ．， Ａｎｔｈｒｅｎｕｓ ｓｐｐ．， Ａｔｔａｇｅｎｕｓ ｓｐｐ．， Ｌｙｃｔｕｓ ｓｐｐ．， Ｍｅｌｉｇｅｔｈｅｓ ａｅｎｅｕｓ， Ｐｔｉｎｕｓ ｓｐｐ．， Ｎｉｐｔｕｓ ｈｏｌｏｌｅｕｃｕｓ， Ｇｉｂｂｉｕｍ ｐｓｙｌｌｏｉｄｅｓ， Ｔｒｉｂｏｌｉｕｍ ｓｐｐ．， Ｔｅｎｅｂｒｉｏ ｍｏｌｉｔｏｒ， Ａｇｒｉｏｔｅｓ ｓｐｐ．， Ｃｏｎｏｄｅｒｕｓ ｓｐｐ．， Ｍｅｌｏｌｏｎｔｈａ ｍｅｌｏｌｏｎｔｈａ， Ａｍｐｈｉｍａｌｌｏｎ ｓｏｌｓｔｉｔｉａｌｉｓ， Ｃｏｓｔｅｌｙｔｒａ ｚｅａｌａｎｄｉｃａ， Ｌｉｓｓｏｒｈｏｐｔｒｕｓ ｏｒｙｚｏｐｈｉｌｕｓ。<br class="style-scope patent-text">
Ｈｙｍｅｎｏｐｔｅｒａ目に属するもの、例えば、Ｄｉｐｒｉｏｎ ｓｐｐ．， Ｈｏｐｌｏｃａｍｐａ ｓｐｐ．， Ｌａｓｉｕｓ ｓｐｐ．， Ｍｏｎｏｍｏｒｉｕｍ ｐｈａｒａｏｎｉｓ， Ｖｅｓｐａ ｓｐｐ。<br class="style-scope patent-text">
Ｄｉｐｔｅｒａ目に属するもの、例えば、Ａｅｄｅｓ ｓｐｐ．， Ａｎｏｐｈｅｌｅｓ ｓｐｐ．， Ｃｕｌｅｘ ｓｐｐ．， Ｄｒｏｓｏｐｈｉｌａ ｍｅｌａｎｏｇａｓｔｅｒ， Ｍｕｓｃａ ｓｐｐ．， Ｆａｎｎｉａ ｓｐｐ．， Ｃａｌｌｉｐｈｏｒａ ｅｒｙｔｈｒｏｃｅｐｈａｌａ， Ｌｕｃｉｌｉａ ｓｐｐ．， Ｃｈｒｙｓｏｍｙｉａ ｓｐｐ．， Ｃｕｔｅｒｅｂｒａ ｓｐｐ．， Ｇａｓｔｒｏｐｈｉｌｕｓ ｓｐｐ．， Ｈｙｐｐｏｂｏｓｃａ ｓｐｐ．， Ｓｔｏｍｏｘｙｓ ｓｐｐ．， Ｏｅｓｔｒｕｓ ｓｐｐ．， Ｈｙｐｏｄｅｒｍａ ｓｐｐ．， Ｔａｂａｎｕｓ ｓｐｐ．， Ｔａｎｎｉａ ｓｐｐ．， Ｂｉｂｉｏ ｈｏｒｔｕｌａｎｕｓ， Ｏｓｃｉｎｅｌｌａ ｆｒｉｔ， Ｐｈｏｒｂｉａ ｓｐｐ．， Ｐｅｇｏｍｙｉａ ｈｙｏｓｃｙａｍｉ， Ｃｅｒａｔｉｔｉｓ ｃａｐｉｔａｔａ， Ｄａｃｕｓ ｏｌｅａｅ， Ｔｉｐｕｌａ ｐａｌｕｄｏｓａ， Ｈｙｌｅｍｙｉａ ｓｐｐ．， Ｌｉｒｉｏｍｙｚａ ｓｐｐ．。<br class="style-scope patent-text">
【０１３９】<br class="style-scope patent-text">
Ｓｉｐｈｏｎａｐｔｅｒａ目に属するもの、例えば、Ｘｅｎｏｐｓｙｌｌａ ｃｈｅｏｐｉｓ， Ｃｅｒａｔｏｐｈｙｌｌｕｓ ｓｐｐ．。<br class="style-scope patent-text">
【０１４０】<br class="style-scope patent-text">
Ａｒａｃｈｎｉｄａ網に属するもの、例えば、Ｓｃｏｒｐｉｏ ｍａｕｒｕｓ， Ｌａｔｒｏｄｅｃｔｕｓ ｍａｃｔａｎｓ， Ａｃａｒｕｓ ｓｉｒｏ， Ａｒｇａｓ ｓｐｐ．， Ｏｒｎｉｔｈｏｄｏｒｏｓ ｓｐｐ．， Ｄｅｒｍａｎｙｓｓｕｓ ｇａｌｌｉｎａｅ， Ｅｒｉｏｐｈｙｅｓ ｒｉｂｉｓ， Ｐｈｙｌｌｏｃｏｐｔｒｕｔａ ｏｌｅｉｖｏｒａ， Ｂｏｏｐｈｉｌｕｓ ｓｐｐ．， Ｒｈｉｐｉｃｅｐｈａｌｕｓ ｓｐｐ．， Ａｍｂｌｙｏｍｍａ ｓｐｐ．， Ｈｙａｌｏｍｍａ ｓｐｐ．， Ｉｘｏｄｅｓ ｓｐｐ．， Ｐｓｏｒｏｐｔｅｓ ｓｐｐ．， Ｃｈｏｒｉｏｐｔｅｓ ｓｐｐ．， Ｓａｒｃｏｐｔｅｓ ｓｐｐ．， Ｔａｒｓｏｎｅｍｕｓ ｓｐｐ．， Ｂｒｙｏｂｉａ ｐｒａｅｔｉｏｓａ， Ｐａｎｏｎｙｃｈｕｓ ｓｐｐ．， Ｔｅｔｒａｎｙｃｈｕｓ ｓｐｐ．， Ｈｅｍｉｔａｒｓｏｎｅｍｕｓ ｓｐｐ．， Ｂｒｅｖｉｐａｌｐｕｓ ｓｐｐ．。<br class="style-scope patent-text">
【０１４１】<br class="style-scope patent-text">
植物寄生線虫としては、例えば、Ｐｒａｔｙｌｅｎｃｈｕｓ ｓｐｐ．， Ｒａｄｏｐｈｏｌｕｓ ｓｉｍｉｌｉｓ， Ｄｉｔｙｌｅｎｃｈｕｓ ｄｉｐｓａｃｉ， Ｔｙｌｅｎｃｈｕｌｕｓ ｓｅｍｉｐｅｎｅｔｒａｎｓ， Ｈｅｔｅｒｏｄｅｒａ ｓｐｐ．， Ｇｌｏｂｏｄｅｒａ ｓｐｐ．， Ｍｅｌｏｉｄｏｇｙｎｅ ｓｐｐ．， Ａｐｈｅｌｅｎｃｈｏｉｄｅｓ ｓｐｐ．， Ｌｏｎｇｉｄｏｒｕｓ ｓｐｐ．， Ｘｉｐｈｉｎｅｍａ ｓｐｐ．， Ｔｒｉｃｈｏｄｏｒｕｓ ｓｐｐ．， Ｂｕｒｓａｐｈｅｌｅｎｃｈｕｓ ｓｐｐ．が挙げられる。<br class="style-scope patent-text">
【０１４２】<br class="style-scope patent-text">
本発明に記載の方法を用いることで見い出された活性物質は、植物、衛生及び貯蔵品の害虫だけでなく、マダニ（ｈａｒｄ ｔｉｃｋｓ）、ヒメダニ（ｓｏｆｔ ｔｉｃｋｓ）、疥癬ダニ（ｍａｎｇｅ ｍｉｔｅｓ）、葉ダニ（ｌｅａｆ ｍｉｔｅｓ）、ハエ （噛むおよび舐める）、寄生性のハエ幼虫、しらみ、毛じらみ、毛皮しらみ（ｆｕｒ ｌｉｃｅ）及びノミなどの動物寄生生物（外寄生生物）に対する動物薬部門についても作用する。この寄生生物には、以下のものが含まれる。<br class="style-scope patent-text">
【０１４３】<br class="style-scope patent-text">
Ａｎｏｐｌｕｒｉｄａ目に属するもの、例えば、Ｈａｅｍａｔｏｐｉｎｕｓ ｓｐｐ．， Ｌｉｎｏｇｎａｔｈｕｓ ｓｐｐ．， Ｐｅｄｉｃｕｌｕｓ ｓｐｐ．， Ｐｈｔｉｒｕｓ ｓｐｐ．， Ｓｏｌｅｎｏｐｏｔｅｓ ｓｐｐ．。<br class="style-scope patent-text">
Ｍａｌｌｏｐｈａｇｉｄａ目に属するもの、並びに、Ａｍｂｌｙｃｅｒｉｎａ及びＩｓｃｈｎｏｃｅｒｉｎａ亜目に属するもの、例えば、Ｔｒｉｍｅｎｏｐｏｎ ｓｐｐ．， Ｍｅｎｏｐｏｎ ｓｐｐ．， Ｔｒｉｎｏｔｏｎ ｓｐｐ．， Ｂｏｖｉｃｏｌａ ｓｐｐ．， Ｗｅｒｎｅｃｋｉｅｌｌａ ｓｐｐ．， Ｌｅｐｉｋｅｎｔｒｏｎ ｓｐｐ．， Ｄａｍａｌｉｎａ ｓｐｐ．， Ｔｒｉｃｈｏｄｅｃｔｅｓ ｓｐｐ．， Ｆｅｌｉｃｏｌａ ｓｐｐ．。<br class="style-scope patent-text">
【０１４４】<br class="style-scope patent-text">
Ｄｉｐｔｅｒａ目に属するもの、並びにＮｅｍａｔｏｃｅｒｉｎａ及びＢｒａｃｈｙｃｅｒｉｎａ亜目に属するもの、例えば、Ａｅｄｅｓ ｓｐｐ．， Ａｎｏｐｈｅｌｅｓ ｓｐｐ．， Ｃｕｌｅｘ ｓｐｐ．， Ｓｉｍｕｌｉｕｍ ｓｐｐ．， Ｅｕｓｉｍｕｌｉｕｍ ｓｐｐ．， Ｐｈｌｅｂｏｔｏｍｕｓ ｓｐｐ．， Ｌｕｔｚｏｍｙｉａ ｓｐｐ．， Ｃｕｌｉｃｏｉｄｅｓ ｓｐｐ．， Ｃｈｒｙｓｏｐｓ ｓｐｐ．， Ｈｙｂｏｍｉｔｒａ ｓｐｐ．， Ａｔｙｌｏｔｕｓ ｓｐｐ．， Ｔａｂａｎｕｓ ｓｐｐ．， Ｈａｅｍａｔｏｐｏｔａ ｓｐｐ．， Ｐｈｉｌｉｐｏｍｙｉａ ｓｐｐ．， Ｂｒａｕｌａ ｓｐｐ．， Ｍｕｓｃａ ｓｐｐ．， Ｈｙｄｒｏｔａｅａ ｓｐｐ．， Ｓｔｏｍｏｘｙｓ ｓｐｐ．， Ｈａｅｍａｔｏｂｉａ ｓｐｐ．， Ｍｏｒｅｌｌｉａ ｓｐｐ．， Ｆａｎｎｉａ ｓｐｐ．， Ｇｌｏｓｓｉｎａ ｓｐｐ．， Ｃａｌｌｉｐｈｏｒａ ｓｐｐ．， Ｌｕｃｉｌｉａ ｓｐｐ．， Ｃｈｒｙｓｏｍｙｉａ ｓｐｐ．， Ｗｏｈｌｆａｈｒｔｉａ ｓｐｐ．， Ｓａｒｃｏｐｈａｇａ ｓｐｐ．， Ｏｅｓｔｒｕｓ ｓｐｐ．， Ｈｙｐｏｄｅｒｍａ ｓｐｐ．， Ｇａｓｔｅｒｏｐｈｉｌｕｓ ｓｐｐ．， Ｈｉｐｐｏｂｏｓｃａ ｓｐｐ．， Ｌｉｐｏｐｔｅｎａ ｓｐｐ．， Ｍｅｌｏｐｈａｇｕｓ ｓｐｐ．。<br class="style-scope patent-text">
【０１４５】<br class="style-scope patent-text">
Ｓｉｐｈｏｎａｐｔｅｒｉｄａ目に属するもの、例えば、Ｐｕｌｅｘ ｓｐｐ．， Ｃｔｅｎｏｃｅｐｈａｌｉｄｅｓ ｓｐｐ．， Ｘｅｎｏｐｓｙｌｌａ ｓｐｐ．， Ｃｅｒａｔｏｐｈｙｌｌｕｓ ｓｐｐ．。<br class="style-scope patent-text">
【０１４６】<br class="style-scope patent-text">
Ｈｅｔｅｒｏｐｔｅｒｉｄａ目に属するもの、例えば、Ｃｉｍｅｘ ｓｐｐ．， Ｔｒｉａｔｏｍａ ｓｐｐ．， Ｒｈｏｄｎｉｕｓ ｓｐｐ．， Ｐａｎｓｔｒｏｎｇｙｌｕｓ ｓｐｐ．。<br class="style-scope patent-text">
【０１４７】<br class="style-scope patent-text">
Ｂｌａｔｔａｒｉｄａ目に属するもの、例えば、Ｂｌａｔｔａ ｏｒｉｅｎｔａｌｉｓ， Ｐｅｒｉｐｌａｎｅｔａ ａｍｅｒｉｃａｎａ， Ｂｌａｔｔｅｌａ ｇｅｒｍａｎｉｃａ， Ｓｕｐｅｌｌａ ｓｐｐ．。<br class="style-scope patent-text">
【０１４８】<br class="style-scope patent-text">
Ａｃａｒｉａ （Ａｃａｒｉｄａ）亜網に属するもの、並びにＭｅｔａ−及びＭｅｓｏｓｔｉｇｍａｔａ目に属するもの、例えば、Ａｒｇａｓ ｓｐｐ．， Ｏｒｎｉｔｈｏｄｏｒｕｓ ｓｐｐ．， Ｏｔｏｂｉｕｓ ｓｐｐ．， Ｉｘｏｄｅｓ ｓｐｐ．， Ａｍｂｌｙｏｍｍａ ｓｐｐ．， Ｂｏｏｐｈｉｌｕｓ ｓｐｐ．， Ｄｅｒｍａｃｅｎｔｏｒ ｓｐｐ．， Ｈａｅｍｏｐｈｙｓａｌｉｓ ｓｐｐ．， Ｈｙａｌｏｍｍａ ｓｐｐ．， Ｒｈｉｐｉｃｅｐｈａｌｕｓ ｓｐｐ．， Ｄｅｒｍａｎｙｓｓｕｓ ｓｐｐ．， Ｒａｉｌｌｉｅｔｉａ ｓｐｐ．， Ｐｎｅｕｍｏｎｙｓｓｕｓ ｓｐｐ．， Ｓｔｅｒｎｏｓｔｏｍａ ｓｐｐ．， Ｖａｒｒｏａ ｓｐｐ．。<br class="style-scope patent-text">
【０１４９】<br class="style-scope patent-text">
Ａｃｔｉｎｅｄｉｄａ （Ｐｒｏｓｔｉｇｍａｔａ） 及びＡｃａｒｉｄｉｄａ （Ａｓｔｉｇｍａｔａ）目に属するもの、例えば、Ａｃａｒａｐｉｓ ｓｐｐ．， Ｃｈｅｙｌｅｔｉｅｌｌａ ｓｐｐ．， Ｏｒｎｉｔｈｏｃｈｅｙｌｅｔｉａ ｓｐｐ．， Ｍｙｏｂｉａ ｓｐｐ．， Ｐｓｏｒｅｒｇａｔｅｓ ｓｐｐ．， Ｄｅｍｏｄｅｘ ｓｐｐ．， Ｔｒｏｍｂｉｃｕｌａ ｓｐｐ．， Ｌｉｓｔｒｏｐｈｏｒｕｓ ｓｐｐ．， Ａｃａｒｕｓ ｓｐｐ．， Ｔｙｒｏｐｈａｇｕｓ ｓｐｐ．， Ｃａｌｏｇｌｙｐｈｕｓ ｓｐｐ．， Ｈｙｐｏｄｅｃｔｅｓ ｓｐｐ．， Ｐｔｅｒｏｌｉｃｈｕｓ ｓｐｐ．， Ｐｓｏｒｏｐｔｅｓ ｓｐｐ．， Ｃｈｏｒｉｏｐｔｅｓ ｓｐｐ．， Ｏｔｏｄｅｃｔｅｓ ｓｐｐ．， Ｓａｒｃｏｐｔｅｓ ｓｐｐ．， Ｎｏｔｏｅｄｒｅｓ ｓｐｐ．， Ｋｎｅｍｉｄｏｃｏｐｔｅｓ ｓｐｐ．， Ｃｙｔｏｄｅｃｔｅｓ ｓｐｐ．， Ｌａｍｉｎｏｓｉｏｐｔｅｓ ｓｐｐ．。<br class="style-scope patent-text">
【０１５０】<br class="style-scope patent-text">
本発明に記載の方法によって見い出された活性物質もまた、ダニ、特に家塵ダニ、例えばＤｅｒｍａｔｏｐｈａｇｏｉｄｅｓ ｐｔｅｒｏｎｙｓｓｉｎｕｓ及びＤ． ｆａｒｉｎａｅを退治するのに好ましい。<br class="style-scope patent-text">
【０１５１】<br class="style-scope patent-text">
本発明に記載の方法を用いることで見い出された活性物質もまた、農業生産家畜、例えばウシ、ヒツジ、ヤギ、ウマ、ブタ、ロバ、ラクダ、水牛、ウサギ、ニワトリ、七面鳥、アヒル、ガチョウ、ミツバチ、その他ペット（例えば、犬、猫、かごの鳥及び観賞魚）、およびいわゆる実験動物（例えば、ハムスター、ギニーピッグ、ラット及びマウス）などに寄生する節足動物を退治するのに好ましい。これらの節足動物の退治は、死亡率の低減や生産性（肉、ミルク、毛、皮、卵、蜂蜜などの）の減少を低減し、その結果、より経済的でより容易な動物の管理が本発明の活性物質の使用を通じて可能になる。<br class="style-scope patent-text">
【０１５２】<br class="style-scope patent-text">
同様に、記載された方法により見い出された化合物及びポリペプチドは、ヒトの、または生産性家畜、ペット、動物園の動物並びに研究および実験用動物の病原内因的寄生虫によって感染した動物やヒトを処置するのに有用である。<br class="style-scope patent-text">
【０１５３】<br class="style-scope patent-text">
正常株、感受性株及び耐性株の開発における全てのストラテジーに、本化合物を用いることができる。これらの化合物の１またはそれ以上を含む組成物を用いる処置によって、生産性家畜における経済的損失を防ぎ、かつヒト及び動物における疾患を処置することが可能である。以下の寄生生物は、見出された活性物質の標的として特に興味深いものである。<br class="style-scope patent-text">
【０１５４】<br class="style-scope patent-text">
<u class="style-scope patent-text">Ｅｎｏｐｌｉｄａ</u>， 例えば、Ｔｒｉｃｈｕｒｉｓ ｓｐｐ．， Ｃａｐｉｌｌａｒｉａ ｓｐｐ．， Ｔｒｉｃｈｏｍｏｓｏｉｄｅｓ ｓｐｐ．， Ｔｒｉｃｈｉｎｅｌｌａ ｓｐｐ．<br class="style-scope patent-text">
<u class="style-scope patent-text">Ｒｈａｂｄｉｔｉａ</u>、例えば、Ｍｉｃｒｏｎｅｍａ ｓｐｐ．、Ｓｔｒｏｎｇｙｌｏｉｄｅｓ ｓｐｐ．<br class="style-scope patent-text">
<u class="style-scope patent-text">Ｓｔｒｏｎｇｙｌｉｄａ</u>、例えば、Ｓｔｒｏｎｇｙｌｕｓ ｓｐｐ．、Ｔｒｉｏｄｏｎｔｏｐｈｏｒｕｓ ｓｐｐ．、Ｏｅｓｏｐｈａｇｏｄｏｎｔｕｓ ｓｐｐ．、Ｔｒｉｃｈｏｎｅｍａ ｓｐｐ．、Ｇｙａｌｏｃｅｐｈａｌｕｓ ｓｐｐ．、Ｃｙｌｉｎｄｒｏｐｈａｒｙｎｘ ｓｐｐ．、Ｐｏｔｅｒｉｏｓｔｏｍｕｍ ｓｐｐ．、Ｃｙｃｌｏｃｏｃｅｒｃｕｓ ｓｐｐ．、Ｃｙｌｉｃｏｓｔｅｐｈａｎｕｓ ｓｐｐ．、Ｏｅｓｏｐｈａｇｏｓｔｏｍｕｍ ｓｐｐ．、Ｃｈａｂｅｒｔｉａ ｓｐｐ．、Ｓｔｅｐｈａｎｕｒｕｓ ｓｐｐ．、Ａｎｃｙｌｏｓｔｏｍａ ｓｐｐ．、Ｕｎｃｉｎａｒｉａ ｓｐｐ．、Ｂｕｎｏｓｔｏｍｕｍ ｓｐｐ．、Ｇｌｏｂｏｃｅｐｈａｌｕｓ ｓｐｐ．、Ｓｙｎｇａｍｕｓ ｓｐｐ．、Ｃｙａｔｈｏｓｔｏｍｕｍ ｓｐｐ．、Ｃｙｌｉｃｏｃｙｃｌｕｓ ｓｐｐ．、Ｎｅｏｓｔｒｏｎｇｙｌｕｓ ｓｐｐ．、Ｃｙｓｔｏｃａｕｌｕｓ ｓｐｐ．、Ｐｎｅｕｍｏｓｔｒｏｎｇｙｌｕｓ ｓｐｐ．、Ｓｐｉｃｏｃａｕｌｕｓ ｓｐｐ．、Ｅｌａｐｈｏｓｔｒｏｎｇｙｌｕｓ ｓｐｐ．、Ｐａｒｅｌａｐｈｏｓｔｒｏｎｇｙｌｕｓ ｓｐｐ．、Ｃｒｅｎｏｓｏｍａ ｓｐｐ．、Ｐａｒａｃｒｅｎｏｓｏｍａ ｓｐｐ．、Ａｎｇｉｏｓｔｒｏｎｇｙｌｕｓ ｓｐｐ．、Ａｅｌｕｒｏｓｔｒｏｎｇｙｌｕｓ ｓｐｐ．、Ｆｉｌａｒｏｉｄｅｓ ｓｐｐ．、Ｐａｒａｆｉｌａｒｏｉｄｅｓ ｓｐｐ．、Ｔｒｉｃｈｏｓｔｒｏｎｇｙｌｕｓ ｓｐｐ．、Ｈａｅｍｏｎｃｈｕｓ ｓｐｐ．、Ｏｓｔｅｒｔａｇｉａ ｓｐｐ．、Ｍａｒｓｈａｌｌａｇｉａ ｓｐｐ．、Ｃｏｏｐｅｒｉａ ｓｐｐ．、Ｎｅｍａｔｏｄｉｒｕｓ ｓｐｐ．、Ｈｙｏｓｔｒｏｎｇｙｌｕｓ ｓｐｐ．、Ｏｂｅｌｉｓｃｏｉｄｅｓ ｓｐｐ．、Ａｍｉｄｏｓｔｏｍｕｍ ｓｐｐ．、Ｏｌｌｕｌａｎｕｓ ｓｐｐ． Ｄｉｃｔｙｏｃａｕｌｕｓ ｓｐｐ．、Ｍｕｅｌｌｅｒｉｕｓ ｓｐｐ．、Ｐｒｏｔｏｓｔｒｏｎｇｙｌｕｓ ｓｐｐ．<br class="style-scope patent-text">
【０１５５】<br class="style-scope patent-text">
<u class="style-scope patent-text">Ｏｘｙｕｒｉｄａ</u>、例えば、Ｏｘｙｕｒｉｓ ｓｐｐ．、Ｅｎｔｅｒｏｂｉｕｓ ｓｐｐ．、Ｐａｓｓａｌｕｒｕｓ ｓｐｐ．、Ｓｙｐｈａｃｉａ ｓｐｐ．、Ａｓｐｉｃｕｌｕｒｉｓ ｓｐｐ．、ヘテラキス（Ｈｅｔｅｒａｋｉｓ） ｓｐｐ．<br class="style-scope patent-text">
【０１５６】<br class="style-scope patent-text">
<u class="style-scope patent-text">Ａｓｃａｒｉｄｉａ</u>、例えば、回虫 ｓｐｐ．、Ｔｏｘａｓｃａｒｉｓ ｓｐｐ．、Ｔｏｘｏｃａｒａ ｓｐｐ．、Ｐａｒａｓｃａｒｉｓ ｓｐｐ．、Ａｎｉｓａｋｉｓ ｓｐｐ．、Ａｓｃａｒｉｄｉａ ｓｐｐ．<br class="style-scope patent-text">
<u class="style-scope patent-text">Ｓｐｉｒｕｒｉｄａ</u>、例えば、Ｇｎａｔｈｏｓｔｏｍａ ｓｐｐ．、Ｐｈｙｓａｌｏｐｔｅｒａ ｓｐｐ．、Ｔｈｅｌａｚｉａ ｓｐｐ．、Ｇｏｎｇｙｌｏｎｅｍａ ｓｐｐ．、Ｈａｂｒｏｎｅｍａ ｓｐｐ．、Ｐａｒａｂｒｏｎｅｍａ ｓｐｐ．、Ｄｒａｓｃｈｉａ ｓｐｐ．、Ｄｒａｃｕｎｃｕｌｕｓ ｓｐｐ．<br class="style-scope patent-text">
<u class="style-scope patent-text">Ｆｉｌａｒｉｉｄａ</u>、例えば、Ｓｔｅｐｈａｎｏｆｉｌａｒｉａ ｓｐｐ．、Ｐａｒａｆｉｌａｒｉａ ｓｐｐ．、Ｓｅｔａｒｉａ ｓｐｐ．、Ｌｏａ ｓｐｐ．、Ｄｉｒｏｆｉｌａｒｉａ ｓｐｐ．、Ｌｉｔｏｍｏｓｏｉｄｅｓ ｓｐｐ．、Ｂｒｕｇｉａ ｓｐｐ．、Ｗｕｃｈｅｒｅｒｉａ ｓｐｐ．、Ｏｎｃｈｏｃｅｒｃａ ｓｐｐ．<br class="style-scope patent-text">
<u class="style-scope patent-text">Ｇｉｇａｎｔｏｒｈｙｎｃｈｉｄａ</u>、例えば、Ｆｉｌｉｃｏｌｌｉｓ ｓｐｐ．、Ｍｏｎｉｌｉｆｏｒｍｉｓ ｓｐｐ．、Ｍａｃｒａｃａｎｔｈｏｒｈｙｎｃｈｕｓ ｓｐｐ．、Ｐｒｏｓｔｈｅｎｏｒｃｈｉｓ ｓｐｐ．<br class="style-scope patent-text">
<u class="style-scope patent-text">Ｍａｓｔｉｇｏｐｈｏｒａ</u> <u class="style-scope patent-text"> </u> <u class="style-scope patent-text">（Ｆｌａｇｅｌｌａｔａ）</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">Ｔｒｙｐａｎｏｓｏｍａｔｉｄａｅ</u>、例えば、Ｔｒｙｐａｎｏｓｏｍａ ｂ． ｂｒｕｃｅｉ、Ｔ． ｂ． ｇａｍｂｉｅｎｓｅ、Ｔ． ｂ． ｒｈｏｄｅｓｉｅｎｓｅ、Ｔ． ｃｏｎｇｏｌｅｎｓｅ、Ｔ． ｃｒｕｚｉ、Ｔ． ｅｖａｎｓｉ、Ｔ． ｅｑｕｉｎｕｍ、Ｔ． ｌｅｗｉｓｉ、Ｔ． ｐｅｒｃａｅ、Ｔ． ｓｉｍｉａｅ、Ｔ． ｖｉｖａｘ、Ｌｅｉｓｈｍａｎｉａ ｂｒａｓｉｌｉｅｎｓｉｓ、Ｌ． ｄｏｎｏｖａｎｉ、Ｌ． ｔｒｏｐｉｃａ<br class="style-scope patent-text">
<u class="style-scope patent-text">Ｔｒｉｃｈｏｍｏｎａｄｉｄａｅ</u> 、例えば、Ｇｉａｒｄｉａ ｌａｍｂｉｌｉａ、Ｇ． ｃａｎｉｓ．<br class="style-scope patent-text">
<u class="style-scope patent-text">Ｓａｒｃｏｍａｓｔｉｇｏｐｈｏｒａ</u> <u class="style-scope patent-text"> </u> <u class="style-scope patent-text">（Ｒｈｉｚｏｐｏｄａ）</u>、例えば、Ｅｎｔａｍｏｅｂａ ｈｉｓｔｏｌｙｔｉｃａ<br class="style-scope patent-text">
<u class="style-scope patent-text">Ｈａｒｔｍａｎｅｌｌｉｄａｅ</u> <u class="style-scope patent-text">、</u>例えば、Ａｃａｎｔｈａｍｏｅｂａ ｓｐ．、Ｈａｒｔｍａｎｅｌｌａ ｓｐｐ．<br class="style-scope patent-text">
<u class="style-scope patent-text">Ａｐｉｃｏｍｐｌｅｘａ</u> <u class="style-scope patent-text"> </u> <u class="style-scope patent-text">（Ｓｐｏｒｏｚｏａ）</u>、例えば、Ｅｉｍｅｒｉａ ａｃｅｒｖｕｌｉｎａ、Ｅ． ａｄｅｎｏｉｄｅｓ、Ｅ． ａｌａｂａｈｍｅｎｓｉｓ、Ｅ． ａｎａｔｉｓ、Ｅ． ａｎｓｅｒｉｓ、Ｅ． ａｒｌｏｉｎｇｉ、Ｅ． ａｓｈａｔａ、Ｅ． ａｕｂｕｒｎｅｎｓｉｓ、Ｅ． ｂｏｖｉｓ、Ｅ． ｂｒｕｎｅｔｔｉ、Ｅ． ｃａｎｉｓ、Ｅ． ｃｈｉｎｃｈｉｌｌａｅ、Ｅ． ｃｌｕｐｅａｒｕｍ、Ｅ． ｃｏｌｕｍｂａｅ、Ｅ． ｃｏｎｔｏｒｔａ、Ｅ． ｃｒａｎｄａｌｉｓ、Ｅ． ｄｅｂｌｉｅｃｋｉ、Ｅ． ｄｉｓｐｅｒｓａ、Ｅ． ｅｌｌｉｐｓｏｉｄａｌｅｓ、Ｅ． ｆａｌｃｉｆｏｒｍｉｓ、Ｅ． ｆａｕｒｅｉ、Ｅ． ｌａｂｂｅａｎａ、Ｅ． ｌｅｕｃａｒｔｉ、Ｅ． ｍａｇｎａ、Ｅ． ｍａｘｉｍａ、Ｅ． ｍｅｄｉａ、Ｅ． ｍｅｌｅａｇｒｉｄｉｓ． Ｅ． ｍｅｌｅａｇｒｉｍｉｔｉｓ、Ｅ． ｍｉｔｉｓ、Ｅ． ｎｅｃａｔｒｉｘ、Ｅ． ｎｉｎａｋｏｈｌｙａｋｉｍｏｖａｅ、Ｅ． ｏｖｉｓ、Ｅ． ｐａｒｖａ、Ｅ． ｐａｖｏｎｉｓ、Ｅ． ｐｅｒｆｏｒａｎｓ、Ｅ． ｐｈａｓａｎｉ、Ｅ． ｐｉｒｉｆｏｒｍｉｓ、Ｅ． ｐｒａｅｃｏｘ、Ｅ． ｒｅｓｉｄｕａ、Ｅ． ｓｃａｂｒａ、Ｅ． ｓｐｅｃ．、Ｅ． ｓｔｉｅｄａｉ、Ｅ． ｓｕｉｓ、Ｅ． ｔｅｎｅｌｌａ、Ｅ． ｔｒｕｎｃａｔａ、Ｅ． ｔｒｕｔｔａｅ、Ｅ． ｚｕｅｒｎｉｉ、Ｇｌｏｂｉｄｉｕｍ ｓｐｅｃ．、Ｉｓｏｓｐｏｒａ ｂｅｌｌｉ、Ｉ． ｃａｎｉｓ、Ｉ． ｆｅｌｉｓ、Ｉ． ｏｈｉｏｅｎｓｉｓ、Ｉ． ｒｉｖｏｌｔａ、Ｉ． ｓｐｅｃ．、Ｉ． ｓｕｉｓ、Ｎｅｏｓｐｏｒａ ｃａｎｉｎｕｍ、Ｃｙｓｔｉｓｏｓｐｏｒａ ｓｐｅｃ． Ｃｒｙｐｔｏｓｐｏｒｉｄｉｕｍ ｓｐｅｃ．<br class="style-scope patent-text">
<u class="style-scope patent-text">Ｔｏｘｏｐｌａｓｍａｄｉｄａｅ</u>、例えば、Ｔｏｘｏｐｌａｓｍａ ｇｏｎｄｉｉ<br class="style-scope patent-text">
<u class="style-scope patent-text">Ｓａｒｃｏｃｙｓｔｉｄａｅ</u>、例えば、Ｓａｒｃｏｃｙｓｔｉｓ ｂｏｖｉｃａｎｉｓ、Ｓ． ｂｏｖｉｈｏｍｉｎｉｓ、Ｓ． ｎｅｕｖｏｎａ、Ｓ． ｏｖｉｃａｎｉｓ、Ｓ． ｏｖｉｆｅｌｉｓ、Ｓ． ｓｐｅｃ．、Ｓ． ｓｕｉｈｏｍｉｎｉｓ<br class="style-scope patent-text">
<u class="style-scope patent-text">Ｌｅｕｃｏｚｏｉｄｅ</u>、例えば、Ｌｅｕｃｏｚｙｔｏｚｏｏｎ ｓｉｍｏｎｄｉ<br class="style-scope patent-text">
<u class="style-scope patent-text">Ｐｌａｓｍｏｄｉｉｄａｅ</u>、例えば、Ｐｌａｓｍｏｄｉｕｍ ｂｅｒｇｈｅｉ、Ｐ． ｆａｌｃｉｐａｒｕｍ、Ｐ． ｍａｌａｒｉａｅ、Ｐ． ｏｖａｌｅ、Ｐ． ｖｉｖａｘ、Ｐ． ｓｐｅｃ．<br class="style-scope patent-text">
<u class="style-scope patent-text">Ｐｉｒｏｐｌａｓｍｅａ</u>、例えば、Ｂａｂｅｓｉａ ａｒｇｅｎｔｉｎａ、Ｂ． ｂｏｖｉｓ、Ｂ． ｃａｎｉｓ、Ｂ． ｓｐｅｃ．、Ｔｈｅｉｌｅｒｉａ ｐａｒｖａ、Ｔ． ｓｐｅｃ．<br class="style-scope patent-text">
<u class="style-scope patent-text">Ａｄｅｌｅｉｎａ</u>、例えば、Ｈｅｐａｔｏｚｏｏｎ ｃａｎｉｓ、Ｈ． ｓｐｅｃ．<br class="style-scope patent-text">
【０１５７】<br class="style-scope patent-text">
さらに、重要なものでは、Ｍｙｘｏｓｐｏｒａ ａｎｄ Ｍｉｃｒｏｓｐｏｒａ、例えば、Ｇｌｕｇｅａ ｓｐｅｃ． 及びＮｏｓｅｍａ ｓｐｅｃ．、及びＰｎｅｕｍｏｃｙｓｔｉｓ ｃａｒｉｎｉｉ、<u class="style-scope patent-text">Ｃｉｌｉｏｐｈｏｒａ</u> <u class="style-scope patent-text"> </u> <u class="style-scope patent-text">（Ｃｉｌｉａｔａ）</u>、例えば、Ｂａｌａｎｔｉｄｉｕｍ ｃｏｌｉ、Ｉｃｈｔｈｉｏｐｈｔｈｉｒｉｕｓ ｓｐｅｃ．、Ｔｒｉｃｈｏｎｄｉｎａ ｓｐｅｃ． 又は<u class="style-scope patent-text">Ｅｐｉｓｔｙｌｉｓ</u> ｓｐｅｃがある。<br class="style-scope patent-text">
【０１５８】<br class="style-scope patent-text">
見出された化合物及び組成物も同様、昆虫の原生動物、例えばＭｉｃｒｏｓｐｏｒｉｄｉａ門の動物、特にＮｏｓｅｍａ目の動物、さらに特にミツバチの寄生虫であるＮｏｓｅｍａ ａｐｉｓ種の動物、に有効である。<br class="style-scope patent-text">
【０１５９】<br class="style-scope patent-text">
したがって、本発明は、蠕虫及び／又は節足動物を退治する組成物を生産するための、本発明の方法または本発明の核酸またはポリペプチドを用いて見出された化合物の使用に関する。<br class="style-scope patent-text">
【０１６０】<br class="style-scope patent-text">
<u class="style-scope patent-text">実施例</u> <br class="style-scope patent-text">
１．ｃＤＮＡライブラリーの構築及びスクリーニング<br class="style-scope patent-text">
ｃＤＮＡライブラリーの構築、ＫＬＨ−ＰＦ１０２２Ａコンジュゲートの製造及びＰＦ１０２２Ａに対する抗血清、及びｃＤＡＮライブラリーの免疫スクリーニング及びＤＮＡ分析は、ＷＯ ９８／１５６２５の記載にしたがって行なった。<br class="style-scope patent-text">
【０１６１】<br class="style-scope patent-text">
２．ＲＮＡの単離<br class="style-scope patent-text">
全ＲＮＡは、ＧＴＣ／ＣｓＣｌクッション法（Ｓａｍｂｒｏｏｋら、１９８９）により、成虫Ｈａｅｍｏｎｃｈｕｓ ｃｏｎｔｏｒｔｕｓ線虫から抽出して単離するか、あるいはＧＴＣ／フェノール／クロロホルム抽出（Ｃｈｏｍｃｚｙｎｓｋｉ及びＳａｃｃｈｉ １９８７） により一工程で得た。ポリ（Ａ）<sup class="style-scope patent-text">＋</sup>ＲＮＡを、オリゴ（ｄＴ）セルロースのクロマトグラフィーにより単離した （Ａｖｉｖ ａｎｄ Ｌｅｄｅｒ， １９７２）。<br class="style-scope patent-text">
【０１６２】<br class="style-scope patent-text">
３．ノーザンブロッティング<br class="style-scope patent-text">
Ｈａｅｍｏｎｃｈｕｓ ｃｏｎｔｏｒｔｕｓ由来のグルオキシル化全ＲＮＡ（１レーン当たり２０μｇ）をアガロースゲルにて分画し（Ｓａｍｂｒｏｏｋら、１９８９； ＭｃＭａｓｔｅｒ及びＣａｒｍｉｃｈａｅｌ １９７７）、標準キャピラリー輸送法（ｔｈｅ ｂａｓｉｃ ｃａｐｉｌｌａｒｙ ｔｒａｎｓｆｅｒ ｍｅｔｈｏｄ）（Ｃｈｏｍｃｚｙｎｓｋｉ， １９９２）によりＨｙｂｏｎｄ Ｎメンブレン（Ａｍｅｒｓｈａｍ）に移動させた。放射能標識プローブは、メガプライム キット（Ａｍｅｒｓｈａｍ， Ｂｒａｕｎｓｃｈｗｅｉｇ， Ｇｅｒｍａｎｙ）と５０μＣｉの［α−<sup class="style-scope patent-text">３２</sup>Ｐ］ｄＣＴＰ （３０００ Ｃｉ／ｍｍｏｌ， ＩＣＮ， Ｍｅｃｋｅｎｈｅｉｍ， Ｇｅｒｍａｎｙ）を用いて、線状化したプラスミドＤＮＡ（ＨＣ１１０−Ｒ）のランダム標識により調製した。ハイブリダイゼーションは、６×ＳＳＣ （１×ＳＳＣ：０．１５ Ｍ ＮａＣｌ， ０．０１５ Ｍ クエン酸ナトリウム）、５×デンハルト試薬 （０．１％ ポリビニルピロリドン， ０．１％ ＢＳＡ， ０．１％ Ｆｉｃｏｌｌ ４００）、０．１％ ＳＤＳ及び１００μｇ／ｍＬ ニシン精子ＤＮＡ中、６５℃にて一晩行なった。フィルターは、０．１×ＳＳＣ及び０．１％ ＳＤＳ中の高いストリンジェンシーで、６５℃にて洗浄し、露光した（−８０℃のＫｏｄａｋ ＢｉｏＭａｘ ＭＳ フィルム）（図１（Ａ） を参照）。<br class="style-scope patent-text">
【０１６３】<br class="style-scope patent-text">
４．５’及び３’ＲＡＣＥ ＰＣＲ<br class="style-scope patent-text">
５’／３’ ＲＡＣＥ法を用いて、同定したｃＤＮＡクローンに欠けている５’及び３’末端を単離した。<br class="style-scope patent-text">
【０１６４】<br class="style-scope patent-text">
５’ ＲＡＣＥは、ｍＲＮＡ由来の遺伝子の５’端を特異的に増幅することに基づく。配列特異的プライマー及びＡＭＶ逆転写酵素を用いて、第１のｃＤＮＡ鎖を合成する。ポリ（Ａ）尾部をその生成物に結合させることにより、後のＰＣＲにおいて、オリゴｄＴアンカープライマーおよびネステッド配列特異的プライマーを用いることが可能になる。別のＰＣＲでは、特異性を確保するため、別のネステッドプライマーを用いることが可能である。<br class="style-scope patent-text">
【０１６５】<br class="style-scope patent-text">
３’ ＲＡＣＥでは、第１のｃＤＮＡ鎖はオリゴｄＴプライマーを用いて合成し、後のＰＣＲ反応は配列特異的プライマーを用いて行なう。<br class="style-scope patent-text">
【０１６６】<br class="style-scope patent-text">
ｃＤＮＡは、プライマー５’−ＧＧＴ ＣＡＣ ＣＧＴ ＣＧＴ ＣＣＣ ＡＧＡ ＡＡ−３’及びＧＩＢＣＯ ＢＲＬ （Ｅｇｇｅｎｓｔｅｉｎ， Ｇｅｒｍａｎｙ）の５’ ＲＡＣＥキットを用いて１μｇのＨ． ｃｏｎｔｏｒｔｕｓ 全ＲＮＡから合成した。スーパークリプト逆転写酵素をこの目的のために用いた。このｃＤＮＡのＣ末端のＣテイリングは、末端デオキシヌクレオチジルトランスフェラーゼを用いて行なった。第１の増幅は、４００ｎＭのオリゴデオキシイノシルアンカープライマー （５’−ＣＵＡ ＣＵＡ ＣＵＡ ＣＵＡ ＧＧＣ ＣＡＣ ＧＣＧ ＴＣＧ ＡＣＴ ＡＧＴ ＡＣＧ ＧＧＩ ＩＧＧ ＧＩＩ ＧＧＧ ＩＩＧ−３’） と、４００ｎＭの第１のネステッドプライマー ５’−ＣＣＡ ＴＴＣ ＧＡＴ ＴＣＣ ＴＣＴ ＴＣＴ ＣＧ−３’ （Ｂｉｒｓｎｅｒ ｕｎｄ Ｇｒｏｂ， Ｄｅｎｚｌｉｎｇｅｎ， Ｇｅｒｍａｎｙ）を用い、２００μＭの各ｄＮＴＰ、１．５ ｍＭのＭｇＣｌ<sub class="style-scope patent-text">２</sub>、５分の１のテイルｃＤＮＡ及び２．５ Ｕの天然Ｔａｑポリメラーゼを含む５０μｌ中にて行なった。最初の変性は、９４℃で５分間行ない、次いで９４℃１分間、５３℃１分間そして７２℃１０分間のサイクルを３５サイクル行ない、次ぎに最後の合成工程を７２℃で１０分間行なった。ネステッドＰＣＲについての反応条件は、テンプレートとして１μｌの最初の増幅産物用い、遺伝子特異的な第２のネステッドプライマー５’−ＧＴＣ ＧＡＴ ＧＧＴ ＧＣＡ ＧＡＴ ＴＴＣ ＧＣ−３’、アンカープライマー（５’−ＣＵＡ ＣＵＡ ＣＵＡ ＣＵＡ ＧＧＣ ＣＡＣ ＧＣＧ ＴＣＧ ＡＣＴ ＡＧＴ ＡＣ−３’）の先端欠失型、及びアニーリン温度を５３℃にしてサイクルを２５サイクルのみで行なったことを除いて、上記と同一である。<br class="style-scope patent-text">
【０１６７】<br class="style-scope patent-text">
３’ ＲＡＣＥ ＰＣＲ （ＧＩＢＣＯ ＢＲＬ， Ｅｇｇｅｎｓｔｅｉｎ， Ｇｅｒｍａｎｙ） は、成虫Ｈ． ｃｏｎｔｏｒｔｕｓ由来の全ＲＮＡ　１μｇ及び５００ ｎＭのオリゴｄＴアダプタープライマー５’−ＧＧＣ ＣＡＣ ＧＣＧ ＴＣＧ ＡＣＴ ＡＧＴ ＡＣＴ ＴＴＴ ＴＴＴ ＴＴＴ ＴＴＴ ＴＴＴ Ｔ−３’を用いて、７０℃、１０分間のプレインキュベーションから開始し、４℃にて２分間行なった。２０μｌ 中の、２．５ｍＭ ＭｇＣｌ<sub class="style-scope patent-text">２</sub>、各ｄＮＴＰ５００μＭ、１０μＭ ＤＴＴ及び２００Ｕのスーパー−スクリプトＩＩ逆転写酵素を加えた後、ｃＤＮＡを４２℃で５０分間インキュベーションし、最後の工程で、７０℃で１５分間、４℃で１０分間インキュベーションした。Ｅ．ｃｏｌｉ ＲＮａｓｅ Ｈ ２Ｕを用いて、３７℃で１０分間インキュベーションしてＲＮＡを除去した。第１の増幅は、各ｄＮＴＰ ２００ｍＭ、１．５ｍＭ ＭｇＣｌ<sub class="style-scope patent-text">２</sub>、１０分の１のテイルｃＤＮＡ及び２．５Ｕの天然Ｔａｑ ＤＮＡ ポリメラーゼを含む５０μｌ中、ユニバーサルアダプタープライマー４００ｎＭ （５’−ＣＵＡ ＣＵＡ ＣＵＡ ＣＵＡ ＧＧＣ ＣＡＣ ＧＣＧ ＴＣＧ ＡＣＴ ＡＧＴ ＡＣ−３’） および４００ｎＭのシークエンス−特異的プライマー５’−ＴＴＴＧＴＴＣＴＴ ＣＣＴ ＴＧＧ ＴＡＴ ＣＣ−３’を用いて行なった。最初の変性工程は、９４℃にて３分間行ない、次いで９４℃にて１分間、５１℃にて１分間及び７２℃にて２分間のサイクルを３５サイクル行い、最後の合成工程は７２℃にて１５分間行った。特に記載しない限り、最初の増幅物２μｌをネステッドＰＣＲに用い、その他の条件は同一であったが、この場合において、短いアダプタープライマー５’−ＧＧＣ ＣＡＣ ＧＣＧ ＴＣＧ ＡＣＴ ＡＧＴ ＡＣ−３’と、ネステッドプライマー５’−ＡＣＡ ＣＴＣ ＴＡＡ ＴＣＴ ＣＣＡ ＡＣＴ Ｇ−３’を用いて３０サイクル行なった。ＰＣＲ産物を２％アガロースゲルにて分析し、溶出し、ＴＡ ベクターｐＭｏｓＢｌｕｅ （Ａｍｅｒｓｈａｍ， Ｂｒａｕｎｓｃｈｗｅｉｇ， Ｇｅｒｍａｎｙ）中にクローニングした。<br class="style-scope patent-text">
【０１６８】<br class="style-scope patent-text">
５．ＲＮＡのトランスファー<br class="style-scope patent-text">
中性のＨｙｂｏｎｄ Ｎ ナイロンメンブレン［Ａｍｅｒｓｈａｍ， Ｂｒａｕｎｓｃｈｗｅｉｇ］への、グリオキサルゲルからの分画したＲＮＡの移動、及びＴＢＥアガロースゲルからのゲノムＤＮＡの移動は、Ｃｈｏｍｃｚｙｎｓｋｉ法 （１９９２） により、アルカリントランスファー溶液中、下向きのアルカリ性の毛細管輸送によって２時間行なう。次いで、このメンブレンを０．２Ｍ リン酸ナトリウム緩衝液（ｐＨ ６．８）中で２０分間中和し、８０℃にて２０〜６０分間乾燥させ、焼き付けた。放射能標識したプローブとハイブリダイズさせるために、メンブレンをプラスチック製バッグ中、５ｍｌ／ｃｍ<sup class="style-scope patent-text">２</sup> のプレハイブリダイゼーション溶液でシールし、６５℃で３時間インキュベーションした。緩衝液を、ハイブリダイゼーション用のハイブリダイゼーション溶液に変える。Ｒａｐｉｄ Ｈｙｂ．溶液［Ａｍｅｒｓｈａｍ， Ｂｒａｕｎｓｃｈｗｅｉｇ］を使用すれば、プレハイブリダイゼーションは、プレハイブリダイゼーション溶液をさらに加えることなく、６５℃にて３０分間で起きる。ランダムプライミングにより放射能標識したしたプローブを加えた後、ハイブリダイゼーションを６５℃にて一晩行なう。その後、そのメンブレンを、２×ＳＳＣ／０．１％ ＳＤＳを用いて６５℃にて２０分間を１回、０．１×ＳＳＣ／０．１％ ＳＤＳを用いてそれぞれ１時間を３回で洗浄した。このメンブレンは、適当な増強スクリーンを用いて、コダックＸ−ＯＭＡＴ又はコダックＢＩＯＭＡＸ−ＭＳ Ｘ線フィルムに−８０℃にて露光する。<br class="style-scope patent-text">
【０１６９】<br class="style-scope patent-text">
６．インビボ転写及び翻訳<br class="style-scope patent-text">
ＴＮＴ Ｔ７／Ｔ３カップリングした網赤血球リゼートシステム （Ｐｒｏｍｅｇａ）を、製造元のプロトコルに従って用い、<sup class="style-scope patent-text">３５</sup>Ｓ標識メチオニン及びシステイン （ＩＣＮ， Ｅｓｃｈｗｅｇｅ， Ｇｅｒｍａｎｙ） の存在下、ＨＣ１１０−Ｒのコード配列の全長を転写及び翻訳した。４０ μＣｉ <sup class="style-scope patent-text">３５</sup>Ｓ標識化混合物 （＞１０００ Ｃｉ／ｍｍｏｌ， ＩＣＮ， Ｍｅｃｋｅｎｈｅｉｍ， Ｇｅｒｍａｎｙ）、１μｇの環状化ＨＣ１１０−Ｒ プラスミドＤＮＡ及び１０ＵのＴ３ ＲＮＡポリメラーゼを用いるウサギ網赤血球リゼートシステム（Ｐｒｏｍｅｇａ， Ｓｅｒｖａ， Ｈｅｉｄｅｌｂｅｒｇ）を用いて、ＲＮＡを翻訳した。反応は３０℃にて９０分間行った。ポジティブコントロールには、１μｇのルシフェラーゼコントロールＤＮＡを含有させた。<br class="style-scope patent-text">
【０１７０】<br class="style-scope patent-text">
反応産物をＳＤＳポリアクリルアミドゲル電気泳動 （Ｌａｅｍｍｌｉ １９７０）により分画し、増幅フルオログラフィー溶液（Ａｍｅｒｓｈａｍ Ｐｈａｒｍａｃｉａ Ｂｉｏｔｅｃｈ）又は１Ｍのサリチル酸ナトリウム（ｐＨ ７）（Ｃｈａｍｂｅｒｌａｉｎ １９７９）を用いて蛍光光度分析し、そしてそのゲルを乾燥させ、露光した （増感剤とともに−８０℃にてＫｏｄａｋ ＢｉｏＭａｘ ＭＲフィルム）（図１（Ｂ）を参照）。<br class="style-scope patent-text">
【０１７１】<br class="style-scope patent-text">
あるいは、Ａｍｂｉｏｎ （Ｈｅｉｄｅｌｂｅｒｇ）のＭＡＸＩｓｃｒｉｐｔインビトロ 転写キットを、ｐＢｌｕｅｓｃｒｉｐｔ ＳＫ中にクローニングしたＨＣ１１０−Ｒ ｃＤＮＡからのＲＮＡ転写物のインビトロ合成のために用いた。ＨＣ１１０−ＲプラスミドＤＮＡ ４μｇを、制限酵素Ｈｉｎｄ ＩＩＩ又はストップコドンの後のＳａｌ Ｉを用いて直線化し、フェノール／クロロホルムで抽出し、３倍量のエタノールを用いて沈殿させ、ＤＥＰＣ／Ｈ<sub class="style-scope patent-text">２</sub>Ｏ中に溶解した。反応混合物５０μｌ中のＨＣ１１０−Ｒ ｃＤＮＡ２μｇを、２００ｍＭ ＤＴＴ ２．５μｌ、１０ｍＭ ＡＴＰ， ＣＴＰ， ＧＴＰ及びＵＴＰ各々２．５μｌ、１０×転写緩衝液 ５μｌ、ＲＮａｓｉｎインヒビター （４０Ｕ／μｌ） （Ｐｒｏｍｅｇａ， Ｈｅｉｄｅｌｂｅｒｇ） １．６μｌ、及びＴ３ファージポリメラーゼ （１０Ｕ／μｌ） ２μｌ と混合し、３７℃で２時間インキュベーションした。１時間後、Ｔ３ファージポリメラーゼ （１０Ｕ／μｌ） ２μｌをさらに加えた。この混合物を、ＲＮａｓｅ不含ＤＮａｓｅ Ｉ （２Ｕ／μｌ） １．５μｌ及びＲＮａｓｉｎインヒビター （４０ Ｕ／μｌ） １μｌと混合し、３７℃で１５分間インキュベーションし、フェノール／クロロホルムを用いて抽出し、３倍量のエタノール中にて沈殿させ、ＤＥＰＣ／Ｈ<sub class="style-scope patent-text">２</sub>Ｏ ２５μｌ中に再懸濁した。試料の１／５の容量をグリオキサールゲルにて分析した。<br class="style-scope patent-text">
【０１７２】<br class="style-scope patent-text">
７．ＤＮＡ分析<br class="style-scope patent-text">
クローンは、自動レーザー蛍光配列分析（ＬＩＣＯＲ ４０００； ＭＷＧ， Ｅｂｅｒｓｂｅｒｇ， Ｇｅｒｍａｎｙ）およびＴｈｅｒｍｏ Ｓｅｑｕｅｎａｓｅ蛍光標識サイクル配列分析キット（Ａｍｅｒｓｈａｍ， Ｂｒａｕｎｓｃｈｗｅｉｇ， Ｇｅｒｍａｎｙ）の支援によりジデオキシヌクレオチド鎖終止法で配列を決定した。両方の鎖の配列を決定し、その配列データをＧＣＧソフトウェアー （Ｇｅｎｅｔｉｃｓ Ｃｏｍｐｕｔｅｒ Ｇｒｏｕｐ Ｉｎｃ．， Ｍａｄｉｓｏｎ， ＷＩ， ＵＳＡ） 及びＰＣ／ＧＥＮＥソフトウェアー （Ｉｎｔｅｌｌｉｇｅｎｅｔｉｃｓ， Ｍｏｕｎｔａｉｎ Ｖｉｅｗ， ＣＡ， ＵＳＡ）で　した。プログラムＦＡＳＴＡ （Ｐｅａｒｓｏｎ 及びＬｉｐｍａｎ １９８８）、ＢＬＩＴＺ （Ｓｍｉｔｈ及びＷａｔｅｒｍａｎ １９８１）、及びＢＬＡＳＴ （Ａｌｔｓｃｈｕｌ及びＬｉｐｍａｎｎ １９９０） を用いて、得られたタンパク質配列の配列類似性についてＥＭＢＬおよびスイスプロット プロテインデータベース（Ｓｗｉｓｓ−Ｐｒｏｔ ｐｒｏｔｅｉｎ ｄａｔａｂａｓｅｓ）をスクリーニングした。タンパク質配列は、ＳＡＰＳ （Ｂｒｅｎｄｅｌら、１９９２）およびＰＲＯＳＩＴＥおよびＰｒｏｔ−Ｐａｒａｍ （Ａｐｐｅｌら、１９９４）を用いて分析した。<br class="style-scope patent-text">
【０１７３】<br class="style-scope patent-text">
８．Ｈａｅｍｏｎｃｈｕｓ ｃｏｎｔｏｒｔｕｓ由来のタンパク質抽出物の調製<br class="style-scope patent-text">
液体窒素中にて凍結させたＨ． ｃｏｎｔｏｒｔｕｓ５０〜１００ｍｇをＴＲＩＺＯＬ ［Ｇｉｂｃｏ， Ｋａｒｌｓｒｕｈｅ］ １ｍｌ中に加えた。線虫を、ガラス容器中、ＴＲＩＺＯＬと共に３×１５秒間ホモジナイズし、室温で５分間インキュベーションした。ＴＲＩＺＯＬ １ｍｌ当たりクロロホルム２００μｌ 加えた後、この試料を１５秒間攪拌し、混合物を室温でさらに２〜３分間インキュベーションし、４℃で１０分間７０００〜１２０００ｒｐｍで遠心分離した。上部の水相にはＲＮＡ、中間相にはゲノムＤＮＡ、赤色の有機相にはタンパク質が含まれている（Ｃｏｏｍｂｓら、１９９０； Ｃｈｏｍｃｚｙｎｓｋｉ １９９３）。水相を除去し、別々に処理した。中間相と有機相を、ＴＲＩＺＯＬ １ｍｌ当たり３００μｌの１００％エタノールとともに混合し、十分に混合し、室温で２〜３分間インキュベーションした。４℃で５分間、２０００ｒｐｍで遠心分離した後、タンパク質の上清を慎重にエッペンドルフ容器に移し、イソプロパノール１ｍｌを用いて室温にて１０分間沈殿させた。再度、遠心分離を、４℃で１０分間、１２０００ｒｐｍで行ない、上清を廃棄し、タンパク質沈殿物を９５％エタノール中の０．３Ｍ 塩酸グアニジン溶液２ｍｌと混合して、攪拌し、室温で２０分間インキュベーションし、４℃にて５分間、７，５００ｒｐｍで３回遠心分離した。次いで、ペレットを１００％エタノール２ｍｌ中に溶解し、室温で２０分間沈殿させ、そして４℃で５分間、７５００ｒｐｍにてペレット化した。ペレットを簡単に真空乾燥し、尿素溶解緩衝液 （８Ｍ）中に再懸濁した。不溶性の物質を４℃で１０分間、１００００ｒｐｍの遠心分離で取り除き、上清を新しいエッペンドルフ容器に移した後、タンパク質濃度を決定し、さらなる処理を行うまで−２０℃で保存した。<br class="style-scope patent-text">
【０１７４】<br class="style-scope patent-text">
９．酵母細胞由来のタンパク質抽出物の調製<br class="style-scope patent-text">
タンパク質抽出物は、ＹＰＡＤ培地５ｍｌに単一の酵母コロニーを植え、飽和するまで（２日間）３０℃で振盪することで酵母培養細胞から調製した。この培養酵母の一部２ｍｌを４℃で２分間、３０００ｒｐｍで遠心分離（Ｈｅｒａｅｕｓ Ｂｉｏｆｕｇｅ １５ Ｒ）し、Ｈ<sub class="style-scope patent-text">２</sub>Ｏで一度洗浄し、酵母溶解緩衝液２５０μｌ中に再懸濁し、小さい試験管に移し、ガラスビーズ（φ ０．５ｍｍ）を液面のすぐ下まで入れ、最大設定で５分間攪拌した。次いで、４×ＲｏｔｉＬｏａｄ緩衝液 （Ｒｏｔｈ， Ｋａｒｌｓｒｕｈｅ）を加え、混合物を９５℃で５分間インキュベーションした。破壊した細胞をエッペンドルフ容器に移し、細胞破片を５分間、１４０００ｒｐｍで遠心分離（エッペンドルフ遠心分離機（Ｅｐｐｅｎｄｏｒｆ Ｃｅｎｔｒｉｆｕｇｅ） ５４１５ Ｃ）することによって除去した。この方法により調製した試料の一部２０μｌを、ＳＤＳポリアクリルアミドゲルに流した。<br class="style-scope patent-text">
【０１７５】<br class="style-scope patent-text">
１０．Ｅ．ｃｏｌｉ細胞由来のタンパク質抽出物の調製<br class="style-scope patent-text">
タンパク質抽出物は、一晩培養した培養液５ｍｌから、Ｈｅｒａｅｕｓフロー遠心分離機にて４℃で５分間、５０００ｒｐｍで遠心分離して、１×１０<sup class="style-scope patent-text">７</sup>のＥ． ｃｏｌｉ細胞をペレット化し、ＰＢＳ５ｍｌを用いて洗浄し、再び遠心分離することにより調製した。次いで、このペレットをＴＲＩＺＯＬ （Ｇｉｂｃｏ， Ｋａｒｌｓｒｕｈｅ）１ｍｌ中に再懸濁し、処理をさらに行なった。<br class="style-scope patent-text">
【０１７６】<br class="style-scope patent-text">
これに代わる方法として、ＰＢＳ洗浄した細胞ペレットをＰＢＳに再懸濁し、細胞を数回の短い超音波パルス（Ｓｏｎｉｆｉｅｒ Ｂ−１２， Ｂｒａｎｓｏｎ Ｓｏｎｉｃ Ｐｏｗｅｒ Ｃｏｍｐａｎｙ， Ｄａｎｂｕｒｙ， Ｕ．Ｓ．Ａ．）、液体窒素及びリゾチームにより破壊した。<br class="style-scope patent-text">
【０１７７】<br class="style-scope patent-text">
続くタンパク質分析では、４×ＲｏｔｉＬｏａｄ緩衝液 （Ｒｏｔｈ， Ｋａｒｌｓｒｕｈｅ）を加え、ＳＤＳポリアクリルアミドゲルに流して画分を分析した。１レーンあたりに流したタンパク質の全量は１０〜２０μｇであった。<br class="style-scope patent-text">
【０１７８】<br class="style-scope patent-text">
１１．培養細胞からのタンパク質抽出物の調製<br class="style-scope patent-text">
３５ｍｍの接着細胞の集密細胞培養皿、又はＦＣＳ含有培地中の５〜１０<sup class="style-scope patent-text">６</sup>個の非接着動物細胞を、トリプシン／ＥＤＴＡ溶液でトリプシン化することにより予め取り出すかあるいは冷却した後に細胞スクレイパーを用いて機械的に剥がし、エッペンドルフ容器に移し、室温で１０秒間、１３０００ｒｐｍにてペレット化し、ＰＢＳで２回洗浄し、再び遠心分離した。その細胞をＴＲＩＺＯＬ １ｍｌ中に溶解した後、これを激しく攪拌するか、又は使い捨てできる注射器の針の中に細胞を数回吸引することにより、細胞を溶解させ、室温で５分間インキュベーションした。この別法として、細胞ペレットをＰＢＳ１ｍｌ中、又は尿素溶解緩衝液（８Ｍ）中に再懸濁し、非常に短かい時間、超音波処理（Ｓｏｎｉｆｉｅｒ Ｂ−１２， Ｂｒａｎｓｏｎ Ｓｏｎｉｃ Ｐｏｗｅｒ Ｃｏｍｐａｎｙ， Ｄａｎｂｕｒｙ， Ｕ．Ｓ．Ａ．）した。次いで、タンパク質量を、Ｂｒａｄｆｏｒｄ （１９７６）又はＬｏｗｒｙら、（１９５１））の方法により測定する。<br class="style-scope patent-text">
【０１７９】<br class="style-scope patent-text">
１２．Ｅ． ｃｏｌｉにおける誘導的タンパク質発現<br class="style-scope patent-text">
ＨＣ１１０−Ｒタンパク質に対するポリクローナル抗体は、発現ベクターｐＲＳＥＴ Ｂ （Ｉｎｖｉｔｒｏｇｅｎ， Ｌｅｅｋ， ＮＬ） にクローニングされ、その結果６×Ｈｉｓがリーディングフレームを満足しながらＮ末端に融合された３つのＨＣ１１０−Ｒ断片、即ち、完全ＨＣ１１０−Ｒ ｃＤＮＡ、膜貫通ドメインを含まないＮ末端、及び７番目の膜貫通ドメインの後のＣ−末端により製造した。<br class="style-scope patent-text">
【０１８０】<br class="style-scope patent-text">
ＨＣ１１０−Ｒの完全なコード領域を、Ｐ８４＿ＡＴＧ ＢａｍＨＩ　５’プライマー ５’−ＣＴＧ ＣＣＧ ＧＡＴ ＣＣＴ ＣＧＧ ＴＴＴ ＡＡＴ ＡＣＣ ＡＡＣ <u class="style-scope patent-text">ＡＴＧ</u> ＡＧＧ−３’および、Ｐ３１２１＿ＴＧＡ ＨｉｎｄＩＩＩ ３’プライマー ５’−ＧＣＡ ＣＴＡ ＡＧＣ ＴＴＧ ＡＣＴ ＧＡＡ ＧＣＧ ＣＡＣ ＡＡＣ ＣＴＣ Ｇ−３’を用いて増幅し、第１の膜貫通ドメインまでのＮ末端を、Ｐ８４＿ＡＴＧ ＢａｍＨＩ ５’プライマー （上記参照）およびＰ１４３４＿ＴＧＡ ＨｉｎｄＩＩＩ ３’プライマー ５’−ＧＧＣ ＴＣＡ ＡＧＣ ＴＴＡ <u class="style-scope patent-text">ＴＣＡ</u> ＧＡＧ ＡＡＣ ＡＡＧ ＣＧＡ ＣＡＣ ＧＧＣ−３’を用いて増幅し、そして第７の膜貫通ドメインの後から始まるＣ末端は、Ｐ２４８６＿ＡＴＧ ＢａｍＨＩ ５’プライマー ５’−ＣＴＡ ＴＣＧ ＧＡＴ ＣＣＣ ＡＡＣ <u class="style-scope patent-text">ＡＴＧ</u> ＧＣＴ ＧＧＣ ＴＣＣ ＣＧＴ ＧＡＴ ＡＣＣ ＴＣＴ ＡＧＧ−３’およびＰ３１２１＿ＴＧＡ ＨｉｎｄＩＩＩ ３’プライマー （上記参照）を用いて増幅した。３つの全てのプラスミドＰＣＲのアニーリング温度は、最初の５サイクルは５６℃、後の３０サイクルは６２℃で行なった。ＰＣＲ産物はＢａｍＨＩ及びＨｉｎｄＩＩＩ酵素を用いて消化し、同様にＢａｍＨＩ／ＨｉｎｄＩＩＩを用いて直線化したｐＲＳＥＴ Ｂ発現ベクター中に直接ライゲートした。<br class="style-scope patent-text">
【０１８１】<br class="style-scope patent-text">
ｐＲＥＳＴ Ｂベクターにおいて、発現は、バクテリオファージ Ｔ７のウィルスプロモーターにより制御されている。従って、クローニングは、Ｔ７ ＲＮＡポリメラーゼ遺伝子を有していないＸＬ１−Ｂｌｕｅ Ｅ． ｃｏｌｉ株にて行なった。次いで、この組換えプラスミドを、クロラムフェニコール耐性により安定化したプラスミドｐＡＣＹＣ１８４をさらに含み、かつＴ７ ＲＮＡポリメラーゼの天然のインヒビターであるＴ７リゾチームの発現量が少ない、Ｔ７ポリメラーゼ発現性ＢＬ２１（Ｄｅ３）ｐＬｙｓＳ大腸菌細胞中へ形質転換した。これらの細胞はｌａｃＵＶ５プロモーターの制御下にあるため、ＩＰＴＧ誘導によりＴ７ ＲＮＡポリメラーゼが発現し、その結果融合タンパク質を発現する。<br class="style-scope patent-text">
【０１８２】<br class="style-scope patent-text">
目的のＨＣ１１０−Ｒプラスミドを有する単一のコロニーを、５０μｇ／ｍＬアンピシリン及び３５μｇ／ｍＬ クロラムフェニコールを添加した新鮮なＬＢプレートから、同じ選択圧下のＬＢ培地 ５０ｍｌに移し、静止期になるまで３７℃にて２８０ｒｐｍで一晩振盪した。この一晩培養した培養物をＯＤ<sub class="style-scope patent-text">６００</sub>が０．３になるよう希釈し、この培養物１００ｍｌをＯＤ<sub class="style-scope patent-text">６００</sub>が０．６〜０．５になるまで３７℃にて２８０ｒｐｍでさらに振盪した。<br class="style-scope patent-text">
【０１８３】<br class="style-scope patent-text">
１ ＯＤ<sub class="style-scope patent-text">６００</sub>のユニットを採取し、未誘導細胞を手短かに遠心分離し、ｐＨ８．０の８Ｍ 尿素溶解緩衝液１５０ μｌ及び４×ＲｏｔｉＬｏａｄ緩衝液 ［Ｒｏｔｈ， Ｋａｒｌｓｒｕｈｅ］５０μｌ中に溶解した。この未誘導試料を２分間変性させ、ゲノムＤＮＡをＳｏｎｉｆｉｅｒ Ｂ−１２の短い超音波パルス ［Ｂｒａｎｓｏｎ Ｓｏｎｉｃ Ｐｏｗｅｒ Ｃｏｍｐａｎｙ， Ｄａｎｂｕｒｙ， Ｕ．Ｓ．Ａ．］ を２、３秒間行なうことにより剪断し、不溶性部分を１４０００ｒｐｍで３分間遠心分離することによりペレット化した。<br class="style-scope patent-text">
【０１８４】<br class="style-scope patent-text">
融合タンパク質の発現は、１ｍＭ ＩＰＴＧを加えることにより誘導し、培養物１００ｍｌをさらに３〜４時間３７℃にてインキュベーションした。インキュベート後、誘導した細胞を５０００ｒｐｍ、４℃にて１５分間遠心分離（Ｈｅｒａｅｕｓ 蛍光遠心分離機）し、ペレットをＰＢＳ中にて洗浄した後、８Ｍ 尿素溶解緩衝液８ｍｌ中に再懸濁した。細胞を液体窒素に液沈して破壊し、３７℃で３回融解した。最初の窒素処理後に、０．７５ｍｇ／ｍｌリゾチームを加えた。液体窒素における最後のインキュベートの後、１６℃で２０分間インキュベーションした後、氷水浴中で冷却しながら、溶液が水と同等の粘度になるまで各１０秒間の短い超音波パルスを与えた。１３０００ｒｐｍで、４℃にて１０分間遠心分離（Ｂｅｃｋｍａｎ Ｊ２−２１； ＪＳ １３．１−Ｒｏｔｏｒ）した後、誘導した試料１５０μｌを取り出し、４×ＲｏｔｉＬｏａｄ緩衝液 （Ｒｏｔｈ）５０μｌと混合し、ＳＤＳ−ＰＡＧＥにより、次いでクマシー染色又はマウス抗Ｈｉｓ抗体を用いたウェスタンブロット分析により、特定のＨＣ１１０−Ｒタンパク質断片を未誘導試料と一緒にチェックした。<br class="style-scope patent-text">
【０１８５】<br class="style-scope patent-text">
残りの上清を新しい容器に移し、アフィニティークロマトグラフィーによりさらに精製するために−２０℃で保存した。<br class="style-scope patent-text">
【０１８６】<br class="style-scope patent-text">
１３．金属アフィニティークロマトグラフィーによるタンパク質精製<br class="style-scope patent-text">
濃縮は、変性条件下にて、クローンテック社［Ｐａｌｏ Ａｌｔｏ， Ｕ．Ｓ．Ａ．］のＴＡＬＯＮスピン カラムにてＩＭＡＣ システム（「<u class="style-scope patent-text">Ｉ</u>ｍｍｏｂｉｌｉｚｅｄ <u class="style-scope patent-text">Ｍ</u>ｅｔａｌ <u class="style-scope patent-text">Ａ</u>ｆｆｉｎｉｔｙ <u class="style-scope patent-text">Ｃ</u>ｈｒｏｍａｔｏｇｒａｐｈｙ」）を用い、Ｎ末端６×Ｈｉｓタグにより行なった。最初に、カラム内の樹脂をｐＨ８の８Ｍ 尿素溶解緩衝液の５倍量で別個に平衡化し、３０００ｒｐｍにて４℃で４分間沈降させて、ゆっくり攪拌しながらＨＣ１１０−Ｒタンパク質上清と室温にて２０分間インキュベーションした。再び遠心分離した後、樹脂を、ゆっくり室温で１０分間攪拌しながら、１０倍量のｐＨ８の８Ｍ 尿素溶解緩衝液で３回洗浄し、再度遠心分離した。最後の洗浄工程の後に、ペレットを８Ｍ 尿素溶解緩衝液１ｍｌ中にとり、カラムにローディングするのに用いた；後者は、３倍量の８Ｍ 尿素溶解緩衝液で２回洗浄し、イミダゾール含有８Ｍ 尿素溶解緩衝液で溶出し、各々１５０μｌのいくつかの画分に分画した。画分中の融合タンパク質量を、ゲル分析及びＢｒａｄｆｏｒｄタンパク質測定法により測定する。<br class="style-scope patent-text">
【０１８７】<br class="style-scope patent-text">
１４．アフィニティークロマトフラフィーによるタンパク質精製<br class="style-scope patent-text">
金属アフィニティークロマトグラフィーによるタンパク質精製は、本明細書中の実施例に記載する。<br class="style-scope patent-text">
濃縮は、変性条件下にて、クローンテック社［Ｐａｌｏ Ａｌｔｏ， Ｕ．Ｓ．Ａ．］のＴＡＬＯＮスピン カラムにてＩＭＡＣ システム（「<u class="style-scope patent-text">Ｉ</u>ｍｍｏｂｉｌｉｚｅｄ <u class="style-scope patent-text">Ｍ</u>ｅｔａｌ <u class="style-scope patent-text">Ａ</u>ｆｆｉｎｉｔｙ <u class="style-scope patent-text">Ｃ</u>ｈｒｏｍａｔｏｇｒａｐｈｙ」）を用い、Ｎ末端６×Ｈｉｓタグにより行なった。最初に、カラム内の樹脂をｐＨ８の８Ｍ 尿素溶解緩衝液の５倍量で別個に平衡化し、３０００ｒｐｍにて４℃で４分間沈降させて、ゆっくり攪拌しながらＨＣ１１０−Ｒタンパク質上清と室温にて２０分間インキュベーションした。再び遠心分離した後、樹脂を、ゆっくり室温で１０分間攪拌しながら、１０倍量のｐＨ８の８Ｍ 尿素溶解緩衝液で３回洗浄し、再度遠心分離した。最後の洗浄工程の後に、ペレットを８Ｍ 尿素溶解緩衝液１ｍｌ中にとり、カラムにローディングするのに用いた；後者は、３倍量の８Ｍ 尿素溶解緩衝液で２回洗浄し、イミダゾール含有８Ｍ 尿素溶解緩衝液で溶出し、各々１５０μｌのいくつかの画分に分画した。画分中の融合タンパク質量を、ゲル分析及びＢｒａｄｆｏｒｄタンパク質測定法により測定する。<br class="style-scope patent-text">
【０１８８】<br class="style-scope patent-text">
１５．アミノ酸配列分析<br class="style-scope patent-text">
ｃＤＮＡ全長クローンＨＣ１１０−Ｒから推定されるアミノ酸配列を確認するため、上流の開始コドン及びコザック（Ｋｏｚａｋ）配列を含む６８８ｂｐ（（２４８６〜３１８２位））を含有する３’末端を、ｐＲＳＥＴ Ｂ発現ベクター中にクローニングし、コンピテントＢＬ２１（ＤＥ３）ｐＬｙｓＳＥ． ｃｏｌｉ細胞における２１ｋＤタンパク質（１８９ ＡＡ）の発現を、１ｍＭ ＩＰＴＧを加えることにより誘導した。このＮ末端Ｈｉｓタグを伴って発現した融合タンパク質を、Ｔａｌｏｎマトリックスにて濃縮し、Ｃｅｎｔｒｉｃｏｎチューブにより濃縮し、脱塩した。Ｎ末端Ｈｉｓタグのため、１ｎＭの２１ｋＤ ＨＣ１１０−Ｒタンパク質の部分的なＣ末端タンパク質の配列分析は、ＴｏｐＬａｂ （Ｍａｒｔｉｎｓｒｉｅｄ）によるＢｏｙｄ （Ｂｏｙｄら、１９９２）の変法の段階的なＳｃｈｌａｃｋ−Ｋｕｍｐｆ分解（Ｓｃｈｌａｃｋら、１９２６）により行なった。除去したアミノ酸の配列分析はＰＲＯＣＩＳＥ ４９２アミノ酸配列分析装置（ＰＥ Ａｐｐｌｉｅｄ Ｂｉｏｓｙｓｔｅｍｓ， Ｗｅｉｔｅｒｓｔａｄｔ）において行ない、ＡＢＩ １４０Ｃマイクロ勾配システム及びＡＢＩ ７８５Ａ ＵＶ／ＶＩＳ検出器からなるＰＲＯＣＩＳＥ Ｃ逆相ＨＰＬＣシステムを用いて分析し、ＰＲＯＣＩＳＥ Ｃコントロールソフトウェアー及びＡＢＩ データ解析ソフトウェアを用いて同定した。<br class="style-scope patent-text">
【０１８９】<br class="style-scope patent-text">
最初に、２１ｋＤ ＨＣ１１０−Ｒタンパク質２５ｐｍｏｌを、２％トリプシン（Ｒｏｃｈｅ Ｍｏｌｅｃｕｌａｒ Ｂｉｏｃｈｅｍｉｃａｌｓ， Ｍａｎｎｈｅｉｍ）を用いて３７℃にて一晩分解した。トリプシン自己分解産物の配列分析を除外するため、トリプシン無しでの分解物のクロマトグラムを、トリプシン消化後のＨＣ１１０−Ｒ標準クロマトグラムと比較することによって、合計４つのペプチド断片を選択した。これら４つのペプチド断片を、ＴｏｐＬａｂ （Ｍａｒｔｉｎｓｒｉｅｄ）によってＨｕｎｋａｐｉｌｌｅｒら、（１９８３）により改変された階段的Ｅｄｍａｎ消化法によって、Ｎ末端部分のタンパク質配列分析を行った。分解したペプチド断片を分離し、ＨＰＬＣにより分画した。イモビロンにてブロッティングされたペプチド画分を、ＰＲＯＣＩＳＥ ４９２アミノ酸配列分析装置 （Ａｐｐｌｉｅｄ Ｂｉｏｓｙｓｔｅｍｓ， Ｗｅｉｔｅｒｓｔａｄｔ）の反応チャンバーに移し、アミノ酸を１４０ Ｃ−ＰＴＨ−分析器及びＵＶ検出器 ７８５ Ａ（Ａｐｐｌｉｅｄ Ｂｉｏｓｙｓｔｅｍｓ， Ｗｅｉｔｅｒｓｔａｄｔ）にて分離した。アミノ酸を逆相ＨＰＬＣにより定量し、配列分析前に作製した標準クロマトグラムと保持時間を比較することにより同定した。<br class="style-scope patent-text">
【０１９０】<br class="style-scope patent-text">
１６．細胞培養系<br class="style-scope patent-text">
以下の細胞培養系は、Ｍｉｃｒｏｏｒｇａｎｉｓｍｅｎ ｕｎｄ Ｚｅｌｌｋｕｌｔｕｒｅｎ ＧｍｂＨ ［Ｂｒａｕｎｓｃｈｗｅｉｇ］ ［Ｄｒｅｘｌｅｒら、１９９５］を介してＤｅｕｔｓｃｈｅ Ｓａｍｍｌｕｎｇから購入した：<br class="style-scope patent-text">
ＣＯＳ−７細胞（ＤＳＭ： ＡＣＣ ６０）　　　　−　サル、腎臓<br class="style-scope patent-text">
ＨＥＫ−２９３細胞 （ＡＴＣＣ： ＣＲＬ １５７３）　−　ヒト、胚、腎臓<br class="style-scope patent-text">
【０１９１】<br class="style-scope patent-text">
１７．種々の細胞培養系の培養<br class="style-scope patent-text">
接着細胞系ＣＯＳ−７やＨＥＫ−２９３は、１１０ｍｍ組織培養皿 ［Ｇｒｅｉｎｅｒ， Ｓｏｌｉｎｇｅｎ］にて、１０ｍＬの培地中、３７℃、５％ＣＯ<sub class="style-scope patent-text">２</sub>及び９５％湿度で培養した。培養細胞は、ＤＭＥＭ培地中でＣＯＳ−７およびＨＥＫ−２９３細胞を培養することにより維持した。３．０２４ ｇ／ｌ ＮａＨＣＯ<sub class="style-scope patent-text">３</sub>、１０％ ＦＣＳ、５０Ｕ／ｍｌペニシリン及び５０μｇ／ｍＬ ストレプトマイシンを含む培地を使用前に３７℃に温めた。ＣＯＳ−７の前培養について、それらを４℃で２時間保存した後、細胞スクレイパーを用いて機械的に培養皿から分離した。ガラスピペットを用いて、ＨＥＫ−２９３細胞を培養皿の底から直接分離できた。<br class="style-scope patent-text">
【０１９２】<br class="style-scope patent-text">
１８．真核生物細胞の一過性トランスフェクション及び安定なトランスフェクション<br class="style-scope patent-text">
Ｒｏｃｈｅ Ｍｏｌｅｃｕｌａｒ Ｂｉｏｃｈｅｍｉｃａｌｓ （Ｍａｎｎｈｅｉｍ）の非リポソームトランスフェクション試薬ＦｕＧＥＮＥ ６を、動物細胞内へ外来ＤＮＡを一過的に導入するために用いた（Ｋｕｒａｃｈｉら、１９９８）。この目的のため、１％ゼラチンでコーティングした滅菌ガラススライドを後の共焦点レーザースキャンニング顕微鏡のために設置した３５ｍｍ 組織培養皿に、培地２ｍｌ中の約０．５〜１．５× １０<sup class="style-scope patent-text">５</sup>個の細胞を置いた。細胞を、３７℃で５％ ＣＯ<sub class="style-scope patent-text">２</sub>及び９５％湿度にて一晩培養した。培地をトランスフェクトの前に再度交換した。トランスフェクションのために、ＦｕＧＥＮＥ６ ［Ｒｏｃｈｅ Ｍｏｌｅｃｕｌａｒ Ｂｉｏｃｈｅｍｉｃａｌｓ］ ３μｌを血清不含培地９７μｌ中に希釈し、各反応混合物について５分間室温でインキュベーションした。各混合物につき、プラスミド−ＤＮＡ２μｇ（０．５〜１μｇ／μｌ）に、希釈したＦｕＧＥＮＥ ６の一部１００μｌをピペッティングして滴下し、慎重に混合した後、室温でさらに１５分間インキュベーションした。その後、完全反応混合物を細胞に滴加して、トランスフェクト混合物を、皿をゆっくり回転させて均一に分配した。培地を交換せずに、細胞をさらに１〜２日間培養した。以下の３つのネガティブコントロール（陰性対照）を、各トランスフェクションに必ず入れた：３５ｍｍ 組織培養皿に０．５〜１．５×１０<sup class="style-scope patent-text">６</sup>細胞を入れトランスフェクトしない、第２の培養皿はＤＮＡをトランスフェクション混合物に加えるが、ＦｕＧＥＮＥ ６は添加しない、そして第３の培養皿には、ＦｕＧＥＮＥ ６を添加するがＤＮＡは添加しない。<br class="style-scope patent-text">
【０１９３】<br class="style-scope patent-text">
安定なトランスフェクションについては、所望のプラスミドＨＣ１１０−Ｒを、若干の修飾を加えた発現ベクターｐＳｅｃＴａｇ Ａ ［Ｉｎｖｉｔｒｏｇｅｎ， Ｌｅｅｋ， ＮＬ］ 又はｐＩＲＥＳｎｅｏ ［Ｃｌｏｎｔｅｃｈ， Ｐａｌｏ Ａｌｔｏ， Ｕ．Ｓ．Ａ．］中へ正しいリーディングフレームでクローニングした。これらのベクターは、マーカーとして耐性遺伝子を有し、その結果、ゼオシン（Ｚｅｏｃｉｎ）及びＧ４１８又はブレオマイシン ４８を一過性トランスフェクションの７２時間後およびその後の培地の各交換時にそれぞれ加えた時に、恒常的に耐性遺伝子産物を発現するトランスフェクに成功した細胞のみが生き残る。Ｚｅｏｃｉｎ又はＧ４１８含有選択培地の最適な濃度は、それぞれの細胞系の希釈系列を設定することで予め決定される。<br class="style-scope patent-text">
【０１９４】<br class="style-scope patent-text">
１９．動物細胞における組換えタンパク質の細胞内局在化<br class="style-scope patent-text">
ＨＣ１１０−Ｒタンパク質をＧＦＰ（緑色蛍光タンパク質）にＣ末端連結させるため、ＨＣ１１０−Ｒ ＤＮＡの完全コード化領域を、ｐＥＧＦＰ−Ｎ３のＨｉｎｄＩＩＩ／ＳａｌＩサイトにクローニングした。 １３７ｋＤａ融合タンパク質は、一過的にトランスフェクションした組換え細胞系において発現させ、ウェスタンブロット分析により実証することができる。ＣＬＳＭ（共焦点レーザースクリーニング顕微鏡）により、ＨＣ１１０−Ｒ−ＧＦＰ融合タンパク質がＣＯＳ−７及びＨＥＫ−２９３細胞の細胞質内に存在し、より小さい程度で、細胞質膜上にも局在化していることが示される（図８も参照）。<br class="style-scope patent-text">
【０１９５】<br class="style-scope patent-text">
Ｌｅｉｃａ ＣＬＳＭ付属ＴＣＳ ＮＴ （「共焦点レーザースキャンニング顕微鏡」、Ｌｅｉｃａ Ｌａｓｅｒｔｅｃｈｎｉｋ， Ｈｅｉｄｅｌｂｅｒｇ）、バージョン１．５．４５１を備えたＺｅｉｓｓ ＩＭ ３５顕微鏡（Ｚｅｉｓｓ， Ｏｂｅｒｋｏｃｈｅｎ）を、共焦点レーザースキャンニング顕微鏡に用いた。ＧＦＰタンパク質の蛍光及び蛍光色素 イソチオシアン酸フルオロセインの蛍光はアルゴンレーザーを用いて４８８ｎｍにて励起され、ローダミン、Ｔｅｘａｓレッド、フィコエリトリン、Ａｌｅｘａ ５６８、ＬｙｓｏＴｒａｃｋｅｒ<sup class="style-scope patent-text">ＴＭ</sup>Ｒｅｄ ＤＮＤ−９９、ＭｉｔｏＴｒａｃｋｅｒ<sup class="style-scope patent-text">ＴＭ</sup>Ｒｅｄ ＣＭＸ Ｒｏｓ及びヨウ化プロピジウムはクリプトンレーザーを用いて５６８ｎｍにて励起した。細胞を透過する光学分画のＺシリーズは、１０２４×１０２４ピクセルの分解能で厚さ０．５μｍをスキャンした（Ｇｉｅｓｅら、１９９５）。評価は、ＡＶＳソフトウェアー（Ａｄｖａｎｃｅｄ Ｖｉｓｕａｌ Ｓｙｓｔｅｍｓ Ｉｎｃ．， Ｗａｌｔｈａｍ， ＭＡ， Ｕ．Ｓ．Ａ．）を用いて行なわれ、後者はウィンドウズ用のＡｄｏｂｅ Ｐｈｏｔｏｓｈｏｐ ５．０およびＣｏｒｅｌ Ｄｒａｗ ８．０を用いて後に行なった。<br class="style-scope patent-text">
【０１９６】<br class="style-scope patent-text">
酸性オルガネラを標識するためのプローブＬｙｓｏｔｒａｃｋｅｒ<sup class="style-scope patent-text">ＴＭ</sup>を用いて示されるように、融合タンパク質は酸リソソームに特に局在する。ＨＣ１１０−Ｒタンパク質を含む粒子は、核酸付近で数の増加が見られた。ＧＦＰ及びマウスβ<sub class="style-scope patent-text">２</sub>−アドレナリン作動性ＧＰＣＲの融合タンパク質をコントロールとして調製し（アクセッションナンバー Ｘ１５５６４３， Ｎａｋａｄａら、１９８９）、そのトランスフェクションは、ＨＣ１１０−Ｒ−ＧＦＰ融合タンパク質の場合と同様に細胞内と同じ分配パターンを生じた（図８）。<br class="style-scope patent-text">
【０１９７】<br class="style-scope patent-text">
２０．一過発現のためのＥＧＦＰ構築物<br class="style-scope patent-text">
ベクターｐＥＧＦＰ Ｃ１及びｐＥＧＦＰ Ｎ３ （Ｃｌｏｎｔｅｃｈ， Ｐａｌｏ Ａｌｔｏ， ＣＡ， Ｕ．Ｓ．Ａ．）を、制限酵素Ｈｏｎｄ ＩＩＩとＳａｌ Ｉを用いて切断した。ＨＣ１１０−Ｒ全長ｃＤＮＡの増幅は、Ｐ８３ＥＧＦＰ＿ＡＴＧ ＨｉｎｄＩＩＩ ５’プライマー ５’−ＧＧＴ ＡＧＡ ＡＧＣ ＴＴＴ ＴＣＧ ＧＴＴ ＴＡＡ ＴＡＣ ＣＡＡ Ｃ<u class="style-scope patent-text">ＡＴ</u> <u class="style-scope patent-text">Ｇ</u>ＡＧ Ｇ−３’と、Ｐ３０５７ＥＧＦＰ＿ｏ．ＴＧＡ ＳａｌＩ ３’プライマー ５’−ＣＴＧ ＴＧＴ ＣＧＡ ＣＡＡ ＣＡＴ ＴＴＣ ＧＣＣ ＡＡＴ ＡＧＴ ＴＡＧ Ｇ−３’を用いてアニーリング温度６５℃にて行なった。次いで、そのＰＣＲ産物を同様に、酵素Ｈｉｎｄ ＩＩＩ及びＳａｌＩを用いて切断し、特定のベクターのＨｉｎｄ ＩＩＩとＳａｌＩとの開裂部位の間のオープンリーディングフレームを形成させるためにライゲートし、形質転換した。その結果得られたＮ末端ＧＦＰタグを有する融合タンパク質を<u class="style-scope patent-text">ＧＦＰ−ＨＣ１１０−Ｒ</u>と称し、Ｃ−末端ＥＧＦＰを有するものを<u class="style-scope patent-text">ＨＣ１１０−Ｒ−ＧＦＰ</u>と称する。マウスβ<sub class="style-scope patent-text">２</sub>アドレナリン作動性受容体（ジーンバンクアクセッションナンバー．： Ｐ１８７６２； Ｎａｋａｄａら、１９８９）は、Ｐ１１７ マウスβ<sub class="style-scope patent-text">２</sub>ＡＲ ＸｈｏＩ ５’プライマー ５’−ＴＡＣ ＣＴＣ ＧＡＧ ＣＴＧ ＣＴＡ ＡＣＣ ＴＧＣ ＣＡＧ ＣＣ<u class="style-scope patent-text">Ａ</u> <u class="style-scope patent-text">ＴＧ</u>−３’と、Ｐ１３４９マウスβ<sub class="style-scope patent-text">２</sub>ＡＲ ＥｃｏＲＩ ３’ プライマー ５’−ＴＧＴ ＡＧＡ ＡＴＴ ＣＴＴ ＣＣＴ ＴＣＣ ＴＴＧ ＧＧＡ ＧＴＣ ＡＡＣ ＧＣＴ−３’とを用いてアニーリング温度５５／６０℃にて全長ｃＤＮＡを増幅させ、制限酵素ＸｈｏＩとＥｃｏＲＩとを用いて切断し、そしてＸｈｏＩ−ＥｃｏＲＩ直線化ｐＥＧＦＰ Ｎ３中にライゲートすることで、Ｃ−末端にＥＧＦＰを融合させた。５５／６０℃にて、Ｐ７０ＨｕｍＭ１Ｒｅｚ ＸｈｏＩ ５’プライマー ５’−ＡＴＡ ＴＣＴ ＣＧＡ ＧＡＧ ＣＣＣ ＣＡＣ ＣＴＡ ＧＣＣ ＡＣＣ <u class="style-scope patent-text">ＡＴＧ</u> ＡＡＣ Ａ−３’と、Ｐ１４６５ＨｕｍＭ１Ｒｅｚ ＥｃｏＲＩ ３’プライマー ５’−ＧＡＣ ＧＡＡ ＴＴＣ ＣＡＴ ＴＧＧ ＣＧＧ ＧＡＧ ＧＧＡ ＧＴＧ ＣＧＧ Ｔ−３’とを用いて、既に増幅されたヒトムスカリン性受容体１の全長ｃＤＮＡ（ｈｕＭ１Ｒｅｚ．； ジーンバンクアクセッション Ｎｏ．： Ｙ００５０８； Ａｌｌａｒｄら、１９８７）を、同様にしてＸｈｏＩ−ＥｃｏＲＩ切断ｐＥＧＦＰ Ｎ３ベクター中にライゲートした。この結果得られたオープンリーディングフレームを有する融合タンパク質を、マウス<u class="style-scope patent-text">β</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">２</u> </sub> <u class="style-scope patent-text">ＡＲ−ＥＧＦＰ</u>及び<u class="style-scope patent-text">ｈｕＭ１Ｒｅｚ−ＥＧＦＰ</u>と称する。<br class="style-scope patent-text">
【０１９８】<br class="style-scope patent-text">
２１．安定なトランスフェクション又は一過性トランスフェクション用のＨＣ１１０−Ｒ−ＭｙｃＨｉｓタグ構築物<br class="style-scope patent-text">
ベクターｐＭｙｃ６ｘＨｉｓは、ベクターｐＳｅｃＴａｇＡ［Ｉｎｖｉｔｒｏｇｅｎ， Ｌｅｅｋ， ＮＬ］ を、制限酵素ＮｈｉＩ及びＳｆｉＩを用いて二重消化した後に、末端を平滑化してそのベクターを再度ライゲーションすることにより得られる。ＨＣ１１０−Ｒのコード領域は、ＰＣＲプライマー Ｐ８３ＭｙｃＴａｇ＿ＡＴＧ ＢａｍＨＩ ５’プライマー ５’−ＡＴＡ ＧＧＡ ＴＣＣ ＴＴＣ ＧＧＴ ＴＴＡ ＡＴＡ ＣＣＡ ＡＣ<u class="style-scope patent-text">Ａ</u> <u class="style-scope patent-text">ＴＧ</u>Ａ ＧＧ−３’と、Ｐ３０５８ＭｙｃＴａｇ＿ｏ．ＴＧＡ ＸｂａＩ ３’プライマー ５’−ＣＣＴ ＧＴＣ ＴＡＧ ＡＡＡ ＣＡＴ ＴＴＣ ＧＣＣ ＡＡＴ ＡＧＴ ＴＡＧ Ｇ−３’とをアニーリング温度５６／６０℃にて用いて増幅し、制限酵素ＢａｍＨＩ及びＸｂａＩを用いて切断し、そして同様にＢａｍＨＩ及びＸｂａＩを用いて直線化したｐＭｙｃ６ｘＨｉｓベクター中にライゲートし、Ｅ． ｃｏｌｉ ＤＨ５α細胞中にトランスフェクションした。続いて、ＣＯＳ−７細胞を、この構築物を用いて安定にトランスフェクトし、Ｚｅｏｃｉｎ選択圧下にて維持した。<br class="style-scope patent-text">
【０１９９】<br class="style-scope patent-text">
これと平行して、ＨＣ１１０−ＲＭｙｃＨｉｓ ｃＤＮＡを、プライマーＰ８３＿ＡＴＧＮｏｔＩ−５’ ５’−ＡＴＡ ＴＴＧ ＣＧＧ ＣＣＧ ＣＴＴ ＣＧＧ ＴＴＴ ＡＡＴ ＡＣＣ ＡＡＣ <u class="style-scope patent-text">ＡＴＧ</u>−３’と、ｐＭｙｃＨｉｓ＿ＴＧＡＢａｍＨＩ−３’ ５’−ＣＧＣ ＧＧＡ ＴＣＣ ＴＡＧ ＡＡＧ ＧＣＡ ＣＡＧ ＴＣＧ ＡＧＧ−３’とを用いて増幅し、次いで切断して、同様にＢａｍＨＩ及びＮｏｔＩを用いて制限切断されたバイシストロン性発現ベクターｐＩＲＥＳ１ｎｅｏ（ＧｅｎＢａｎｋアクセッション Ｎｏ．： Ｕ８９６７３） （Ｃｌｏｎｔｅｃｈ， Ｐａｌｏ Ａｌｔｏ， Ｕ．Ｓ．Ａ．）中にライゲートした。ｐＩＲＥＳ１ｎｅｏベクターは、さらにネオマイシン耐性遺伝子（Ｒｅｅｓら、１９９６）の開始部位ＡＴＧのすぐ前にある脳心筋炎ウイルス（ＥＣＭＶ）のリボソーム内結合部位（ＩＲＥＳ）を含んでいる。この方法において、ＨＣ１１０−Ｒの、及び抗生物質耐性マーカーの２つのオープンリーディングフレームは、ヒトサイトメガロウイルス（ＣＭＶ）プロモーター（Ｊａｃｋｓｏｎら、１９９０； Ｊａｎｇら、１９８８）を有する１つのｍＲＮＡからのみ翻訳される。選択は、ＣＯＳ−７細胞及びＨＥＫ−２９３細胞中のＧ４１８ （Ｃａｌｂｉｏｃｈｅｍ−Ｎｏｖａｂｉｏｃｈｅｍ， Ｌａ Ｊｏｌｌａ， ＣＡ， Ｕ．Ｓ．Ａ．） を用いて行なった。<br class="style-scope patent-text">
【０２００】<br class="style-scope patent-text">
２２．共焦点レーザースキャンニング顕微鏡<br class="style-scope patent-text">
Ｌｅｉｃａ ＣＬＳＭ付属ＴＣＳ ＮＴ （「共焦点レーザースキャンニング顕微鏡」、Ｌｅｉｃａ Ｌａｓｅｒｔｅｃｈｎｉｋ， Ｈｅｉｄｅｌｂｅｒｇ）、バージョン１．５．４５１を備えたＺｅｉｓｓ ＩＭ ３５顕微鏡（Ｚｅｉｓｓ， Ｏｂｅｒｋｏｃｈｅｎ）を、共焦点レーザースキャンニング顕微鏡に用いた。蛍光はアルゴンレーザーを用いて４８８ｎｍにて励起され、そしてクリプトンレーザーを用いて５６８ｎｍにて励起された。細胞を透過する光学分画のＺシリーズは、１０２４×１０２４ピクセルの分解能で厚さ０．５μｍをスキャンした（Ｇｉｅｓｅら、１９９５）。評価は、ＡＶＳソフトウェアー（Ａｄｖａｎｃｅｄ Ｖｉｓｕａｌ Ｓｙｓｔｅｍｓ Ｉｎｃ．， Ｗａｌｔｈａｍ， ＭＡ， Ｕ．Ｓ．Ａ．）を用いて行なわれ、後者はウィンドウズ用のＡｄｏｂｅ Ｐｈｏｔｏｓｈｏｐ ５．０およびＣｏｒｅｌ Ｄｒａｗ ８．０を用いて後に行なった。<br class="style-scope patent-text">
【０２０１】<br class="style-scope patent-text">
２３．ＨＣ１１０−Ｒ断片に対するα−ＬＴＸの結合の研究<br class="style-scope patent-text">
タンパク質をＳＤＳ−ＰＡＧＥ（Ｌａｅｍｍｌｉら、１９７０）により分画し、ニトロセルロース膜上で電気泳動した。α−ＬＴＸ結合実験の場合、その染色は、ＴＳＴ中、濃度２０ｎＭのα−ＬＴＸを用いて室温で２時間インキュベーションした。ＴＳＴを用いて３回洗浄した後、抗−α−ＬＴＸ抗体（ウサギ由来Ｃａｌｂｉｏｃｈｅｍ−Ｎｏｖａｂｉｏｃｈｅｍ）を濃度０．１μｇ／ｍＬにて用い、そしてペルオキシダーゼを連結した抗体及びウサギＩｇＧに対する抗体（ヤギ由来、１：２５０００希釈）を用いた。抗体は、全ての実験でＥＣＬ（Ａｍｅｒｓｈａｍ−Ｐｈａｒｍａｃｉａ）を用いて検出した（図９を参照）。<br class="style-scope patent-text">
【０２０２】<br class="style-scope patent-text">
２４．カルシウムイメージング<br class="style-scope patent-text">
細胞内の遊離Ｃａ<sup class="style-scope patent-text">２＋</sup>濃度［Ｃａ<sup class="style-scope patent-text">２＋</sup>］<sub class="style-scope patent-text">ｉ</sub>は、ＨＣ１１０−Ｒ−ＧＦＰ又はβ<sub class="style-scope patent-text">２</sub>−ＡＲ−ＥＧＦＰ構築物を用いて一過的にトランスフェクションしたＤＯＳ−７細胞及びＨＥＫ−２９３細胞にて、カルシウムイメージング法を用いて測定した（図１１も参照）。各々の場合について、２×１０５ ＣＯＳ−７細胞及びＨＥＫ−２９３細胞を、ＤＭＥＭ培地（１０％ ＦＣＳ及びｐｅｎ／ｓｔｒｅｐを含む）５ｍｌを有する５５ｍｍ組織培養皿にて１％ゼラチンを用いてコーティングした４２ｍｍカバーガラスに用いた。トランスフェクションは、非トランスフェクション試薬ＦｕＧＥＮＥ ６（Ｒｏｃｈｅ Ｍｏｌｅｃｕｌａｒ Ｂｉｏｃｈｅｍｉｃａｌｓ， Ｍａｎｎｈｅｉｍ）を用いて行なった。これには、ＦＣＳを含まないＤＭＥＭ培地２００μｌにて初めに室温で５分間インキュベーションしたＦｕＧＥＮＥ ６ ６μｌを含み、その後プラスミドＤＮＡ４μｇを加え、さらに１５分間室温にてインキュベーションし、完全トランスフェクション混合物をその細胞にピペットにて滴加した。正しいリーディングフレームに融合されたＧＦＰタグを有するＨＣ１１０−Ｒ全長クローンの構築物、及び同様にその３’端にＧＦＰタグを有するβ<sub class="style-scope patent-text">２</sub>−アドレナリン駆動性受容体の完全ｃＤＮＡの構築物をトランスフェクションした。純粋なｐＥＧＦＰ−Ｎ３発現ベクター（Ｃｌｏｎｔｅｃｈ， Ｈｅｉｄｅｌｂｅｒｇ）のプラスミドＤＮＡ４μｇと、トランスフェクション試薬ＦｕＧＥＮＥをＤＮＡなしで加えた非トランスフェクト細胞をコントロールとして保存した。<br class="style-scope patent-text">
【０２０３】<br class="style-scope patent-text">
１μＭ Ｆｕｒａ−２−アセトキシメチルエステル （Ｆｕｒａ−２ ／ ＡＭ） （Ｓｉｇｍａ， Ｄｅｉｓｅｎｈｏｆｅｎ） を用いた細胞のローディングは、３７℃、５％ ＣＯ<sub class="style-scope patent-text">２</sub>及び９５％湿度で、３０分間、Ｎａ<sup class="style-scope patent-text">＋</sup>−ＨＢＳ 溶液 （水中、１５０ ｍＭ ＮａＣｌ； ５．４ ｍＭ ＫＣｌ； １．８ ｍＭ ＣａＣｌ<sub class="style-scope patent-text">２</sub>； ０．８ ｍＭ ＭｇＳＯ<sub class="style-scope patent-text">４</sub> <sup class="style-scope patent-text">．</sup> ７ Ｈ<sub class="style-scope patent-text">２</sub>Ｏ； ２０ ｍＭ フルコース； ２０ ｍＭ ヘペス（Ｈｅｐｅｓ）， ｐＨ ７．３） 中にてトランスフェクションした４８時間後に行なった。インキュベート後にＦｕｒａ−２／ＡＭと共にローディングした細胞を、倒立顕微鏡（Ｚｅｉｓｓ， Ａｘｉｏｖｅｒｔ， Ｇｅｒｍａｎｙ）の下で、及びそれと平行して、デジタルイメージング蛍光顕微鏡（ＰＴＩ）の下で試験し、４４０ｎｍと４９０ｎｍそれぞれの波長でトランスフェクト細胞と、非トランスフェクト細胞を区別した。平均して、５〜７のトランスフェクト細胞及び非トランスフェクト細胞は、ＲＯＩ（目的領域）を固定化することで、選択した。吸光は３４０ｎｍ（カルシウム結合Ｆｕｒａ−２／ＡＭ）と、３８０ｎｍ（遊離Ｆｕｒａ−２／ＡＭ）にて測定され、発光は５１０ｎｍにて測定された。イメージマスター（Ｉｍａｇｅ Ｍａｓｔｅｒ） １×ソフトウェアーを用いて、加えた試薬の機能としての３４０：５１０ｎｍ、３８０：５１０ｎｍ及び３４０／３８０：５１０ｎｍの比率の商 （バックグラウンド補正した画像）を形成することで、評価した。<br class="style-scope patent-text">
【０２０４】<br class="style-scope patent-text">
試薬は、常に、Ｎａ<sup class="style-scope patent-text">＋</sup> ＨＢＳ緩衝液の適当量を取り測定を開始した６分後に加え、さらに３０〜５０分間、試料容器中に直接ピペッティングする。試料容器中の全量を、実験を通じて１．５ｍｌと一定にした。それぞれの場合、実験を始める分前に、初めに３０ｎＭ及び７５ｎＭ α−ラトロトキシン（α−ＬＴＸ， ＲＢＩ． Ｎａｔｉｃｋ， Ｕ．Ｓ．Ａ．）を、用量依存を決定するため、ＨＣ１１０−Ｒ−ＧＦＰ融合タンパク質を発現するＣＯＳ−７細胞に種々の濃度のα−ＬＴＸ（７．５ ｎＭ； ２５ ｎＭ； ５０ ｎＭ， ７５ ｎＭ， ９０ ｎＭ 及び１２０ ｎＭ）を加える、及び最適な活性濃度を決定するため、種々の濃度の環状デプシペプチド ＢＡＹ ４４−４４００ （１００ｎｇ／ｍＬ （８９．３ ｎＭ）、３３３ｎｇ／ｍＬ （２９７ ｎＭ）； ４００ｎｇ／ｍＬ （３５７ ｎＭ）、１μｇ／ｍＬ （８９３ ｎＭ）、１０μｇ／ｍＬ （８．９μＭ）を、ＨＣ１１０−Ｒ−ＧＦＰを発現するＨＥＫ−２９３細胞に加える。幾つかの実験において、ＨＥＫ−２９３細胞を、駆虫活性を有しない、Ｎａ<sup class="style-scope patent-text">＋</sup> ＨＢＳ中の光学対掌体ＰＦ１０２２−００１ ４又は４００ｎｇ／ｍＬ ＢＡＹ ４４−４４００あるいは４又は４００ｎｇ／ｍＬと共に、３７℃で５％ＣＯ<sub class="style-scope patent-text">２</sub>及び９７％湿度にて９０分間、プレインキュベーションし、細胞は、１μＭ Ｆｕｒａ−２／ＡＭをＢＡＹ４４−４４００溶液又はＰＦ１０２２−００１に加えることによって６０分後にローディングし、３０分間維持した。細胞を器具に導入した後、７５ｎＭ α−ＬＴＸをさらにそれらに実験開始の６分後に添加した。最適なα−ＬＴＸ濃度 ７５ｎＭを、Ｃ−末端ＧＦＰタグを有するβ<sub class="style-scope patent-text">２</sub>−アドレナリン作動性受容体（β<sub class="style-scope patent-text">２</sub>−Ｒ−ＧＦＰ）を発現するＨＥＫ−２９３細胞にて試験した。ＣｄＣｌ<sub class="style-scope patent-text">２</sub>（それぞれの場合に１μＭ及び１０μＭ）をＮａ<sup class="style-scope patent-text">＋</sup> ＨＢＳ中に溶解し、ニフェジピン（１５μＭ）及びＥＧＴＡ（２ｍＭ）を０．１％ ＤＭＳＯ中に溶解した。ＣｄＣｌ<sub class="style-scope patent-text">２</sub>及びニフェジピンを実験開始時にすぐ加え、次いでα−ＬＴＸを加え、そしてＥＧＴＡを実験の開始時とα−ＬＴＸの添加の４分後の両方で加えた。溶解α−ＬＴＸは、５０ｍＭ トリス−ＨＣｌ中で濃度３００ｎＭにて存在する；ＢＡＹ４４−４４００は最初、純粋なＤＭＳＯ中に溶解した（ストック溶液は０．００４〜１０μｇ／ｍＬ）。ストック溶液は、Ｎａ<sup class="style-scope patent-text">＋</sup> ＨＢＳ緩衝液中にて所望の濃度に調整した。最終濃度０．１％ ＤＭＳＯに溶解した活性物質ＢＡＹ４４−４４００の最大量は、Ｎａ<sup class="style-scope patent-text">＋</sup> ＨＢＳにおける希釈系列を行なって見出した。０．１％ ＤＭＳＯ及びそのたの被験成分のいずれもが、Ｆｕｒａ−２／ＡＭと選択した濃度では相互作用しなかった。<br class="style-scope patent-text">
【０２０５】<br class="style-scope patent-text">
エクセル（Ｅｘｃｅｌ）９８ の表計算プログラムを用いて、このデータを分析した。結果は少なくとも２〜４回の再現実験、それぞれの場合４〜８のトランスフェクト細胞から導く。<br class="style-scope patent-text">
【０２０６】<br class="style-scope patent-text">
細胞内カルシウム濃度は、ＭｃＣｏｒｍａｃｋらの方法（１９９１）により前較正した後に、Ｇｒｙｎｋｉｅｗｉｃｚらの方法により（１９８５）計算した。<br class="style-scope patent-text">
【０２０７】<br class="style-scope patent-text">
２５．ＨＣ１１０−Ｒに対するＰＦ１０２２Ａの結合<br class="style-scope patent-text">
ＨＣ１１０−Ｒに対するＰＦ１０２２Ａ及びモルホリン誘導体ＢＡＹ４４−４４００の結合は、ＳＤＳ−ＰＡＧＥ、リガンド調製及び以下の分析流動細胞計測器（フローサイトメトリー）により示される。さらに、ＰＦ１０２２Ａ及びその誘導体が、α−ＬＴＸのように、ＨＣ１１０−ＲトランスフェクトＨＥＫ−２９３細胞の［Ｃａ<sup class="style-scope patent-text">２＋</sup>］<sub class="style-scope patent-text">ｉ</sub>に変化を引き起こすか否かあるいはＨＣ１１０−Ｒ媒介α−ＬＴＸシグナリングにも影響があるか否かを確認する。<br class="style-scope patent-text">
【０２０８】<br class="style-scope patent-text">
場合によって、免疫蛍光において明らかなシグナルを与える抗体又はタンパク質が、免疫ブロット法を使用しても反応しないことがある。ＳＤＳ−ＰＡＧＥを行なうには、タンパク質の変性が必要なため、コンフォメーションに依存するエピトープが破壊され得る。そのようなエピトープを特異的に認識する抗体又はタンパク質はもはや、結合できない。したがって、ＨＣ１１０−Ｒ特異的結合はウェスタンブロットにおいて、ビオチン化活性物質ＰＦ１０２２Ａを用いるか、又はヒトＰＦ１０２２Ａよりもより可溶性のモルホリン誘導体 ＢＡＹ４４−４４００を用いるかのいずれかによっては同定できない。ＢＡＹ４４−４４００は、ＰＦ１０２２ＡのＤ−フェニルアクチル（ｐｈｅｎｙｌｌａｃｔｙｌ）ラジカルのフェニル環と共有結合している２個のモルホリン残基についてＰＦ１０２２Ａと異なっている。しかしながら、疎水性相互作用を破壊することを通じて、ＳＤＳを部分的に除去して、タンパク質を、尿素を用いてＳＤＳ分離ゲルにて再生させる場合、ウェスタンブロットにおいてＨＣ１１０−Ｒ特異的結合を検出することができる。この目的のために、非トランスフェクトＨＥＫ−２９３細胞及びＨＣ１１０−Ｒ−Ｍｙｃ／Ｈｉｓを一過的に発現するＨＥＫ−２９３細胞由来の全タンパク質、及びＥ． ｃｏｌｉにて発現されるＨＣ１１０−Ｒの５４ ｋＤａのＮ末端及び２１ ｋＤａのＣ末端を、ＳＤＳ−ＰＡＧＥにより分画し、再生して常法によりブロッティングした。免疫検出は、リガンドＢＡＹ４４−４４００と共に、ウサギ抗ＰＦ１０２２Ａ−ＫＬＪ免疫血清と共に、及びヤギ抗−ウサギＩｇＧ ＨＲＰ抗体と共にインキュベーションした後に行なった。さらに、非トランスフェクトＨＥＫ−２９３細胞、ＨＣ１１０−Ｒ−Ｍｙｃ／Ｈｉｓを用いて一過的にトランスフェクションしたＨＥＫ−２９３細胞、及びＥ． ｃｏｌｉ中にて発現されるＨＣ１１０−ＲのＮ末端、及びＨ． ｃｏｎｔｏｒｔｕｓ由来の全タンパク質を用いた部分的再生ＳＤＳポリアクリルアミドゲルをブロッティングし、ＰＦ１０２２Ａ−ビオチンと共にインキュベーションし、ストレプトアビジン ＨＲＰを用いて検出した。２つのブロットの各々については、ＨＣ１１０−Ｒ−Ｍｙｃ／Ｈｉｓを安定に発現するＨＥＫ−２９３細胞ではサイズ１１６ｋＤａの明確なバンドを示したのに対し、非トランスフェクト細胞を用いたレーンではこのレベルではバンドを示さない。さらに、モルホリン誘導体ＢＡＹ４４−４４００と、２１ｋＤａのＣ−末端を除くＨＣ１１０−Ｒの５４ｋＤａ Ｎ末端と結合しているビオチン化ＰＦ１０２２Ａとの両方が、特異的ＰＦ１０２２Ａ結合を示さない。成虫Ｈ． ｃｏｎｔｏｒｔｕｓ 線虫由来の全タンパク質分画の２つのバンドンの全量は、ビオチン化ＰＦ１０２２Ａを用いて検出できる：サイズ１１０ｋＤａのバンド及びサイズ約８８ｋＤａの別のバンド。特に、サイズ１１０ｋＤａのバンドとは対照的に検出をストレプトアビジンＨＲＰを用いて排他的に行なった場合でさえ検出されるため、おそらく後者は、すでに線虫ヘテラキスｓｐｕｍｏｓａについて記載した８３ｋＤａのタンパク質のようなビオチン化タンパク質である。もう一方は、ＨＣ１１０−Ｒ−Ｍｙｃ／Ｈｉｓを用いて安定にトランスフェクションしたＨＥＫ−２９３細胞はもはや、ストレプトアビジンＨＲＰのみのサイズ１１６ｋＤａのバンドを示さない。さらにヤギ抗ウサギＩｇＧ ＨＲＰ二次抗体単独により生じる非特異的シグナルを排除できた。<br class="style-scope patent-text">
【０２０９】<br class="style-scope patent-text">
さらにこの結果を検証すために、以下のリガンド沈殿を行なった。磁性Ｄｙｎａｌ Ｍ−２８０ストレプトアビジン結合ビーズの一部２ｍｇ及び４ｍｇを、ビオチン化ＰＦ１０２２Ａ５００μｇと共に混合した。Ｄｙｎａｌビーズ４ｍｇを用いたコントロール混合物において、ＴＳＴ緩衝液をＰＦ１０２２Ａに代えて加えた。過剰量のＰＦ１０２２Ａビオチンを磁性分離により除去し、次いでＥ． ｃｏｌｉにて発現され、事前にアフィニティークロマトフラフィーにより精製したＰＦ１１０−Ｒ末端及びＣ末端を加えた。非結合ＨＣ１１０−Ｒ断片を除去するための再生磁性分離の後に、Ｄｙｎａｌビーズ２ｍｇ、及び４ｍｇから得られる部分標本をＳＤＳ−ＰＡＧＥにより分画し、ブロッティングした。沈殿物の検出は、マウス抗−Ｈｉｓ ＩｇＧ及びウサギ抗−マウス ＩｇＧ ＨＲＰ抗体を有するＮ末端融合Ｈｉｓタグを介して行なった。ＰＦ１０２２Ａに結合しないＨＣ１１０−ＲのＣ−末端が事前に磁性分離により分離されていることに基づいて、ＨＣ１１０−ＲのＮ末端 ５４ｋＤａ領域のみをＰＦ１０２２Ａにより沈殿させる。ストレプトアビジン結合ビーズに対するＨＣ１１０−ＲのＮ−又はＣ−末端の非特異的結合は、反応混合物にビオチン化ＰＦ１０２２Ａを加えないことで排除した。<br class="style-scope patent-text">
【０２１０】<br class="style-scope patent-text">
インビボにおけるＨＣ１１０−Ｒに対するリガンドＰＦ１０２２Ａの結合を、さらにＦＡＣＳ分析により分析した（図１３）。この目的のために、ＨＥＫ−２９３細胞を、ＨＣ１１０−Ｒ−ＧＦＰ又はＧＦＰ−ＨＣ１１０−Ｒを用いて一過トランスフェクションするか、その他にはＨＣ１１０−Ｒ−Ｍｙｃ／Ｈｉｓ及びＧＦＰを用いて同時トランスフェクションした。非トランスフェクトＨＥＫ−２９３細胞、及びβ<sub class="style-scope patent-text">２</sub>−Ｒ−ＧＦＰ又はＭ１−Ｒ−ＧＦＰを用いて一過的にトランスフェクションしたＨＥＫ−２９３をコントロールとして用いた。トランスフェクションの２４時間後に、細胞をビオチン化ＰＦ１０２２Ａと共にインキュベーションし、、ＰＦ１０２２Ａ結合細胞をストレプトアビジン−フィコエリトリンを用いて検出し、最終的に固定化した。ネガティブコントロールであるＨＣ１１０−Ｒ−ＧＦＰを用いてトランスフェクションした細胞を、ＰＦ１０２２Ａ−ビオチンを用いず、ストレプトアビジン−フィコエリトリンのみを用いてインキュベーションした。<br class="style-scope patent-text">
【０２１１】<br class="style-scope patent-text">
ＦＡＣＳｃａｎは、細胞サイズ、粒状度及び蛍光染色についてそれぞれ１００００ ＨＥＫ−２９３細胞を蛍光分析するために、励起波長４８８ｍｍを用いて使用した。フィコエリトリンは、ＴＲＩＴＣのように、ＥＧＦＰとオーバーラップした吸光スペクトルを有する一方で、発光スペクトルは十分に離れているため、両方の蛍光色素を単一の波長のみで励起できる。細胞破砕物は、主な細胞集団に「ゲート」を設けることで蛍光強度測定から排除できる。定量的評価については、非トランスフェクト細胞及びＧＦＰトランスフェクト細胞の基礎に基づく陰性（ネガティブ）、非染色及び陽性（ポジティブ）、ＧＦＰ−蛍光細胞についての制限は固定した。非トランスフェクトＨＥＫ−２９３細胞の緑色蛍光４．６％（自己蛍光）は、他のＧＦＰ蛍光試料から引いた；そしてフィコエリトリン−結合ストレプトアビジン （５．４％） による細胞の非特異的染色の値を、全てのレッド蛍光細胞から引いた（表１）。<br class="style-scope patent-text">
表１　ＦＡＣＳｃａｎによる、ＨＣ１１０−Ｒを用いてトランスフェクションしたＨＥＫ−２９３細胞に結合するＰＦ１０２２Ａの検出<br class="style-scope patent-text">
【表１】<br class="style-scope patent-text">
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/04/4c/a0/92d3e6f2c972b2/2004508052-99.png" class="style-scope patent-text"><img he="76" id="000003" wi="151" file="2004508052.tif" img-format="tif" img-content="drawing" width="604" height="304" alt="Figure 2004508052" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/04/4c/a0/92d3e6f2c972b2/2004508052-99.png"></a></div>
【０２１２】<br class="style-scope patent-text">
自己蛍光及びストレプトアビジン−フィコエリトリンによる非特異的な赤染色を引いた後の、赤（レッド）蛍光でもある緑色蛍光細胞の百分率を計算することで、ＨＣ１１０−Ｒ−ＧＦＰを発現する細胞が４１．２％、ＧＦＰ−ＨＣ１１０−Ｒを発現する細胞が２６．８％、そしてＨＣ１１０−Ｒ−Ｍｙｃ／ＨｉｓとＧＦＰ結合ＰＦ１０２２Ａとを用いて同時トランスフェクションした細胞が４４．５％であることが示されたが、ＧＦＰを発現している細胞は僅かに７．５％であり、β<sub class="style-scope patent-text">２</sub>−Ｒ−ＧＦＰを発現している細胞は９．９％、そしてＭ１−Ｒ−ＧＦＰ ｂｉｎｄ ＰＦ １０２２Ａを発現している細胞は１９．２％であった（図１３）。<br class="style-scope patent-text">
【０２１３】<br class="style-scope patent-text">
２６．ＨＣ１１０−Ｒ媒介性α−ＬＴＸシグナル伝達を用いたＰＦ１０２２Ａ誘導体の相互作用<br class="style-scope patent-text">
ＰＦ１０２２Ａは、線虫種に応じて１０<sup class="style-scope patent-text">−９</sup>〜１０<sup class="style-scope patent-text">−３</sup>ｍｇ／ｍｌの間のインビトロにおける神経薬理学的活性を示す。ＨＣ１１０−Ｒ及びＨＣ１１０−Ｒにより媒介されるα−ＬＴＸシグナリングを用いてＰＦ１０２２Ａとその誘導体の任意の干渉を検出するため、ＢＡＹ４４−４４００、より可溶性のＰＦ１０２２Ａモルホリン変異体の効果は、Ｃａ<sup class="style-scope patent-text">２＋</sup>イメージング法を用いて、ＨＣ１１０−Ｒを一過又は安定に発現するＨＥＫ−２９３細胞において調査した。ＰＦ１０２２Ａの光学対掌体であって、インビトロ及びインビボにおいて１００倍以上の活性を有するＰＦ１０２２−００１を、コントロールとして用いた。ＢＡＹ４４−４４００及びＰＦ１０２２Ａ−００１の疎水性のため、初めにＢＡＹ４４−４４００及びＰＦ１０２２−００１を、純粋なＤＭＳＯ中に溶解した。０．１％ＤＭＳＯがいつも実験混合物中に存在するように、ストック濃度を選択した。対照実験においては、非トランスフェクトＨＣ１１０−Ｒ細胞及びＨＣ１１０−Ｒ−ＧＦＰを用いてトランスフェクションしたＨＣ１１０−Ｒ細胞の実験結果に支障をきたさない最大のＤＭＳＯ濃度、０．１％にまで排除できる（図１４）。Ｆｕｒａ−２−ローディングした非トランスフェクト細胞及びＨＣ１１０−Ｒ−ＧＦＰを用いてトランスフェクションした細胞を、一方では１００、３００又は４００ｎｇ／ｍＬ及び１又は１０μｇ／ｍＬのＢＡＹ４４−４４００か、又は他方では同じ濃度のＰＦ１０２２−００１を用いて刺激した。濃縮なしで、Ｃａ<sup class="style-scope patent-text">２＋</sup>媒介応答は５０分の前期間に渡って検出可能であった。図１４Ｂ及びＣは、４００ｎｇ／ｍＬ ＢＡＹ４４−４４００及びＰＦ１０２２−００１を用いた、ＨＣ１１０−Ｒ−ＧＦＰ及びＭ１−Ｒ−ＧＦＰでトランスフェクションした細胞の刺激を、実施例のように示す。さらにＰＦ１０２２Ａ変異体は細胞に取り込まれ、シグナル伝達経路を２次的に阻害して、寄生虫に応じて寄生虫内で長期間、ＰＦ１０２２Ａ誘導体は維持され得るため、幾つかの実験において細胞を該誘導体と共に９０秒間プレインキュベーションした。４ｎｇ／ｍＬ又は４００ｎｇ／ｍＬ ＢＡＹ４４−４４００又はＰＦ１０２２−００１を用いてプレインキュベーションした細胞は、［Ｃａ<sup class="style-scope patent-text">２＋</sup>］<sub class="style-scope patent-text">ｉ</sub>に変化がない（図１４Ｄ）。濃度３００ｎｇ／ｍＬ又はそれ以上のＢＡＹ４４−４４００を直接加える場合は、光学対掌体とは対照的に、４０倍の倍率をもって細胞を表すモニター上で、数分のうちに逆転する僅かな膨張が、ＨＣ１１０−Ｒ−ＧＦＰを用いてトランスフェクションしたＨＥＫ−２９３細胞における駆虫薬の効果を直接的に観察できた。<br class="style-scope patent-text">
【０２１４】<br class="style-scope patent-text">
最近の実験では、ピペラジンが、インビトロ及びインビボにおいてヘテラキスｓｐｕｍｏｓａを用いた実験においてＰＦ１０２２Ａ／ＢＡＹ４４−４４００の効果を相乗的に増大することが示された。４００ｎｇ／ｍＬ ＢＡＹ４４−４４００を１又は１０μＭ ピペラジンと同時に与えた場合（図１４Ｆ）、非トランスフェクトＨＥＫ−２９３細胞又はＨＣ１１０−Ｒ−ＧＦＰを用いて一過的にトランスフェクションしたＨＥＫ−２９３細胞のいずれにおいても、［Ｃａ<sup class="style-scope patent-text">２＋</sup>］<sub class="style-scope patent-text">ｉ</sub>の変化は検出できなかった。１０μＭ ピペラジンを用いたコントロール混合物は、同様に、非トランスフェクト及びＨＣ１１０−Ｒ−ＧＦＰトランスフェクト細胞のＣａ<sup class="style-scope patent-text">２＋</sup>バランスに変化を引き起こさなかった（図１４Ｅ）。<br class="style-scope patent-text">
【０２１５】<br class="style-scope patent-text">
これとは対照的に、範囲は変えてあるが、ＢＡＹ４４−４４００及び光学対掌体ＰＦ１０２２−００１の両方は、７５ ｎＭα−ＬＴＸの存在下にて、ＨＣ１１０−Ｒ−ＧＦＰ発現ＨＥＫ−２９３細胞のα−ＬＴＸ誘導型シグナル伝達に影響を及ぼした（図１４Ｂ〜Ｅ）。ＨＣ１１０−Ｒ−ＧＦＰ又はＭ１−Ｒ−ＧＦＰを用いてトランスフェクションした細胞を、刺激の６分前に７５ｎＭ α−ＬＴＸ、０．１％ ＤＭＳＯを用いて処置する対照実験においては、後者の濃度のＢＡＹ４４−４４００及びＰＦ１０２２−００１に用いられる溶媒により発揮される［Ｃａ<sup class="style-scope patent-text">２＋</sup>］<sub class="style-scope patent-text">ｉ</sub>におけるα−ＬＴＸ誘導型変化の効果を排除できる。Ｍ１−Ｒ−ＧＦＰ発現細胞とは対照的に、ＨＣ１１０−Ｒ−ＧＦＰ発現細胞は、α−ＬＴＸを加えた後の［Ｃａ<sup class="style-scope patent-text">２＋</sup>］<sub class="style-scope patent-text">ｉ</sub>の値と匹敵する上記の二相性のプロファイルを示した（図１５Ａ）。４ｎｇ／ｍＬのＢＡＹ４４−４４００で６分間、ＨＣ１１０−Ｒ−ＧＦＰ−発現細胞を誘導した後、α−ＬＴＸを加え、Ｃａ<sup class="style-scope patent-text">２＋</sup> 濃度に対するα−ＬＴＸの記載された効果を減少させた。：α−ＬＴＸによって誘導される［Ｃａ<sup class="style-scope patent-text">２＋</sup>］<sub class="style-scope patent-text">ｉ</sub> の最初の小さな増加は、消失し、２番目の送れたピークは、α−ＬＴＸの添加から１４分後に４４±６．０ ｎＭ Ｃａ<sup class="style-scope patent-text">２＋</sup> に減少した （図１５Ｂ）。４ｎｇ／ｍＬのＰＦ１０２２−００１の存在下で、α−ＬＴＸでの刺激の６分前に添加を行った、１０３±１１．５ ｎＭ Ｃａ<sup class="style-scope patent-text">２＋</sup> の急速な増加がみられた（図１５Ｂ）。４００ ｎｇ／ｍＬ ＢＡＹ４４−４４００をα−ＬＴＸの添加の６分前にＨＣ１１０−Ｒ−ＧＦＰ−発現細胞に添加した場合、４ ｎｇ／ｍＬ ＢＡＹ４４−４４００ （図１５Ｂ）の場合と同様に、２３分間で４９±４．２ ｎＭの、［Ｃａ<sup class="style-scope patent-text">２＋</sup>］<sub class="style-scope patent-text">ｉ</sub> の遅延された増加がみられ、８分後に水平に減少し、最初の値と比較して、１１±１．４ ｎＭにわずかに増加した（図１５Ｃ）。α−ＬＴＸとインキュベーションする６分前に、４００ ｎｇ／ｍＬ ＰＦ１０２２−００１ ７５ ｎＭ添加すると、以前４ ｎｇ／ｍＬ ＰＦ１０２２−００１の添加で観察された（図１５Ｂ）のと同様に、１１２±１４．３ ｎＭ Ｃａ<sup class="style-scope patent-text">２＋</sup>というＣａ<sup class="style-scope patent-text">２＋</sup>の急速な増加がみられた（図１５Ｃ）。別の実験計画では、各ケースにおいて、ＨＣ１１０−Ｒ−ＧＦＰ−発現 ＨＥＫ−２９３細胞を４ ｎｇ／ｍＬ （図１５Ｄ）または４００ ｎｇ／ｍＬ ＢＡＹ４４−４４００またはＰＦ１０２２−００１と９０分間プレインキュベーションした （図１５Ｅ）。インキュベーション後、結合しなかったまたは取り出した活性物質を注意深く洗浄し、細胞にＦｕｒａ−２／ＡＭを加えた後、細胞を７５ ｎＭα−ＬＴＸで刺激した。光学対掌体 ＰＦ１０２２−００１とプレインキュベーションしたＨＣ１１０−Ｒ−トランスフェクト細胞は、４ ｎｇ／ｍＬ ＰＦ１０２２−００１で、１０２±６．４ ｎＭの［Ｃａ<sup class="style-scope patent-text">２＋</sup>］<sub class="style-scope patent-text">ｉ</sub> の増加を示し（図１５Ｄ）、４００ ｎｇ／ｍＬで１０９±８．４ ｎＭ Ｃａ<sup class="style-scope patent-text">２＋</sup> の同様の増加を示した（図１５Ｅ）。α−ＬＴＸの添加後たった２、３分で観察されたＣａ<sup class="style-scope patent-text">２＋</sup>のこの増加は、α−ＬＴＸによる刺激の直前にＰＦ１０２２−００１を添加した場合、図１５Ｂおよび１５Ｃにおいて前に観察された［Ｃａ<sup class="style-scope patent-text">２＋</sup>］<sub class="style-scope patent-text">ｉ</sub> の急速な変化と類似していた。対照的に、ＢＡＹ４４−４４００は、ＨＣ１１０−Ｒ−ＧＦＰ−発現細胞を４ ｎｇ／ｍＬ ＢＡＹ４４−４４００と９０分プレインキュベーションした場合、α−ＬＴＸ−減少したＣａ<sup class="style-scope patent-text">２＋</sup> 流入と関係して、異なった反応を示した：α−ＬＴＸ誘発は、２３±２．６ ｎＭ Ｃａ<sup class="style-scope patent-text">２＋</sup> に上昇した広範囲の水平になる前に、１０分で９５±２０．５ ｎＭという最大の増加を導いた［Ｃａ<sup class="style-scope patent-text">２＋</sup>］<sub class="style-scope patent-text">ｉ</sub>（図１５Ｄ）。４００ ｎｇ／ｍＬ ＢＡＹ４４−４４００でのプレインキュベーションでは、α−ＬＴＸ刺激の後、 ［Ｃａ<sup class="style-scope patent-text">２＋</sup>］<sub class="style-scope patent-text">ｉ</sub> が最大６５±７．５ ｎＭに増加し（図１５Ｄ）、これは４ ｎｇ／ｍＬ ＢＡＹ４４−４４００でのプレインキュベーションと比較して１２分の遅延であった （図１５Ｃ）。<br class="style-scope patent-text">
【０２１６】<br class="style-scope patent-text">
４００ ｎｇ／ｍＬ ＢＡＹ４４−４４００の、α−ＬＴＸの添加の６分前の、ＨＣ１１０−Ｒ−Ｍｙｃ／Ｈｉｓを安定に発現しているＨＥＫ−２９３細胞への添加により、２６７±４５．８ ｎＭ の［Ｃａ<sup class="style-scope patent-text">２＋</sup>］<sub class="style-scope patent-text">ｉ</sub> の観察された急速な増加の完全な阻害がみられた （図１５Ｆ）。これとは対照的に、４００ ｎｇ／ｍＬ ＰＦ１０２２−００１の添加は、 ［Ｃａ<sup class="style-scope patent-text">２＋</sup>］<sub class="style-scope patent-text">ｉ</sub>の有意の変化は誘導せず、Ｃａ<sup class="style-scope patent-text">２＋</sup>の増加は２０９±３３．４ ｎＭ Ｃａ<sup class="style-scope patent-text">２＋</sup> であった（図１５Ｆ）。<br class="style-scope patent-text">
【０２１７】<br class="style-scope patent-text">
ＨＣ１１０−Ｒ−発現細胞におけるα−ＬＴＸ−媒介Ｃａ<sup class="style-scope patent-text">２＋</sup> シグナル伝達に対するＢＡＹ４４−４４００の特異的な効果を証明するために、以下の対照実験を行った：最初の非トランフェクトＨＥＫ−２９３細胞を、４００ ｎｇ／ｍＬ ＢＡＹ４４−４４００の存在下および非存在下で、ムスカリン性アセチルコリン受容体に対するリガンドである、１ ｍＭ　塩化カルバミルコリン（カルバコール）で刺激した（図１５Ｇ）。両ケースにおいて、ＢＡＹ４４−４４００の存在下でＨＥＫ−２９３細胞について５８±８．１ ｎＭ Ｃａ<sup class="style-scope patent-text">２＋</sup>および駆虫薬の非存在下で５３±６．８ ｎＭ Ｃａ<sup class="style-scope patent-text">２＋</sup>の、内因性の、天然のムスカリン性アセチルコリン受容体による［Ｃａ<sup class="style-scope patent-text">２＋</sup>］<sub class="style-scope patent-text">ｉ</sub> の類似した急速な増加が見られた。ＧＦＰ （Ｍ１−Ｒ−ＧＦＰ）にＣ末端融合したヒトムスカリン性 Ｍ１−アセチルコリン受容体による、ＨＥＫ−２９３細胞の更なる一過性トランスフェクションは、４００ ｎｇ／ｍＬ ＢＡＹ４４−４４００の存在下で８９±５．５ ｎＭ、非存在下で８５±６．１ ｎＭ Ｃａ<sup class="style-scope patent-text">２＋</sup> の、非トランスフェクト細胞（図１５Ｇ）と比較して［Ｃａ<sup class="style-scope patent-text">２＋</sup>］<sub class="style-scope patent-text">ｉ</sub>のわずかな増加につながった（図１５Ｈ）。Ｍ１−Ｒ−ＧＰＣＲに対するＢＡＹ４４−４４００の有意な効果は観察できなかった。非トランスフェクトＨＥＫ−２９３細胞における、１ ｍＭ イソプロテレノールでの、内因的に存在する天然のβ<sub class="style-scope patent-text">２</sub>−アドレナリン作動性受容体の刺激、または１ ｍＭアレコリンでの、ニコチン受容体の刺激は、カルバコールについて記載したように、４００ ｎｇ／ｍＬ ＢＡＹ４４−４４００の存在下および非存在下では、またしても、［Ｃａ<sup class="style-scope patent-text">２＋</sup>］<sub class="style-scope patent-text">ｉ</sub> の有意な違いはなかった（図１５Ｉ）。イソプロテレノールは、ＢＡＹ４４−４４００の存在下で４５±４．７ ｎＭ［Ｃａ<sup class="style-scope patent-text">２＋</sup>］<sub class="style-scope patent-text">ｉ</sub>、およびＢＡＹ４４−４４００非存在下で４８±５．７ ｎＭ Ｃａ<sup class="style-scope patent-text">２＋</sup>の増加を誘導したアレコリン刺激後、ＢＡＹ４４−４４００の存在下でＣａ<sup class="style-scope patent-text">２＋</sup>の２８±４．１ ｎＭ、およびこの活性物質の非存在下で２７±３．５ ｎＭ ｉｎ Ｃａ<sup class="style-scope patent-text">２＋</sup>の増加がみられた（図１５Ｉ）。<br class="style-scope patent-text">
【０２１８】<br class="style-scope patent-text">
２７．抗体の入手<br class="style-scope patent-text">
抗体は、雌性ＮＭＲＩマウスおよびウサギ （チンチラクロス） を用いることによって入手した。ＮＭＲＩマウスの免疫は、３×１５μｇの精製２１ｋＤ　Ｃ末端ＨＣ１１０−Ｒタンパク質断片をそれぞれ１００ μｌのＦＣＡとともに１００μｌのＰＢＳ<sup class="style-scope patent-text">−</sup> 中に溶解し、１、８および１５日目に２匹のナイーブ ＮＭＲＩマウスに皮下注射した。血液サンプルの採取と血清の入手は２３日目に行った。<br class="style-scope patent-text">
【０２１９】<br class="style-scope patent-text">
血清を入手するために、心臓穿刺により得た血液を、最初に３７℃で１時間インキュベーションした後、４℃で少なくとも２時間インキュベーションした。次いで、細胞の構成成分を、Ｂｅｃｋｍａｎ ＧＰＫＲ 遠心機にて、２回、３０００ ｒｐｍ、４℃で１０分間ペレット化し、上清を５６℃で４５分間不活化した。Ｈｅｒａｅｕｓ ｂｉｏｆｕｇｅ １５Ｒ にて、１３ ０００ ｒｐｍ、４℃で１０分間さらに遠心した後、血清を取り出し、さらに使用するまで−２０℃で保存することができる。<br class="style-scope patent-text">
【０２２０】<br class="style-scope patent-text">
最初の血液採取および免疫前血清の入手の後、２匹のウサギに最初に、等部分のＰＢＳ<sup class="style-scope patent-text">−</sup>およびＦＣＡからなる懸濁液中の、５０ μｇのＣ末端２１ ｋＤ ＨＣ１１０−Ｒタンパク質、および５０ μｇの５４ ｋＤ Ｎ末端ＨＣ１１０−Ｒタンパク質を皮下注射で投与した。最初の免疫後、３１日目および７９日目に、さらに２回、１００ μｇの抗原を用いて免疫した。最初の血液採取は４３日目に行った。２回目の血液採取と血清の入手は、最初の免疫から９８日目に行った。<br class="style-scope patent-text">
【０２２１】<br class="style-scope patent-text">
参考文献<br class="style-scope patent-text">
１．Ａｌｌａｒｄ Ｗ．Ｊ．， Ｓｉｇａｌ Ｉ．Ｓ．及びＤｉｘｏｎ Ｒ．Ａ．Ｆ． （１９８７） ヒトＭ１ムスカリン性アセチルコリン受容体をコードしている遺伝子の配列． Ｎｕｃｌｅｉｃ Ａｃｉｄｓ Ｒｅｓ． ２４， １０６０４。<br class="style-scope patent-text">
２．Ａｌｔｓｃｈｕｌ Ｓ．Ｆ．及びＬｉｐｍａｎ Ｄ．Ｊ． （１９９０）多重アライメントについてのタンパク質データベースサーチ（探索）． Ｐｒｏｃ． Ｎａｔｌ． Ａｃａｄ． Ｓｃｉ． Ｕ．Ｓ．Ａ． ８７， ５５０９−５５１３。<br class="style-scope patent-text">
３．Ａｐｐｅｌ Ｒ．Ｄ．， Ｂａｉｒｏｃｈ Ａ． 及びＨｏｃｈｓｔｒａｓｓｅｒ Ｄ．Ｆ． （１９９４） 生物学者用の情報検索ツールの新たな形成： ＥｘＰＡＳｙ ＷＷＷ ｓｅｒｖｅｒの例． Ｔｒｅｎｄｓ Ｂｉｏｃｈｅｍ． Ｓｃｉ． １９， ２５８ − ２６０。<br class="style-scope patent-text">
４．Ａｖｉｖ Ｈ． 及びＬｅｄｅｒｅｒ Ｐ． （１９７２） オリゴチミジル酸セルロース上のクロマトフラフィーによる生物学的活性グロビンメッセンジャーＲＮＡの精製． Ｐｒｏｃ． Ｎａｔｌ． Ａｃａｄ． Ｓｃｉ． Ｕ．Ｓ．Ａ． ６９， １４０８−１４１２。<br class="style-scope patent-text">
５．Ｂａｃｏｎ Ｋ．Ｂ．， Ｗｅｓｔｗｉｃｋ Ｊ． 及びＣａｍｐ Ｒ．Ｄ． （１９８９） カルシウムチャネルアゴニストによるＩＬ−８−、ＩＬ−１ α−及びＩＬ−１ β−誘導性インビトロ ヒトリンパ球遊走の潜在的かつ特異的な阻害． Ｂｉｏｃｈｅｍ． Ｂｉｏｐｈｙｓ． Ｒｅｓ． Ｃｏｍｍ． １６５， ３４９−３５４。<br class="style-scope patent-text">
６．　Ｂｏｙｄ Ｖ．Ｌ．， Ｂｏｚｚｉｎｉ Ｍ．， Ｚｏｎ Ｇ．， Ｎｏｂｌｅ Ｒ．Ｌ． 及びＭａｔｔａｌｉａｎｏ Ｒ．Ｊ． （１９９２） カルボキシ末端からのペプチド及びタンパク質のシークエンシング． Ａｎａｌ． Ｂｉｏｃｈｅｍ． ２０６， ３４４ − ３５２。<br class="style-scope patent-text">
７．　Ｂｒａｄｆｏｒｄ Ｍ． （１９７６） タンパク質染色結合の原理に利用できるタンパク質（μｇ量）の定量化についての迅速且つ敏感な方法． Ａｎａｌ． Ｂｉｏｃｈｅｍ． ７２， ２４８ − ２５２。<br class="style-scope patent-text">
８．　Ｂｒｅｎｄｅｌ Ｖ．， Ｂｕｃｈｅｒ Ｐ．， Ｎｏｕｒｂａｋｈｓｈ Ｉ．Ｒ．， Ｂｌａｉｓｄｅｌｌ Ｂ．Ｅ． 及びＫａｒｌｉｎ Ｓ． （１９９２） タンパク質配列の統計学的分析用の方法及びアルゴリズム． Ｐｒｏｃ． Ｎａｔｌ． Ａｃａｄ． Ｓｃｉ． Ｕ．Ｓ．Ａ． ８９， ２００２ − ２００６。<br class="style-scope patent-text">
９．　Ｃｈａｌｆｉｅ Ｍ．， Ｔｕ Ｙ．， Ｅｕｓｋｉｒｃｈｅｎ Ｇ．， Ｗａｒｄ Ｗ．Ｗ． 及びＰｒａｓｈｅｒ Ｄ．Ｃ． （１９９４） 遺伝子発現用のマーカーとしての緑色蛍光タンパク質． Ｓｃｉｅｎｃｅ ２６３， ７２５ − ８８８。<br class="style-scope patent-text">
１０．　Ｃｈａｎ Ｍ−Ｓ． （１９９７） ５０年間の−腸管の線虫感染症の世界的な苦悩． Ｐａｒａｓｉｔｏｌ． Ｔｏｄａｙ １３， ４３８−４４３。<br class="style-scope patent-text">
１１．Ｃｈｅｎ Ｗ．， Ｔｅｒａｄａ Ｍ． 及びＣｈｅｎｇ Ｊ．Ｔ． （１９９６）γ−アミノブチル酸受容体におけるＰＦ１０２２Ａ、新規駆虫薬の結合検定及び結合による、Ａｓｃａｒｉｓ筋肉調製におけるγ−アミノブチル酸受容体のサブタイプの特徴づけ． Ｐａｒａｓｉｔｏｌ． Ｒｅｓ． ８２， ９７−１０１。<br class="style-scope patent-text">
１２．Ｃｈｏｍｃｚｙｎｓｋｉ Ｐ． （１９９２） ＤＮＡ及びＲＮＡのブロッティングについての１時間下方アルカリンキャピラリートランスファー． Ａｎａｌ． Ｂｉｏｃｈｅｍ． ２０１， １３４−１３９。<br class="style-scope patent-text">
１３．Ｃｈｏｍｃｚｙｎｓｋｉ Ｐ． （１９９３） 細胞及び組織試料由来のＲＮＡ、ＤＮＡ及びタンパク質の単一工程同時単離用の試薬． ＢｉｏＴｅｃｈｎｉｑｕｅｓ １５， ５３２ − ５３４； ５３６ − ５３７。<br class="style-scope patent-text">
１４．Ｃｈｏｍｃｚｙｎｓｋｉ Ｐ． ａｎｄ Ｓａｃｃｈｉ Ｎ． （１９８７） 酸グアニジウム チオシアネート−フェノール−クロロホルム抽出によるＲＮＡ単離についての単一工程方法． Ａｎａｌ． Ｂｉｏｃｈｅｍ． １６２， １５６−１５９。<br class="style-scope patent-text">
１５．Ｃｏｏｍｂｓ Ｌ．Ｍ．， Ｐｉｇｏｔｔ Ｄ．， Ｐｒｏｃｔｏｒ Ａ．， Ｅｙｄｍａｎｎ Ｍ．， Ｄｅｎｎｅｒ Ｊ． 及びＫｎｏｗｌｅｓ Ｍ．Ａ． （１９９０） グアニジンイソチオシアネートを用いる、小腫瘍試料由来のＤＮＡ、ＲＮＡ及びキナーゼ活性を示す抗原性タンパク質の同時単離． Ａｎａｌ． Ｂｉｏｃｈｅｍ． １８８， ３３８ − ３４３。<br class="style-scope patent-text">
１６．　Ｃｏｎｄｅｒ Ｇ．Ａ．， Ｊｏｈｎｓｏｎ Ｓ．Ｓ．， Ｎｏｗａｋｏｗｓｋｉ Ｄ．Ｓ．， Ｂｌａｋｅ Ｔ．Ｅ．， Ｄｕｔｔｏｎ Ｆ．Ｅ．， Ｎｅｌｓｏｎ Ｓ．Ｊ．， Ｔｈｏｍａｓ Ｅ．Ｍ．， Ｄａｖｉｓ Ｊ．Ｐ． 及びＴｈｏｍｐｓｏｎ Ｄ．Ｐ． （１９９５） インビトロ及びインビボモデルにおけるシクロデプシペプチドＰＦ１０２２Ａの駆虫薬プロファイル． Ｊ． Ａｎｔｉｂｉｏｔｉｃｓ ４８， ８２０−８２３。<br class="style-scope patent-text">
１７．　Ｄａｖｌｅｔｏｖ Ｂ．Ａ．， Ｍｅｕｎｉｅｒ Ｆ．Ａ．， Ａｓｈｔｏｎ Ａ．Ｃ．， Ｍａｔｓｕｓｈｉｔａ Ｈ．， Ｈｉｒｓｔ Ｗ．Ｄ．， Ｌｅｌｉａｎｏｖａ Ｖ．Ｇ．， Ｗｉｌｋｉｎ Ｇ．Ｐ．， Ｄｏｌｌｙ Ｊ．Ｏ． 及びＵｓｈｋａｒｙｏｖ Ｙ．Ａ． （１９９８） α−ラトロトキシンによる刺激される小胞エキソサイトーシスは、ラトロフィリンにより媒介され、外部Ｃａ<sup class="style-scope patent-text">２＋</sup>と貯蔵Ｃａ<sup class="style-scope patent-text">２＋</sup>の両方を必要とする． ＥＭＢＯ Ｊ． １７， ３９０９−３９２０。<br class="style-scope patent-text">
１８．　Ｄａｖｌｅｔｏｖ Ｂ．Ａ．， Ｓｈａｍｏｔｉｅｎｋｏ Ｏ．Ｇ．， Ｌｅｌｉａｎｏｖａ Ｖ．Ｇ．， Ｇｒｉｓｈｉｎ Ｅ．Ｖ． 及びＵｓｈｋａｒｙｏｖ Ｙ．Ａ． Ｃａ２＋依存性α−ラトロトキシン結合タンパク質の単離及び特徴づけ． Ｊ． Ｂｉｏｌ． Ｃｈｅｍ． ２７１， ２３２３９−２３２４５。<br class="style-scope patent-text">
１９．　Ｄｒｅｘｌｅｒ Ｈ．Ｇ．， Ｄｉｒｋｓ Ｗ．， ＭａｃＬｅｏｄ Ｒ．Ａ．Ｆ．， Ｑｕｅｎｔｍｅｉｅｒ Ｈ． 及びＳｔｅｕｂｅ Ｋ． （ｅｄｓ．） （１９９５） ヒト及び動物細胞系のＤＳＭカタログ； Ｆｉｆｔｈ Ｅｄｉｔｉｏｎ， Ｂｒａｕｎｓｃｈｗｅｉｇ。<br class="style-scope patent-text">
２０．　Ｊａｃｋｓｏｎ Ｒ． Ｊ．， Ｈｏｗｅｌｌ Ｍ． Ｔ． 及びＫａｍｉｎｓｋｉ Ａ． （１９９０）ピコルナウイルスＲＮＡ翻訳の開始の新規メカニズム。Ｔｒｅｎｄｓ Ｂｉｏｃｈｅｍ． Ｓｃｉ． １５， ４７７ − ４８３。<br class="style-scope patent-text">
２１．Ｄｅｖｅｒｅｕｘ Ｊ．， Ｈａｅｂｅｒｌｉ Ｐ． 及びＳｍｉｔｈｉｅｓ Ｏ． （１９８４） ＶＡＸの配列分析プログラムの包括的セット． Ｎｕｃｌｅｉｃ Ａｃｉｄｓ Ｒｅｓ． １２， ３８７−３９５。<br class="style-scope patent-text">
２２．Ｆｉｖａｓｈ Ｍ．， Ｔｏｗｌｅｒ Ｅ．Ｍ．， Ｆｉｓｈｅｒ Ｒ．Ｊ． （１９９８） 巨大分子相互作用についてのビアコア． Ｃｕｒｒ． Ｏｐｉｎ． Ｂｉｏｔｅｃｈｎｏｌ． ９， ９７−１０１。<br class="style-scope patent-text">
２３．Ｆｕｋａｓｈｅ Ｔ．， Ｋｏｉｋｅ Ｔ．， Ｃｈｉｎｏｎｅ Ｓ．， Ａｋｉｈａｍａ Ｓ．， Ｉａｇａｋｅ Ｈ．， Ｔａｋａｇｉ Ｍ．， Ｓｈｉｍｉｚｕ Ｔ．， Ｙａｇｕｃｈｉ Ｔ．， Ｓａｓａｋｉ Ｔ． 及びＯｋａｄａ Ｔ． （１９９０）犬及び猫における腸寄生性線虫のＰＦ１０２２Ａ、新規環状デプシペプチドの駆虫薬効果． Ｐｒｏｃ １１０ｔｈ Ｍｅｅｔ Ｊａｐ Ｓｏｃ ｖｅｔ Ｓｃｉ， １２２ （Ａｂｓｔｒ．）。<br class="style-scope patent-text">
２４．Ｇｉｅｓｅ Ｇ．， Ｗｉｅｇｅｒｓ Ｗ．， Ｋｕｂｂｉｅｓ Ｍ．， Ｓｃｈｅｒｂａｒｔｈ Ａ． 及びＴｒａｕｂ Ｐ． （１９９５） ＭＰＣ−１１マウスプラズマ細胞腫細胞におけるオカダ酸共誘導性ビメンチン発現及び細胞周期停止． Ｊ． Ｃｅｌｌ． Ｐｈｙｓｉｏｌ． １６３， １４５−１５４。<br class="style-scope patent-text">
２５．Ｇｅβｎｅｒ Ｇ．， Ｍｅｔｈｅ Ｓ．， Ｒｉｎｋ Ｔ． 及びＢｏｈｅｉｍ Ｇ． （１９９６） イオン透過孔及びＰＦ１０２２Ａの駆虫活性、シクロオクタデプシペプチドは関連していない． Ｐｅｓｔｉｃ． Ｓｃｉ． ４８， ３９９−４０７。<br class="style-scope patent-text">
２６．　Ｇｒｙｎｋｉｅｗｉｃｚ Ｇ．， Ｐｏｅｎｉｅ Ｍ．Ｍ． 及びＴｓｉｅｎ Ｒ．Ｙ． （１９８５） 大きく改良した蛍光特性を有するＣａ<sup class="style-scope patent-text">２＋</sup>指示薬の新たな発生． Ｊ． Ｂｉｏｌ． Ｃｈｅｍ． ２６０， ３４４０ − ３４５０。<br class="style-scope patent-text">
２７．　Ｇｙｕｒｉｓ Ｊ．， Ｇｏｌｅｍｉｓ Ｅ．， Ｃｈｅｒｔｋｏｖ Ｈ． 及びＢｒｅｎｔ Ｒ． （１９９３） Ｃｄｋ ２と結合するＣｄｉ １、ヒトＧ１及びＳ相タンパク質ホスファターゼ． Ｃｅｌｌ ７５， ７９１−８０３。<br class="style-scope patent-text">
２８．　Ｈａｒｄｅｒ Ａ．， Ｌｏｎｄｅｒｓｈａｕｓｅｎ Ｍ． 及びＭｅｈｌｈｏｒｎ Ｈ． （１９９７） ヘテラキスｓｐｕｍｏｓａ の４の幼虫期及び成虫は、駆虫薬 シクロデプシペプチドＰＦ １０２２Ａにより障害を負う． Ｚｂｌ． Ｂａｋｔｅｒｉｏｌ． ２８６， ２１２。<br class="style-scope patent-text">
２９．　Ｈｅｎｋｅｌ Ａ．Ｗ． 及びＳａｎｋａｒａｎａｒａｙａｎａｎ Ｓ． （１９９９）α−ラトロトキシン作用メカニズム． Ｃｅｌｌ Ｔｉｓｓｕｅ Ｒｅｓ． ２９６， ２２９−２３３。<br class="style-scope patent-text">
３０．　Ｈｏｌｚ Ｇ．Ｇ． 及びＨａｂｅｎｅｒ Ｊ．Ｆ． （１９９８） クロゴケグモ（Ｂｌａｃｋ ｗｉｄｏｗ ｓｐｉｄｅｒ）α−ラトロトキシン：構造の相同性を分泌促進性ホルモンのグルカゴン様ペプチド−１ファミリーと共有しているシナプス前神経毒、Ｃｏｍｐ． Ｂｉｏｃｈｅｍ． Ｐｈｙｓｉｏｌ． Ｂ． Ｂｉｏｃｈｅｍ． Ｍｏｌ． Ｂｉｏｌ． １２１， １７７−１８４。<br class="style-scope patent-text">
３１．Ｈｕｎｋａｐｉｌｌｅｒ Ｍ．Ｗ．， Ｈｅｗｉｃｋ Ｒ．Ｍ．， Ｄｒｅｙｅｒ Ｗ．Ｊ． 及びＨｏｏｄ Ｌ．Ｅ． （１９８３） ガス相配列決定装置を用いた高感度シークエンシング． Ｍｅｔｈ． Ｅｎｚｙｍｏｌ． ９１， ３９９−４１３。<br class="style-scope patent-text">
３２．Ｉｃｈｔｃｈｅｎｋｏ， Ｋ．， Ｂｉｔｔｎｅｒ， Ｍ．Ａ．， Ｋｒａｓｎｏｐｅｒｏｖ， Ｖ．， Ｌｉｔｔｌｅ， Ａ．Ｒ．， Ｃｈｅｐｕｒｎｙ， Ｏ．， Ｈｏｌｚ， Ｒ．Ｗ． 及びＰｅｔｒｅｎｋｏ， Ａ．Ｇ． （１９９９） 新規広域発現性α−ラトロトキシン受容体は、Ｇタンパク共役受容体のＣＩＲＬファミリーのメンバーである． Ｊ． Ｂｉｏｌｏｇｉｃａｌ Ｃｈｅｍ． ２７４， ５４９１−５４９８。<br class="style-scope patent-text">
３３．Ｊａｃｋｓｏｎ Ｒ．Ｊ．， Ｈｏｗｅｌｌ Ｍ．Ｔ． 及びＫａｍｉｎｓｋｉ Ａ． （１９９０）ピコルナウイルスＲＮＡ翻訳阻害の新しいメカニズム． Ｔｒｅｎｄｓ Ｂｉｏｃｈｅｍ． Ｓｃｉ． １５， ４７７−４８３。<br class="style-scope patent-text">
３４．Ｊａｎｇ Ｓ．Ｋ．， Ｋｒａｕｓｓｌｉｃｈ Ｈ．Ｇ．， Ｎｉｃｋｌｉｎ Ｍ．Ｊ．， Ｄｕｋｅ Ｇ．Ｍ．， Ｐａｌｍｅｎｂｅｒｇ Ａ．Ｃ． 及びＷｉｍｍｅｒ Ｅ． （１９８８） 脳心筋炎ウイルスＲＮＡの５’非翻訳領域セグメントは、インビトロ翻訳中のリボソームの内部侵入を引き起こす． Ｊ． Ｖｉｒｏｌ． ６２， ２６３６−２６４３。<br class="style-scope patent-text">
３５．Ｋａｃｈｉ Ｓ．， Ｉｓｈｉｈ Ａ． 及びＴｅｒａｄａ Ｍ． （１９９４） ラット及びマウスの中枢神経系に定住する広東住血線虫（Ａｎｇｉｏｓｔｒｏｎｇｙｌｕｓ ｃａｎｔｏｎｅｎｓｉｓ）のＰＦ１０２２Ａの効果． Ｊｐｎ． Ｊ． Ｐａｒａｓｉｔｏｌ． ４３， ４８３−４８８。<br class="style-scope patent-text">
３６．　Ｋａｃｈｉ Ｓ．， Ｉｓｈｉｈ Ａ． 及びＴｅｒａｄａ Ｍ． （１９９５） ラットの中枢神経系中へ移住する肺動脈及び肝臓中の成人広東住血線虫のＰＦ１０２２Ａの効果． Ｐａｒａｓｉｔｏｌ． Ｒｅｓ． ８１， ６３１−６３７。<br class="style-scope patent-text">
３７．　Ｋａｃｈｉ Ｓ．， Ｔｅｒａｄａ Ｍ． 及びＨａｓｈｉｍｏｔｏ Ｈ． （１９９７） インビトロにおける広東住血線虫の移動性についてのＰＦ１０２２Ａの影響． Ｐａｒａｓｉｔｏｌ． Ｒｅｓ． ８３， ５７８−５８２。<br class="style-scope patent-text">
３８．　Ｋａｃｈｉ Ｓ．， Ｔｅｒａｄａ Ｍ． 及びＨａｓｈｉｍｏｔｏ Ｈ． （１９９８）<br class="style-scope patent-text">
マウスにおける広東住血線虫（Ａｎｇｉｏｓｔｒｏｎｇｙｌｕｓ ｃｏｓｔａｒｉｃｅｎｓｉｓ）についてのＰＦ１０２２Ａ、新規抗線虫薬のアーマーフォウ（ａｒｍｏｒｐｈｏｕ）及び多型の効果． Ｊｐｎ．Ｊ． Ｐｈａｒｍａｃｏｌ． ７７， ２３５−２４５。<br class="style-scope patent-text">
３９．　Ｋｌｅｉｎ Ｒ．Ｄ． 及びＧｅａｒｙ Ｔ．Ｇ． （１９９７） 非抗菌化合物についての高スループットスクリーニングのための道具としての組換え微生物， Ｊ． Ｂｉｏｍｏｌ． Ｓｃｒｅｅｎｉｎｇ ２， ４１−４９。<br class="style-scope patent-text">
４０．　Ｋｒａｓｎｏｐｅｒｏｖ Ｖ．， Ｂｉｔｔｎｅｒ Ｍ．Ａ．， Ｈｏｌｚ Ｒ．Ｗ．， Ｃｈｅｐｕｒｎｙ Ｏ． 及びＰｅｔｒｅｎｋｏ Ａ．Ｇ． （１９９９）α−ラトロトキシン結合及びα−ラトロトキシン刺激性分泌についての構造的要求． Ｊ． Ｂｉｏｌｏｇｉｃａｌ Ｃｈｅｍ． ２７４， ３５９０−３５９６。<br class="style-scope patent-text">
４１．Ｋｏｚａｋ Ｍ． （１９８９） 翻訳についてのスキャンニングモデル： Ａｎ ｕｐｄａｔｅ． Ｊ． Ｃｅｌｌ Ｂｉｏｌ． １０８， ２２９−２４１。<br class="style-scope patent-text">
４２．Ｋｕｒａｃｈｉ Ｓ．， Ｓｚｅ Ｌ． 及びＫｕｒａｃｈｉ Ｋ． （１９９８） ＦｕＧＥＮＥ<sup class="style-scope patent-text">ＴＭ</sup> ６トランスフェクション試薬を用いるＨｅｐ Ｇ２細胞の改良トランスフェクション． Ｂｉｏｃｈｅｍｉｃａ ３， ４３−４４。<br class="style-scope patent-text">
４３．Ｌａｅｍｍｌｉ　Ｕ．Ｋ． （１９７０） バクテリオファージＴ４の頭部の会合中の構造タンパク質の開裂． Ｎａｔｕｒｅ ２２７， ６８０−６８５。<br class="style-scope patent-text">
４４．Ｌｏｗｒｙ Ｏ．Ｈ．， Ｒｏｓｅｂｒｏｕｇｈ Ｎ．Ｊ．， Ｆａｒｒ Ａ．Ｌ． 及びＲａｎｄａｌｌ Ｒ．Ｊ． （１９５１）フォリン（Ｆｏｌｉｎ）フェノール試薬を用いたタンパク質測定． Ｊ． Ｂｉｏｌ． Ｃｈｅｍ． １９３， ２６５−２７５。<br class="style-scope patent-text">
４５．Ｍａｒｔｉｎ Ｒ．Ｊ． （１９９７） 駆虫薬の作用モデル． Ｖｅｔｅｒｉｎａｒｙ Ｊ． １５４， １１−３４。<br class="style-scope patent-text">
４６．　Ｍａｒｔｉｎ Ｒ．Ｊ．， Ｒｏｂｅｒｔｓｏｎ Ａ．Ｐ． 及びＢｊｏｒｎ Ｈ． （１９９７） 駆虫薬の標的部位． Ｐａｒａｓｉｔｏｌ． １１４， １１１−１２４。<br class="style-scope patent-text">
４７．　Ｍａｒｔｉｎ Ｒ．Ｊ．， Ｈａｒｔｈｅ Ａ．， Ｌｏｎｄｅｒｓｈａｕｓｅｎ Ｍ． 及びＪｅｓｃｈｋｅ Ｐ． （１９９６） シクロデプシペプチドＰＦ１０２２Ａの駆虫作用、及び回虫 ｓｕｕｍの筋細胞における電気生理学的効果． Ｐｅｓｔｉｃ． Ｓｃｉ． ４８， ３４３−３４９。<br class="style-scope patent-text">
４８．　ＭｃＣｏｒｍａｃｋ Ｊ．Ｇ． 及びＣｏｂｂｏｌｄ Ｐ．Ｈ． （１９９１） 細胞カルシウム： 実用的アプローチ． Ｔｈｅ ｐｒａｃｔｉｃａｌ ａｐｐｒｏａｃｈ ｓｅｒｉｅｓ， ＩＲＬ ｐｒｅｓｓ， Ｏｘｆｏｒｄ ， ３０−４２。<br class="style-scope patent-text">
４９．　ＭｃＭａｓｔｅｒ Ｇ．Ｋ． 及びＣａｒｍｉｃｈａｅｌ Ｇ．Ｇ． （１９７７） グリオキサール及びアクリジンオレンジを用いる、ポリアクリルアミドゲル及びアガロースゲル上の１本鎖及び２本鎖核酸の分析． Ｐｒｏｃ． Ｎａｔｌ． Ａｃａｄ． Ｓｃｉ． ７４， ４８３５−４８３８。<br class="style-scope patent-text">
５０．　Ｎａｋａｄａ Ｍ．Ｔ．， Ｈａｓｋｅｌｌ Ｋ．Ｍ．， Ｅｃｋｅｒ Ｄ．Ｊ．， Ｓｔａｄｅｌ Ｊ．Ｍ． 及びＣｒｏｏｋｅ Ｓ．Ｔ． （１９８９） ３Ｔ３−Ｌ１繊維芽細胞におけるβ<sub class="style-scope patent-text">２</sub>−アドレナリン作動性受容体の遺伝的退治． Ｂｉｏｃｈｅｍ． Ｊ． ２６０， ５３−５９。<br class="style-scope patent-text">
５１．Ｐｅａｒｓｏｎ Ｗ．Ｒ． 及びＬｉｐｍａｎ Ｄ．Ｊ． （１９８８） 生物学的配列比較のための改良型ツール． Ｐｒｏｃ． Ｎａｔｌ． Ａｃａｄ． Ｓｃｉ．， Ｕ．Ｓ．Ａ． ８５， ２４４４−２４４８。<br class="style-scope patent-text">
５２．Ｐｅｔｒｅｎｋｏ Ａ．Ｇ． （１９９３）α−ラトロトキシン受容体． 神経終末機能における意味． ＦＥＢＳ Ｌｅｔｔ． ３２５， ８１−８５．<br class="style-scope patent-text">
５３．Ｐｌａｓｔｅｒｋ　Ｒ． Ｈ． （１９９６） Ｔｃ１／マリナートランスポゾンファミリー． Ｃｕｒｒ． Ｔｏｐ Ｍｉｃｒｏｂｉｏｌ． Ｉｍｍｕｎｏｌ． ２０４， １２５−４３。<br class="style-scope patent-text">
５４．Ｒａｈｍａｎ Ｍ．Ａ．， Ａｓｈｔｏｎ Ａ．Ｃ．， Ｍｅｕｎｉｅｒ Ｆ．Ａ．， Ｄａｖｌｅｔｏｖ Ｂ．Ａ．， Ｄｏｌｌｙ Ｊ．Ｏ． 及びＵｓｈｋａｒｙｏｖ Ｙ．Ａ． （１９９９） α−ラトロトキシンにより刺激されるノエルピネフリンエキソサイトーシスは、外部Ｃａ２＋及び貯蔵Ｃａ２＋の両方を必要とし、ラトロフィリン、Ｇタンパク質及びホスホリパーゼＣにより媒介される． Ｐｈｉｌ． Ｔｒａｎｓ． Ｒ． Ｓｏｃ． Ｌｏｎｄ． Ｂ ３５４， ３７９−３８６。<br class="style-scope patent-text">
５５．Ｒｅｅｓ Ｓ．， Ｃｏｏｔｅ Ｊ．， Ｓｔａｂｌｅｓ Ｊ．， Ｇｏｏｄｓｏｎ Ｓ．， Ｈａｒｒｉｓ Ｓ． 及びＬｅｅ Ｍ．Ｇ． （１９９６） 組換えタンパク質を発現する全ての抗生物質耐性細胞を病気に罹らせる安定な哺乳動物細胞系を創り出すためのビシストロン性ベクター． ＢｉｏＴｅｃｈｎｉｑｕｅｓ ２０， １０２−１１２。<br class="style-scope patent-text">
５６．　Ｓａｍｂｒｏｏｋ Ｊ．， Ｆｒｉｔｓｃｈ Ｅ．Ｆ． 及びＭａｎｉａｔｉｓ Ｔ． （１９８９） 分子クローニング． Ａ ｌａｂｏｒａｔｏｒｙ ｈａｎｄｂｏｏｋ． Ｃｏｌｄ Ｓｐｒｉｎｇ Ｈａｒｂｏｒ Ｌａｂｏｒａｔｏｒｙ Ｐｒｅｓｓ， Ｎｅｗ Ｙｏｒｋ， ７．４３−７．４５。<br class="style-scope patent-text">
５７．　Ｓａｍｓｏｎ−Ｈｉｍｍｅｌｓｔｊｅｒｎａ Ｇ． ｖｏｎ， Ｈａｒｄｅｒ Ａ．， Ｓｃｈｎｉｅｄｅｒ Ｔ．， Ｋａｌｂｅ Ｊ． 及びＭｅｎｃｋｅ Ｎ． （２０００）新規駆虫薬デプシペプチド ＰＦ１０２２Ａのインビボ活性． Ｐａｒａｓｉｔｏｌ． Ｒｅｓ． ８６， １９４−１９９。<br class="style-scope patent-text">
５８．　Ｓａｓａｋｉ Ｔ．， Ｔａｋａｇｉ Ｍ．， Ｙａｇｕｃｈｉ Ｔ．， Ｍｉｙａｄｏｈ Ｓ．， Ｏｋａｄａ Ｔ． 及びＫｏｙａｍａ Ｍ． （１９９２） 新規駆虫薬シクロデプシペプチド、ＰＦ１０２２Ａ． Ｊ． Ａｎｔｉｂｉｏｔｉｃｓ ４５， ６９２−６９７．<br class="style-scope patent-text">
５９．　Ｓｃｈｌａｃｋ Ｐ． 及びＫｕｍｐｆ Ｗ． （１９２６） Ｕｅｂｅｒ ｅｉｎｅ ｎｅｕｅ Ｍｅｔｈｏｄｅ ｚｕｒ Ｅｒｍｉｔｔｌｕｎｇ ｄｅｒ Ｋｏｎｓｔｉｔｕｔｉｏｎ ｖｏｎ Ｐｅｐｔｉｄｅｎ． Ｚ． Ｐｈｙｓｉｏｌ．Ｃｈｅｍｉｅ Ｈｏｐｐｅ−Ｓｅｙｌｅｒ １５４， １２５−１７０。<br class="style-scope patent-text">
６０．　Ｓｃｈｍｉｔｔ−Ｗｒｅｄｅ Ｈ．−Ｐ．， Ｗａｌｄｒａｆｆ Ａ．， Ｋｒｕｅｃｋｅｎ Ｊ．， Ｈａｒｄｅｒ Ａ． 及びＷｕｎｄｅｒｌｉｃｈ Ｆ． （１９９９）寄生線虫ヘモンクス コントルタスのヘキソキナーゼコード化ｃＤＮＡの特徴づけ． Ｂｉｏｃｈｉｍ． Ｂｉｏｐｈｙｓ． Ａｃｔａ １４４４， ４３９−４４４。<br class="style-scope patent-text">
６１．Ｓｅａｇａｒ Ｍ．， Ｌ騅麭ｕｅ Ｃ．， Ｃｈａｒｖｉｎ Ｎ．， Ｍａｒｑｕ閊ｅ Ｂ．， Ｍａｒｔｉｎ−Ｍｏｕｔｏｔ Ｎ．， Ｂｏｕｄｉｅｒ Ｊ．Ａ．， Ｂｏｕｄｉｅｒ Ｊ．−Ｌ．， Ｓｈｏｊｉ−Ｋａｓａｉ Ｙ．， Ｓａｔｏ Ｋ． 及びＴａｋａｈａｓｈｉ Ｍ． （１９９９） エキソサイトーシスに関連付けられるタンパク質と、電位作動型カルシウムチャネルとの間の相互作用． Ｐｈｉｌ． Ｔｒａｎｓ． Ｒ． Ｓｏｃ． Ｌｏｎｄ． Ｂ　３５４， ２８９−２９７。<br class="style-scope patent-text">
６２．Ｓｍｉｔｈ Ｔ．Ｆ． 及びＷａｔｅｒｍａｎ Ｍ．Ｓ． （１９８１） 共通分子配列の同定． Ｊ． Ｍｏｌ． Ｂｉｏｌ． １４７， １９５−１９７。<br class="style-scope patent-text">
６３．Ｓｕｇｉｔａ Ｓ．， Ｉｃｈｔｃｈｅｎｋｏ Ｋ．， Ｋｈｖｏｔｃｈｅｖ Ｍ． 及びＳｕｅｄｈｏｆ Ｔ．Ｃ． （１９９８）α−ラトロトキシン受容体ＣＩＲＬ／ラトロフィリン１ （ＣＬ１） は、遍在性Ｇタンパク連結受容体の異常ファミリーを規定する． Ｊ． Ｂｉｏｌｏｇｉｃａｌ Ｃｈｅｍ． ２７３， ３２７１５−３２７２４。<br class="style-scope patent-text">
６４．Ｔａｇａｋｉ Ｍ．， Ｓａｓａｋｉ Ｔ．， Ｙａｇｕｃｈｉ Ｔ．， Ｋｏｄａｍａ Ｙ．， Ｏｋａｄａ Ｔ．， Ｍｉｙａｄｏｈ Ｓ． 及びＫｏｙａｍａ Ｍ． （１９９１）駆虫効果を有する新規シクロデプシペプチド、ＰＦ１０２２Ａについて． Ｎｉｐｐｏｎ Ｎｏｇｅｉｋａｇａｋｕ Ｋａｉｓｈｉ ６５， ３２６ （Ａｂｓｔｒ．）。<br class="style-scope patent-text">
６５．Ｔｅｒａｄａ Ｍ． （１９９２） 広東住血線虫及び単離されたカエル直筋における、シクロデプシペプチドの新規構造を有する抗線虫駆虫薬、ＰＦ１０２２Ａの神経薬理学的作用機構． Ｊｐｎ． Ｊ． Ｐａｒａｓｉｔｏｌ． ４１， １−１８。<br class="style-scope patent-text">
６６．　Ｔｅｒａｄａ Ｍ．， Ｉｓｈｉｈ Ａ．， Ｔｕｎｇｔｒｏｎｇｃｈｉｔｒ Ａ．， Ｓａｎｏ Ｍ． 及びＳｈｏｍｕｒａ Ｔ． （１９９３） 経路、用量及び剤系に対する特別の基準を用いた、マウスにおいて広東住血線虫の幼虫を発育させる際のＰＦ１０２２Ａの効果． Ｊｐｎ． Ｊ． Ｐａｒａｓｉｔｏｌ． ４２， １９９−２１０。<br class="style-scope patent-text">
６７．　Ｔｈｏｍａｓ Ａ．Ｐ． 及びＤｅｌａｖｉｌｌｅ Ｆ． （１９９１） 細胞集団及び単一細胞において細胞基質不含カルシウム濃度を測定するための蛍光指標の使用． ＩＲＬ Ｐｒｅｓｓ， １−５４．<br class="style-scope patent-text">
６８．　Ｗａｌｌｅｒ Ｐ．Ｊ． （１９９７） 駆虫薬 ｒｅｓｉｓｔａｎｃｅ． Ｖｅｔｅｒｉｎａｒｙ Ｐａｒａｓｉｔｏｌｏｇｙ ７２， ３９１−４１２ 。<br class="style-scope patent-text">
６９．　Ｗａｌｌｅｒ Ｐ．Ｊ． （１９９８） 家畜の線虫寄生虫を統合退治する概念に対する国際的アプローチ． Ｖｅｔｅｒｉｎａｒｙ Ｐａｒａｓｉｔｏｌｏｇｙ ７３， １５５−１６４。<br class="style-scope patent-text">
７０．　Ｙａｎｇ Ｆ．， Ｍｏｓｓ Ｌ．Ｇ． 及びＰｈｉｌｌｉｐｓ Ｇ．Ｎ． Ｊｒ． （１９９６ａ．） 緑色蛍光タンパク質の分子構造． Ｎａｔｕｒｅ Ｂｉｏｔｅｃｈｎｏｌｏｇｙ １４， １２４６−１２５１。<br class="style-scope patent-text">
７１．Ｙａｎｇ Ｔ．Ｔ．， Ｃｈｅｎｇ Ｌ．Ｚ． 及びＫａｉｎ Ｓ． Ｒ． （１９９６ｂ） 最適コドン使用頻度及び発色団突然変異により、感受性が増進された緑色蛍光タンパク質が提供される． Ｎｕｃｌｅｉｃ Ａｃｉｄ Ｒｅｓ． ２４， ４５９２−４５９３。<br class="style-scope patent-text">
【図面の簡単な説明】<br class="style-scope patent-text">
【図１】ＨＣ１１０−Ｒ ｍＲＮＡ及びタンパク質<br class="style-scope patent-text">
（Ａ） ヘモンクス コントルタス由来の全量ＲＮＡ及びＨＣ１１０−Ｒの３．６ｋｂｐ ｃＤＮＡを使用したノーザンブロット分析。<br class="style-scope patent-text">
（Ｂ）インビトロ翻訳<sup class="style-scope patent-text">３５</sup>Ｓ−標識化ＨＣ１１０−Ｒタンパク質の１０％ ＳＤＳ−ＰＡＧＥフルオログラム。インビトロ転写ＨＣ１１０−Ｒ ｍＲＮＡ （ＨＣ１１０−Ｒ）１μｇのインビトロ翻訳、ＨＣ１１０−Ｒ ｍＲＮＡ （コントロール）を含まないネガティブコントロール、ポジティブコントロールとしてのルシフェラーゼｍＲＮＡ（ルシフェラーゼ） １μｇ。<br class="style-scope patent-text">
【図２】ＨＣ１１０−Ｒの全長ｃＤＮＡ配列及び誘導アミノ酸配列<br class="style-scope patent-text">
ＨＣ１１０−ＲのＫｏｚａｋモチーフ（Ｋｏｚａｋ， １９８９）及びポリアデニル化シグナル（ジーンバンクアクセッション Ｎｏ．： ＡＪ２７２２７０）は下線で示す；１００位の開始コドンは太字で示す。シグナルペプチド（残基１〜２１、太字）、レクチン様配列（残基２２〜１２５、点）、Ｔｈｒストレッチ（残基１２８から１４７、グレーの網掛け）；構造ＣＸ<sub class="style-scope patent-text">９</sub>ＷＸ<sub class="style-scope patent-text">１２</sub>ＣＸ<sub class="style-scope patent-text">９</sub>ＷＸＣＸ<sub class="style-scope patent-text">５</sub>ＷＸ<sub class="style-scope patent-text">９</sub>ＣＸ<sub class="style-scope patent-text">３</sub>Ｗのシステイン リッチ（豊富）領域（残基１６６−２２１、波線、Ｃｙｓ及びＴｒｐ残基はさらに太字）；構造ＣＸＷＷＸ<sub class="style-scope patent-text">６</sub>ＷＸ<sub class="style-scope patent-text">４</sub>ＣＸ<sub class="style-scope patent-text">１１</sub>ＣＸＣの４−Ｃｙｓ領域（残基７８−５２４、破線、Ｃｙｓ及びＴｒｐ残基はさらに太字）；７回膜貫通領域（残基５６３〜７７２の間、グレーの網掛け）ＰＥＳＴ領域（残基９１５〜９３３、グレーの網掛け）；Ｎ−グリコシル化部位（残基２６、４９９及び８６２、太字）；セクレチンＧＰＣＲ間（部位５９５及び６６６、太字及び二重下線）のＣｙｓ−Ｃｙｓペアーの高保存推定ジスルフィド結合。<br class="style-scope patent-text">
【図３】Ｈ． ｃｏｎｔｏｒｔｕｓ ＨＣ１１０−Ｒ及び線虫エレガンス コスミドクローン Ｂ０４５７ （ＣＥ−Ｂ０４５７； ＧｅｎＢａｎｋアクセッションＮｏ．： Ｚ５４３０６）の誘導アミノ酸配列のアライメント<br class="style-scope patent-text">
シグナルペプチド（ＳＰ、残基１〜２１、太字）、レクチン様配列（レクチン、残基２２〜１２５、点）；Ｔｈｒストレッチ（Ｔ−リッチ、残基１２８〜１４７、グレーの網掛け）；構造ＣＸ<sub class="style-scope patent-text">９</sub>ＷＸ<sub class="style-scope patent-text">１２</sub>ＣＸ<sub class="style-scope patent-text">９</sub>ＷＸＣＸ<sub class="style-scope patent-text">５</sub>ＷＸ<sub class="style-scope patent-text">９</sub>ＣＸ<sub class="style-scope patent-text">３</sub>ＷのＣｙｓ−リッチ領域（Ｃシグネーチャー、残基１６６〜２２１、波線、Ｃｙｓ及びＴｒｐ残基はさらに太字）；構造ＣＸＷＷＸ<sub class="style-scope patent-text">６</sub>ＷＸ<sub class="style-scope patent-text">４</sub>ＣＸ<sub class="style-scope patent-text">１１</sub>ＣＸＣの４−Ｃｙｓモチーフ（４Ｃ 領域、残基４７８−５２４、破線、Ｃｙｓ及びＴｒｐ残基はさらに太字）；７回膜貫通領域（残基５３６〜７７２の間、太字及び下線）Ｐｒｏ−リッチストレッチ（Ｐ−リッチ、残基８４５〜８６１、グレーの網掛け）；ＰＥＳＴ領域（ＰＥＳＴ、残基９１５〜９３３、グレーの網掛け）；Ｎ−グリコシル化部位（残基２６、４９９及び８６２、太字）；セクレチンＧＰＣＲ間のＣｙｓ−Ｃｙｓペアーの高保存推定ジスルフィド結合（５９５及び６６６部位、太字及び二重下線）。同一アミノ酸は星印をもって、非常に関連するアミノ酸はコロンをもって、関連のあるアミノ酸は単一の点をもって示す。<br class="style-scope patent-text">
【図４】７回膜貫通受容体 ＨＣ１１０−Ｒ及びセクレチン サブファミリーの種々の他の受容体のアライメント<br class="style-scope patent-text">
ＨＣ１１０−Ｒ： ヘモンクス コントルタス７回ラセンオーファン膜貫通受容体 （アクセッション ｎｏ．： ＡＪ２７２２７０）； ＢＴＬＡＴ３： Ｂｏｓ ｔａｕｒｕｓ ラトロフィリン−３ （種々のスプライシング変異体アクセッション ｎｏ．： Ｇ４１６４０５３−Ｇ４１６４０７５）； ＲＮＬＡＴ１： ラッタス（Ｒａｔｔｕｓ）ｎｏｒｖｅｇｉｃｕｓ ラトロフィリン−１ （アクセッション ｎｏ．： Ｕ７８１０５， Ｕ７２４８７）； ＭＭＥＭＲ１： Ｍｕｓ 筋肉ＥＭＲ１ホルモン受容体前駆体 （アクセッション ｎｏ．： Ｑ６１５４９）； ＨＳＣＤ９７： ホモサピエンス白血球活性化抗原ＣＤ９７ （アクセッション ｎｏ．： Ｐ４８９６０）； ＭＭＣＡＤＨ： Ｍ． ｍｕｓｃｕｌｕｓ幼虫７回膜貫通受容体前駆体 （アクセッション ｎｏ．： Ｇ３８００７３８）； ＸＬＸＲＦ１： Ｘｅｎｏｐｕｓ ｌａｅｖｉｓコルチコトロピン関連受容体前駆体 （アクセッション ｎｏ．： Ｏ４２６０２）； ＲＮＶＩＰ１： Ｒ． ｎｏｒｖｅｇｉｃｕｓ血管作動性腸管ポリペプチド受容体前駆体２ （アクセッション ｎｏ．： Ｑ０２６４３）。この７回膜貫通ドメインはグレーの網掛け（Ｉ−ＶＩＩ）で示し、高度に保存された推定ジスルフィド結合を太字で示す。<br class="style-scope patent-text">
【図５】Ｈ． ｃｏｎｔｏｒｔｕｓ ＨＣ １１０−Ｒ及びＲ． ｎｏｒｖｅｇｉｃｕｓ ラトロフィリン−１ （ＧｅｎＢａｎｋ Ａｃｃ． Ｎｏ． Ｕ７８１０５， Ｕ７２４８７）の誘導アミノ酸配列のアライメント<br class="style-scope patent-text">
シグナルペプチド （ＳＰ、残基１〜２１、太字）、レクチン様配列 （ｌｅｃｔｉｎ、残基２２〜１２５、点）； Ｔｈｒストレッチ （Ｔ−リッチ、残基１２８〜１４７、グレーの網掛け）； 構造ＣＸ<sub class="style-scope patent-text">９</sub>ＷＸ<sub class="style-scope patent-text">１２</sub>ＣＸ<sub class="style-scope patent-text">９</sub>ＷＸＣＸ<sub class="style-scope patent-text">５</sub>ＷＸ<sub class="style-scope patent-text">９</sub>ＣＸ<sub class="style-scope patent-text">３</sub>Ｗ のＣｙｓ−リッチ領域 （Ｃシグネーチャー、残基１６６〜２２１、破線、Ｃｙｓ及びＴｒｐ残基はさらに太字）； 構造ＣＸＷＷＸ<sub class="style-scope patent-text">６</sub>ＷＸ<sub class="style-scope patent-text">４</sub>ＣＸ<sub class="style-scope patent-text">１１</sub>ＣＸＣの４−Ｃｙｓモチーフ （４Ｃ領域、残基４７８〜５２４、破線、Ｃｙｓ及びＴｒｐ残基はさらに太字）； ７回膜貫通領域 （残基５３６と７７２との間、太字及び下線）； Ｐｒｏ−リッチストレッチ （Ｐ−リッチ、残基８４５〜８６１、グレーの網掛け）； ＰＥＳＴ領域 （ＰＥＳＴ、残基９１５〜９３３、グレーの網掛け）； Ｎ−グリコシル化部位 （残基２６、４９９及び８６２、太字）； セクレチンＧＰＣＲｓ間 （部位５９５及び６６６、太字及び二重下線）のＣｙｓ−Ｃｙｓペアーの高度に保存された推定ジスルフィド結合。同一アミノ酸は星印により、非常に関連するアミノ酸はコロンにより、関連アミノ酸は１個の点で示す。<br class="style-scope patent-text">
【図６】ＨＣ１１０−Ｒタンパク質の構造及びラトロフィリン−１の構造<br class="style-scope patent-text">
（Ａ）　７回膜貫通ドメインを有するＨＣ１１０−Ｒの疎水性ブロッティング。<br class="style-scope patent-text">
（Ｂ）　以下の特徴的なモチーフを有するＨＣ１１０−Ｒのタンパク質構造：シグナル配列 （ＳＰ）、レクチンドメイン （レクチン）、Ｔｈｒストレッチ （Ｔ−ストレッチ）、Ｃｙｓモチーフ （シグネーチャー）、４−Ｃｙｓ領域 （４Ｃ領域）、７回膜貫通ドメイン （１−７、黒色）、Ｐｒｏ−リッチモチーフ （Ｐ−リッチ） 及びＰＥＳＴ配列 （ＰＥＳＴ）。推定グリコシル化領域部位は下部のダイアグラム（Ｎ）にて示す、推定ジスルフィド結合 （大文字なしの細線）の４Ｃ領域のＣｙｓ残基及び２つの保存Ｃｙｓ残基である。<br class="style-scope patent-text">
（Ｃ）　ラトロフィリン−１のタンパク質構造。ラトロフィリン−１は、Ｔｈｒストレッチを有していないが、付加的なオルファクトメディンモチーフ（オルファクトメディン）、Ｐｒｏ−Ｔｈｒ領域（Ｐ−Ｔ領域）、リンカードメイン（リンカー）及び幾つかの繰り返しを含む長い領域を含む。<br class="style-scope patent-text">
【図７】ＨＥＫ−２９３及びＣＯＳ−７細胞におけるＨＣ１１０−Ｒ−ＧＦＰの発現<br class="style-scope patent-text">
（Ａ）　ＧＦＰ （ＧＦＰ） 又はＨＣ１１０−Ｒ−ＧＦＰ （ＨＣ１１０−Ｒ） を用いて一過的にトランスフェクションしたＨＥＫ−２９３及びＣＯＳ−７細胞、及び非トランスフェクト （ｎ． ｔ．） ＨＥＫ−２９３及びＣＯＳ−７細胞由来の全タンパク質は、トランスフェクションの２４時間後にＴｒｉｚｏｌ法により単離した。<br class="style-scope patent-text">
（Ｂ）　β<sub class="style-scope patent-text">２</sub>−Ｒ−ＧＦＰ （β<sub class="style-scope patent-text">２</sub>−Ｒ）又はＭ１−Ｒ−ＧＦＰ （Ｍ１−Ｒ）を用いて一過的にトランスフェクションしたＨＥＫ−２９３細胞、及び非トランスフェクト （ｎ． ｔ．） ＨＥＫ−２９３細胞由来の全タンパク質は、トランスフェクションの２４時間後にＴｒｉｚｏｌ法により単離した。ＳＤＳマーカーバンドは、１１６、９０、７０及び５５ｋＤａ （マーカー）である。<br class="style-scope patent-text">
レーン当たり全タンパク質２０μｇを１０％ポリアクリルアミドゲルにて分画化し、ニトロセルロース膜にブロットした。ＲｏｔｉＢｌｏｃｋ溶液中にて一晩中ブロッキングして、モノクローナルマウス抗−ＧＦＰ ＩｇＧ一次抗体（０．４μｇ／ｍＬ）とモノクローナルウサギ抗マウスＩｇＧ−ＨＲＰ二次抗体（１：２５０００）を用いて、ＥＣＬシステムによる免疫検出を行なった。<br class="style-scope patent-text">
【図８】ＣＬＳＭによるトランスフェクトＣＯＳ−７におけるＨＣ１１０−Ｒ及びβ<sub class="style-scope patent-text">２</sub>−Ｒの細胞局所化<br class="style-scope patent-text">
いずれもＣ末端ＧＦＰタグを有しているＨＣ１１０−Ｒ−ＧＦＰ及びβ２−Ｒ−ＧＦＰを用いて、ＣＯＳ−７細胞をトランスフェクションした。トランスフェクトの２４時間後にＣＬＳＭを行なった。棒線は１０μｍに相当する。<br class="style-scope patent-text">
（Ａ）　ＨＣ１１０−Ｒ−ＧＦＰは、原形質膜上及び細胞区画中に発現する。細胞小胞のコンパクションが核近傍に見られる。<br class="style-scope patent-text">
（Ｂ）　 酸リソソームと緑色ＨＣ１１０−Ｒ−ＧＦＰタンパク質とのＣＬＳＭ共存は、ＬｙｓｏＴｒａｃｋｅｒ Ｒｅｄ ＤＮＤ−９９を用いて、３７℃で１時間染色した。<br class="style-scope patent-text">
（Ｃ）　β<sub class="style-scope patent-text">２</sub>−Ｒ−ＧＦＰ−トランスフェクト細胞は、ＨＣ１１０−Ｒ−ＧＦＰと類似のＧＦＰ蛍光パターン、又は以下の（Ａ）に記載のようなＧＦＰ蛍光パターンを示す。この受容体は、原形質膜及び小胞中に局在化し、幾つかの場合には酸リソソームと共に局在化し得る（染色はＬｙｓｏＴｒａｃｋｅｒ Ｒｅｄ ＤＮＤ−９９を用いて３７℃にて１時間で行なった）。<br class="style-scope patent-text">
（Ｄ）　発現したβ<sub class="style-scope patent-text">２</sub>−Ｒ−ＧＦＰは、幾つかの場合、小胞体と共に局在化する（染色はモノクローナル抗ＫＤＥＬ抗体を用いて行なった）。<br class="style-scope patent-text">
【図９】ＨＣ１１０−Ｒに対するα−ラトロトキシンの結合<br class="style-scope patent-text">
（Ａ）　単離したＬａｔｒｏｄｅｃｔｕｓ ｒｅｖｉｖｅｎｓｉｓ 毒液腺（ｖｅｎｏｍ ｇｌａｎｄｓ）（１）由来の全タンパク質５μｇ、及び純粋な１３０ ｋＤａ α−ＬＴＸ （２）、ｐＩＲＥＳ１ｎｅｏベクターのＨＣ１１０−Ｒ−Ｍｙｃ／Ｈｉｓ構築物を用いて安定にトランスフェクションしたＨＥＫ−２９３細胞由来の各ケースの全タンパク質４０μｇ （３）、非トランスフェクト細胞 （４） 及び５ Ｅ． ｃｏｌｉに導入したＨＣ１１０−Ｒの４ ｋＤａ Ｎ末端（６） 及び２１ ｋＤａ Ｃ末端（７） を、１０％ ＳＤＳポリアクリルアミドゲルにて分画し、一晩中ブロッティング及びブロッキングした。変性タンパク質は、２０ｎＭ α−ＬＴＸと共に２時間インキュベーションし、ウサギ抗−α−ＬＴＸ ＩｇＧ−ＨＲＰ（１：５０００）及びヤギ抗−ウサギＩｇＧ抗体（１：２５０００）及びＥＣＬシステムを用いて検出されるα−ＬＴＸの結合が可能となる。<br class="style-scope patent-text">
（Ｂ）　Ｅ． ｃｏｌｉに導入したＨＣ１１０−ＲのＣ末端（１）及びＮ末端（２）由来の各ケースの全タンパク質４０μｇ、及び非トランスフェクトＨＥＫ−２９３細胞由来の全タンパク質（３）、及びＨＣ１１０−Ｒ−Ｍｙｃ／Ｈｉｓを用いて安定にトランスフェクションしたＨＥＫ−２９３細胞（４）、及び生体Ｈ． ｃｏｎｔｏｒｔｕｓ 線虫（５）を、１０％ ＳＤＳポリアクリルアミドゲルにて分画し、４Ｍ 尿素含有再生緩衝液を用いて部分的に再生させた。ブロットを一晩中ブロッキングし、２０ｎＭ 純粋α−ＬＴＸを用いてインキュベーションし、、そしてα−ＬＴＸ結合タンパク質をウサギ抗−α−ＬＴＸ ＩｇＧ抗体（１：５０００）、ビオチンタンパク質Ａ（１：１００）、ストレプトアビジン−ペルオキシダーゼ（１：３０００）及びＥＣＬシステムを用いて検出した。<br class="style-scope patent-text">
【図１０】ＨＣ１１０−Ｒ媒介Ｃａ<sup class="style-scope patent-text">２＋</sup>シグナリングにおけるα−ＬＴＸの用量依存性<br class="style-scope patent-text">
ＨＣ１１０−Ｒ−ＧＦＰを用いて一過的にトランスフェクションした４８時間後に、ＨＥＫ−２９３細胞を１μＭ Ｆｕｒａ−２／ＡＭを用いて３０分間ローディングした。この細胞を、種々のα−ＬＴＸ濃度の測定を開始した６分後にさらに４４分間刺激した。３４０／３８０ｎｍの商（比率） は、時間の機能として計測した。選択した細胞の数をｎとして表す。<br class="style-scope patent-text">
（Ａ）　ＨＣ１１０−Ｒ−ＧＦＰ−発現細胞は、７．５ｎＭ （黒線） 又は２５ｎＭ α−ＬＴＸ （グレーの線）を用いて刺激した。<br class="style-scope patent-text">
（Ｂ）　５０ ｎＭ （グレーの線） 又は７５ｎＭ α−ＬＴＸ （黒線） を、ＨＣ１１０−Ｒ−ＧＦＰ−発現細胞に加えた。<br class="style-scope patent-text">
（Ｃ）　ＨＣ１１０−Ｒ−ＧＦＰ−発現細胞は、９０ｎＭ （グレーの線） 又は１２０ｎＭ α−ＬＴＸ （黒線）を用いて刺激した。<br class="style-scope patent-text">
（Ｄ）　［Ｃａ<sup class="style-scope patent-text">２＋</sup>］<sub class="style-scope patent-text">ｉ</sub> は、横軸にｎＭでプロットし、ＨＣ１１０−Ｒ−ＧＦＰ発現ＨＥＫ−２９３細胞を刺激して得られた第一の迅速型ピーク（第一のピーク、グレーの線）及び第二の遅延型ピーク（第二のピーク、黒線）についてα−ＬＴＸ濃度（０， ７．５， ２５， ５０， ７５， ９０及び１２０ｎＭ）を縦軸にプロットした。<br class="style-scope patent-text">
【図１１】ＨＣ１１０−ＲトランスフェクトＨＥＫ−２９３細胞のＣａ<sup class="style-scope patent-text">２＋</sup>イメージング<br class="style-scope patent-text">
（Ａ）　Ｃ−末端ＧＦＰタグを有するＨＣ１１０−Ｒ（ＨＣ１１０−Ｒ−ＧＦＰ）： 黒線。Ｎ末端ＧＦＰタグを有するＨＣ１１０−Ｒ（ＧＦＰ−ＨＣ１１０−Ｒ）： 灰色線。<br class="style-scope patent-text">
（Ｂ）　非トランスフェクトＨＥＫ−２９３細胞（ｎ． ｔ．、黒線）及びＧＦＰトランスフェクト細胞を用いた７５ｎＭ α−ＬＴＸ （ＧＦＰ、灰色線）。<br class="style-scope patent-text">
（Ｃ）　Ｃ−末端標的ヒトＭ１ ムスカリン性アセチルコリン受容体 （Ｍ１−Ｒ−ＧＦＰ、灰色線）及びＣ−末端標的化マウスβ<sub class="style-scope patent-text">２</sub>アドレナリン作動性アセチルコリン受容体 （β<sub class="style-scope patent-text">２</sub>−Ｒ−ＧＦＰ、黒線）を用いてトランスフェクションした細胞を用いた７５ ｎＭα−ＬＴＸ。<br class="style-scope patent-text">
（Ｄ）　ＨＣ１１０−Ｒ−ＧＦＰ−トランスフェクト細胞を、２ｍＭ ＥＧＴＡを用いて６分間処理した後、α−ＬＴＸ （７５ ｎＭ） （＋ＥＧＴＡ、灰色線）を加えた。ＥＧＴＡはコントロールから省いた （−ＥＧＴＡ、黒線）。<br class="style-scope patent-text">
（Ｅ）　２ｍＭ ＥＧＴＡは、α−ＬＴＸ（７５ ｎＭ）を加えた１０分後に加えた（＋ＥＧＴＡ、灰色線）。コントロール混合物にはＥＧＴＡは加えなかった （−ＥＧＴＡ、灰色線）。<br class="style-scope patent-text">
（Ｆ）　コントロールとして、非トランスフェクト細胞 （ｎ． ｔ．、灰色線） 及びＨＣ１１０−Ｒ−ＧＦＰ−発現細胞 （黒線）を、２ｎＭ ＥＧＴＡと共に３０分間混合した。<br class="style-scope patent-text">
【図１２】α−ＬＴＸにより生じるシグナル伝達を用いた、ＢＡＹ４４−４４００による干渉<br class="style-scope patent-text">
ＨＥＫ−２９３を、ＧＦＰタグ化ＨＣ１１０−Ｒタンパク質を用いて一過的にトランスフェクトし、そのトランスフェクションの４８時間後に刺激した（矢印）。Ｃａ<sup class="style-scope patent-text">２＋</sup>イメージングを５０分間行なった（図Ａ〜Ｄ）、非トランスフェクトＨＥＫ−２９３細胞の種々の内因性天然受容体を用いた対照実験は２０分間行なった。ｎは細胞の数を示す。<br class="style-scope patent-text">
（Ａ）　４００ｎｇ／ｍＬのＢＡＹ４４−４４００ （黒線）又はＰＦ１０２２−００１ （灰色線）を細胞に添加する。コントロールとして、ＢＡＹ４４−４４００又はＰＦ１０２２−００１を加えた後に、その細胞を、種々の物質の溶剤としても供するＮａ<sup class="style-scope patent-text">＋</sup> ＨＢＳ／ＨＥＰＥＳ緩衝液（ＨＢＳ）を用いて処理した。<br class="style-scope patent-text">
（Ｂ）　４ｎｇ／ｍＬ ＢＡＹ４４−４４００ （黒線） 及びＰＦ１０２２−００１ （灰色線）の存在下にて、α−ＬＴＸ（７５ｎＭ）により生じるシグナル伝達。<br class="style-scope patent-text">
（Ｃ）　４ｎｇ／ｍＬ ＢＡＹ４４−４４００ （黒線） 又はＰＦ１０２２−００１ （灰色線）と共に９０分間、プレインキュベーションした細胞におけるα−ＬＴＸにより生じるシグナル伝達。この物質はα−ＬＴＸを加える前に除いた。<br class="style-scope patent-text">
（Ｄ）　４００ｎｇ／ｍＬ ＢＡＹ４４−４４００ （黒線） 又はＰＦ１０２２−００１ （灰色線）と共に９０分間、プレインキュベーションしたＨＥＫ−２９３−ＧＦＰトランスフェクト細胞により生じるシグナル伝達。この物質はα−ＬＴＸを加える前に除いた。<br class="style-scope patent-text">
（Ｅ）　非トランスフェクトＨＥＫ−２９３細胞は、１ｍＭ 塩化カルバミルコリン（カルバコール）を用いて、４００ｎｇ／ｍＬ ＢＡＹ４４−４４００の存在下（４００ｎｇ／ｍＬ ＢＡＹ４４−４４００、黒線）又は非存在下（灰色線、−ＢＡＹ４４−４４００）にて１００秒間刺激した。<br class="style-scope patent-text">
（Ｆ）　非トランスフェクトＨＥＫ−２９３細胞は、１ｍＭ イソプロテレノール及び１ｍＭアレコリンを用いて、４００ｎｇ／ｍＬ ＢＡＹ４４−４４００の存在下（４００ｎｇ／ｍＬ ＢＡＹ４４−４４００、黒線）又は非存在下（灰色線、−ＢＡＹ４４−４４００）にて、各場合において１００秒間刺激した。<br class="style-scope patent-text">
【図１３】ＦＡＣＳｃａｎによるＨＣ１１０−ＲトランスフェクトＨＥＫ−２９３細胞に対するＰＦ１０２２Ａ結合の検出<br class="style-scope patent-text">
トランスフェクトしていない、ＧＦＰ、ＨＣ１１０−Ｒ−ＧＦＰ、ＧＦＰ−ＨＣ１１０−Ｒ、β<sub class="style-scope patent-text">２</sub>−Ｒ−ＧＦＰ及びＭ１−Ｒ−ＧＦＰを用いて一過的にトランスフェクションした、及びＨＣ１１０−Ｒ−Ｍｙｃ／Ｈｉｓを用いて一過的に同時トランスフェクションした５×１０<sup class="style-scope patent-text">５</sup> ＨＥＫ−２９３細胞の各場合において、トランスフェクション後、０．５μｇ／ｍＬ ＰＦ１０２２Ａ−ビオチン及びストレプトアビジン−フィコエリトリン（ｐｈｙｃｏｅｒｙｔｈｒｉｎ）（１：３００）と共に２４時間インキュベーションし、そして固定した。ネガティブコントロールとして、ＨＣ１１０−Ｒ−ＧＦＰトランスフェクト細胞を、ＰＦ１０２２Ａ−ビオチンを除いてストレプトアビジン−フィコエリトリンのみとインキュベーションした。自己蛍光の減算、即ち、全ての緑色蛍光細胞の緑色チャネルにおける非トランスフェクト細胞 （ｎ． ｔ．） ４．６％ 、及び赤色チャネルにおけるストレプトアビジン−フィコエリトリンにより生じる非特異的染色４．４％の減算の後、ＰＦ１０２２Ａと結合しているＧＦＰ蛍光細胞 （ＧＦＰ、ＨＣ１１０−Ｒ−ＧＦＰ、ＧＦＰ−ＨＣ１１０−Ｒ、β<sub class="style-scope patent-text">２</sub>−Ｒ−ＧＦＰ、Ｍ１−Ｒ−ＧＦＰ及びＨＣ１１０−Ｒ−Ｍｙｃ／Ｈｉｓ＋ＧＦＰ）の比率を見出した （％におけるＰＦ１０２２Ａ結合）。３組みの混合物の平均を決定して、標準偏差を求めた。<br class="style-scope patent-text">
【図１４】ＨＣ１１０−Ｒ媒介Ｃａ<sup class="style-scope patent-text">２＋</sup>シグナル伝達に対するＢＡＹ４４−４４００及び光学対掌体ＰＦ１０２２−００１の効果<br class="style-scope patent-text">
１μＭ Ｆｕｒａ−２／ＡＭを用いた細胞のローディングを、非トランスフェクトＨＥＫ−２９３細胞、およびＨＥＫ−２９３−ＧＦＰ又はＭ１−Ｒ−ＧＦＰを用いて一過的にトランスフェクションした４８時間後に行なった。３４０／３８０ｎｍの商 （比率） を、時間の関数として測定した。選択した細胞の数をｎにより示す。<br class="style-scope patent-text">
（Ａ）　非トランスフェクト （ｎ． ｔ、灰色線） 及びＨＣ１１０−Ｒ−ＧＦＰ−トランスフェクト（ＨＣ１１０−Ｒ−ＧＦＰ、黒線） 細胞を、Ｎａ<sup class="style-scope patent-text">＋</sup> ＨＢＳ緩衝液中の０．１％溶媒ＤＭＳＯを用いてコントロールとして６分後に混合した。<br class="style-scope patent-text">
（Ｂ）　ＨＣ１１０−Ｒ−ＧＦＰ− （黒線） 及びＭ１−Ｒ−ＧＦＰ− （灰色線） トランスフェクト細胞を、４００ｎｇ／ｍＬ ＢＡＹ４４−４４００を用いて６分後に刺激した。<br class="style-scope patent-text">
（Ｃ）　（Ｂ）と同様に、ＨＣ１１０−Ｒ−ＧＦＰ− （黒線） 及びＭ１−Ｒ−ＧＦＰ− （灰色線） トランスフェクト細胞を、４００ｎｇ／ｍＬ ＰＦ１０２２−００１を用いて６分後に刺激した。<br class="style-scope patent-text">
（Ｄ）　ＨＣ１１０−Ｒ−ＧＦＰ−発現細胞を、４００ｎｇ／ｍＬ ＢＡＹ４４−４４００ （黒線） 又はＰＦ１０２２−００１ （灰色線） を用いて９０分間プレインキュベーションし、非結合物質を測定前に洗い流した。<br class="style-scope patent-text">
（Ｅ）　１０μＭ ピペラジンを、非トランスフェクト細胞 （ｎ． ｔ．、灰色線） 及びＨＣ１１０−Ｒ−ＧＦＰ−発現細胞 （ＨＣ１１０−Ｒ−ＧＦＰ、黒線） に６分後に加えた。<br class="style-scope patent-text">
（Ｆ）　１０μＭ ピペラジン及び４００ｎｇ／ｍＬ ＢＡＹ４４−４４００の混合物を、非トランスフェクト細胞 （ｎ． ｔ．、灰色線） 及びＨＣ１１０−Ｒ−ＧＦＰ−発現細胞 （ＨＣ１１０−Ｒ−ＧＦＰ、黒線） に６分後に加えることを除いて、（Ｅ）と同様に行った。<br class="style-scope patent-text">
【図１５】ＰＦ１０２２Ａ誘導体を介するＨＣ１１０−Ｒ媒介α−ＬＴＸシグナル伝達の相互作用<br class="style-scope patent-text">
１μＭ Ｆｕｒａ−２／ＡＭを用いた細胞のローディングは、非トランスフェクトＨＥＫ−２９３、およびＨＣ１１０−Ｒ−ＧＦＰ又はＭ１−Ｒ−ＧＦＰを用いて一過的にトランスフェクションした４８時間後に行なった。用いたα−ＬＴＸの量は、常に７５ｎＭであった。コントロール物質を用いた実験については、細胞は、流速１．６ｍｌ Ｎａ<sup class="style-scope patent-text">＋</sup> ＨＢＳ／分で流した。３４０／３８０ｎｍの商 （比率） は、時間の関数として測定した。選択した細胞の数はｎにて示す。<br class="style-scope patent-text">
（Ａ）　［Ｃａ<sup class="style-scope patent-text">２＋</sup>］<sub class="style-scope patent-text">ｉ</sub>．におけるα−ＬＴＸで誘導される変化に対する効果を有するＤＭＳＯを排除するため、α−ＬＴＸ刺激の６分前に、ＨＣ１１０−Ｒ−ＧＦＰ− （黒線） 及びＭ１−Ｒ−ＧＦＰ− （灰色線） 発現細胞を、０．１％ ＤＭＳＯと混合した。<br class="style-scope patent-text">
（Ｂ）　ＨＣ１１０−Ｒ−ＧＦＰ−トランスフェクト細胞は、α−ＬＴＸを添加する６分前に４ｎｇ／ｍＬ ＢＡＹ４４−４４００ （黒線） 又はＰＦ１０２２−００１ （灰色線）と混合した。<br class="style-scope patent-text">
（Ｃ）α−ＬＴＸを用いた刺激の６分前に、４００ｎｇ／ｍＬ ＢＡＹ４４−４４００ （黒線） 又はＰＦ１０２２−００１ （灰色線）をＨＣ１１０−Ｒ−ＧＦＰ−発現細胞に添加したことを除き、（Ｂ）と同様に行った。<br class="style-scope patent-text">
（Ｄ）　ＨＣ１１０−Ｒ−ＧＦＰ−トランスフェクト細胞は、４ｎｇ／ｍＬ ＢＡＹ４４−４４００ （黒線） 又はＰＦ１０２２−００１ （灰色線） と９０分間プレインキュベーションし、非結合物質を測定前に除去した。細胞の刺激はα−ＬＴＸを用いて６分後に行なった。<br class="style-scope patent-text">
（Ｅ）　ＨＣ１１０−Ｒ−ＧＦＰ−トランスフェクト細胞を４００ｎｇ／ｍＬ ＢＡＹ４４−４４００ （黒線） 又はＰＦ１０２２−００１ （灰色線）と９０分間プレインキュベーションして、非結合物質を測定前に除去し、細胞をα−ＬＴＸで６分後に刺激したことを除いて、（Ｄ）と同様に行った。<br class="style-scope patent-text">
（Ｆ）　ＨＣ１１０−Ｒ−Ｍｙｃ／Ｈｉｓを安定に発現する細胞を、α−ＬＴＸの添加の６分前に、４００ｎｇ／ｍＬ ＢＡＹ４４−４４００ （黒線） 又はＰＦ１０２２−００１ （灰色線）と混合した。<br class="style-scope patent-text">
（Ｇ）　コントロールとして、１ｍＭ 塩化カルバミルコリン（カルバコール） を６分後に１００秒間加え、再びＮａ<sup class="style-scope patent-text">＋</sup> ＨＢＳを用いて洗浄し、４００ｎｇ／ｍＬ ＢＡＹ４４−４４００の存在下（４００ ｎｇ／ｍＬ ＢＡＹ４４−４４００、黒線）及び非存在下（−ＢＡＹ４４−４４００、灰色線）にて非トランスフェクト細胞に対し、再度Ｎａ<sup class="style-scope patent-text">＋</sup> ＨＢＳ用いて洗浄した。<br class="style-scope patent-text">
（Ｈ）　Ｍ１−Ｒ−ＧＦＰ−トランスフェクト細胞を、４００ｎｇ／ｍＬ ＢＡＹ４４−４４００の存在下 （４００ｎｇ／ｍＬ ＢＡＹ４４−４４００、黒線） 又は非存在下 （−ＢＡＹ４４−４４００、灰色線） で６分後に１ｍＭ カルバコールで１００秒間刺激し、再度Ｎａ<sup class="style-scope patent-text">＋</sup> ＨＢＳを用いて洗浄することを除いては、（Ｇ）と同様に行った。<br class="style-scope patent-text">
（Ｉ）　コントロールとして、４００ｎｇ／ｍＬ ＢＡＹ４４−４４００の存在下（４００ｎｇ／ｍＬ ＢＡＹ４４−４４００、黒線） 又は非存在下 （−ＢＡＹ４４−４４００、灰色線）で、３分後に１ｍＭ イソプロテレノールで１００秒間刺激し、１２分後に１ｍＭアレコリンで１００秒間刺激した。１００秒後に、物質をＮａ<sup class="style-scope patent-text">＋</sup> ＨＢＳを用いて再度洗浄した。[0001]<br class="style-scope patent-text">
The present invention relates to test systems based on transmembrane receptors from helminth and arthropods, and to identify and characterize substances acting on helminths, arthropods or on the calcium balance of biological host cells. The use of this test system. The invention furthermore relates to the use of a specific ligand in the present test system, and to the use of the ligand as an anthelmintic or arthropodidic active.<br class="style-scope patent-text">
[0002]<br class="style-scope patent-text">
Parasitic helminths and arthropods are a significant human and animal health problem. In the agricultural sector alone, the cost of combating or preventing the damage caused by such parasites totals more than 7 billion German marks annually (statistics from 1997). A number of active substances belonging to a number of active substance classes are used to treat endoparasites caused mainly by helminths and ectoparasites mainly caused by arthropods. Have been. During the last two decades, it has expanded to a number of parasite species within the phylum (eg, helminths) or to a range of various zoological phyla (eg, helminths and insects). Even so, the importance of active substances which simultaneously exhibit a very good effect is particularly increasing. In particular, the former include broad-spectrum anthelmintics, such as benzimidazole or imidazothiazole, and the latter include macrocyclic lactones.<br class="style-scope patent-text">
[0003]<br class="style-scope patent-text">
Last time, a group of new, broadly active active substances was on the market about 20 years ago, which was a macrocyclic lactone. However, many endogenous and exogenous parasite species have acquired resistance to individual and, in some cases, simultaneously various classes of active agents. Therefore, the need to develop new substances with anthelmintic activity continues and the urgency is increasing.<br class="style-scope patent-text">
[0004]<br class="style-scope patent-text">
A few promising new groups of currently active active substances include the cyclic depsipeptides which have been the subject of numerous patents (WO 93/19053, EP 626 376, WO 94/19334, WO 95/07272, EP 626 375, EP 657). 171, EP 657 172, EP 657 173) and their activity has been investigated (Conder et al., 1995; Martin et al., 1996; Sasaki et al., 1992; Terada M 1992; Samson-Himmelstjerna et al., 2000).<br class="style-scope patent-text">
[0005]<br class="style-scope patent-text">
One representative of this group of actives, PF 1022A (cyclo (-D-Lac-L-MeLeu-D-PhLac-L-MeLeu-)<sub class="style-scope patent-text">2</sub>Many studies have already been described to elucidate the mechanism of action of () (for reference, the relevant information in DE-A-197 04 024). These describe the identification and characterization of DNA sequences encoding binding proteins specific for cyclic depsipeptides and proteins derived from the sheep parasite Haemonchus contortus (DE-A-197 04 024). Was. Within the scope of the present invention, the functional interaction of the protein referred to as HC110-R, in particular the ligand BAY 44-4400 (cyclo (-D-Lac-L-MeLeu-Dp) as a further representative of cyclic depsipeptides Functional interaction with morpholinyl-PhLac-L-MeLeu-), for which purpose HC110-R is converted to HC110-R based on SEQ ID NO: 2 described in the earlier application DE-A-197 04 024. A expressing recombinant eukaryotic cell line was constructed.<br class="style-scope patent-text">
[0006]<br class="style-scope patent-text">
The present invention therefore relates to the invention, in particular from helminths and arthropods, preferably from nematodes and mites, particularly preferably from ciliate nematodes (Trichostrongylidae), even more preferably from Haemonchus spp. Transmembrane receptors of particular origin include H. It is an object of the present invention to provide a test system capable of high-speed, high-throughput treatment of a test compound (high-throughput screening assay; HTS assay) based on the H. contortus-derived receptor HC110-R.<br class="style-scope patent-text">
[0007]<br class="style-scope patent-text">
The homologous protein comprises at least 20, preferably at least 25, particularly preferably at least 20, the sequence shown in SEQ ID NO: 2 described in the document DE-A-197 04 024 (the teachings of this document are included in the present application). It is a protein that is at least 70%, preferably 80%, particularly preferably 90%, more preferably 95% identical over its entire length, and more particularly preferably over its entire length.<br class="style-scope patent-text">
[0008]<br class="style-scope patent-text">
Preferably, amino acid sequence identity is determined using the GAP program of the default GCG program package, version 9.1 (Devereux et al., 1984).<br class="style-scope patent-text">
[0009]<br class="style-scope patent-text">
It is an object of the present invention to provide polypeptides that exert at least one biological activity of the GPC receptor, and to provide methods for obtaining these polypeptides, as well as nematicidal and arthropodic activities This is achieved by providing a method for identifying a compound having<br class="style-scope patent-text">
[0010]<br class="style-scope patent-text">
Test systems based on recombinant microorganisms have already been used in many places to identify pharmaceutically active substances, and in particular also microorganisms which recombinantly express parasite genes (Klein and Geary). 1997). However, a system using a parasite transmembrane receptor as a target in a eukaryote as a recombinant functional protein has not been disclosed so far. The test system described in the present invention can be used to identify new classes of receptors in high-throughput-screening (HTS) or ultra-HTS.<br class="style-scope patent-text">
[0011]<br class="style-scope patent-text">
It is usually difficult to recombinantly express a nematode-derived receptor. Thus, it is currently generally not possible to express a G protein-coupled receptor (GPCR) from a nematode in a manner such that its functional properties (eg, sensitivity to inhibitors) correspond to those of the natural receptor. It is.<br class="style-scope patent-text">
[0012]<br class="style-scope patent-text">
The functional expression of helminths, especially nematode-derived, and arthropod-derived receptors in eukaryotic systems has proved to be extremely practical in the search for new anthelmintic or arthropodicides, for example. is important.<br class="style-scope patent-text">
[0013]<br class="style-scope patent-text">
Accordingly, the present invention further aims to provide a method capable of expressing a transmembrane receptor, in particular a GPC receptor from nematodes and arthropods. It is based on developing a test system that can identify new substances with foot activity.<br class="style-scope patent-text">
[0014]<br class="style-scope patent-text">
Accordingly, the invention is particularly directed to helminths and arthropods, preferably to nematodes and mites, particularly preferably to ciliate nematodes, even more preferably to torsion stomachs, and most preferably to parasitic nematodes H. The present invention relates to expressing and using an orphan G protein-coupled receptor from C. contortus as a target protein for efficient search for nematicidal actives.<br class="style-scope patent-text">
[0015]<br class="style-scope patent-text">
This receptor is designated G. elegans H. Identification was performed using a cDNA library obtained from C. contortus. The cDNA is a nematode transmembrane protein having a size of 110 kDa and encodes a transmembrane protein called HC110-R. This protein belongs to the secretin family of G protein-coupled receptors (GPCRs) and shows high similarity to latrophilin (FIG. 5).<br class="style-scope patent-text">
[0016]<br class="style-scope patent-text">
<u class="style-scope patent-text">HC110-R receptor as target</u> <br class="style-scope patent-text">
GPCR latrophilin was uniquely isolated from mammalian brain. Latrophilin has a molecular weight of 210 kDa and undergoes <figure-callout id="18" label="post-translational cleavage" filenames="2004508052-20.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">post-translational cleavage</a></figure-callout> 18 residues upstream of the first transmembrane segment, and is thus composed of two non-covalent subunits. The p120 subunit contains an N-terminal hydrophilic extracellular protein and the p85 subunit contains a seven transmembrane domain and the intracellular C-terminal region of latrophilin, which is unusually large for GPCRs. Two close homologs, latrophilin-2 and latrophilin-3, were recently identified (see also FIG. 6). The latter is preferentially expressed in the brain like latrophilin-1, whereas latrophilin-2 is preferentially expressed ubiquitously in mammalian placenta, kidney, spleen, ovary, heart and lung. (Ichtchenko et al., 1999; Sugita et al., 1998).<br class="style-scope patent-text">
[0017]<br class="style-scope patent-text">
Although HC110-R is only half the size of latrophilin 210 kDa, sequence similarity extends to functional similarity. Although endogenous ligands for both receptors are not yet known, both latrophilin and HC110-R are known to be affected by the artificial ligand α-LTX (α-latrotoxin).<br class="style-scope patent-text">
[0018]<br class="style-scope patent-text">
For example, when HEK-293 cells are transiently transfected with latrophilin, radioactive<sup class="style-scope patent-text">45</sup>Ca<sup class="style-scope patent-text">2+</sup>As can be shown by the experimental design using α-LTX, addition of external Ca<sup class="style-scope patent-text">2+</sup>Cause influx. Furthermore, α-LTX was also found to be Ca2 + in HEK-293 cells transiently transfected with HC110-R.<sup class="style-scope patent-text">2+</sup>Cause an influx, which, for example,<sup class="style-scope patent-text">2+</sup>Observable by imaging) (see also FIGS. 10 and 11).<br class="style-scope patent-text">
[0019]<br class="style-scope patent-text">
However, this Ca<sup class="style-scope patent-text">2+</sup>The inflow is very complex. When HC110-R is in the form of a construct with a C-terminally attached green fluorescent protein (GFP), the influx is biphasic. That is, one change is seen after about 3 minutes and another is seen after about 22 minutes. However, if there is only an N-terminal Myc-His tag before HC110-R, the main influx is only observed about 2-3 minutes after the addition of α-LTX. Although the reason for this is not yet known, the response to α-LTX addition is specific as shown by the following explanation:<br class="style-scope patent-text">
1. Ca<sup class="style-scope patent-text">2+</sup>Influx was from untransfected cells and mouse β<sub class="style-scope patent-text">2</sub>-Not observed in cells transiently transfected with adrenergic receptors.<br class="style-scope patent-text">
2. [Ca<sup class="style-scope patent-text">2+</sup>]<sub class="style-scope patent-text">i</sub>Changes depend on the dose of α-LTX (FIG. 10).<br class="style-scope patent-text">
3. Biphasic changes include Cd as evidenced by their sensitivity to nifedipine<sup class="style-scope patent-text">2+</sup>Ca that can be blocked by<sup class="style-scope patent-text">2+</sup>Ca occurring through channels, especially L-type channels<sup class="style-scope patent-text">2+</sup>It needs to be an inflow.<br class="style-scope patent-text">
[0020]<br class="style-scope patent-text">
The exact mechanism of interaction and signaling between α-LTX and HC110-R requires further explanation. For the example of latrophilin-1, Ca into HEK-293 cells caused by α-LTX<sup class="style-scope patent-text">2+</sup>It is possible to demonstrate that only a single transmembrane domain is required for influx (Kraspernov et al., 1999).<br class="style-scope patent-text">
[0021]<br class="style-scope patent-text">
The fact that nifedipine blocks the effects of α-LTX in the system described herein indicates that the system is also suitable for identifying novel specific calcium channel blockers (blockers). Is shown. Nifedipine belongs to the class of calcium channel agonists and antagonists, which are classified on the basis of binding to specific sites of the calcium channel, for example binding to L-type channels. The three major classes of calcium channel blockers (L type) include benzylacetonitrile (eg, verapamil, WO 91/02497), benzothiazepinones (eg, diltiazem), and 1,4 -There are dihydropyridine derivatives (e.g. nifedipine, nivaldipine, nimodipine, nicardipine, isradipine, amlodipine, nitrendipine, felodipine or nisoldipine) (Bacon et al., 1989; WO 90/09792). Another class of L-type calcium channel blockers includes 1,3-diphosphonates, such as verfosodyl.<br class="style-scope patent-text">
[0022]<br class="style-scope patent-text">
Accordingly, the present invention also relates to the use of α-LTX binding transmembrane receptors to identify novel calcium channel blockers. Seven-fold helical transmembrane receptors are particularly preferred for use for this purpose, and are particularly preferred G-protein coupled receptors. The use of transmembrane receptors of the secretin family is particularly highly preferred. Most preferred is the use of the HC110-R receptor set forth in SEQ ID NO: 2 and receptor proteins that are 70%, preferably 80%, particularly preferably 90%, and very preferably 95% homologous thereto. is there.<br class="style-scope patent-text">
[0023]<br class="style-scope patent-text">
The available data further indicate that HC110-R is a target for the novel anthelmintic depsipeptide BAY44-4400. BAY44-4400 blocks signaling by α-LTX in HEK-293 cells transfected with HC110-R (FIG. 12). This interference can result from the ionotropic activity of BAY44-4400, as is typical for other depsipeptides, such as beauvericin, enniatin, and the like (Geβner et al., 1996). However, BAY44-4400 does not cause any changes in untransfected cells. Furthermore, BAY44-4400 is a mouse β<sub class="style-scope patent-text">2</sub>Does not interfere with isoproterenol-induced signal transduction through HEK-293 cells transfected with adrenergic receptors. In addition, BAY44-4400 acts as an antagonist of α-LTX, but alone by Ca in HEK-293 cells transfected with HC110-R.<sup class="style-scope patent-text">2+</sup>Does not affect concentration.<br class="style-scope patent-text">
[0024]<br class="style-scope patent-text">
HC110-R protein<br class="style-scope patent-text">
The membrane protein described in DE 197 04 024 A1 has been identified as a potential target protein for the anthelmintic active PF1022A. A λZAPII cDNA expression library of the parasitic nematode Haemonchus contortus was prepared and screened using a conjugate of PF1022A with KLH (keyhole limpet hemocyanin) PF1022A-KLH and a polyclonal antibody against this conjugate. A potential target protein was identified (see Example 1). Non-propagating recombinant clone about 1.5 × 10<sup class="style-scope patent-text">6</sup>According to the test of H. A 3036 bp cDNA clone was found that hybridized with the 3.6 kb mRNA from S. contortus (see also Example 2). Using the RACE PCR method, the 3 'end and the 5' end were complemented (Example 4). Finally, a cDNA having a length of 3539 bp was obtained and designated as HC110-R. This cDNA is ATG<sup class="style-scope patent-text">100</sup>Encodes 986 amino acids (110 kDa) with an open reading frame starting with (Figure 2). This initiation codon is surrounded by Kozak sequences for optimal initiation of translation. The derived molecular weight of this protein was confirmed by in vitro translation of HC110-R RNA transcribed in vitro.<br class="style-scope patent-text">
[0025]<br class="style-scope patent-text">
The amino acid sequence of the HC110-R protein shows some specific structures. The extracellular N-terminal portion of this protein consists of a total of 535 residues. The N-terminus contains a 21 amino acid long signal peptide and a cleavage site at <figure-callout id="18" label="position" filenames="2004508052-20.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">position</a></figure-callout> 18. Next, there is a so-called "Thr stretch" (AA 128-147) in which the lectin-like sequence (AA 22-215) and the serine at position 144 are only interrupted. Downstream of this "Thr stretch" is the structure CX<sub class="style-scope patent-text">9</sub>WX<sub class="style-scope patent-text">12</sub>CX<sub class="style-scope patent-text">9</sub>WXCX<sub class="style-scope patent-text">5</sub>WX<sub class="style-scope patent-text">9</sub>CX<sub class="style-scope patent-text">3</sub>There is a cysteine-rich (rich) motif with W (AA166-221). In addition, the HC110-R protein contains a hydrophobic helical transmembrane domain seven times between 536 and 772 residues. Immediately upstream of this transmembrane region, the structure CXWWX<sub class="style-scope patent-text">6</sub>WX<sub class="style-scope patent-text">4</sub>CX<sub class="style-scope patent-text">11</sub>There is also a 4-Cys region of CXC (AA 478-524). In the transmembrane region there are three extracellular loops containing residues 587-597, 654-673 and 743-749, and three intracellular loops (positions 559-569, 627-636, 696-724). . The C-terminus is 214 residues (24 kDa) in length and includes a proline-rich portion (AA845-861) and a PEST region (AA915-933). Finally, there are three additional putative N-glycosylation sites at <figure-callout id="14" label="residues" filenames="2004508052-21.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">residues</a></figure-callout> 26, 499 and 862, and 14 putative phosphorylation sites in the derived intracellular domain (see also FIG. 6). ).<br class="style-scope patent-text">
[0026]<br class="style-scope patent-text">
According to database analysis, the HC110-R protein was found to be genomic clone B0457 (Genebank) of the nematode Caenorhabditis elegans.<sup class="style-scope patent-text">TM</sup>Accession number Z54306) was found to be 48% identical and 78% similar to the unknown transmembrane protein (10014 AA) (see also FIG. 3).<br class="style-scope patent-text">
[0027]<br class="style-scope patent-text">
As used herein, the term "identity" refers to the number of sequence sites that match in a so-called alignment. This is shown as a percentage of the alignment length.<br class="style-scope patent-text">
[0028]<br class="style-scope patent-text">
The term "similarity" as used herein is the similarity of sequences based on a similarity measure, in other words, a measure of how similar they are, for example, assuming valine as threonine or leucine. .<br class="style-scope patent-text">
[0029]<br class="style-scope patent-text">
As used herein, the term "homologous" means an evolutionary relationship, in other words, whether two homologous proteins are derived from a common ancestral sequence. The term need not usually be related to identity or similarity apart from the fact that homologous sequences are usually more similar or have more matches in alignments than non-homologous sequences.<br class="style-scope patent-text">
[0030]<br class="style-scope patent-text">
Comparison of the two sequences reveals features common to both proteins, such as, for example, lectin-like sequences, “Thr stretch”, Cys motifs and PEST sequences. The highest identity is found in the transmembrane region (62%), whereas the identity in the N-terminal region (44%) and the C-terminal region (50%) is less pronounced.<br class="style-scope patent-text">
[0031]<br class="style-scope patent-text">
In addition, the HC110-R protein has 20-30% identity to the 7-fold helical G protein-coupled transmembrane receptor (GPCR), particularly the secretin subfamily. Comparison of the seven transmembrane domains shows high identity and similarity between the various GPCRs of the secretin subfamily and HC110-R in structure and sequence (FIG. 4).<br class="style-scope patent-text">
[0032]<br class="style-scope patent-text">
Latrophilin, a member of the secretin subfamily, derived from mammals such as humans (Genebank<sup class="style-scope patent-text">TM</sup>Accession number: E1360690), bovine (eg, G416021, G416053 and G4185804), and rat-derived (U78105 or U72487) show somewhat higher identity to HC110-R than other secretin receptors. . In particular, the identity of the transmembrane regions is between 45 and 48%. The HC110-R and the 1466 amino acid rat latrophilin-1 GPCR (U78105) exhibit common features, such as, for example, a lectin domain, a cysteine-rich domain, and a conserved 4-Cys motif in front of the transmembrane region. The latter has recently been shown to be a proteolytic site for latrophilin and other large secretin GPCRs. By comparison, the N-terminus of HC110-R does not include the olfactomedin and Pro / Thr regions of latrophylline, but latrophilin instead has no "Thr stretch" of HC110-R.<br class="style-scope patent-text">
[0033]<br class="style-scope patent-text">
Accordingly, the present application further relates to the use of a G protein-coupled transmembrane receptor with a seven transmembrane domain from a helminth to identify substances with anthelmintic activity. According to the invention, the use of transmembrane receptors which the secretin subfamily may have is preferred.<br class="style-scope patent-text">
[0034]<br class="style-scope patent-text">
<u class="style-scope patent-text">Localization in cells</u> <br class="style-scope patent-text">
Transient transfection experiments were performed in various mammalian cell lines, such as COS-7 cells or HEK-293 cells, using the HC110-R-GFP fusion protein (FIG. 7). H. Heterologous expression was chosen because the controlus cell line has not yet been established.<br class="style-scope patent-text">
[0035]<br class="style-scope patent-text">
Green fluorescent protein (GFP) from the Pacific jellyfish Aequorea victoria can be used to localize proteins in living cells (see FIG. 8). GFP is used at the cellular level as an in vivo reporter to indicate the frequency of transient or stable transfections, and at the subcellular level to determine protein localization. Wild-type GFP is a 27 kDa monomer composed of 238 amino acids that emits green light up to 509 nm after excitation by UV light (360-400 nm; 395 nm max) or blue light (440-480 nm; 475 nm max). No substance or cofactor is required (Chalphi et al., $ 1994). Thus, GFP can be directly detected in vivo by fluorescence microscopy and its fluorescence characteristics remain essentially unchanged even if it is part of the fusion protein. EGFP (enhanced GFP) is a genetic variant of wild-type GFP and is used for transfecting mammalian cells (Yang et al., 1996). The maximum excitation of EGFP is<sup class="style-scope patent-text">65</sup>Was moved to the only 490 nm peak by replacing with Thr. Vectors pEGFP-C1 (Genebank Accession Number: U55763) and pEGFP-N3 (Genebank Accession Number: U55762) [Clontech, Palo Alto, CA, U.S.A. S. A. ] Can be used to express EGFP under the eradication of a strong constitutive CMV promoter and to fuse another protein to each of the N- and C-termini of EGFP.<br class="style-scope patent-text">
[0036]<br class="style-scope patent-text">
Stable cell lines are advantageous over transient expression in that all cells constitutively express the desired protein and can isolate the desired protein after localization. Select an expression vector that requires an antibody against the desired protein to detect the protein with the aid of fluorescence microscopy or Western blot, or that fuses the Myc or His tag to the C-terminus of the actual protein in the correct reading frame It is appropriate to do so, and in most cases, even if it is a monoclonal antibody, an antibody against it can be purchased.<br class="style-scope patent-text">
[0037]<br class="style-scope patent-text">
Similarly, the invention relates to cells that stably express the HC 110-R receptor and possibly proteins homologous thereto.<br class="style-scope patent-text">
[0038]<br class="style-scope patent-text">
<u class="style-scope patent-text">Effect of α-Latrotoxin on HC110-R protein</u> <br class="style-scope patent-text">
To further demonstrate the similarity between HC110-R and latrophilin, and to test the function of recombinantly expressed HC110-R, HEK-293 cells were purified using the HC110-R-GFP fusion protein. Transfected and stably transfected transiently and stimulated with α-Latrotoxin (α-LTR).<br class="style-scope patent-text">
[0039]<br class="style-scope patent-text">
α-Latrotoxin is a presynaptic neurotoxin that can be isolated from the venom of the Latrodectus mactans. Its toxicity to the vertebrate central nervous system is known;<sup class="style-scope patent-text">2+</sup>]<sub class="style-scope patent-text">i</sub>Causes neuronal depolarization by stimulating non-eliminating exocytosis of neurotransmitters. Thus, it was also clarified that the effect of α-latrotoxin was mediated, at least in part, by latrophilin. Furthermore, the toxicity of α-Latrotoxin is presumed to be due to its ability to interact with receptors (GPCRs) that couple to GTP binding proteins. These receptors usually mediate the effects of endogenous hormones or neuropeptides (Holz and Habener 1998).<br class="style-scope patent-text">
[0040]<br class="style-scope patent-text">
In order to test the response of transfected HEK-293 cells to α-LTX, the present invention uses the Ca present in these cells.<sup class="style-scope patent-text">2+</sup>&nbsp;That is, [Ca<sup class="style-scope patent-text">2+</sup>]<sub class="style-scope patent-text">i</sub>By measuring the change in the so-called Ca<sup class="style-scope patent-text">2+</sup>An imaging technique was used (see Example 24 and FIGS. 9, 10 and 11).<br class="style-scope patent-text">
[0041]<br class="style-scope patent-text">
α-LRX is [Ca<sup class="style-scope patent-text">2+</sup>]<sub class="style-scope patent-text">i</sub>Causes a biphasic increase in At a concentration of 75 nM, α-LTX first produced a very small increase of only 5 ± 0.2 <figure-callout id="2" label="nm" filenames="2004508052-10.png,2004508052-15.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">nm</a></figure-callout> 2 minutes after the addition of α-LTX, and about 220 ± 14.9 nM Ca after 22 minutes.<sup class="style-scope patent-text">2+</sup>Causes a large delay type increase. As the concentration of α-LTX increases (7.5 nM to 120 nM), the first increase increases and the second decreases. At an α-LTX concentration of 120 nM, the first increase was about 135 ± 13.6 nM Ca<sup class="style-scope patent-text">2+</sup>, While the second increase value is about 50 ± 7.1 nM Ca<sup class="style-scope patent-text">2+</sup>Down to The same profile using 90 nM and 120 nM α-LTX shows saturation.<br class="style-scope patent-text">
[0042]<br class="style-scope patent-text">
Transfecting HEK-293 cells with the N-terminal GFP-tagged HC110-R construct and stimulating it with 75 nM α-LTX slightly reduces the second peak. Also, when the HC110-R protein was provided with an N-terminal GFP tag, the response to α-LTX ultimately was only slightly reduced. Therefore, binding of the GFP tag to the N- or C-terminus would have negligible effects on HC-RTX binding and subsequent signaling by HC110-R.<br class="style-scope patent-text">
[0043]<br class="style-scope patent-text">
Cells not transfected or simply transiently transfected with GFP show no response to α-LTX. Other G protein-coupled receptors with a C-terminal GFP tag, such as mouse β<sub class="style-scope patent-text">2</sub>Transient transfection of HEK-293 cells with adrenergic receptors or the human muscarinic H1 acetylcholine receptor causes a 75 nM concentration of [alpha] -LTX [Ca<sup class="style-scope patent-text">2+</sup>]<sub class="style-scope patent-text">i</sub>The increase is negligible (approximately 40 ± 10.4 after 20 minutes) or zero.<br class="style-scope patent-text">
[0044]<br class="style-scope patent-text">
[Ca caused by α-LTX<sup class="style-scope patent-text">2+</sup>]<sub class="style-scope patent-text">i</sub>Increase in extracellular Ca<sup class="style-scope patent-text">2+</sup>Influx and intracellular Ca<sup class="style-scope patent-text">2+</sup>Can lead to both outflows. Before or after adding α-LTX, extracellular Ca<sup class="style-scope patent-text">2+</sup>Was removed using 2 mM EGTA, the [Ca] of HEK-293 cells expressing the HC110-R-GFP fusion protein was<sup class="style-scope patent-text">2+</sup>]<sub class="style-scope patent-text">i</sub>Shows only a slight increase. From this, α-LTX is mainly composed of extracellular Ca<sup class="style-scope patent-text">2+</sup>It is clear that it causes influx of water. This Ca<sup class="style-scope patent-text">2+</sup>The influx is not based on simple diffusion, but rather<sup class="style-scope patent-text">2+</sup>Caused by channel forces.<br class="style-scope patent-text">
[0045]<br class="style-scope patent-text">
15 μM nifedipine is [Ca<sup class="style-scope patent-text">2+</sup>]<sub class="style-scope patent-text">i</sub>Is sufficient to significantly reduce the α-LTX-induced increase in<sup class="style-scope patent-text">2+</sup>Ca involved in inflow<sup class="style-scope patent-text">2+</sup>Most of the channels are L-type. In addition, the first increase is completely inhibited and the second falls from 267 ± 12.7 nM to 30 ± 5.4 nM.<br class="style-scope patent-text">
[0046]<br class="style-scope patent-text">
Also, stable or transient HEK-293 cell lines expressing the HC110-R receptor with a C-terminal Myc / His tag respond to α-LTX in a dose-dependent manner (see FIG. 10). . At 7.5 nM α-LTX, again, α-LTX-induced Ca<sup class="style-scope patent-text">2+</sup>Too little to cause inflow. However, an additional 25 nM α-LTX was obtained after only 2 minutes [Ca<sup class="style-scope patent-text">2+</sup>]<sub class="style-scope patent-text">i</sub>Is sufficient to increase to 130 ± 38.0 nM. 296 ± 91.5 nM Ca was added by adding 75 nM α-LTX.<sup class="style-scope patent-text">2+</sup>An influx occurs, which also increases greatly 2 minutes after the addition of α-LTX, and returns to the original Ca only after 27 minutes.<sup class="style-scope patent-text">2+</sup>Return to content. This Ca<sup class="style-scope patent-text">2+</sup>The signal is the second delayed Ca of HC110-R-GFP transfected HEK293 cells at the same α-LTX concentration (75 nM) for the signal height and its profile.<sup class="style-scope patent-text">2+</sup>Although similar to the peak, the response occurs immediately after the addition of α-LTX (also for high concentrations (90 nM and 120 nM) of HC110-R-GFP transfected cells).<br class="style-scope patent-text">
[0047]<br class="style-scope patent-text">
Accordingly, the present invention also relates to the use of α-LTX as an agonist of the transmembrane receptor of the secretin family from nematodes. α-LTX is an agonist of the HC110-R receptor set forth in SEQ ID NO: 2 and a receptor protein that is 70%, preferably 80%, particularly preferably 90%, more particularly very preferably 95% homologous thereto. Preferably, it is used.<br class="style-scope patent-text">
[0048]<br class="style-scope patent-text">
Similarly, the invention relates to the use of α-LTX as a nematicide.<br class="style-scope patent-text">
[0049]<br class="style-scope patent-text">
Similarly, the invention relates to the use of α-LTX in a method for identifying compounds having nematicidal or arthropodicidal activity, compounds that may be active as agonists or antagonists of the transmembrane receptor. .<br class="style-scope patent-text">
[0050]<br class="style-scope patent-text">
Similarly, the invention relates to the use of α-LTX in a method for identifying compounds that block calcium channels.<br class="style-scope patent-text">
[0051]<br class="style-scope patent-text">
<u class="style-scope patent-text">Effect of BAY 44-4400 on the action of α-LTX</u> <br class="style-scope patent-text">
PF1022A exerts its effects on nematodes in a concentration range of 100-800 ng / mL, depending on the specific species (Terada, 1992). To investigate in each case any possible interactions between HC110-R and PF1022A, and signaling mediated by HC110-R, BAY44-4400, a readily solubilizing derivative of PF1022A, The following Ca in HEK-293 cells loaded with FURA-2 and transfected with HC110-R-GFP:<sup class="style-scope patent-text">2+</sup>Used for imaging experiments.<br class="style-scope patent-text">
[0052]<br class="style-scope patent-text">
At a concentration of 400 ng / mL, both the highly effective nematicide BAY44-4400 and the virtually ineffective enantiomer PF1022-001, after preincubation of the cells with the active substance for 90 minutes, have no effect on HC110-R-. Ca in HEK293 cells transfected with GFP<sup class="style-scope patent-text">2+</sup>Cause no response. In contrast, both substances affect signaling, albeit to a different extent, depending on α-LTX (FIGS. 12 and 14). In the presence of 4 ng / mL BAY44-4400, α-LTX shows a maximum of 44 ± 6.0 nM Ca after 14 minutes.<sup class="style-scope patent-text">2+</sup>Small Ca<sup class="style-scope patent-text">2+</sup>Induces only the increase (FIG. 12). However, in the presence of PF1022-001, α-LTX increased to 103 ± 11.5 nM Ca after 6 minutes.<sup class="style-scope patent-text">2+</sup>Causes a greater increase in In another method, cells were pre-incubated with 4 ng / mL or 400 ng / mL of BAY44-4400 and PF1022A for 90 minutes, then, after removing the active substance, cells were stimulated with α-LTX. HEK-293 cells pre-incubated with PF1022A had no significant change in response to α-LTX. Only BAY44-4400 affected the sensitivity of cells to α-LTX. In BAY44-4400 at a concentration of 4 ng / mL, α-LTX shows stable Ca<sup class="style-scope patent-text">2+</sup>19 minutes before reaching the level, Ca<sup class="style-scope patent-text">2+</sup>Increase (95 ± 20.5 nM Ca<sup class="style-scope patent-text">2+</sup>). At 400 ng / mL BAY44-4400, α-LTX is about 65 ± 7.5 nM Ca<sup class="style-scope patent-text">2+</sup>Only Ca<sup class="style-scope patent-text">2+</sup>Resulted in an increase in concentration. In addition, this small increase moved for 12 minutes.<br class="style-scope patent-text">
[0053]<br class="style-scope patent-text">
To confirm the specificity of these results, the effect of 1 mM carbachol on endogenous native M1-R was further measured in untransfected HEK-293 cells. The presence of 400 ng / mL BAY44-4400 did not change the response of the cells. In HEK-293 cells, endogenous native β<sub class="style-scope patent-text">2</sub>Neither -R nor the nicotinic cholinergic receptor stimulation induced by isoproterenol and arecoline was affected by BAY44-4400 in any way.<br class="style-scope patent-text">
[0054]<br class="style-scope patent-text">
Finally, within the scope of the present invention, the PF1022A mutant against the HC110-R protein in HEK-293 cells transiently or stably expressing the HC110-R protein provided with GFP at the C-terminus The effect of the more soluble mutant, BAY44-4400, was<sup class="style-scope patent-text">2+</sup>It was examined by imaging. When HEK-293 cells were incubated with only 400 ng / mL BAY44-4400, the cells lost intracellular Ca<sup class="style-scope patent-text">2+</sup>Responded for 50 minutes in a manner not analogous to the change in concentration. However, the effect of BAY44-4400 is seen in the presence of α-LTX. Prior to adding 75 nM α-LTX, cells were incubated with BAY44-4400 for 6 minutes to provide Ca<sup class="style-scope patent-text">2+</sup>The effect of α-LTX on concentration is reduced. [Ca<sup class="style-scope patent-text">2+</sup>]<sub class="style-scope patent-text">i</sub>The first small increase in is not seen and the second increase drops to 85% 15 minutes after the addition of α-LTX. The response to α-LTX is even stronger when cells are pre-incubated with BAY44-4400 for 60 minutes before being treated with FURA for 30 minutes. Ca<sup class="style-scope patent-text">2+</sup>Was not seen at all, and 70 nM [Ca<sup class="style-scope patent-text">2+</sup>]<sub class="style-scope patent-text">i</sub>Is only seen 30 minutes after the addition of 75 nM α-LTX.<br class="style-scope patent-text">
[0055]<br class="style-scope patent-text">
Two control experiments were performed to show the specific effects of BAY44-4400 on the effects of α-LTX. First, HEK-293 cells were transformed with mouse β provided with a GFP tag at the C-terminus.<sub class="style-scope patent-text">2</sub>-Transfected or stably transfected with adrenergic receptors, using isoproterenol as ligand.<br class="style-scope patent-text">
[0056]<br class="style-scope patent-text">
In fact, isoproterenol also has significant Ca<sup class="style-scope patent-text">2+</sup>Produces a response: Immediately after adding isoproterenol, Ca<sup class="style-scope patent-text">2+</sup>Only increase. However, this increase is not affected by BAY44-4400.<br class="style-scope patent-text">
[0057]<br class="style-scope patent-text">
Furthermore, the specificity of the interaction between BAY44-4400 and HC110-R is demonstrated by the optical enantiomer occupying the site of BAY44-4400 as a ligand. PF1022A derivative with 100 times weaker anthelmintic activity, PF1022-001: cyclo (-L-Lac-D-MeLeu-L-PhLac-D-Me-Leu-)<sub class="style-scope patent-text">2</sub>&nbsp;(Also called optical enantiomer) was pretreated with 400 ng / mL for 90 minutes, then 6 minutes after the addition of 75 nM α-LTX, only 110 nM Ca<sup class="style-scope patent-text">2+</sup>Increased, which means reduced to 59%. If 4 ng / mL of the enantiomer was added 6 minutes before the addition of 75 nM α-LTX, then 67 nM [Ca<sup class="style-scope patent-text">2+</sup>]<sub class="style-scope patent-text">i</sub>Increase is seen. When the concentration of the optical enantiomer was increased, the increase was 20 nM Ca<sup class="style-scope patent-text">2+</sup>Down to.<br class="style-scope patent-text">
[0058]<br class="style-scope patent-text">
The term "polypeptide" as used herein refers to both short amino acid chains, commonly referred to as peptides, oligopeptides or oligomers, and long amino acid chains, commonly referred to as proteins. This includes amino acid chains that can be modified either by natural processes, such as by post-translational processing, or by state-of-the-art chemical methods. Such modifications can occur at various sites in the polypeptide, and one or more may occur, for example, in the peptide backbone, at the amino acid side chains, at the amino-terminal host carboxy-terminus. These include, for example, acetylation, acylation, ADP ribosylation, amidation, flavin, heme moieties, nucleotides or nucleotide derivatives, lipids or lipid derivatives or covalent bonds with phosphatidylinositol, cyclization, disulfide bridge formation, dimethylation, Cystine formation, formylation, gamma-carboxylation, glycosylation, hydroxylation, iodination, methylation, myristoylation, oxidation, proteolytic processing, phosphorylation, selenoylation and tRNA-mediated amino acid addition are included.<br class="style-scope patent-text">
[0059]<br class="style-scope patent-text">
Polypeptides can be used according to the invention in the form of a "mature" protein or as part of a larger protein (eg, a fusion protein). This may further include secretory or “leader” sequences, pro-sequences, sequences that allow for easy purification (eg, multiple histidine residues), or additional stabilizing amino acids.<br class="style-scope patent-text">
[0060]<br class="style-scope patent-text">
The homologous protein or polypeptide is at least 70%, preferably 80%, particularly preferably at least 70% with the sequence shown in SEQ ID NO: 2 described in the document DE-A-197 04 024 (the teachings of this document are included in the present application). Is 90%, very particularly preferably 95% identical, a protein or polypeptide having at least 20, preferably at least 25, particularly preferably at least 30 contiguous amino acids, very particularly preferably its full length. .<br class="style-scope patent-text">
[0061]<br class="style-scope patent-text">
According to the use of the polypeptides of the present invention, the polypeptide need not represent the entire receptor, but may only be a fragment thereof, as long as it has at least the biological activity of the entire receptor. In addition, the polypeptide is H. It does not need to be derived from the transmembrane receptor. A polypeptide corresponding to a helminth or even a transmembrane receptor of another species of arthropod or a fragment thereof as long as it can exert the biological activity of that receptor is according to the invention.<br class="style-scope patent-text">
[0062]<br class="style-scope patent-text">
With respect to the use of the polypeptides of the present invention, the polypeptide may be deleted or deleted as compared to the corresponding region of the native GPC receptor, as long as it exerts at least one biological activity of the entire GPC receptor. It may have amino acid substitutions. Conservative substitutions are preferred. Such conservative substitutions include variants in which one amino acid has been replaced with another amino acid from the following group:<br class="style-scope patent-text">
1. Small aliphatic, non-polar or slightly polar residues: Ala, Ser, Thr, Pro and Gly;<br class="style-scope patent-text">
2. Polar, negatively charged residues and their amides: Asp, Asn, Glu and Gln;<br class="style-scope patent-text">
3. Polar, positively charged residues: His, Arg and Lys;<br class="style-scope patent-text">
4. Large aliphatic, non-polar residues: Met, Leu, Ile, Val and Cys;<br class="style-scope patent-text">
5. Aromatic residues: Phe, Tyr and Trp.<br class="style-scope patent-text">
[0063]<br class="style-scope patent-text">
The following list shows preferred conservative substitutions:<br class="style-scope patent-text">
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/04/4c/a0/92d3e6f2c972b2/2004508052-99.png" class="style-scope patent-text"><img he="177" id="000002" wi="151" file="2004508052.tif" img-format="tif" img-content="drawing" width="604" height="708" alt="Figure 2004508052" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/04/4c/a0/92d3e6f2c972b2/2004508052-99.png"></a></div>
[0064]<br class="style-scope patent-text">
The above sequence, and the sequences set forth in SEQ ID NOs: 1 and 3 of DE-A-197 04 024, describe polypeptides involved in the structure of functionally similar transmembrane receptors in helminths or arthropods. It can also be used to find the encoding gene. Functionally similar receptors according to the present invention include polypeptides that differ in amino acid sequence from the polypeptides described herein, but have essentially the same biological function. Means receptor.<br class="style-scope patent-text">
[0065]<br class="style-scope patent-text">
As used herein, the term “essentially the same biological function” refers to the involvement in the structure of a G protein-coupled seven-helix transmembrane receptor, particularly a receptor of the secretin subfamily, that is capable of functioning, Or H. It means a function corresponding to the HC110-R receptor derived from S. contortus. The function also includes the above properties of the receptor, such as sensitivity to α-LTX as an agonist or nifedipine as an antagonist of α-LTX.<br class="style-scope patent-text">
[0066]<br class="style-scope patent-text">
As used herein, the term “hybridize” refers to the process by which a single-stranded nucleic acid molecule base pairs with a complementary strand. Starting from the sequence of information described herein, for example, DNA fragments encoding polypeptides having GPC receptor biological activity from other nematodes other than C. contortus and from arthropods can be isolated.<br class="style-scope patent-text">
[0067]<br class="style-scope patent-text">
For suitable probes, the amino and carboxy terminal cDNA portions are preferred. Hybridization conditions are chosen such that low similarity sequences from other organisms can also be detected. Hybridization conditions with low stringency may be as follows: For example, hybridization is performed at 40-55 ° C. in 6 × SSC / 0% formamide as a hybridization solution. The conditions of the second washing step must be tested, for example, first at 50 ° C. in 2 × SSC, and then assess the intensity of the signal. Next, the washing conditions are changed.<br class="style-scope patent-text">
[0068]<br class="style-scope patent-text">
Suitable hybridization conditions are shown below by way of example:<br class="style-scope patent-text">
Hybridization solution: 6 × SSC / 0% formamide, preferred hybridization solution: 6 × SSC / 0% formamide<br class="style-scope patent-text">
Hybridization temperature: 34 ° C, preferred hybridization temperature: 42 ° C<br class="style-scope patent-text">
First washing step: 2 × SSC at 40 ° C.<br class="style-scope patent-text">
Second washing step: 2 × SSC at 45 ° C .; Preferred second washing step: 0.6 × SSC at 55 ° C .: Particularly preferred second washing step: 0.3 × SSC at 65 ° C.<br class="style-scope patent-text">
[0069]<br class="style-scope patent-text">
Hybridization conditions are calculated as appropriate according to the following formula:<br class="style-scope patent-text">
Melting temperature Tm = 81.5 ° C. + 16.6 log [c (Na<sup class="style-scope patent-text">+</sup>)] + 0.41 (% G + C))-500 / n<br class="style-scope patent-text">
(Lottspeich and Zorbas @ 1998).<br class="style-scope patent-text">
[0070]<br class="style-scope patent-text">
Where c is the concentration and n is the length of the base-pair hybridizing sequence portion. The 500 / n term is excluded for sequences greater than 100 bp. The highest stringency wash is at an ionic strength of 15 mM Na + (equivalent to 0.1 × SSC) at a temperature 5-15 ° C. below the Tm. When an RNA probe is used for hybridization, the dissolution temperature increases by 10 to 15 ° C.<br class="style-scope patent-text">
[0071]<br class="style-scope patent-text">
The polypeptide used in the method of the present invention for identifying a compound having nematicidal activity and arthropodicidal activity is obtained by using the nucleic acid described in SEQ ID NO: 1 and SEQ ID NO: 3 described in DE-A-197 04 024. Coded.<br class="style-scope patent-text">
[0072]<br class="style-scope patent-text">
Also included in the method of the invention are at least 20, preferably at least 100, particularly preferably at least 500 contiguous nucleotides, and especially more preferably over the full length of SEQ ID NO: 1 or SEQ ID NO: 3 At least 70%, preferably 80%, particularly preferably 90%, particularly preferably 95%.<br class="style-scope patent-text">
[0073]<br class="style-scope patent-text">
Similarly, the nucleic acids according to the present invention can be used to make transgenic invertebrates. The latter can be used in test systems based on the expression of the receptor of the invention or a variant thereof different from the wild type. This also includes all transgenic invertebrates in which modification of another gene or gene excision sequence (eg, a promoter) causes a change in the expression of a receptor of the invention or a variant thereof.<br class="style-scope patent-text">
[0074]<br class="style-scope patent-text">
Production of transgenic invertebrates is performed, for example, by P-factor-mediated gene transfer in Drosophila melanogaster or by transposon-mediated gene transfer in Caenorhabditis elegans (eg, Tc1, Plastark 1996).<br class="style-scope patent-text">
[0075]<br class="style-scope patent-text">
Accordingly, the present invention also relates to a transgenic invertebrate, preferably a transgenic invertebrate of the species Drosophila melanogaster or Caenorhabditis elegans, comprising the at least one nucleic acid of the invention, and the progeny of the transgenic variant . The transgenic invertebrate preferably comprises the receptor according to the invention in a form different from the wild type.<br class="style-scope patent-text">
[0076]<br class="style-scope patent-text">
The nucleic acid of the present invention can be prepared by a conventional method. For example, complete chemical synthesis of nucleic acid molecules is possible. In addition, only a short piece of the sequences of the invention can be chemically synthesized and such oligonucleotides can be labeled by radioactivity or fluorescent staining. The labeled oligonucleotide can be used to screen a cDNA library prepared using nematode mRNA or insect mRNA as a starting material. Clones that hybridize to the labeled oligonucleotide are selected for isolation from related DNA. After characterizing the isolated DNA, the nucleic acids of the invention are obtained in a simple manner.<br class="style-scope patent-text">
[0077]<br class="style-scope patent-text">
The nucleic acid according to the present invention can also be prepared by a PCR method using a chemically synthesized oligonucleotide.<br class="style-scope patent-text">
[0078]<br class="style-scope patent-text">
As used herein, the term "oligonucleotide" means a DNA molecule consisting of 10 to 50 nucleotides, preferably 15 to 30 nucleotides. They can be chemically synthesized, for example, and used as probes.<br class="style-scope patent-text">
[0079]<br class="style-scope patent-text">
The nucleic acids according to the present invention can be used for the isolation and characterization of regulatory regions naturally present near the coding region.<br class="style-scope patent-text">
[0080]<br class="style-scope patent-text">
Similarly, the method of the invention uses a vector comprising a nucleic acid used according to the invention or a DNA construct used according to the invention. Vectors that can be used are all phages, plasmids, phagemids, phasmids, cosmids, YACs, BACs, artificial chromosomes or particles suitable for particle bombardment used in molecular biology laboratories.<br class="style-scope patent-text">
[0081]<br class="style-scope patent-text">
Preferred vectors include pBIN and its derivatives for plant cells, pFL61 for yeast cells, pBLUESCRIPT vector for bacterial cells, and λZAP for phage (Stratagene).<br class="style-scope patent-text">
[0082]<br class="style-scope patent-text">
A variety of vectors are used, and many constructs are made within the scope of the present invention. Similarly, the invention relates to vectors used for transient or stable transformation of cell lines and stable expression of the HC110-R receptor.<br class="style-scope patent-text">
[0083]<br class="style-scope patent-text">
An EGFP construct expressing a fusion protein with an N-terminal EGFP tag (EGFP-HC110-R) or a fusion protein with a C-terminal EGFP tag (HC110-R-EGFP) can be used for transient expression in eukaryotic cells. Produced. Similarly, the invention relates to polypeptides encoded by these vectors and conventional GFP vectors, as well as red shift and blue shift variants.<br class="style-scope patent-text">
[0084]<br class="style-scope patent-text">
A further construct, the vector pMyc6xHis, can be used for stable expression, as well as the invention relates to them. The vector pMyc6xHis is obtained from the vector pSecTagA [Invitrogen, Leek, NL] by double digestion with the restriction enzymes NhiI and SfiI, blunting the ends and ligating the vector again.<br class="style-scope patent-text">
[0085]<br class="style-scope patent-text">
Furthermore, the present invention relates to a host cell comprising a nucleic acid used according to the present invention or a vector used according to the present invention.<br class="style-scope patent-text">
[0086]<br class="style-scope patent-text">
The invention is particularly directed to the HEK-293 cell line stably transformed with HC110-R-Myc / His (38 124 Braunschweig, Mascherorder Weg 1b, Microorganismen und Zellkulturen GmbH, from the International Depositary Authority DSMZDmSmDgMsDmMsDmMsDmMsDmMsDmZDMsDmZDMsDmZDMsDmZDMsDmZDMsDmZDMsDMZDMsDmZDMsDmZMDMsmMsDmZmMsDmZDMsMsDmZDMsMsDmZDMsMdMsMdMsmMsDmZmMsDMZMsmZm ACC2464).<br class="style-scope patent-text">
[0087]<br class="style-scope patent-text">
The invention likewise relates to a nucleic acid used according to the invention or a vector used according to the invention, and a cell comprising Ca<sup class="style-scope patent-text">2+</sup>And a host cell comprising a vector that allows expression of aequorin, a photoprotein that emits light in the presence of E. coli. The corresponding host cell is Ca<sup class="style-scope patent-text">2+</sup>The change in concentration, ie the effect of the substance on, for example, HC110-R, can be tracked with the aid of an aequorin indicator. The present invention is particularly capable of expressing aequorin, 38 124 Braunschweig, Mascheroder Weg 1b, the International Depository Authority DSMZ-Deutsche Sammlung from Microorganismen und Zellkulturen GmbH, HC110-R-Myc / His deposited as number DSM ACC2465 HEK-293 cell line stably transformed by<br class="style-scope patent-text">
[0088]<br class="style-scope patent-text">
As used herein, the term "host cell" relates to a cell that does not naturally contain a nucleic acid of the present invention.<br class="style-scope patent-text">
[0089]<br class="style-scope patent-text">
Suitable and preferred host cells are eukaryotic cells such as yeast, mammalian, amphibian, insect or plant cells. Preferred eukaryotic host cells include HEK-293, Schneider S2, Spodoptera Sf9, Kc, CHO, HepG-2, K1, COS-1, COS-7, HeLa, C127, 3T3 or BHK cells, especially African Xenopus oocytes and HEK-293 or COS-7 cells are particularly preferred.<br class="style-scope patent-text">
[0090]<br class="style-scope patent-text">
Similarly, the present invention relates to the extraction of DNA from helminths, particularly preferably from the phylum Nematoda, particularly preferably from the Ciliate nematode family, particularly preferably from the genus Torchidium, and most preferably from Haemonchus contortus. It relates to the use of the DNA corresponding to SEQ ID NO: 2 as described in application number DE-A-197 04 024 for detection.<br class="style-scope patent-text">
[0091]<br class="style-scope patent-text">
Furthermore, the present invention relates to an oligonucleotide corresponding to the above-mentioned region of the DNA sequence or its complementary strand, and an oligonucleotide capable of hybridizing thereto. The present invention relates to those oligonucleotides or parts thereof,<br class="style-scope patent-text">
a) a probe in Northern or Southern blot analysis;<br class="style-scope patent-text">
b) PCR primers in the above diagnostic method for detecting helminths (where the PCR primers and the PCR technique are used to specifically amplify and identify the DNA of related helminths)<br class="style-scope patent-text">
As for its use.<br class="style-scope patent-text">
[0092]<br class="style-scope patent-text">
Furthermore, the present invention relates to a method for detecting helminths of the phylum Nematodes, preferably of the phylum Nematoda, particularly preferably of the family Ciliate, even more preferably of the genus Tortorida, and most preferably of Haemonchus contortus. Oligonucleotides relate to a method that specifically hybridizes to a DNA sequence from the organism and is then amplified by PCR techniques.<br class="style-scope patent-text">
[0093]<br class="style-scope patent-text">
Detection of the above-mentioned organisms is, for example,<br class="style-scope patent-text">
a) an oligonucleotide probe or primer which hybridizes with the DNA encoding HC110-R of the present invention or a complementary strand thereof, or a 5 'or 3' adjacent region thereof,<br class="style-scope patent-text">
b) contacting the oligonucleotide probe or primer with an appropriately prepared DNA-containing sample,<br class="style-scope patent-text">
c) detecting the hybridization of the oligonucleotide or primer (eg, using the polymerase chain reaction);<br class="style-scope patent-text">
d) determining the sequence of the detected HC110-R gene, and<br class="style-scope patent-text">
e) {compare this sequence with the DNA sequence according to the invention, preferably the sequence SEQ ID NO: 2 according to application number DE-A-197 04 024,<br class="style-scope patent-text">
It can be done by doing.<br class="style-scope patent-text">
[0094]<br class="style-scope patent-text">
Similarly, the present invention relates to a diagnostic test kit for detecting helminths of the nematodes, preferably of the nematode, particularly preferably of the family Ciliate, even more preferably of the genus Tortorida, and most preferably of the Haemonchus contortus. The kit particularly utilizes the oligonucleotides described above, which can be used in a method for detecting a species from the group of strains.<br class="style-scope patent-text">
[0095]<br class="style-scope patent-text">
Similarly, the invention relates to a diagnostic test kit as described above, wherein the oligonucleotides usable in this test kit are provided with a detectable marker. Such detectable markers include, inter alia, enzymes, enzyme substrates, coenzymes, enzyme inhibitors, fluorescent markers, chromophores, luminescent markers and radioisotopes.<br class="style-scope patent-text">
[0096]<br class="style-scope patent-text">
Furthermore, the present invention relates to the above HC110-R polypeptide or a fragment thereof, from a helminth, preferably a nematode, particularly preferably from the Ciliate nematode, even more preferably from the genus Torchinia and most preferably from Haemonchus contortus. Or at least one HC110-R polypeptide or a fragment thereof of a <figure-callout id="70" label="receptor protein" filenames="2004508052-18.png,2004508052-5.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">receptor protein</a></figure-callout> 70%, preferably 80%, particularly preferably 90% and even more preferably 95% homologous thereto, or 70%, preferably 70% thereof, It relates to the use for producing vaccines containing 80%, particularly preferably 90% and even more preferably 95% homologous receptor proteins. In this case, the vaccine can elicit an immune response specific for the HC110-R protein.<br class="style-scope patent-text">
[0097]<br class="style-scope patent-text">
In a preferred embodiment, the vaccine is encoded by an antigenic determinant, for example a single determinant of a polypeptide having the amino acid sequence of SEQ ID NO: 2 as described in application number DE-A-197 04 024, or the above DNA or a fragment thereof. Contains one determinant of a polypeptide.<br class="style-scope patent-text">
[0098]<br class="style-scope patent-text">
Furthermore, the present invention relates to a method for producing a polypeptide used according to the present invention. A polypeptide encoded by a known nucleic acid can be produced by culturing a host cell containing the nucleic acid under preferable conditions. The desired polypeptide can then be isolated from the cells or medium by conventional methods. The polypeptide can also be produced in an in vitro system.<br class="style-scope patent-text">
[0099]<br class="style-scope patent-text">
A rapid method for isolating a polypeptide according to the invention synthesized by a host cell using a nucleic acid according to the invention is to affinity purify the fusion partner in a simple manner, for example as described in the examples. Initiated by expression of the possible fusion protein. Fusion partners include, for example, glutathione S-transferase. The fusion protein can then be purified on a glutathione affinity column. The fusion partner can be removed by partial proteolytic cleavage, for example, with a linker between the fusion partner and the polypeptide of the invention to be purified. The linker can be designed to include a target amino acid such as an arginine or lysine residue that defines a site for cleavage by trypsin. Such linkers can be made by using standard cloning techniques using oligonucleotides. Another possible method is to use a histidine fusion protein and use Ni<sup class="style-scope patent-text">2+</sup>Based on its purification on Talon columns.<br class="style-scope patent-text">
[0100]<br class="style-scope patent-text">
Further possible purification methods include preparative electrophoresis, FPLC, HPLC (e.g. using a gel filtration column, reversed phase column or a lightly hydrophobic column), gel filtration, differential purification. , Ion exchange chromatography and affinity chromatography.<br class="style-scope patent-text">
[0101]<br class="style-scope patent-text">
Since receptor-like protein kinases are membrane proteins, in this purification method, for example, detergents that have little or no effect on the secondary and tertiary structure of the polypeptide, such as nonionic surfactants Preferably, surfactant extraction is performed using a surfactant.<br class="style-scope patent-text">
[0102]<br class="style-scope patent-text">
Purification of a polypeptide used in accordance with the present invention may include isolation of a membrane starting from a host cell that expresses a nucleic acid of the present invention. Such cells may have at least 10-fold, preferably at least 100-fold, and even more preferably at least 1000-fold the amount of polyclones found in the membrane compartment as compared to membranes derived from cells originally expressing the HC110-R gene. It is preferable that the cell expresses a sufficient number of copies of the polypeptide for the peptide amount.<br class="style-scope patent-text">
[0103]<br class="style-scope patent-text">
As used herein, the term "isolated or purified" refers to separating a polypeptide from other proteins or other macromolecules of cells or tissues. Preferably, a composition of the invention comprising a polypeptide is at least 10-fold, particularly preferably at least 100-fold, enriched in protein compared to preparations derived from host cells.<br class="style-scope patent-text">
[0104]<br class="style-scope patent-text">
Further, the polypeptide of the present invention can be affinity-purified without using a fusion partner by using an antibody that binds to the polypeptide.<br class="style-scope patent-text">
[0105]<br class="style-scope patent-text">
Furthermore, the present invention relates to an antibody that specifically binds to the above polypeptide or receptor. Such antibodies are purified by conventional methods. For example, such antibodies have been used in H.sub. The transmembrane receptor of the present invention, such as the HC110-R receptor from S. contortus, or a fragment thereof, may be produced by injecting an amount sufficient for antibody production and then isolating the antibody. Furthermore, immortalized cell lines which produce monoclonal antibodies can be obtained in a manner known per se. Antibodies can be appropriately labeled using a detection reagent. Preferred examples of such labeling reagents include enzymes, radiolabeled elements, fluorescent chemicals, or biotin. Instead of a complete antibody, it is also possible to use fragments having the desired specific binding properties.<br class="style-scope patent-text">
[0106]<br class="style-scope patent-text">
As used herein, the term “agonist” refers to a molecule that activates a transmembrane receptor.<br class="style-scope patent-text">
[0107]<br class="style-scope patent-text">
As used herein, the term "antagonist" refers to a molecule that displaces or inhibits the function of an agonist at the binding site of the agonist.<br class="style-scope patent-text">
[0108]<br class="style-scope patent-text">
The term "modulator" as used herein is a generic term for agonists and antagonists. A modulator may be a small organic compound molecule, peptide or antibody that binds a polypeptide according to the invention. Further, a modulator may be a small organic compound molecule, peptide or antibody that binds to a molecule, which in turn affects its biological activity by binding to a polypeptide of the invention. . Modulators can be mimics of natural substrates and ligands.<br class="style-scope patent-text">
[0109]<br class="style-scope patent-text">
Preferably, the modulator is a small organic compound.<br class="style-scope patent-text">
[0110]<br class="style-scope patent-text">
Binding of modulators to the polypeptides can alter the processes of helminth or arthropod cells treated with them, resulting in death.<br class="style-scope patent-text">
[0111]<br class="style-scope patent-text">
Thus, the invention further extends to the use of polypeptide modulators as anthelmintics and arthropodicides.<br class="style-scope patent-text">
[0112]<br class="style-scope patent-text">
The invention likewise relates in particular to the use of α-LTX as an anthelmintic.<br class="style-scope patent-text">
[0113]<br class="style-scope patent-text">
Also, the use according to the invention of a nucleic acid or polypeptide in the method of the invention makes it possible to find compounds which bind to the receptor of the invention. Similarly, the latter can be used as an anthelmintic, for example as a nematicide for plants or as an anthelmintic active for animals. For example, a host cell containing a nucleic acid and expressing its corresponding receptor or polypeptide, or its gene product, can be treated under conditions that allow the host cell, receptor or individual polypeptide to interact with at least one compound. Contact with a compound or mixture of compounds.<br class="style-scope patent-text">
[0114]<br class="style-scope patent-text">
The invention relates to transmembrane receptors from helminths or arthropods, preferably GPCRs of the secretin subfamily, particularly preferably H. a nematicidal active substance that binds to a receptor HC110-R from C. contortus and binds to a receptor whose sequence matches 70%, preferably 80%, particularly preferably 90% and even more preferably 95% of them. Particularly relevant are methods suitable for identification. However, the method may be practiced with HC110-R homologous receptors from species other than those described herein. The method of using the receptor other than HC110-R of the present invention is completely included in the present invention.<br class="style-scope patent-text">
[0115]<br class="style-scope patent-text">
The methods according to the present invention include high-throughput screening (eg, high-throughput screening (HTS) and ultra-high-throughput screening (UHTS)). For this purpose, both host cells and cell-free preparations containing the nucleic acids of the invention and / or the polypeptides of the invention can be used.<br class="style-scope patent-text">
[0116]<br class="style-scope patent-text">
<u class="style-scope patent-text">Cell-free test system</u> <br class="style-scope patent-text">
Many test systems aimed at testing compounds and natural extracts are designed for high throughput in order to maximize the number of substances tested in a given time period. Test systems based on cell-free operation require purified or semi-purified proteins. They are suitable for "early" tests, which are mainly aimed at detecting the potential effect of a substance on the target protein.<br class="style-scope patent-text">
[0117]<br class="style-scope patent-text">
Effects such as cytotoxicity are usually neglected in these in vitro systems. This test system further tests both the inhibitory or inhibitory and stimulatory effects of the substance. The effect of a substance can be confirmed by a series of concentration-dependent tests. A control mixture without test substance can be used to evaluate its effect.<br class="style-scope patent-text">
[0118]<br class="style-scope patent-text">
<u class="style-scope patent-text">Cell-based test system</u> <br class="style-scope patent-text">
The development of a cell-based test system for identifying substances that modulate the activity of HC110-R and homologous receptors has been developed with cell lines stably transfected with the HC110-R receptor that can be used according to the present invention. Although possible, they can also be developed with corresponding homologous receptors from other species that can be identified according to the present invention.<br class="style-scope patent-text">
[0119]<br class="style-scope patent-text">
Similarly, the present invention allows for the identification of other compounds that are effective as calcium channel blockers.<br class="style-scope patent-text">
[0120]<br class="style-scope patent-text">
Modulators can be used to modulate a synthesis reaction mixture (eg, the product of in vitro translation) or a material that constitutes a cell, eg, a membrane or any other preparation containing the polypeptide, in the presence of candidate molecules that can be agonists and antagonists, or It can be found by incubating with a labeled substrate or ligand of the polypeptide in the absence. The ability of a candidate molecule to increase or decrease the activity of a polypeptide of the invention will be evident from increasing or decreasing the binding of a labeled ligand or increasing or decreasing the conversion of a labeled substrate. Molecules that bind well and increase the activity of the polypeptide of the invention are agonists. Molecules that bind well but do not cause the biological activity of the polypeptide according to the invention are probably good antagonists.<br class="style-scope patent-text">
[0121]<br class="style-scope patent-text">
<u class="style-scope patent-text">Scintillation proximity assay (SPA)</u> <br class="style-scope patent-text">
One possibility for identifying substances that modulate the activity of HC110-R and its homologous receptor proteins is called a scintillation proximity assay (SPA) (EP-A-015 473). This test system utilizes the interaction of a radiolabeled ligand (eg, a small organic molecule or a second radiolabeled protein molecule) with a receptor (eg, HC110-R). In this case, the receptor is bound to microparticles or beads provided with the scintillating molecule. During the decay of radioactivity, the spherical scintillating material is excited by the elementary particles of the radioactive marker and emits detectable photons. The test conditions are optimized such that only particles emitted by the ligand to emit a signal will be emitted by the ligand bound to the receptor or HC110-R.<br class="style-scope patent-text">
[0122]<br class="style-scope patent-text">
In one possible embodiment, HC110-R is bound to beads with or without interaction or binding with a test substance. Furthermore, in this case, a fragment of the HC110-R receptor could also be used. The radiolabeled ligand can be, for example, labeled α-LTX, nifedipine or labeled depsipeptide. When the binding ligand binds to the immobilized HC110-R receptor, the ligand is present between the immobilized HC110-R and the labeled ligand to bind itself to the area of the contact moiety. Will need to be inhibited or destroyed. Successful binding to the labeled HC110-R receptor can then be detected by flash. Similarly, the complex between the immobilized labeled ligand and the non-immobilized labeled ligand is destroyed by the binding of the test substance and attenuates to an intensity that can be detected by a flash. The test system then responds to the auxiliary inhibition system<br class="style-scope patent-text">
[0123]<br class="style-scope patent-text">
<u class="style-scope patent-text">Two hybrid system</u> <br class="style-scope patent-text">
Another example of a whole cell based test system is what is called a two-hybrid system. A specific example is a so-called interaction trap. This involves the genetic selection of interacting proteins in yeast (see, eg, Gyuris et al., 1993). The test system is designed to detect and delineate the interaction of the two proteins through successful interactions that produce a detectable signal.<br class="style-scope patent-text">
[0124]<br class="style-scope patent-text">
Such a test system can be applied to test a large amount of a test substance within a predetermined period.<br class="style-scope patent-text">
[0125]<br class="style-scope patent-text">
This system is based on the construction of two vectors, a "decoy" vector and a "prey" vector. The gene encoding the HC110-R of the present invention or a fragment thereof is cloned into a decoy vector, and then expressed as a fusion protein with a LexA protein which is a DNA binding protein. A second gene encoding an HC110-R interaction partner, eg, α-LTX, is cloned into a bait vector and expressed as a fusion protein with the B42 bait protein. Both vectors are present in Saccharomyces cerevisiae hosts that contain a copy of LexA-binding DNA 5 'to the lacZ or HIS2 reporter gene. Interaction between the two fusion proteins activates transcription of the receptor gene. If the interaction is inhibited or disrupted by the presence of the test substance, the two fusion proteins can no longer interact and no reporter gene product is produced.<br class="style-scope patent-text">
[0126]<br class="style-scope patent-text">
<u class="style-scope patent-text">Replacement test</u> <br class="style-scope patent-text">
An example of another way in which modulators of the polypeptides according to the invention can be found are displacement tests, which, under conditions suitable for this purpose, comprise a potential modulator of the polypeptides of the invention and potential modulators. Is a test in which a compound known to bind to the polypeptide of the present invention, for example, a natural substrate or ligand, or a substrate or ligand mimic is combined. α-LTX is preferably used in this test according to the method of the present invention.<br class="style-scope patent-text">
[0127]<br class="style-scope patent-text">
Known analytical systems, such as those of Biacore AB, Uppsala, Sweden, are based on the complete HC110-R protein, or the N-host C-terminal deletion mutant of HC110-R, in vitro mutagenesis or other known methods. Other variants of the modified HC110-R molecule can be used for molecular interaction studies. This includes one<br class="style-scope patent-text">
(I) Binding of the HC110-R receptor or a fragment thereof by known chemical methods (coupling via amines, thiols, aldehydes), or affinity binding to a biochip (eg, streptavidin-biotin, IMAC) or, to another,<br class="style-scope patent-text">
(Ii) It is necessary to attach α-LTX or another modulator, such as BAY44-4400 or another potential ligand, to the chip as described in (i).<br class="style-scope patent-text">
[0128]<br class="style-scope patent-text">
The binding between the immobilized molecule and a ligand (such as the HC110-R protein or any modulator, such as BAY44-4400) present in solution is physically measured. The ligand is immobilized on a Biacore Instrument on a sensor chip having a thin layer of gold. The analyte solution is diffused by the micro flow cell on the chip. Binding of the analyte to the immobilized ligand increases the local concentration of the surface and gradually increases the refractive index of the gold layer near the medium. This is an effect on the interaction between free electrons (plasmons) in the metal and photons emitted from the instrument. This physical change is proportional to the mass and number of molecules on the chip, and its ligand-analyte binding can be recorded in real-time and the apparent binding / dissociation constant determined (Fivash et al., 1998). The specificity of the binding is demonstrated by competition experiments.<br class="style-scope patent-text">
[0129]<br class="style-scope patent-text">
In addition, the corresponding measurements are used to determine the HC110-R protein domain important for ligand binding and to identify new, previously undisclosed ligands for HC110-R.<br class="style-scope patent-text">
[0130]<br class="style-scope patent-text">
<u class="style-scope patent-text">Calcium imaging</u> <br class="style-scope patent-text">
Calcium imaging or signaling is considered as another method of detecting substances that interact with HC110-R (see, for example, FIGS. 11 and 10). This requires the use of calcium indicators to help detect changes in intracellular calcium levels. HC110-R expressing cells loaded with a calcium indicator are used in this method. When there is calcium influx caused by the HC110-R agonist, or release of intracellular calcium, there is a change in absorbance under UV irradiation as a function of the calcium uptake of the indicator. Antagonists can be identified in this system by completely or partially inhibiting the calcium signal induced by an agonist (eg, α-LTX). Possible calcium indicators preferred for this purpose include Fura-2 (Sigma) or Indo-1 (molecular probes).<br class="style-scope patent-text">
[0131]<br class="style-scope patent-text">
In addition, calcium indicators are excited by visible light and their fluorescent properties change in a detectable manner depending on calcium uptake. Indicators Fluo-3 and Fluo-4 have high calcium affinity. Fluo-4 has a strong fluorescent signal and is particularly preferred for measurement in test systems that use cells only at low concentrations, as in the case of HEK-293 cells. Further, as indicators, Rhod-2, x-Rhod-1, Fluo-5N, Fluo-5F, Mag-Fluo-4, Rhod-5F, Rhod-5N, Y-Rhod-5N, Mag-Rhod-2, Mag -X-Rhod-1, calcium green-1 and -2, calcium green-5N, Oregon green 488 BAPTA-1, Oregon green 488 BAPTA-2 and -5N, Fura red, calcein and the like.<br class="style-scope patent-text">
[0132]<br class="style-scope patent-text">
Another method of loading a calcium indicator into cells is recombinant expression of a photoprotein in target cells. These photoproteins respond to emit light when they form a complex with calcium ions. Aequorin is a photoprotein that is already widely used in many research and test systems. Cells that express the target protein simultaneously with aequorin are first loaded with the luminophore coelenterazine in this test method. Apoaequorin formed by cells forms a complex with coelenterazine and carbon dioxide. Subsequently, calcium also enters the cells and, when bound to this complex, releases carbon dioxide and emits blue light (maximum emission about 466 nm). The light emission in this case correlates with the concentration of calcium present in the cell.<br class="style-scope patent-text">
[0133]<br class="style-scope patent-text">
Thus, the invention also relates to the use of HC110-R, fragments thereof, or similar proteins from other organisms, wherein the function of the receptor or the binding of a modulator to the receptor is aequorin or a similar photoprotein. Detected by a light signal mediated by<br class="style-scope patent-text">
[0134]<br class="style-scope patent-text">
In this method, a substance that changes the expression of the receptor can be found by using a host cell or a transgenic invertebrate containing the nucleic acid of the present invention. Such substances may also represent valuable anthelmintics.<br class="style-scope patent-text">
[0135]<br class="style-scope patent-text">
Therefore, the active substances found by the method of the present invention are preferred for the control of animal pests, especially insects, spiders and nematodes occurring on farms, forests, warehouses, the protection of materials, and the hygiene sector. Active substances found by the method of the invention are particularly preferred for combating nematodes and spiders. The above pests include:<br class="style-scope patent-text">
[0136]<br class="style-scope patent-text">
Those belonging to the order Isopoda, for example, Oniscus asellus, Armadillidium vulgare, Porcellio scaber.<br class="style-scope patent-text">
Those belonging to the order Diplopoda, for example, Blaniulus guttulatus.<br class="style-scope patent-text">
Those belonging to the order Chilopoda, for example, Geophilus carpophagus, Scutigera spp. .<br class="style-scope patent-text">
Those belonging to the order Symphyla, for example, Scutigella immaculata.<br class="style-scope patent-text">
Those belonging to the order Thysanura, such as Lepisma saccharina.<br class="style-scope patent-text">
Those belonging to the order of the Collembola, for example, Onychiurus armatus.<br class="style-scope patent-text">
Those belonging to the order Orthoptera, for example, Acheta domesticus, Grylotalpa spp. , Locusta migratoria migratrioides, Melanoplus spp. , Schistocerca gregaria.<br class="style-scope patent-text">
Those belonging to the order Blattaria, for example, Blatta orientalis, Periplaneta americana, Leucophaea maderaae, Blattella germanica.<br class="style-scope patent-text">
Those belonging to the order Dermaptera, for example, Forficula auricularia.<br class="style-scope patent-text">
Those belonging to the order Isoptera, for example, Reticulitermes spp. .<br class="style-scope patent-text">
Those belonging to the order Phthiraptera, for example, Pediculus humanus corporis, Haematopinus spp. , Linognatus spp. , Trichodictes spp. , Damalinia spp. .<br class="style-scope patent-text">
Those belonging to the order Thysanoptera, for example, Hercinothrips femoralis, Trips tabaci, Trips palmi, Franklinella accidentalis.<br class="style-scope patent-text">
Heteroptera, for example, Eurygaster spp. , Dysdercus intermedius, Piesma quadrata, Cimex lectulararius, Rhodnius prolixus, Triatoma spp.<br class="style-scope patent-text">
[0137]<br class="style-scope patent-text">
Those belonging to the Homoptera eyes, for example, Aleurodes brassicae, Bemisia tabaci, Trialeurodes vaporariorum, Aphis gossypii, Brevicoryne brassicae, Cryptomyzus ribis, Aphis fabae, Aphis pomi, Eriosoma lanigerum, Hyalopterus arundinis, Phylloxera vastatrix, Pemphigus spp. , Macrosiphum avenae, Myzus spp. , Phorodon humuli, Rhopalosiphum padi, Empoasca spp. , Eucelis bilobatus, Nephotettix cinctipeps, Lecanium corni, Saissetia oleae, Laodelphax striatelus, Nilaparvati rugosa, elapa itai, italy. , Psylla spp.<br class="style-scope patent-text">
[0138]<br class="style-scope patent-text">
Those belonging to the Lepidoptera eyes, for example, Pectinophora gossypiella, Bupalus piniarius, Cheimatobia brumata, Lithocolletis blancardella, Hyponomeuta padella, Plutella xylostella, Malacosoma neustria, Euproctis chrysorrhoea, Lymantria spp. , Bucculix thurberella, Phyllocnistis citrella, Agrotis spp. , Euxoa spp. , Feltia spp. , Earias insulana, Heliothis spp. , Mamestra brassicae, Panolis flamemma, Spodoptera spp. , Trichoplusia ni, Carpocapsa pomonella, Pieris spp. , Chilo spp. , Pyrausta nubilalis, Ephestia kuehniella, Galleria mellonella, Tineola bisselliella, Tinea pellionella, Hofmannophila pseudospretella, Cacoecia podana, Capua reticulana, Choristoneura fumiferana, Clysia ambiguella, Homona magnanima, Tortrix viridana, Cnaphalocerus spp. , Olema oryzae.<br class="style-scope patent-text">
Those belonging to the Coleoptera eyes, for example, Anobium punctatum, Rhizopertha dominica, Bruchidius obtectus, Acanthoscelides obtectus, Hylotrupes bajulus, Agelastica alni, Leptinotarsa decemlineata, Phaedon cochleariae, Diabrotica spp. , Psylliodes chrysocephala, Epilachna varivestis, Atomaria spp. , Oryzaephilus surinamensis, Anthonomus spp. , Sitophilus spp. , Otiorrhynchus sulcatus, Cosmopolites sordius, Ceutorrhynchus assimilis, Hypera postica, Dermestes spp. , Trogoderma spp. , Anthrenus spp. , Attagenus spp. , Lyctus spp. , Meligethes aeneus, Ptinus spp. , Niptus holleucus, Gibium psylloides, Tribolium spp. , Tenebrio molitor, Agriotes spp. , Conoderus spp. , Mellontha melonlontha, Amphimalon solstitialis, Costetra zealandica, Lisorhoptrus oryzophilus.<br class="style-scope patent-text">
Hymenoptera, for example, Diprion spp. , Hoplocampa spp. , Lasius spp. , Monomorium pharaonis, Vespa spp.<br class="style-scope patent-text">
Those belonging to the order Diptera, for example, Aedes spp. , Anopheles spp. , Culex spp. , Drosophila melanogaster, Musca spp. , Fannia spp. , Calliphora erythrocephala, Lucilia spp. , Chrysomyia spp. , Cuterebra spp. , Gastrophilus spp. , Hypobosca spp. , Stomoxys spp. , Oestrus spp. , Hypoderma spp. , Tabanus spp. , Tannia spp. , Biohortullanus, Oscinella frit, Phorbia spp. , Pegomyia hyoscamimi, Ceratitis capitata, Dacus oleae, Tipula paulodosa, Hylemyia spp. , Liriomyza spp. .<br class="style-scope patent-text">
[0139]<br class="style-scope patent-text">
From the order of the Siphonaptera, for example, Xenopsylla cheopis, Ceratophyllus spp. .<br class="style-scope patent-text">
[0140]<br class="style-scope patent-text">
Those belonging to the Arachnida network, such as Scorpio maurus, Latrodectus mactans, Acarus siro, Argas spp. , Ornithodoros spp. , Dermanyssus gallinae, Eriophys livis, Phylocoptrutta oleivora, Boilophilus spp. , Rhipicephalus spp. , Amblyomma spp. , Hyalomma spp. , Ixodes spp. , Psoroptes spp. , Chorioptes spp. , Sarcoptes spp. , Tarsonmus spp. , Bryobia praetiosa, Panonychus spp. , Tetranychus spp. , Hemitarsonemus spp. , Brevipalpus spp. .<br class="style-scope patent-text">
[0141]<br class="style-scope patent-text">
As the plant parasitic nematode, for example, Pratylenchus spp. , Radiopholus similis, Ditylenchus dipsaci, Tylenchurus semiipenetrans, Heterodera spp. , Globodera spp. , Meloidogyne spp. , Aphelenchoides spp. , Longidorus spp. , Xifinema spp. , Trichodorus spp. , Bursaphelenchus spp. Is mentioned.<br class="style-scope patent-text">
[0142]<br class="style-scope patent-text">
Active substances found using the method according to the present invention include not only plant, sanitary and stored pests, but also hard ticks, soft ticks, mange mites, leaf mites. It also acts on the veterinary medicine department against animal parasites (ectoparasites), such as (leaf mites), flies (chewing and licking), parasitic fly larvae, lice, fur, fur flies and fleas. The parasites include:<br class="style-scope patent-text">
[0143]<br class="style-scope patent-text">
Those belonging to the order of Anoplurida, for example, Haematopinus spp. , Linognatus spp. , Pediculus spp. , Phtirus spp. , Solenopotes spp. .<br class="style-scope patent-text">
Those belonging to the order of Mallophagida, and those belonging to the suborders of Amblycerina and Ischnocerina, such as Trimenopon spp. , Menopon spp. , Trinoton spp. , Bovicola spp. , Werneckiella spp. , Lepikentron spp. , Damalina spp. , Trichodictes spp. , Felicola spp. .<br class="style-scope patent-text">
[0144]<br class="style-scope patent-text">
Those belonging to the order Diptera and those belonging to the order Nematocerina and Brachycerina, such as Aedes spp. , Anopheles spp. , Culex spp. , Simulium spp. , Eusimulium spp. , Phlebotomus spp. , Lutzomia spp. , Curicoides spp. , Chrysops spp. , Hybomitra spp. , Atylotus spp. , Tabanus spp. , Haematopota spp. , Philippomyia spp. , Braula spp. , Musca spp. , Hydrotaea spp. , Stomoxys spp. , Haematobia spp. , Morellia spp. , Fannia spp. , Glossina spp. , Calliphora spp. , Lucilia spp. , Chrysomyia spp. , Wohlfahrtia spp. , Sarcophaga spp. , Oestrus spp. , Hypoderma spp. , Gasterophilus spp. , Hippobosca spp. , Lipoptena spp. , Melophagus spp. .<br class="style-scope patent-text">
[0145]<br class="style-scope patent-text">
Those belonging to the order of Siphonapterida, for example, Pulex spp. , Ctenocephalides spp. , Xenopsylla spp. , Ceratophyllus spp. .<br class="style-scope patent-text">
[0146]<br class="style-scope patent-text">
Those belonging to the order Heteropterida, for example, Cimex spp. , Triatoma spp. , Rhodnius spp. , Panstrongylus spp. .<br class="style-scope patent-text">
[0147]<br class="style-scope patent-text">
Those belonging to the order Blattarida, for example, Blatta orientalis, Periplaneta americana, Blattela germanica, Superella spp. .<br class="style-scope patent-text">
[0148]<br class="style-scope patent-text">
Acaria (Acarida) belonging to the sub-net and those belonging to the order Meta- and Mesostigmata, for example, Argas spp. , Ornithodorus spp. , Otobius spp. , Ixodes spp. , Amblyomma spp. , Boophilus spp. , Dermacentor spp. , Haemophysalis spp. , Hyalomma spp. , Rhipicephalus spp. , Dermanyssus spp. , Railillia spp. , Pneumonyssus spp. , Sternostoma spp. , Varroa spp. .<br class="style-scope patent-text">
[0149]<br class="style-scope patent-text">
Those belonging to the order of Actinedida (Prostigmata) and Acaridida (Astigmata), for example, Acarapis spp. , Cheyletiella spp. , Ornithocheletia spp. , Myobia spp. , Psorergates spp. , Demodex spp. , Trombicula spp. , Listrophorus spp. , Acarus spp. , Tyrophagus spp. , Caloglyphus spp. , Hypodectes spp. , Pterolichus spp. , Psoroptes spp. , Chorioptes spp. , Otodictes spp. , Sarcoptes spp. , Notoedres spp. , Knemidoptes spp. , Cytodictes spp. , Laminosoptes spp. .<br class="style-scope patent-text">
[0150]<br class="style-scope patent-text">
The active substances found by the method according to the invention are also mites, especially house dust mites, such as Dermatophagoides pteronyssinus and It is preferable to get rid of farinae.<br class="style-scope patent-text">
[0151]<br class="style-scope patent-text">
The active substances found using the method according to the invention can also be agriculturally produced livestock, such as cattle, sheep, goats, horses, pigs, donkeys, camels, buffaloes, rabbits, chickens, turkeys, ducks, geese, honeybees. And other pets (for example, dogs, cats, cage birds and ornamental fish), and so-called experimental animals (for example, hamsters, guinea pigs, rats and mice), and are preferred for combating arthropods. Elimination of these arthropods reduces mortality and loss of productivity (meat, milk, fur, hide, eggs, honey, etc.), resulting in more economical and easier animal management Is made possible through the use of the active substances according to the invention.<br class="style-scope patent-text">
[0152]<br class="style-scope patent-text">
Similarly, compounds and polypeptides found by the described methods can treat animals and humans infected by pathogenic endogenous parasites in human or productive livestock, pets, zoo animals, and research and laboratory animals. Useful to do.<br class="style-scope patent-text">
[0153]<br class="style-scope patent-text">
The compounds can be used in all strategies in the development of normal, sensitive and resistant strains. Treatment with compositions containing one or more of these compounds makes it possible to prevent economic losses in productive livestock and to treat diseases in humans and animals. The following parasites are of particular interest as targets for the active substances found.<br class="style-scope patent-text">
[0154]<br class="style-scope patent-text">
<u class="style-scope patent-text">Enoplida</u>For example, Trichuris spp. , Capillaria spp. , Trichomosoides spp. , Trichinella spp.<br class="style-scope patent-text">
<u class="style-scope patent-text">Rhabditia</u>For example, Micronema spp. , Strongyloides spp.<br class="style-scope patent-text">
<u class="style-scope patent-text">Strongylida</u>For example, Strongylus spp. , Tridonotophorus spp. Oesophagodontus spp. , Trichonema spp. , Gialocephalus spp. Cylindropharynx spp. , Poteriostomum spp. , Cyclococercus spp. , Cylicostephanus spp. Oesophagostomum spp. Chabertia spp. , Stephanurus spp. , Ancylostoma spp. Uncinaria spp. Bunostum spp. , Globocephalus spp. Syngamus spp. Cyathostum spp. , Cylicocyclus spp. , Neostrongylus spp. , Cystocaulus spp. , Pneumostrongyrus spp. , Spicocaurus spp. , Elaphostrongylus spp. Parellaphostrongylus spp. , Crenosoma spp. Paracrenosoma spp. , Angiostrongylus spp. Aelurostrongylus spp. Filaroides spp. Parafiaroides spp. , Trichostrongylus spp. Haemonchus spp. , Ostertagia spp. Marshallia spp. Cooperia spp. , Nematodirus spp. , Hydrostrongylus spp. Obeliscoides spp. , Amidostomum spp. , Olulanus spp. Dictyocaulus spp. Muellerius spp. Protostrongylus spp.<br class="style-scope patent-text">
[0155]<br class="style-scope patent-text">
<u class="style-scope patent-text">Oxyurida</u>For example, Oxyuris spp. , Enterobius spp. , Passalurus spp. , Syphacia spp. , Aspiculuris spp. Heterakis spp.<br class="style-scope patent-text">
[0156]<br class="style-scope patent-text">
<u class="style-scope patent-text">Ascaridia</u>For example, roundworm spp. , Toxascaris spp. , Toxocara spp. , Parascaris spp. Anisakis spp. , Ascaridia spp.<br class="style-scope patent-text">
<u class="style-scope patent-text">Spirurida</u>For example, Gnathostoma spp. , Physaloptera spp. , Thelazia spp. , Gongylonema spp. Habronema spp. Parabonema spp. , Drashia spp. , Dracunculus spp.<br class="style-scope patent-text">
<u class="style-scope patent-text">Filariida</u>For example, Stephanofilaria spp. Parafiaria spp. , Setaria spp. , Loa spp. , Dirofilaria spp. , Litomosoides spp. , Brugia spp. Wuchereria spp. , Onchocerca spp.<br class="style-scope patent-text">
<u class="style-scope patent-text">Gigantorhynchida</u>For example, in Filicollis spp. Moniliformis spp. , Macracanthorhynchus spp. Prosthenorchis spp.<br class="style-scope patent-text">
<u class="style-scope patent-text">Mastigophora</u> <u class="style-scope patent-text"> </u> <u class="style-scope patent-text">(Flagellata)</u> <br class="style-scope patent-text">
<u class="style-scope patent-text">Trypanosomatidae</u>For example, Trypanosoma b. brucei, T .; b. gambiense, T .; b. rhodesense, T.W. congolense, T .; cruzi, T .; evansi, T .; equinum, T .; lewisi, T .; percae, T .; simiae, T .; Vivax, Leishmania brasiliensis, L. et al. donovani, L .; tropica<br class="style-scope patent-text">
<u class="style-scope patent-text">Trichomonadidae</u>&nbsp;For example, Giardia lambilia, G. et al. canis.<br class="style-scope patent-text">
<u class="style-scope patent-text">Sarcomastigophora</u> <u class="style-scope patent-text"> </u> <u class="style-scope patent-text">(Rhizopoda)</u>For example, Entamoeba histolytica<br class="style-scope patent-text">
<u class="style-scope patent-text">Hartmanellidae</u> <u class="style-scope patent-text">,</u>For example, Acanthamoeba sp. Hartmanella spp.<br class="style-scope patent-text">
<u class="style-scope patent-text">Apicomplexa</u> <u class="style-scope patent-text"> </u> <u class="style-scope patent-text">(Sporozoa)</u>For example, Eimeria acervulina, E. et al. adenoides, E.A. alabahmensis, E .; anatis, E .; anseris, E .; arloingi, E .; ashata, E .; auburnensis, E.C. bovis, E .; Brunetti, E .; canis, E .; chinchillae, E.C. clupearum, E .; colbae, E.C. contacta, E.C. Candalis, E. et al. debriecki, E .; dispersa, E .; ellipsoidales, E.C. falciformis, E.C. faurei, E .; labbeana, E.C. leucarti, E.L. magna, E .; maxima, E .; media, E .; meleagridis. E. FIG. meleagrimitis, E .; mitis, E .; necatrix, E.C. ninakohlyakimovae, E .; ovis, E .; parva, E .; pavonis, E .; perforans, E .; phasani, E .; piriformis, E.P. praecox, E.C. Residua, E.C. scbra, E.C. Spec. , E .; stiedai, E .; suis, E. tenella, E .; truncata, E.C. truttae, E.P. zuernii, Globidium spec. , Isospora belli, I .; canis, I .; felis, I .; ohioensis, I .; rivolta, I .; Spec. , I .. suis, Neospora caninum, Cystospora spec. Cryptosporium spec.<br class="style-scope patent-text">
<u class="style-scope patent-text">Toxoplasmadidae</u>For example, Toxoplasma gondii<br class="style-scope patent-text">
<u class="style-scope patent-text">Sarcocysidae</u>For example, Sarcocytis bovicanis, S. et al. bovihominis, S .; neuvona, S .; ovicanis, S .; oviferis, S .; Spec. , S.P. suihominis<br class="style-scope patent-text">
<u class="style-scope patent-text">Leucozide</u>For example, Leucozytozoon simondi<br class="style-scope patent-text">
<u class="style-scope patent-text">Plasmodiidae</u>For example, Plasmodium berghei, P.M. falciparum, P .; malariae, P .; ovale, p. vivax, P.E. Spec.<br class="style-scope patent-text">
<u class="style-scope patent-text">Piroplasmea</u>For example, Babesia argentina, B.A. bovis, B .; canis, B .; Spec. , Theileria parva, T.W. Spec.<br class="style-scope patent-text">
<u class="style-scope patent-text">Adeleina</u>For example, Hepatozoon canis, H .; Spec.<br class="style-scope patent-text">
[0157]<br class="style-scope patent-text">
Furthermore, of interest, Myxospora and Microspora, for example, Glugea spec. And Nosema spec. , And Pneumocystis carinii,<u class="style-scope patent-text">Ciliophora</u> <u class="style-scope patent-text"> </u> <u class="style-scope patent-text">(Ciliata)</u>For example, Balantidium coli, Ichthiophthirius spec. , Trichondina spec. Or<u class="style-scope patent-text">Epistylis</u>&nbsp;Spec.<br class="style-scope patent-text">
[0158]<br class="style-scope patent-text">
The compounds and compositions found are likewise effective against protozoa of the insects, for example animals of the phylum Microsporidia, in particular of the order Nosema, more particularly of the species Nosema apis, a honeybee parasite.<br class="style-scope patent-text">
[0159]<br class="style-scope patent-text">
Accordingly, the invention relates to the use of a compound of the invention or a nucleic acid or polypeptide of the invention for producing a composition for combating helminths and / or arthropods.<br class="style-scope patent-text">
[0160]<br class="style-scope patent-text">
<u class="style-scope patent-text">Example</u> <br class="style-scope patent-text">
1. Construction and screening of cDNA library<br class="style-scope patent-text">
Construction of a cDNA library, production of a KLH-PF1022A conjugate, and antiserum against PF1022A, and immunoscreening of a cDNA library and DNA analysis were performed as described in WO 98/15625.<br class="style-scope patent-text">
[0161]<br class="style-scope patent-text">
2. RNA isolation<br class="style-scope patent-text">
Total RNA was isolated by extraction from adult Haemonchus contortus nematodes by GTC / CsCl cushion method (Sambrook et al., 1989) or obtained in one step by GTC / phenol / chloroform extraction (Chomczynski and Sacchi 1987). . Poly (A)<sup class="style-scope patent-text">+</sup>RNA was isolated by chromatography on oligo (dT) cellulose (Aviv and Leder, 1972).<br class="style-scope patent-text">
[0162]<br class="style-scope patent-text">
3. Northern blotting<br class="style-scope patent-text">
Gluoxylated total RNA (20 μg per lane) derived from Haemonchus contortus was fractionated on an agarose gel (Sambrook et al., 1989; McMaster and Carmichael 1977), and standard capillary transport method (the basic capsular transport chemistry, medium and free shipping). To move to a Hybond N membrane (Amersham). The radiolabeled probe was purchased from Megaprime Kit (Amersham, Braunschweig, Germany) and 50 μCi of [α-<sup class="style-scope patent-text">32</sup>P] dCTP (3000 Ci / mmol, ICN, Meckenheim, Germany) was prepared by random labeling of the linearized plasmid DNA (HC110-R). Hybridization was performed using 6 × SSC (1 × SSC: 0.15 M NaCl, 0.015 M sodium citrate), 5 × Denhardt's reagent (0.1% polyvinylpyrrolidone, 0.1% BSA, 0.1% Ficoll) 400), 0.1% SDS and 100 μg / mL herring sperm DNA at 65 ° C. overnight. The filters were washed and exposed at 65 ° C. with high stringency in 0.1 × SSC and 0.1% SDS (−80 ° C. Kodak BioMax MS film) (see FIG. 1 (A)).<br class="style-scope patent-text">
[0163]<br class="style-scope patent-text">
4.5 'and 3' RACE PCR<br class="style-scope patent-text">
Using the 5 '/ 3' RACE method, the missing 5 'and 3' ends of the identified cDNA clones were isolated.<br class="style-scope patent-text">
[0164]<br class="style-scope patent-text">
5 'RACE is based on specifically amplifying the 5' end of mRNA-derived genes. First strand cDNA is synthesized using sequence specific primers and AMV reverse transcriptase. Attachment of the poly (A) tail to the product allows the use of oligo dT anchor primers and nested sequence specific primers in subsequent PCR. In another PCR, another nested primer can be used to ensure specificity.<br class="style-scope patent-text">
[0165]<br class="style-scope patent-text">
In 3 'RACE, the first cDNA strand is synthesized using an oligo dT primer, and subsequent PCR reactions are performed using sequence-specific primers.<br class="style-scope patent-text">
[0166]<br class="style-scope patent-text">
The cDNA was purified using primers 5'-GGT CAC CGT CGT CCC AGA AA-3 'and 1 g H.C. using the 5' RACE kit from GIBCO BRL (Eggenstein, Germany). contortus synthesized from total RNA. Supercrypt reverse transcriptase was used for this purpose. C tailing of the C-terminus of this cDNA was performed using terminal deoxynucleotidyl transferase. The first amplification consisted of a 400 nM oligodeoxyinosyl anchor primer (5′-CUA CUA CUA CUA GGC CAC GCG TCG ACT AGT ACG GGI IGG GII GGG IIG-3 ′) and a 400 nM first nested <figure-callout id="5" label="primer" filenames="2004508052-10.png,2004508052-16.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">primer</a></figure-callout> 5′-. Using CCA TTC GAT TCC TCT TCT CG-3 ′ (Birsner and Grob, Denzlingen, Germany), 200 μM of each dNTP and 1.5 mM of <figure-callout id="2" label="MgCl" filenames="2004508052-10.png,2004508052-15.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">MgCl</a></figure-callout> 2 were used.<sub class="style-scope patent-text">2</sub>Performed in 50 μl containing 1/5 tail cDNA and 2.5 U of native Taq polymerase. The first denaturation was performed at 94 ° C. for 5 minutes, then 35 cycles of 94 ° C. for 1 minute, 53 ° C. for 1 minute and 72 ° C. for 10 minutes, followed by a final synthesis step at 72 ° C. for 10 minutes. The reaction conditions for the nested PCR were as follows: 1 μl of the first amplification product was used as a template, the gene-specific second <figure-callout id="5" label="nested primer" filenames="2004508052-10.png,2004508052-16.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">nested primer</a></figure-callout> 5′-GTC GAT GGT GCA GAT TTC GC-3 ′, anchor primer (5′-CUA CUA CUA) CUA GGC CAC GCG TCG ACT AGT AC-3 ′) is the same as described above, except that the cycle was performed with only 25 cycles at an annealing temperature of 53 ° C.<br class="style-scope patent-text">
[0167]<br class="style-scope patent-text">
3 'RACE PCR (GIBCO BRL, Eggenstein, Germany) was used for adult H. starting from preincubation at 70 ° C. for 10 minutes with 1 μg of total RNA from S. contortus and 500 nM of oligo <figure-callout id="5" label="dT adapter primer" filenames="2004508052-10.png,2004508052-16.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">dT adapter primer</a></figure-callout> 5′-GGC CAC GCG TCG ACT AGT ACT TTT TTT TTT TTT TTT TTT T-3 ′; C. for 2 minutes. 2.5 mM MgCl in 20 μl<sub class="style-scope patent-text">2</sub>After the addition of 500 μM, 10 μM DTT of each dNTP and 200 U of Super-Script II reverse transcriptase, the cDNA was incubated at 42 ° C. for 50 minutes and in the last step at 70 ° C. for 15 minutes and 4 ° C. for 10 minutes. E. FIG. RNA was removed by incubating at 37 ° C. for 10 minutes using E. coli RNase H 2U. The first amplification consisted of 200 mM each dNTP, 1.5 <figure-callout id="400" label="mM MgCl" filenames="2004508052-10.png,2004508052-16.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">mM MgCl<sub class="style-scope patent-text"></sub></a></figure-callout><sub class="style-scope patent-text">2</sub>400 nM universal adapter primer (5'-CUA CUA CUA CUA GGC CAC GCG TCG ACT AGT AC-3 ') and 400 nM sequence in 50 μl containing 1 / 10th tail cDNA and 2.5 U of native Taq DNA polymerase This was performed using a <figure-callout id="5" label="specific primer" filenames="2004508052-10.png,2004508052-16.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">specific primer</a></figure-callout> 5′-TTTGTCTCTT CCT TGG TAT CC-3 ′. The first denaturation step is performed at 94 ° C. for 3 minutes, then 35 cycles of 94 ° C. for 1 minute, 51 ° C. for 1 minute and 72 ° C. for 2 minutes, and the final synthesis step is carried out at 72 ° C. For 15 minutes. Unless otherwise stated, 2 μl of the first amplification was used for nested PCR and the other conditions were the same, but in this case the <figure-callout id="5" label="short adapter primer" filenames="2004508052-10.png,2004508052-16.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">short adapter primer</a></figure-callout> 5′-GGC CAC GCG TCG ACT AGT AC-3 ′ and the nested <figure-callout id="30" label="primer" filenames="2004508052-12.png,2004508052-13.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">primer</a></figure-callout> 30 cycles were performed using 5'-ACA CTC TAA TCT CCA ACT G-3 '. The PCR product was analyzed on a 2% agarose gel, eluted and cloned into the TA vector pMosBlue (Amersham, Braunschweig, Germany).<br class="style-scope patent-text">
[0168]<br class="style-scope patent-text">
5. RNA transfer<br class="style-scope patent-text">
Transfer of fractionated RNA from glyoxal gel to neutral Hybond N nylon membrane [Amersham, Braunschweig] and transfer of genomic DNA from TBE agarose gel were carried out in the alkaline transfer solution by the Chomczynski method (1992). Perform for 2 hours by downward alkaline capillary transport. The membrane was then neutralized in a 0.2 M sodium phosphate buffer (pH 6.8) for 20 minutes, dried at 80 ° C. for 20-60 minutes and baked. To hybridize with the radiolabeled probe, place the membrane in a plastic bag at 5 ml / cm<sup class="style-scope patent-text">2</sup>&nbsp;And incubated at 65 ° C for 3 hours. The buffer is changed to a hybridization solution for hybridization. Rapid Hyb. If a solution [Amersham, Braunschweig] is used, prehybridization occurs at 65 ° C. for 30 minutes without additional prehybridization solution. After the addition of a probe radiolabeled by random priming, hybridization is carried out at 65 ° C. overnight. Thereafter, the membrane is washed once at 65 ° C. for 20 minutes using 2 × SSC / 0.1% SDS and three times for 1 hour each using 0.1 × SSC / 0.1% SDS. did. The membrane is exposed to Kodak X-OMAT or Kodak BIOMAX-MS X-ray film at -80 ° C using a suitable intensifying screen.<br class="style-scope patent-text">
[0169]<br class="style-scope patent-text">
6. In vivo transcription and translation<br class="style-scope patent-text">
The TNT T7 / T3 coupled reticulocyte lysate system (Promega) was used according to the manufacturer's protocol,<sup class="style-scope patent-text">35</sup>The entire coding sequence of HC110-R was transcribed and translated in the presence of S-labeled methionine and cysteine (ICN, Eschwege, Germany). 40 μCi<sup class="style-scope patent-text">35</sup>S-labeled mixture (&gt; 1000 Ci / mmol, ICN, Meckenheim, Germany), rabbit reticulocyte lysate system (Promega, Serva, Heidelberg) using 1 μg of circularized HC110-R plasmid DNA and 10 U of T3 RNA polymerase. Was used to translate the RNA. The reaction was performed at 30 ° C. for 90 minutes. The positive control contained 1 μg of luciferase control DNA.<br class="style-scope patent-text">
[0170]<br class="style-scope patent-text">
The reaction products were fractionated by SDS polyacrylamide gel electrophoresis (Laemmli 1970) and analyzed fluorometrically using an amplified fluorography solution (Amersham Pharmacia Biotech) or 1 M sodium salicylate (pH 7) (Chamberlain 1979) and The gel was dried and exposed (Kodak BioMax MR film at -8O &lt;0&gt; C with sensitizer) (see Figure 1 (B)).<br class="style-scope patent-text">
[0171]<br class="style-scope patent-text">
Alternatively, the MAXIscript in vitro transcription kit from Ambion (Heidelberg) was used for the in vitro synthesis of RNA transcripts from HC110-R cDNA cloned into pBluescript SK. 4 μg of HC110-R plasmid DNA was linearized with the restriction enzyme Hind III or Sal I after the stop codon, extracted with phenol / chloroform, precipitated with 3 volumes of ethanol and DEPC / H<sub class="style-scope patent-text">2</sub>Dissolved in O. 2 μg of HC110-R cDNA in 50 μl of the reaction mixture was combined with 2.5 μl of 200 mM DTT, 2.5 μl each of 10 mM ATP, CTP, GTP and UTP, 5 μl of 10 × transcription buffer, RNasin inhibitor (40 U / μl) (Promega, Heidelberg) 1 0.6 μl and 2 μl of T3 phage polymerase (10 U / μl) and incubated at 37 ° C. for 2 hours. One hour later, 2 μl of T3 phage polymerase (10 U / μl) was further added. This mixture is mixed with 1.5 μl of RNase-free DNase I (2 U / μl) and 1 μl of RNasin inhibitor (40 U / μl), incubated at 37 ° C. for 15 minutes, extracted with phenol / chloroform and tripled Precipitated in an amount of ethanol, DEPC / H<sub class="style-scope patent-text">2</sub>Resuspended in 25 μl O. One fifth of the volume of the sample was analyzed on a glyoxal gel.<br class="style-scope patent-text">
[0172]<br class="style-scope patent-text">
7. DNA analysis<br class="style-scope patent-text">
Clones were sequenced by dideoxynucleotide chain termination with the aid of automated laser fluorescence sequence analysis (LICOR 4000; MWG, Ebersberg, Germany) and Thermo Sequenase fluorescent labeling cycle sequencing kit (Amersham, Braunschweig, Germany). The sequences of both strands were determined, and the sequence data was analyzed with GCG software (Genetics Computer Group Inc., Madison, WI, USA) and PC / GENE software (Intelligenetics, Mountain View, CA, USA). Using the programs FASTA (Pearson and Lipman 1988), BLITZ (Smith and Waterman 1981), and BLAST (Altschul and Lipmann 1990), the EMBL and Swiss plot protein databases (Swiss-Prot protein) for the sequence similarity of the resulting protein sequences. databases). Protein sequences were analyzed using SAPS (Brendel et al., 1992) and PROSITE and Prot-Param (Appel et al., 1994).<br class="style-scope patent-text">
[0173]<br class="style-scope patent-text">
8. Preparation of protein extract from Haemonchus controlus<br class="style-scope patent-text">
H.Frozen in liquid nitrogen 50-100 mg of controlus were added to 1 ml of TRIZOL [Gibco, Karlsruhe]. The nematodes were homogenized with TRIZOL in a glass container for 3 × 15 seconds and incubated at room temperature for 5 minutes. After adding 200 μl of chloroform per ml of TRIZOL, the sample was stirred for 15 seconds, the mixture was incubated at room temperature for another 2-3 minutes, and centrifuged at 4 ° C. for 10 minutes at 7000-12000 rpm. The upper aqueous phase contains RNA, the intermediate phase contains genomic DNA, and the red organic phase contains proteins (Coombs et al., 1990; Chomczynski 1993). The aqueous phase was removed and treated separately. The interphase and organic phase were mixed with 300 μl of 100% ethanol per ml of TRIZOL, mixed well and incubated at room temperature for 2-3 minutes. After centrifugation at 2000 rpm for 5 minutes at 4 ° C., the protein supernatant was carefully transferred to an Eppendorf vessel and precipitated with 1 ml of isopropanol for 10 minutes at room temperature. Centrifugation is again performed at 4 ° C. for 10 minutes at 12000 rpm, the supernatant is discarded and the protein precipitate is mixed with 2 ml of a 0.3 M guanidine hydrochloride solution in 95% ethanol, stirred and stirred at room temperature for 20 minutes. Incubate and <figure-callout id="3" label="centrifuge" filenames="2004508052-10.png,2004508052-12.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">centrifuge</a></figure-callout> 3 times at 7,500 rpm for 5 minutes at 4 ° C. The pellet was then dissolved in 2 ml of 100% ethanol, precipitated at room temperature for 20 minutes and pelleted at 4500C for 5 minutes at 7500 rpm. The pellet was briefly vacuum dried and resuspended in urea lysis buffer (8M). Insoluble material was removed by centrifugation at 10,000 rpm for 10 minutes at 4 ° C. and the supernatant was transferred to a new Eppendorf vessel, after which the protein concentration was determined and stored at −20 ° C. until further processing.<br class="style-scope patent-text">
[0174]<br class="style-scope patent-text">
9. Preparation of protein extract from yeast cells<br class="style-scope patent-text">
Protein extracts were prepared from cultured yeast cells by inoculating a single yeast colony in 5 ml of YPAD medium and shaking at 30 ° C. until saturation (2 days). A portion (2 ml) of the cultured yeast was centrifuged (Heraeus Biofuge 15 R) at 3000 rpm for 2 minutes at 4 ° C.<sub class="style-scope patent-text">2</sub>Washed once with O, resuspended in 250 μl yeast lysis buffer, transferred to a small test tube, filled with glass beads (φ 0.5 mm) just below the liquid level and stirred for 5 minutes at maximum setting. Then 4 × RotiLoad buffer (Roth, Karlsruhe) was added and the mixture was incubated at 95 ° C. for 5 minutes. The disrupted cells were transferred to an Eppendorf vessel and cell debris was removed by centrifugation (Eppendorf Centrifuge 5415 C) at 14000 rpm for 5 minutes. A 20 μl portion of the sample prepared by this method was run on an SDS polyacrylamide gel.<br class="style-scope patent-text">
[0175]<br class="style-scope patent-text">
10. E. FIG. Preparation of protein extract from E. coli cells<br class="style-scope patent-text">
The protein extract was centrifuged at 5000 rpm for 5 minutes at 4 ° C. in a Heraeus flow centrifuge from 5 ml of the overnight culture to give 1 × 10<sup class="style-scope patent-text">7</sup>E. E. coli cells were prepared by pelleting, washing with 5 ml of PBS and centrifuging again. The pellet was then resuspended in 1 ml of TRIZOL (Gibco, Karlsruhe) for further processing.<br class="style-scope patent-text">
[0176]<br class="style-scope patent-text">
As an alternative, the PBS-washed cell pellet is resuspended in PBS and the cells are pulsed with several short ultrasonic pulses (Sonifier B-12, Branson Sonic Power Company, Danbury, USA), liquid nitrogen. And destroyed by lysozyme.<br class="style-scope patent-text">
[0177]<br class="style-scope patent-text">
For subsequent protein analysis, 4 × RotiLoad buffer (Roth, Karlsruhe) was added and run on an SDS polyacrylamide gel to analyze fractions. The total amount of protein passed per lane was 10 to 20 μg.<br class="style-scope patent-text">
[0178]<br class="style-scope patent-text">
11. Preparation of protein extract from cultured cells<br class="style-scope patent-text">
Confluent cell culture dishes of 35 mm adherent cells or 5-10 cells in FCS containing medium<sup class="style-scope patent-text">6</sup>Individual non-adherent animal cells are either removed beforehand by trypsinization with a trypsin / EDTA solution or mechanically detached after cooling using a cell scraper, transferred to an Eppendorf vessel and pelleted at 13000 rpm for 10 seconds at room temperature. , Washed twice with PBS and centrifuged again. After lysing the cells in 1 ml of TRIZOL, the cells were lysed by shaking vigorously or by aspirating the cells several times into the needle of a disposable syringe and incubating at room temperature for 5 minutes. As an alternative, the cell pellet is resuspended in 1 ml of PBS or in urea lysis buffer (8M) and sonicated for a very short time (Sonifier B-12, Branson Sonic Power Company, Danbury, USA). A.). The amount of protein is then measured by the method of Bradford (1976) or Lowry et al. (1951).<br class="style-scope patent-text">
[0179]<br class="style-scope patent-text">
12. E. FIG. inducible protein expression in E. coli<br class="style-scope patent-text">
A polyclonal antibody against the HC110-R protein was cloned into the expression vector pRSETB (Invitrogen, Leek, NL), resulting in three HC110-R fragments fused to the N-terminus with 6 × His satisfying the reading frame, ie, , Complete HC110-R cDNA, N-terminus without transmembrane domain, and C-terminus after the seventh transmembrane domain.<br class="style-scope patent-text">
[0180]<br class="style-scope patent-text">
The complete coding region of HC110-R was replaced with P84_ATG BamHI '5' primer 5'-CTG CCG GAT CCT CGG TTT AAT ACC AAC<u class="style-scope patent-text">ATG</u>&nbsp;AGG-3 'and P3121_TGA HindIII 3' primer 5'-GCA CTA AGC TTG ACT GAA GCG CAC AAC CTC G-3 ', and the N-terminal to the first transmembrane domain is P84_ATG BamHI 5' Primer (see above) and <figure-callout id="3" label="P1434_TGA HindIII" filenames="2004508052-10.png,2004508052-12.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">P1434_TGA HindIII</a></figure-callout> 3 ′ <figure-callout id="5" label="primer" filenames="2004508052-10.png,2004508052-16.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">primer</a></figure-callout> 5′-GGC TCA AGC TTA<u class="style-scope patent-text">TCA</u>&nbsp;Amplified using GAG AAC AAG CGA CAC GGC-3 'and C-terminal beginning after the seventh transmembrane domain was P2486_ATG BamHI 5' primer 5'-CTA TCG GAT CCC AAC<u class="style-scope patent-text">ATG</u>&nbsp;Amplification was performed using GCT GGC TCC CGT GAT ACC TCT AGG-3 'and P3121_TGA HindIII 3' primers (see above). The annealing temperature of all three plasmid PCRs was 56 ° C. for the first 5 cycles and 62 ° C. for the last 30 cycles. The PCR product was digested with BamHI and HindIII enzymes and ligated directly into a pRSET B expression vector that was also linearized with BamHI / HindIII.<br class="style-scope patent-text">
[0181]<br class="style-scope patent-text">
In the pREST B vector, expression is controlled by the viral promoter of bacteriophage T7. Therefore, cloning was performed using XL1-Blue E. coli without the T7 RNA polymerase gene. E. coli strains. Next, the recombinant plasmid further comprises a plasmid pACYC184 stabilized by chloramphenicol resistance, and the expression level of T7 lysozyme, a natural inhibitor of T7 RNA polymerase, is low in T7 polymerase-expressing BL21 (De3) pLysSp. Transformed into E. coli cells. Since these cells are under the control of the lacUV5 promoter, IPTG induction causes the expression of T7 RNA polymerase and consequently the fusion protein.<br class="style-scope patent-text">
[0182]<br class="style-scope patent-text">
A single colony carrying the HC110-R plasmid of interest is transferred from a fresh LB plate supplemented with 50 μg / mL ampicillin and 35 μg / mL chloramphenicol to 50 ml of LB medium under the same selection pressure, until stationary phase Shake at 280 rpm at 37 ° C. overnight. This overnight culture is placed on an OD<sub class="style-scope patent-text">600</sub>Is diluted to 0.3, and 100 ml of this culture is OD<sub class="style-scope patent-text">600</sub>Was further shaken at 280 rpm at 37 ° C. until the pH became 0.6 to 0.5.<br class="style-scope patent-text">
[0183]<br class="style-scope patent-text">
1 OD<sub class="style-scope patent-text">600</sub>Were harvested and uninduced cells were briefly centrifuged and lysed in 150 μl of 8M urea lysis buffer pH 8.0 and 50 μl of 4 × RotiLoad buffer [Roth, Karlsruhe]. The uninduced sample was denatured for 2 minutes and the genomic DNA was sonicated with a short ultrasonic pulse of Sonifier B-12 [Branson Sonic Power Company, Danbury, U.S.A. S. A. For 2 to 3 seconds, and the insoluble portion was pelletized by centrifugation at 14000 rpm for 3 minutes.<br class="style-scope patent-text">
[0184]<br class="style-scope patent-text">
Expression of the fusion protein was induced by adding 1 mM IPTG, and 100 ml of the culture was incubated at 37 ° C. for an additional 3-4 hours. After incubation, the induced cells were centrifuged (Heraeus fluorescence centrifuge) at 5000 rpm, 4 ° C. for 15 minutes, the pellet was washed in PBS, and then resuspended in 8 ml of 8M urea lysis buffer. Cells were disrupted by submersion in liquid nitrogen and thawed at 37 ° C. three times. After the first nitrogen treatment, 0.75 mg / ml lysozyme was added. After a final incubation in liquid nitrogen, incubation at 16 ° C. for 20 minutes was followed by a short ultrasonic pulse of 10 seconds each while cooling in an ice-water bath until the solution had a viscosity equivalent to water. After centrifugation at 13000 rpm at 4 ° C. for 10 minutes (Beckman J2-21; JS 13.1-Rotor), 150 μl of the induced sample was taken out, mixed with 50 μl of 4 × RotiLoad buffer (Roth), and mixed with SDS-PAGE. Then, specific HC110-R protein fragments were checked along with uninduced samples by Coomassie staining or Western blot analysis using a mouse anti-His antibody.<br class="style-scope patent-text">
[0185]<br class="style-scope patent-text">
The remaining supernatant was transferred to a new container and stored at -20 ° C for further purification by affinity chromatography.<br class="style-scope patent-text">
[0186]<br class="style-scope patent-text">
13. Protein purification by metal affinity chromatography<br class="style-scope patent-text">
Concentration is performed under denaturing conditions under the conditions of Clontech [Palo Alto, U.S.A. S. A. ] TALON spin column with IMAC system ("<u class="style-scope patent-text">I</u>mmobilized<u class="style-scope patent-text">M</u>etal<u class="style-scope patent-text">A</u>finity<u class="style-scope patent-text">C</u>Chromatography ") with an N-terminal 6 × His tag. First, the resin in the column was separately equilibrated with 5 volumes of 8M urea lysis buffer at <figure-callout id="8" label="pH" filenames="2004508052-11.png,2004508052-14.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">pH</a></figure-callout> 8, sedimented at 3000 rpm for 4 minutes at 4 ° C, and allowed to cool to room temperature with HC110-R protein supernatant with gentle stirring. For 20 minutes. After centrifugation again, the resin was washed three times with 10 volumes of 8M urea lysis buffer, <figure-callout id="8" label="pH" filenames="2004508052-11.png,2004508052-14.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">pH</a></figure-callout> 8, with slow stirring at room temperature for 10 minutes, and centrifuged again. After the last washing step, the pellet was taken up in 1 ml of 8M urea lysis buffer and used for loading on the column; the latter was washed twice with 3 volumes of 8M urea lysis buffer and imidazole-containing 8M urea lysis Eluted with buffer and fractionated into several fractions of 150 μl each. The amount of fusion protein in the fraction is determined by gel analysis and Bradford protein assay.<br class="style-scope patent-text">
[0187]<br class="style-scope patent-text">
14． Protein purification by affinity chromatography<br class="style-scope patent-text">
Protein purification by metal affinity chromatography is described in the Examples herein.<br class="style-scope patent-text">
Concentration is performed under denaturing conditions under the conditions of Clontech [Palo Alto, U.S.A. S. A. ] TALON spin column with IMAC system ("<u class="style-scope patent-text">I</u>mmobilized<u class="style-scope patent-text">M</u>etal<u class="style-scope patent-text">A</u>finity<u class="style-scope patent-text">C</u>Chromatography ") with an N-terminal 6 × His tag. First, the resin in the column was separately equilibrated with 5 volumes of 8M urea lysis buffer at <figure-callout id="8" label="pH" filenames="2004508052-11.png,2004508052-14.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">pH</a></figure-callout> 8, sedimented at 3000 rpm for 4 minutes at 4 ° C, and allowed to cool to room temperature with HC110-R protein supernatant with gentle stirring. For 20 minutes. After centrifugation again, the resin was washed three times with 10 volumes of 8M urea lysis buffer, <figure-callout id="8" label="pH" filenames="2004508052-11.png,2004508052-14.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">pH</a></figure-callout> 8, with slow stirring at room temperature for 10 minutes, and centrifuged again. After the last washing step, the pellet was taken up in 1 ml of 8M urea lysis buffer and used for loading on the column; the latter was washed twice with 3 volumes of 8M urea lysis buffer and imidazole-containing 8M urea lysis Eluted with buffer and fractionated into several fractions of 150 μl each. The amount of fusion protein in the fraction is determined by gel analysis and Bradford protein assay.<br class="style-scope patent-text">
[0188]<br class="style-scope patent-text">
15. Amino acid sequence analysis<br class="style-scope patent-text">
In order to confirm the amino acid sequence deduced from the cDNA full-length clone HC110-R, the 3 ′ end containing 688 bp ((positions 2486 to 3182)) containing an upstream initiation codon and a Kozak sequence was inserted into a pRSET B expression vector. And cloned into competent BL21 (DE3) pLysSE. Expression of the 21 kD protein (189 AA) in E. coli cells was induced by adding 1 mM IPTG. The fusion protein expressed with this N-terminal His tag was concentrated in a Talon matrix, concentrated in a Centricon tube, and desalted. Due to the N-terminal His tag, sequence analysis of the partial C-terminal protein of the 1 nM 21 kD HC110-R protein was performed by a stepwise Schlack-Kumpf digestion of a variant of Boyd (Boyd et al., 1992) by TopLab (Martinsried). Schlack et al., 1926). Sequence analysis of the removed amino acids was performed on a PROCISE 492 amino acid sequence analyzer (PE Applied Biosystems, Weiterstadt) and analyzed using a PROCISE C reverse phase HPLC system consisting of an ABI 140C micro gradient system and an ABI 785A UV / VIS detector. Identification was performed using PROCISE C control software and ABI data analysis software.<br class="style-scope patent-text">
[0189]<br class="style-scope patent-text">
First, 25 pmol of the 21 kD HC110-R protein was digested with 2% trypsin (Roche Molecular Biochemicals, Mannheim) at 37 ° C. overnight. A total of four peptide fragments were selected by comparing the chromatogram of the digest without trypsin to the HC110-R standard chromatogram after trypsin digestion to rule out sequence analysis of tryptic autolysates. These four peptide fragments were subjected to protein sequence analysis of the N-terminal part by a stepwise Edman digestion method modified by TopLab (Martinsried) by Hunkapiller et al., (1983). Degraded peptide fragments were separated and fractionated by HPLC. The peptide fraction blotted with Immobilon was transferred to a reaction chamber of a PROCISE 492 amino acid sequence analyzer (Applied Biosystems, Weiterstadt), and the amino acids were analyzed using a 140 C-PTH-analyzer and a UV detector 785 A (Applied Biosystems, Waters). And separated. Amino acids were quantified by reversed-phase HPLC and identified by comparing retention times with a standard chromatogram generated prior to sequence analysis.<br class="style-scope patent-text">
[0190]<br class="style-scope patent-text">
16. Cell culture system<br class="style-scope patent-text">
The following cell culture systems were purchased from Deutsch Sammlung via Microorganismen und Zellkulturen GmbH [Braunschweig] [Drexler et al., 1995]:<br class="style-scope patent-text">
COS-7 cells (DSM: ACC 60)-monkey, kidney<br class="style-scope patent-text">
HEK-293 cells (ATCC: CRL 1573)-human, embryo, kidney<br class="style-scope patent-text">
[0191]<br class="style-scope patent-text">
17． Culture of various cell culture systems<br class="style-scope patent-text">
The adherent cell lines COS-7 and HEK-293 were placed in a 110 mm tissue culture dish [Greiner, Solingen] at 37 ° C., 5<figure-callout id="2" label="% CO" filenames="2004508052-10.png,2004508052-15.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">% CO</a></figure-callout> 2 in 10 mL of medium.<sub class="style-scope patent-text">2</sub>And 95% humidity. Cultured cells were maintained by culturing COS-7 and HEK-293 cells in DMEM medium. 3.024 g / l NaHCO<sub class="style-scope patent-text">3</sub>Medium containing 10% FCS, 50 U / ml penicillin and 50 μg / mL streptomycin was warmed to 37 ° C. before use. For COS-7 precultures, they were stored at 4 ° C. for 2 hours and then mechanically separated from the culture dishes using a cell scraper. HEK-293 cells could be separated directly from the bottom of the culture dish using a glass pipette.<br class="style-scope patent-text">
[0192]<br class="style-scope patent-text">
18. Transient and stable transfection of eukaryotic cells<br class="style-scope patent-text">
The non-liposome <figure-callout id="6" label="transfection reagent FuGENE" filenames="2004508052-10.png,2004508052-12.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">transfection reagent FuGENE</a></figure-callout> 6 from Roche Molecular Biochemicals (Mannheim) was used to transiently introduce foreign DNA into animal cells (Kurachi et al., 1998). For this purpose, sterile glass slides coated with 1% gelatin were placed in 35 mm tissue culture dishes, which were set up for a later confocal laser scanning microscope, at approximately 0.5-1.5 × 10 5 in 2 ml of medium.<sup class="style-scope patent-text">5</sup>Individual cells were placed. Cells are grown at 37 ° C. with 5<figure-callout id="2" label="% CO" filenames="2004508052-10.png,2004508052-15.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">% CO</a></figure-callout> 2<sub class="style-scope patent-text">2</sub>And 95% humidity overnight. The medium was changed again before transfection. For transfection, 3 μl of FuGENE6 [Roche Molecular Biochemicals] was diluted in 97 μl of serum-free medium and each reaction mixture was incubated for 5 minutes at room temperature. For each mixture, 100 μl of the diluted <figure-callout id="6" label="FuGENE" filenames="2004508052-10.png,2004508052-12.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">FuGENE</a></figure-callout> 6 was added dropwise to 2 μg (0.5-1 μg / μl) of plasmid-DNA by pipetting, mixed carefully, and incubated at room temperature for another 15 minutes. Thereafter, the complete reaction mixture was added dropwise to the cells and the transfection mixture was evenly distributed by gently rotating the dish. Cells were cultured for an additional 1-2 days without changing media. The following three negative controls (negative controls) were included in each transfection: 0.5-1.5 × 10 5 in 35 mm tissue culture dishes<sup class="style-scope patent-text">6</sup>The second culture dish containing cells and not transfected adds DNA to the transfection mixture, but does not add <figure-callout id="6" label="FuGENE" filenames="2004508052-10.png,2004508052-12.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">FuGENE</a></figure-callout> 6, and the third culture dish contains <figure-callout id="6" label="FuGENE" filenames="2004508052-10.png,2004508052-12.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">FuGENE</a></figure-callout> 6 but no DNA.<br class="style-scope patent-text">
[0193]<br class="style-scope patent-text">
For stable transfection, the desired plasmid HC110-R was transformed with the expression vector pSecTag A [Invitrogen, Leek, NL] or pIRESneo [Clontech, Palo Alto, U.S.A. S. A. ] With the correct reading frame. These vectors have the resistance gene as a marker so that Zeocin and G418 or Bleomycin 48 are constitutively added 72 hours after transient transfection and at each subsequent medium change. Only cells successfully transfected that express the resistance gene product survive. The optimal concentration of the selective medium containing Zeocin or G418 is predetermined by setting up a dilution series for each cell line.<br class="style-scope patent-text">
[0194]<br class="style-scope patent-text">
19. Subcellular localization of recombinant proteins in animal cells<br class="style-scope patent-text">
To C-terminate the HC110-R protein to GFP (green fluorescent protein), the complete coding region of HC110-R DNA was cloned into the HindIII / SalI site of pEGFP-N3. The 137 kDa fusion protein can be expressed in transiently transfected recombinant cell lines and demonstrated by Western blot analysis. CLSM (confocal laser screening microscopy) shows that the HC110-R-GFP fusion protein is present in the cytoplasm of COS-7 and HEK-293 cells and, to a lesser extent, also localized on the plasma membrane. (See also FIG. 8).<br class="style-scope patent-text">
[0195]<br class="style-scope patent-text">
The TCS NT with Leica CLSM ("Confocal Laser Scanning Microscope", Leica Lasertechnik, Heidelberg), a Zeiss IM 35 microscope with version 1.5.451 (Zeiss, Oberkochen) was used for the confocal laser scanning microscope. . GFP Protein Fluorescence and Fluorescent Dye Fluorescein isothiocyanate fluorescence was excited at 488 nm using an argon laser, rhodamine, Texas red, phycoerythrin, Alexa 568, LysoTracker.<sup class="style-scope patent-text">TM</sup>Red DND-99, MitoTracker<sup class="style-scope patent-text">TM</sup>Red CMX Ros and propidium iodide were excited at 568 nm using a krypton laser. The Z series of optical fractions penetrating cells scanned 0.5 μm thick with a resolution of 1024 × 1024 pixels (Giese et al., 1995). The evaluation was performed using AVS software (Advanced Visual Systems Inc., Waltham, Mass., USA), the latter using Adobe Photoshop 5.0 and Corel Draw 8.0 for Windows. Done.<br class="style-scope patent-text">
[0196]<br class="style-scope patent-text">
Lysotracker probe for labeling acidic organelles<sup class="style-scope patent-text">TM</sup>, The fusion protein is specifically located in the acid lysosome. Particles containing the HC110-R protein showed an increase in number near the nucleic acid. GFP and mouse β<sub class="style-scope patent-text">2</sub>-A fusion protein of an adrenergic GPCR was prepared as a control (accession number X155564, Nakada et al., 1989), and the transfection resulted in the same distribution pattern as in the cell as in the case of the HC110-R-GFP fusion protein. (FIG. 8).<br class="style-scope patent-text">
[0197]<br class="style-scope patent-text">
20. EGFP constructs for transient expression<br class="style-scope patent-text">
Vectors pEGFP C1 and pEGFP N3 (Clontech, Palo Alto, CA, USA) were cut with restriction enzymes Hand III and Sal I. Amplification of HC110-R full-length cDNA was performed using P83EGFP_ATG HindIII 5 'primer 5'-GGT AGA AGC TTT TCG GTT TAA TAC CAAC.<u class="style-scope patent-text">AT</u>&nbsp;<u class="style-scope patent-text">G</u>AG G-3 'and P3057EGFP_o. This was performed at an annealing temperature of 65 ° C. using <figure-callout id="3" label="TGA SalI" filenames="2004508052-10.png,2004508052-12.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">TGA SalI</a></figure-callout> 3 ′ <figure-callout id="5" label="primer" filenames="2004508052-10.png,2004508052-16.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">primer</a></figure-callout> 5′-CTG TGT CGA CAA CAT TTC GCC AAT AGT TAG G-3 ′. The PCR product was then similarly cut with the enzymes HindIII and SalI, ligated to form an open reading frame between the HindIII and SalI cleavage sites of the particular vector, and transformed. The resulting fusion protein having an N-terminal GFP tag<u class="style-scope patent-text">GFP-HC110-R</u>And having a C-terminal EGFP<u class="style-scope patent-text">HC110-R-GFP</u>Called. Mouse β<sub class="style-scope patent-text">2</sub>The adrenergic receptor (Genebank Accession Number .: P18762; Nakada et al., 1989) is a P117 mouse β<sub class="style-scope patent-text">2</sub>AR XhoI 5 'primer 5'-TAC CTC GAG CTG CTA ACC TGC CAG CC<u class="style-scope patent-text">A</u>&nbsp;<u class="style-scope patent-text">TG</u>-3 'and P1349 mouse β<sub class="style-scope patent-text">2</sub><figure-callout id="3" label="AR EcoRI" filenames="2004508052-10.png,2004508052-12.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">AR EcoRI</a></figure-callout> 3 ′ <figure-callout id="5" label="primer" filenames="2004508052-10.png,2004508052-16.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">primer</a></figure-callout> 5′-TGT AGA ATT CTT CCT TCC TTG GGA GTC AAC GCT-3 ′ to amplify full-length cDNA at an annealing temperature of 55/60 ° C., and cut with restriction enzymes XhoI and EcoRI. The EGFP was fused to the C-terminus by ligating into XhoI-EcoRI linearized pEGFP N3. At 55/60 ° C., <figure-callout id="5" label="P70HumM1Rez XhoI" filenames="2004508052-10.png,2004508052-16.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">P70HumM1Rez XhoI</a></figure-callout> 5 ′ <figure-callout id="5" label="primer" filenames="2004508052-10.png,2004508052-16.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">primer</a></figure-callout> 5′-ATA TCT CGA GAG CCC CAC CTA GCC ACC<u class="style-scope patent-text">ATG</u>&nbsp;Using AAC A-3 'and P1465HumM1Rez EcoRI 3' primer 5'-GAC GAA TTCCAT TGG CGG GAG GGA GTG CGG T-3 ', the full-length cDNA of human muscarinic receptor 1 (huM1Rez. Genebank Accession No .: Y00508; Allard et al., 1987) were similarly ligated into the XhoI-EcoRI cut pEGFP N3 vector. The resulting fusion protein having an open reading frame was<u class="style-scope patent-text">β</u> <sub class="style-scope patent-text"> <u class="style-scope patent-text">2</u> </sub> <u class="style-scope patent-text">AR-EGFP</u>as well as<u class="style-scope patent-text">huM1Rez-EGFP</u>Called.<br class="style-scope patent-text">
[0198]<br class="style-scope patent-text">
21. HC110-R-MycHis tag construct for stable or transient transfection<br class="style-scope patent-text">
The vector pMyc6xHis is obtained by double digesting the vector pSecTagA [Invitrogen, Leak, NL] with the restriction enzymes NhiI and SfiI, blunting the ends, and ligating the vector again. The coding region of HC110-R is a PCR primer P83MycTag_ATG BamHI 5 'primer 5'-ATA GGA TCC TTC GGT TTA ATA CCA AC<u class="style-scope patent-text">A</u>&nbsp;<u class="style-scope patent-text">TG</u>AGG-3 'and P3058MycTag_o. <figure-callout id="3" label="TGA XbaI" filenames="2004508052-10.png,2004508052-12.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">TGA XbaI</a></figure-callout> 3 ′ <figure-callout id="5" label="primer" filenames="2004508052-10.png,2004508052-16.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">primer</a></figure-callout> 5′-CCT GTC TAG AAACAT TTC GCC AAT AGT TAG G-3 ′ was amplified at an annealing temperature of 56/60 ° C., digested with restriction enzymes BamHI and XbaI, and likewise Ligated into the pMyc6xHis vector linearized with BamHI and XbaI, E. coli DH5α cells. Subsequently, COS-7 cells were stably transfected with this construct and maintained under Zeocin selection pressure.<br class="style-scope patent-text">
[0199]<br class="style-scope patent-text">
In parallel with this, HC110-RMycHis cDNA was combined with the primer P83_ATGNotI-5 '5'-ATA TTG CGG CCG CTT CGG TTT AAT ACC AAC<u class="style-scope patent-text">ATG</u>-3 'and pMycHis_TGABamHI-3' 5'-CGC GGA TCC TAG AAG GCA CAG TCG AGG-3 ', followed by cleavage, and similarly cleaved bicistron with BamHI and NotI. Ligated into the sex expression vector pIRES1neo (GenBank Accession No .: U89673) (Clontech, Palo Alto, USA). The pIRES1neo vector also contains an intraribosomal binding site (IRES) of encephalomyocarditis virus (ECMV) immediately before the start site ATG of the neomycin resistance gene (Rees et al., 1996). In this method, the two open reading frames of HC110-R and of the antibiotic resistance marker are translated only from one mRNA having the human cytomegalovirus (CMV) promoter (Jackson et al., 1990; Jang et al., 1988). You. Selection was performed using G418 (Calbiochem-Novabiochem, La Jolla, CA, USA) in COS-7 cells and HEK-293 cells.<br class="style-scope patent-text">
[0200]<br class="style-scope patent-text">
22. Confocal laser scanning microscope<br class="style-scope patent-text">
The TCS NT with Leica CLSM ("Confocal Laser Scanning Microscope", Leica Lasertechnik, Heidelberg), a Zeiss IM 35 microscope with version 1.5.451 (Zeiss, Oberkochen) was used for the confocal laser scanning microscope. . Fluorescence was excited at 488 nm with an argon laser and at 568 nm with a krypton laser. The Z series of optical fractions penetrating cells scanned 0.5 μm thick with a resolution of 1024 × 1024 pixels (Giese et al., 1995). The evaluation was performed using AVS software (Advanced Visual Systems Inc., Waltham, Mass., USA), the latter using Adobe Photoshop 5.0 and Corel Draw 8.0 for Windows. Done.<br class="style-scope patent-text">
[0201]<br class="style-scope patent-text">
23. Study of α-LTX binding to HC110-R fragment<br class="style-scope patent-text">
Proteins were fractionated by SDS-PAGE (Laemmli et al., 1970) and electrophoresed on nitrocellulose membrane. For α-LTX binding experiments, the staining was incubated for 2 hours at room temperature with 20 nM α-LTX in TST. After washing three times with TST, an anti-α-LTX antibody (rabbit-derived Calbiochem-Novabiochem) was used at a concentration of 0.1 μg / mL, and a peroxidase-linked antibody and an antibody against rabbit IgG (goat-derived, 1 : 25000 dilution). Antibodies were detected using ECL (Amersham-Pharmacia) in all experiments (see FIG. 9).<br class="style-scope patent-text">
[0202]<br class="style-scope patent-text">
24. Calcium imaging<br class="style-scope patent-text">
Free Ca in cells<sup class="style-scope patent-text">2+</sup>Concentration [Ca<sup class="style-scope patent-text">2+</sup>]<sub class="style-scope patent-text">i</sub>Is HC110-R-GFP or β<sub class="style-scope patent-text">2</sub>-Measured using calcium imaging in DOS-7 cells and HEK-293 cells transiently transfected with the AR-EGFP construct (see also FIG. 11). In each case, 2 × 10 5 COS-7 cells and HEK-293 cells were coated with 1% gelatin in a 55 mm tissue culture dish with 5 ml of DMEM medium (containing 10% FCS and pen / strep) using 1% gelatin. Used for cover glass. Transfection was performed using the non-transfection reagent FuGENE 6 (Roche Molecular Biochemicals, Mannheim). This included 6 μl of <figure-callout id="6" label="FuGENE" filenames="2004508052-10.png,2004508052-12.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">FuGENE</a></figure-callout> 6 which was first incubated for 5 minutes at room temperature in 200 μl of FMEM-free DMEM medium, followed by addition of 4 μg of plasmid DNA and incubation for a further 15 minutes at room temperature, allowing the complete transfection mixture to reach the cells. It was added dropwise with a pipette. Construction of a HC110-R full length clone with a GFP tag fused to the correct reading frame, and also a β with a GFP tag at its 3 'end<sub class="style-scope patent-text">2</sub>-Transfected with the construct of the complete cDNA of the adrenergic driven receptor. Untransfected cells with 4 μg of pure pEGFP-N3 expression vector (Clontech, Heidelberg) plasmid DNA and the transfection reagent FuGENE added without DNA were stored as controls.<br class="style-scope patent-text">
[0203]<br class="style-scope patent-text">
Loading of cells using 1 μM Fura-2-acetoxymethyl ester (Fura-2 / AM) (Sigma, Deisenhofen) was performed at 37 ° C. and 5% CO 2.<sub class="style-scope patent-text">2</sub>And 95% humidity for 30 minutes with Na<sup class="style-scope patent-text">+</sup>-HBS solution (150 mM NaCl in water; 5.4 mM KCl; 1.8 mM CaCl<sub class="style-scope patent-text">2</sub>0.8 mM MgSO<sub class="style-scope patent-text">4</sub> <sup class="style-scope patent-text">.</sup>&nbsp;7H<sub class="style-scope patent-text">2</sub>O; 20 mM full course; 20 mM Hepes, pH 7.3) 48 hours after transfection. Cells that were loaded with Fura-2 / AM after incubation were examined under a digital imaging fluorescence microscope (PTI) under an inverted microscope (Zeiss, Axiovert, Germany) and in parallel with it, at 440 nm and 490 nm, respectively. Transfected and non-transfected cells were distinguished by wavelength. On average, 5-7 transfected and untransfected cells were selected by immobilizing the ROI (region of interest). Absorbance was measured at 340 nm (calcium-bound Fura-2 / AM) and 380 nm (free Fura-2 / AM), and emission was measured at 510 nm. By using Image Master 1x software to form a quotient (background corrected image) of the ratio of 340: 510 nm, 380: 510 nm and 340/380: 510 nm as a function of the reagent added. ,evaluated.<br class="style-scope patent-text">
[0204]<br class="style-scope patent-text">
The reagent is always Na<sup class="style-scope patent-text">+</sup>&nbsp;Take an appropriate amount of HBS buffer, add 6 minutes after the start of measurement, and pipet directly into the sample container for another 30-50 minutes. The total volume in the sample container was kept constant at 1.5 ml throughout the experiment. In each case, 30 min and 75 nM α-Latrotoxin (α-LTX, RBI. Natick, USA) was first added to the HC110-R-GFP fusion to determine dose dependence, just before starting the experiment. To add various concentrations of α-LTX (7.5 nM; 25 nM; 50 nM, 75 nM, 90 nM and 120 nM) to COS-7 cells expressing the protein, and to determine the optimal activity concentration, Various concentrations of cyclic depsipeptide BAY 44-4400 (100 ng / mL (89.3 nM), 333 ng / mL (297 nM); 400 ng / mL (357 nM), 1 μg / mL (893 nM), 10 μg / mL (8 .9 μM) are added to HEK-293 cells expressing HC110-R-GFP. -293 cells were transformed into Na without anthelmintic activity.<sup class="style-scope patent-text">+</sup>&nbsp;Optical enantiomer PF1022-001 in <figure-callout id="4" label="HBS" filenames="2004508052-10.png,2004508052-15.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"><figure-callout id="400" label="HBS" filenames="2004508052-10.png,2004508052-16.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">HBS</a></figure-callout></a></figure-callout> 4 or 400 ng / mL BAY 44-4400 or 4 or 400 ng / mL with 5% CO at 37 ° C<sub class="style-scope patent-text">2</sub>And pre-incubation for 90 minutes at 97% humidity, cells were loaded after 60 minutes by adding 1 μM Fura-2 / AM to BAY44-4400 solution or PF1022-001 and maintained for 30 minutes. After the cells were introduced into the instrument, 75 nM α-LTX was further added to them 6 minutes after the start of the experiment. Optimal α-LTX concentration of 75 nM was compared to β with C-terminal GFP tag.<sub class="style-scope patent-text">2</sub>-Adrenergic receptors (β<sub class="style-scope patent-text">2</sub>-R-GFP) was tested in HEK-293 cells. CdCl<sub class="style-scope patent-text">2</sub>(1 μM and 10 μM in each case)<sup class="style-scope patent-text">+</sup>&nbsp;Dissolved in HBS, nifedipine (15 μM) and EGTA (2 mM) were dissolved in 0.1% DMSO. CdCl<sub class="style-scope patent-text">2</sub>And nifedipine were added immediately at the start of the experiment, then α-LTX was added, and EGTA was added both at the start of the experiment and 4 minutes after the addition of α-LTX. Dissolved α-LTX is present at a concentration of 300 nM in 50 mM Tris-HCl; BAY44-4400 was initially dissolved in pure DMSO (stock solution 0.004-10 μg / mL). Stock solution is Na<sup class="style-scope patent-text">+</sup>&nbsp;Adjusted to the desired concentration in HBS buffer. The maximum amount of active substance BAY44-4400 dissolved in a final concentration of 0.1% DMSO is Na<sup class="style-scope patent-text">+</sup>&nbsp;A dilution series in HBS was performed and found. Neither 0.1% DMSO nor any of the other test components interacted with Fura-2 / AM at selected concentrations.<br class="style-scope patent-text">
[0205]<br class="style-scope patent-text">
The data was analyzed using an Excel 98 spreadsheet program. The results are derived from at least 2-4 replicate experiments, in each case 4-8 transfected cells.<br class="style-scope patent-text">
[0206]<br class="style-scope patent-text">
Intracellular calcium concentration was calculated by the method of Glynkiewicz et al. (1985) after pre-calibration by the method of McCormack et al. (1991).<br class="style-scope patent-text">
[0207]<br class="style-scope patent-text">
25. Binding of PF1022A to HC110-R<br class="style-scope patent-text">
Binding of PF1022A and the morpholine derivative BAY44-4400 to HC110-R is demonstrated by SDS-PAGE, ligand preparation and the following analytical flow cytometer (flow cytometry). In addition, PF1022A and its derivatives, like α-LTX, were found to be expressed in HC110-R transfected HEK-293 cells [Ca<sup class="style-scope patent-text">2+</sup>]<sub class="style-scope patent-text">i</sub>To determine whether it causes a change in HC110-RTX signaling.<br class="style-scope patent-text">
[0208]<br class="style-scope patent-text">
In some cases, antibodies or proteins that give a clear signal in immunofluorescence may not respond using immunoblotting. Performing SDS-PAGE requires denaturation of the protein, which can destroy conformation-dependent epitopes. Antibodies or proteins that specifically recognize such epitopes can no longer bind. Thus, HC110-R specific binding cannot be identified in Western blots either by using the biotinylated activator PF1022A or by using the more soluble morpholine derivative BAY44-4400 than human PF1022A. BAY44-4400 differs from PF1022A by two morpholine residues covalently linked to the phenyl ring of the D-phenylactyl radical of PF1022A. However, if the SDS is partially removed through disrupting the hydrophobic interaction and the protein is regenerated on an SDS separation gel using urea, detecting HC110-R specific binding in a Western blot Can be. For this purpose, total proteins from untransfected HEK-293 cells and from HEK-293 cells transiently expressing HC110-R-Myc / His; The N-terminal of 54 kDa and the C-terminal of 21 kDa of HC110-R expressed in E. coli were fractionated by SDS-PAGE, regenerated, and blotted by a conventional method. Immunodetection was performed after incubation with ligand BAY44-4400, with rabbit anti-PF1022A-KLJ immune serum, and with goat anti-rabbit IgG HRP antibody. In addition, untransfected HEK-293 cells, HEK-293 cells transiently transfected with HC110-R-Myc / His, and E. coli. the N-terminus of HC110-R expressed in E. coli; A partially regenerated SDS polyacrylamide gel using total proteins from S. contortus was blotted, incubated with PF1022A-biotin, and detected using streptavidin HRP. For each of the two blots, HEK-293 cells stably expressing HC110-R-Myc / His showed a distinct band of 116 kDa in size, whereas lanes using untransfected cells showed this level. No bands are shown. In addition, both the morpholine derivative BAY44-4400 and the biotinylated PF1022A bound to the 54 kDa N-terminus of HC110-R except for the 21 kDa C-terminus show no specific PF1022A binding. Adult H. The total amount of the two bandons of the total protein fraction from C. contortus nematodes can be detected using biotinylated PF1022A: a band of <figure-callout id="110" label="size" filenames="2004508052-10.png,2004508052-4.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">size</a></figure-callout> 110 kDa and another band of size approximately 88 kDa. In particular, the latter is likely to be detected, as is the case with the 83 kDa protein already described for the nematode Heterakis spumosa, since it is detected even when detection is performed exclusively with streptavidin HRP in contrast to the band of <figure-callout id="110" label="size" filenames="2004508052-10.png,2004508052-4.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">size</a></figure-callout> 110 kDa. It is a biotinylated protein. On the other hand, HEK-293 cells stably transfected with HC110-R-Myc / His no longer show a band of <figure-callout id="116" label="size" filenames="2004508052-7.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">size</a></figure-callout> 116 kDa with only streptavidin HRP. Furthermore, non-specific signals generated by the goat anti-rabbit IgG HRP secondary antibody alone could be eliminated.<br class="style-scope patent-text">
[0209]<br class="style-scope patent-text">
In order to further verify this result, the following ligand precipitation was performed. Aliquots of 2 mg and 4 mg of magnetic Dynal M-280 streptavidin-conjugated beads were mixed with 500 μg of biotinylated PF1022A. In a control mixture using 4 mg of Dynal beads, TST buffer was added instead of PF1022A. Excess PF1022A biotin was removed by magnetic separation. The PF110-R terminus and C terminus expressed in E. coli and previously purified by affinity chromatography were added. After regenerative magnetic separation to remove unbound HC110-R fragment, aliquots obtained from 2 mg and 4 mg of Dynal beads were fractionated by SDS-PAGE and blotted. Detection of the precipitate was performed via an N-terminal fused His tag with mouse anti-His IgG and rabbit anti-mouse IgG HRP antibodies. Based on the fact that the C-terminus of HC110-R that does not bind to PF1022A was previously separated by magnetic separation, only the N-terminal 54 kDa region of HC110-R is precipitated by PF1022A. Non-specific binding of HC110-R N- or C-terminal to streptavidin-conjugated beads was eliminated by not adding biotinylated PF1022A to the reaction mixture.<br class="style-scope patent-text">
[0210]<br class="style-scope patent-text">
The binding of ligand PF1022A to HC110-R in vivo was further analyzed by FACS analysis (FIG. 13). For this purpose, HEK-293 cells are transiently transfected with HC110-R-GFP or GFP-HC110-R, or otherwise cotransfected with HC110-R-Myc / His and GFP. Was taken. Untransfected HEK-293 cells and β<sub class="style-scope patent-text">2</sub>HEK-293 transiently transfected with -R-GFP or M1-R-GFP was used as a control. Twenty-four hours after transfection, cells were incubated with biotinylated PF1022A and PF1022A-bound cells were detected using streptavidin-phycoerythrin and finally immobilized. Cells transfected with HC110-R-GFP, a negative control, were incubated with only streptavidin-phycoerythrin without PF1022A-biotin.<br class="style-scope patent-text">
[0211]<br class="style-scope patent-text">
FACScan was used to fluorescence analyze 10,000 HEK-293 cells for cell size, granularity and fluorescent staining, respectively, using an excitation wavelength of 488 mm. Phycoerythrin, like TRITC, has an absorption spectrum that overlaps with EGFP, but the emission spectra are sufficiently far apart to excite both fluorochromes at only a single wavelength. Cell debris can be excluded from fluorescence intensity measurements by providing a "gate" for the main cell population. For quantitative evaluation, the limits for negative (negative), unstained and positive (positive), GFP-fluorescent cells based on untransfected and GFP transfected cells were fixed. The 4.6% green fluorescence (autofluorescence) of untransfected HEK-293 cells was subtracted from other GFP fluorescence samples; and the value of nonspecific staining of cells with phycoerythrin-conjugated streptavidin (5.4%) Was subtracted from all red fluorescent cells (Table 1).<br class="style-scope patent-text">
Table 1. Detection of PF1022A binding to HEK-293 cells transfected with HC110-R by FACScan<br class="style-scope patent-text">
[Table 1]<br class="style-scope patent-text">
<div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/04/4c/a0/92d3e6f2c972b2/2004508052-99.png" class="style-scope patent-text"><img he="76" id="000003" wi="151" file="2004508052.tif" img-format="tif" img-content="drawing" width="604" height="304" alt="Figure 2004508052" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/04/4c/a0/92d3e6f2c972b2/2004508052-99.png"></a></div>
[0212]<br class="style-scope patent-text">
After subtracting autofluorescence and non-specific red staining with streptavidin-phycoerythrin, cells expressing HC110-R-GFP were calculated by calculating the percentage of green fluorescent cells that were also red (red) fluorescent. 2%, 26.8% cells expressing GFP-HC110-R, and 44.5% cells co-transfected with HC110-R-Myc / His and GFP-conjugated PF1022A. However, only 7.5% of cells express GFP,<sub class="style-scope patent-text">2</sub>Cells expressing -R-GFP were 9.9% and cells expressing M1-R-GFP bind PF 1022A were 19.2% (Fig. 13).<br class="style-scope patent-text">
[0213]<br class="style-scope patent-text">
26. Interaction of PF1022A Derivatives Using HC110-R-Mediated α-LTX Signaling<br class="style-scope patent-text">
PF1022A has 10 depending on the nematode species.<sup class="style-scope patent-text">-9</sup>-10<sup class="style-scope patent-text">-3</sup>1 shows neuropharmacological activity in vitro between mg / ml. To detect any interference of PF1022A and its derivatives using HC110-R and α-LTX signaling mediated by HC110-R, the effect of BAY44-4400, a more soluble PF1022A morpholine mutant, was Ca<sup class="style-scope patent-text">2+</sup>Investigation was performed on HEK-293 cells transiently or stably expressing HC110-R using an imaging method. PF1022-001, which is an optical antipode of PF1022A and has an activity of 100 times or more in vitro and in vivo, was used as a control. BAY44-4400 and PF1022-001 were first dissolved in pure DMSO due to the hydrophobicity of BAY44-4400 and PF1022A-001. Stock concentrations were chosen so that 0.1% DMSO was always present in the experimental mixture. In control experiments, the maximum DMSO concentration that does not interfere with the experimental results of untransfected HC110-R cells and HC110-R cells transfected with HC110-R-GFP, 0.1%, can be eliminated (0.1%). (FIG. 14). Fura-2-loaded untransfected cells and cells transfected with HC110-R-GFP were either 100, 300 or 400 ng / mL and 1 or 10 μg / mL BAY44-4400 on the one hand, or the same on the other hand. Stimulation was performed with a concentration of PF1022-001. Without concentration, Ca<sup class="style-scope patent-text">2+</sup>The mediated response was detectable over the previous 50 minute period. 14B and C show stimulation of HC110-R-GFP and M1-R-GFP transfected cells with 400 ng / mL BAY44-4400 and PF1022-001 as in the examples. In addition, the PF1022A variant is taken up by cells and secondarily inhibits signal transduction pathways and, depending on the parasite, the PF1022A derivative may be maintained in the parasite for an extended period of time, so that in some experiments the cell is Preincubated with derivative for 90 seconds. Cells pre-incubated with 4 ng / mL or 400 ng / mL BAY44-4400 or PF1022-001 are [Ca<sup class="style-scope patent-text">2+</sup>]<sub class="style-scope patent-text">i</sub>Does not change (FIG. 14D). When BAY44-4400 at a concentration of 300 ng / mL or higher is added directly, a slight swelling that reverses within minutes on a monitor representing the cells at a magnification of 40 times, in contrast to the optical antipode. The effect of anthelmintics on HEK-293 cells transfected with HC110-R-GFP could be directly observed.<br class="style-scope patent-text">
[0214]<br class="style-scope patent-text">
Recent experiments have shown that piperazine synergistically increases the effect of PF1022A / BAY44-4400 in experiments with Heterakis spumosa in vitro and in vivo. When 400 ng / mL BAY44-4400 was given simultaneously with 1 or 10 μM piperazine (FIG. 14F), either untransfected HEK-293 cells or HEK-293 cells transiently transfected with HC110-R-GFP. In [Ca<sup class="style-scope patent-text">2+</sup>]<sub class="style-scope patent-text">i</sub>Could not be detected. A control mixture with 10 μM piperazine was also used for CaCl in untransfected and HC110-R-GFP transfected cells.<sup class="style-scope patent-text">2+</sup>It did not cause a change in balance (FIG. 14E).<br class="style-scope patent-text">
[0215]<br class="style-scope patent-text">
In contrast, with varying ranges, both BAY44-4400 and the optical enantiomer PF1022-001, in the presence of 75 nM α-LTX, were capable of expressing HC110-R-GFP expressing HEK-293 cells. Affects α-LTX induced signaling (FIGS. 14B-E). In a control experiment in which cells transfected with HC110-R-GFP or M1-R-GFP were treated with 75 nM α-LTX, 0.1<figure-callout id="6" label="% DMSO" filenames="2004508052-10.png,2004508052-12.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">% DMSO</a></figure-callout> 6 minutes before stimulation, the latter concentration was used. [Ca exerted by the solvent used for BAY44-4400 and PF1022-001]<sup class="style-scope patent-text">2+</sup>]<sub class="style-scope patent-text">i</sub>Can eliminate the effects of α-LTX-induced alterations in. In contrast to M1-R-GFP expressing cells, HC110-R-GFP expressing cells have [Ca<sup class="style-scope patent-text">2+</sup>]<sub class="style-scope patent-text">i</sub>(FIG. 15A). After inducing HC110-R-GFP-expressing cells with 4 ng / mL BAY44-4400 for 6 minutes, α-LTX was added, and Ca was added.<sup class="style-scope patent-text">2+</sup>&nbsp;The described effect of α-LTX on concentration was reduced. : [Ca-induced by α-LTX<sup class="style-scope patent-text">2+</sup>]<sub class="style-scope patent-text">i</sub>&nbsp;The first small increase disappeared, and the second transmitted peak was 44 ± 6.0 <figure-callout id="14" label="nM CaM" filenames="2004508052-21.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">nM CaM</a></figure-callout> 14 minutes after the addition of α-LTX.<sup class="style-scope patent-text">2+</sup>&nbsp;(FIG. 15B). In the presence of 4 ng / mL PF1022-001, the addition was performed 6 minutes before stimulation with α-LTX, 103 ± 11.5 nM Ca<sup class="style-scope patent-text">2+</sup>&nbsp;Rapidly increased (FIG. 15B). When 400 ng / mL BAY44-4400 was added to HC110-R-GFP-expressing <figure-callout id="6" label="cells" filenames="2004508052-10.png,2004508052-12.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">cells</a></figure-callout> 6 minutes before the addition of α-LTX, 23 minutes as in the case of 4 ng / mL BAY44-4400 (FIG. 15B). 49 ± 4.2 nM, [Ca<sup class="style-scope patent-text">2+</sup>]<sub class="style-scope patent-text">i</sub>&nbsp;Was observed, decreased horizontally after 8 minutes, and increased slightly to 11 ± 1.4 nM compared to the original value (FIG. 15C). Sixty minutes before incubation with α-LTX, 400 ng / mL PF1022-001 at 75 nM was added, 112 ± 14. as was previously observed with the addition of 4 ng / mL PF1022-001 (FIG. 15B). 3 nM Ca<sup class="style-scope patent-text">2+</sup>Ca<sup class="style-scope patent-text">2+</sup>Rapidly increased (FIG. 15C). In another experimental design, in each case, HC110-R-GFP-expressing HEK-293 cells were pre-incubated with 4 ng / mL (FIG. 15D) or 400 ng / mL BAY44-4400 or PF1022-001 for 90 minutes (FIG. 15E). After incubation, unbound or removed actives were carefully washed and cells were stimulated with 75 nM α-LTX after adding Fura-2 / AM to the cells. HC110-R-transfected cells pre-incubated with the optical enantiomer PF1022-001 were treated with 4 ng / mL PF1022-001 at 102 ± 6.4 nM [Ca<sup class="style-scope patent-text">2+</sup>]<sub class="style-scope patent-text">i</sub>&nbsp;(FIG. 15D), 109 ± 8.4 nM Ca at 400 ng / mL.<sup class="style-scope patent-text">2+</sup>&nbsp;(FIG. 15E). Ca observed only a few minutes after the addition of α-LTX<sup class="style-scope patent-text">2+</sup>This increase was previously observed in FIGS. 15B and 15C when PF1022-001 was added just prior to stimulation with α-LTX [Ca<sup class="style-scope patent-text">2+</sup>]<sub class="style-scope patent-text">i</sub>&nbsp;Was similar to the rapid change. In contrast, BAY44-4400 showed α-LTX-reduced Ca when HC110-R-GFP-expressing cells were pre-incubated with 4 ng / mL BAY44-4400 for 90 minutes.<sup class="style-scope patent-text">2+</sup>&nbsp;In relation to the influx, a different response was shown: α-LTX induction was 23 ± 2.6 nM Ca<sup class="style-scope patent-text">2+</sup>&nbsp;Led to a maximal increase of 95 ± 20.5 nM at 10 min before leveling wide range [Ca<sup class="style-scope patent-text">2+</sup>]<sub class="style-scope patent-text">i</sub>(FIG. 15D). In the preincubation with 400 ng / mL BAY44-4400, [Ca<sup class="style-scope patent-text">2+</sup>]<sub class="style-scope patent-text">i</sub>&nbsp;Increased up to 65 ± 7.5 nM (FIG. 15D), which was a 12 minute delay compared to pre-incubation with 4 ng / mL BAY44-4400 (FIG. 15C).<br class="style-scope patent-text">
[0216]<br class="style-scope patent-text">
Addition of 400 ng / mL BAY44-4400 to HEK-293 cells stably expressing HC110-R-Myc / His 6 minutes prior to the addition of α-LTX resulted in 267 ± 45.8 nM. [Ca<sup class="style-scope patent-text">2+</sup>]<sub class="style-scope patent-text">i</sub>&nbsp;There was complete inhibition of the observed rapid increase in (FIG. 15F). In contrast, the addition of 400 ng / mL PF1022-001 resulted in [Ca<sup class="style-scope patent-text">2+</sup>]<sub class="style-scope patent-text">i</sub>Does not induce significant changes in<sup class="style-scope patent-text">2+</sup>Increase is 209 ± 33.4 nM Ca<sup class="style-scope patent-text">2+</sup>&nbsp;(FIG. 15F).<br class="style-scope patent-text">
[0217]<br class="style-scope patent-text">
Α-LTX-mediated Ca in HC110-R-expressing cells<sup class="style-scope patent-text">2+</sup>&nbsp;To demonstrate the specific effect of BAY44-4400 on signaling, the following control experiments were performed: the first non-transfected HEK-293 cells were grown in the presence and absence of 400 ng / mL BAY44-4400. Were stimulated with 1 mM carbamylcholine chloride (carbacol), a ligand for the muscarinic acetylcholine receptor (FIG. 15G). In both cases, 58 ± 8.1 nM Ca for HEK-293 cells in the presence of BAY44-4400.<sup class="style-scope patent-text">2+</sup>And 53 ± 6.8 nM Ca in the absence of anthelmintic<sup class="style-scope patent-text">2+</sup>Of the endogenous, natural muscarinic acetylcholine receptor [Ca<sup class="style-scope patent-text">2+</sup>]<sub class="style-scope patent-text">i</sub>&nbsp;A similar rapid increase was seen. Further transient transfection of HEK-293 cells with human muscarinic M1-acetylcholine receptor C-terminally fused to GFP (M1-R-GFP) was performed at 89 ± in the presence of 400 ng / mL BAY44-4400. 5.5 nM, 85 ± 6.1 nM Ca in the absence<sup class="style-scope patent-text">2+</sup>&nbsp;Compared to untransfected cells (FIG. 15G)<sup class="style-scope patent-text">2+</sup>]<sub class="style-scope patent-text">i</sub>(FIG. 15H). No significant effect of BAY44-4400 on M1-R-GPCR could be observed. Endogenous naturally occurring β at 1 mM isoproterenol in untransfected HEK-293 cells<sub class="style-scope patent-text">2</sub>-Stimulation of adrenergic receptors, or nicotine receptors with 1 mM arecoline, as described for carbachol, again in the presence and absence of 400 ng / mL BAY44-4400 , [Ca<sup class="style-scope patent-text">2+</sup>]<sub class="style-scope patent-text">i</sub>&nbsp;Was not significantly different (FIG. 15I). Isoproterenol has 45 ± 4.7 nM [Ca in the presence of BAY44-4400.<sup class="style-scope patent-text">2+</sup>]<sub class="style-scope patent-text">i</sub>, And 48 ± 5.7 nM Ca in the absence of BAY44-4400<sup class="style-scope patent-text">2+</sup>After arecoline stimulation induced an increase in Ca in the presence of BAY44-4400<sup class="style-scope patent-text">2+</sup>Of 28 ± 4.1 nM, and 27 ± 3.5 nM in Ca in the absence of this active substance<sup class="style-scope patent-text">2+</sup>(Fig. 15I).<br class="style-scope patent-text">
[0218]<br class="style-scope patent-text">
27. Obtaining antibodies<br class="style-scope patent-text">
Antibodies were obtained by using female NMRI mice and rabbits (Chinchilla cross). Immunization of NMRI mice was performed by adding 3 × 15 μg of purified 21 kD ΔC-terminal HC110-R protein fragment to 100 μl of PBS together with 100 μl of FCA each.<sup class="style-scope patent-text">−</sup>&nbsp;And injected subcutaneously on <figure-callout id="1" label="days" filenames="2004508052-10.png,2004508052-14.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"><figure-callout id="8" label="days" filenames="2004508052-11.png,2004508052-14.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"><figure-callout id="15" label="days" filenames="2004508052-17.png,2004508052-20.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">days</a></figure-callout></a></figure-callout></a></figure-callout> 1, 8 and 15 into two naive NMRI mice. Blood samples were collected and serum was obtained on day 23.<br class="style-scope patent-text">
[0219]<br class="style-scope patent-text">
To obtain serum, blood obtained by cardiac puncture was first incubated at 37 ° C. for 1 hour and then at 4 ° C. for at least 2 hours. The cell components were then pelleted twice in a Beckman GPKR centrifuge at 3000 rpm for 10 minutes at 4 ° C and the supernatant was inactivated at 56 ° C for 45 minutes. After further centrifugation at 13,000 rpm, 4 ° C. for 10 minutes in Heraeus biofuge 15R, the serum can be removed and stored at −20 ° C. until further use.<br class="style-scope patent-text">
[0220]<br class="style-scope patent-text">
After the initial blood collection and obtaining pre-immune serum, two rabbits are first given an equal volume of PBS.<sup class="style-scope patent-text">−</sup>50 μg of the C-terminal 21 kD HC110-R protein and 50 μg of the 54 kD N-terminal HC110-R protein in a suspension consisting of and FCA were administered by subcutaneous injection. On day 31 and day 79 after the first immunization, two more immunizations with 100 μg of antigen were performed. The first blood collection was performed on day 43. A second blood draw and serum was obtained on day 98 after the first immunization.<br class="style-scope patent-text">
[0221]<br class="style-scope patent-text">
References<br class="style-scope patent-text">
1. Allard W. J. , Sigal I .; S. And Dixon R .; A. F. (1987) Sequence of the gene encoding the human M1 muscarinic acetylcholine receptor. Nucleic Acids Res. 24, 10604.<br class="style-scope patent-text">
2. Altschul S.A. F. And Lipman D.A. J. (1990) Protein database search for multiple alignments. Proc. Natl. Acad. Sci. U. S. A. 87, 5509-5513.<br class="style-scope patent-text">
3. Appel R .; D. , Bairoch A .; And Hochstrasser D.A. F. (1994) Emerging information retrieval tools for biologists: ExPASy WWW server example. Trends Biochem. Sci. 19, 258-260.<br class="style-scope patent-text">
4. Aviv H. And Lederer P .; (1972) Purification of biologically active globin messenger RNA by chromatography on oligothymidylate cellulose. Proc. Natl. Acad. Sci. U. S. A. 69, 1408-1412.<br class="style-scope patent-text">
5. Bacon K. et al. B. , Westwick J .; And Camp R.A. D. (1989) Potential and specific inhibition of IL-8-, IL-1α- and IL-1β-induced in vitro human lymphocyte migration by calcium channel agonists. Biochem. Biophys. Res. Comm. 165, 349-354.<br class="style-scope patent-text">
6. Boyd V. L. , Bozzini M .; , Zon G .; Noble R .; L. And Mattaliano R .; J. (1992) Sequencing of peptides and proteins from the carboxy terminus. Anal. Biochem. 206, 344-352.<br class="style-scope patent-text">
7. Bradford M. (1976) A rapid and sensitive method for quantification of protein (μg amount) which can be used for the principle of protein staining binding. Anal. Biochem. 72, 248-252.<br class="style-scope patent-text">
8. {Brendel V. , Bucher P .; , Nourbakhsh I .; R. , Blaisdell B .; E. FIG. And Karlin S. et al. (1992) Methods and algorithms for statistical analysis of protein sequences. Proc. Natl. Acad. Sci. U. S. A. 89, 2002-2006.<br class="style-scope patent-text">
9. Challie M. , Tu Y. Euskirchen G., et al. , Ward W .; W. And Prasher D .; C. (1994) Green fluorescent protein as a marker for gene expression. Science 263, 725-888.<br class="style-scope patent-text">
10. {Chan MS. (1997) 50 years-worldwide distress of intestinal nematode infections. Parasitol. <figure-callout id="13" label="Today" filenames="2004508052-22.png,2004508052-23.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Today</a></figure-callout> 13, 438-443.<br class="style-scope patent-text">
11. Chen W. , Terada M .; And Cheng J. et al. T. (1996) Characterization of γ-aminobutyric acid receptor subtypes in Ascaris muscle preparations by binding assay and binding of PF1022A, a novel anthelmintic drug at γ-aminobutyric acid receptor. Parasitol. Res. 82, 97-101.<br class="style-scope patent-text">
12. Chomczynski P. et al. (1992) One hour downward alkaline capillary transfer for DNA and RNA blotting. Anal. Biochem. 201, 134-139.<br class="style-scope patent-text">
13. Chomczynski P. et al. (1993) Reagents for single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. <figure-callout id="15" label="BioTechniques" filenames="2004508052-17.png,2004508052-20.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">BioTechniques</a></figure-callout> 15, 532-534; 536-537.<br class="style-scope patent-text">
14． Chomczynski P. et al. and Sacchi N.S. (1987) Single-step method for RNA isolation by guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159.<br class="style-scope patent-text">
15. Coombs L. M. Pigott D., et al. , Proctor A .; , Eidmann M .; , Denner J. et al. And Knowles M .; A. (1990) Simultaneous isolation of DNA, RNA and antigenic proteins exhibiting kinase activity from small tumor samples using guanidine isothiocyanate. Anal. Biochem. 188, 338-343.<br class="style-scope patent-text">
16. ＯｎConder G. A. , Johnson S .; S. , Nowowski D .; S. , Blake T .; E. FIG. , Duton F .; E. FIG. , Nelson S.A. J. , Thomas E., et al. M. , Davis J. et al. P. And Thompson D.A. P. (1995) Anthelmintic profiles of the cyclodepsipeptide PF1022A in in vitro and in vivo models. J. Antibiotics 48, 820-823.<br class="style-scope patent-text">
17． Davletov B. A. , Meunier F .; A. , Ashton A .; C. , Matsushita H .; , Hirst W .; D. , Lelianova V .; G. FIG. , Wilkin G .; P. , Dolly J .; O. And Ushkariov Y. A. (1998) Vesicular exocytosis stimulated by α-latrotoxin is mediated by latrophilin,<sup class="style-scope patent-text">2+</sup>And storage Ca<sup class="style-scope patent-text">2+</sup>Requires both. EMBO J.S. 17, 3909-3920.<br class="style-scope patent-text">
18. Davletov B. A. , Shamotienko O .; G. FIG. , Lelianova V .; G. FIG. , Grishin E. et al. V. And Ushkariov Y. A. Isolation and characterization of Ca2 + -dependent α-latrotoxin binding protein. J. Biol. Chem. 271, 23239-23245.<br class="style-scope patent-text">
19. Drexler H. G. FIG. , Dirks W .; , MacLeod R .; A. F. , Quentmeier H .; And Steube K .; (Eds.) (1995) DSM catalog of human and animal cell lines; Fifth Edition, Braunschweig.<br class="style-scope patent-text">
20. Jackson R. J. , Howell M .; T. And Kaminski A .; (1990) Novel mechanism of initiation of picornavirus RNA translation. Trends Biochem. Sci. 15, 477-483.<br class="style-scope patent-text">
21. Devereux J. , Haeberli P .; And Smithes O.M. (1984) A comprehensive set of sequence analysis programs for VAX. Nucleic Acids Res. 12, 387-395.<br class="style-scope patent-text">
22. FiveM. , Towler E., et al. M. , Fisher R .; J. (1998) Biacore for macromolecular interactions. Curr. Opin. Biotechnol. 9, 97-101.<br class="style-scope patent-text">
23. Fukashe T. , Koike T .; , Chinone S .; , Akihama S .; , Iagake H .; , Takagi M .; , Shimizu T .; , Yaguchi T .; , Sasaki T .; And Okada T .; (1990) Anthelmintic effect of intestinal parasitic nematode PF1022A, a novel cyclic depsipeptide in dogs and cats. Proc 110th Meet Jap Soc Vet Sci, 122 (Abstr.).<br class="style-scope patent-text">
24. Giese G. , Wiegers W .; , Kubbies M .; , Scherbarth A .; And Traub P .; (1995) Okadaic acid co-induced vimentin expression and cell cycle arrest in MPC-11 mouse plasmacytoma cells. J. Cell. Physiol. 163, 145-154.<br class="style-scope patent-text">
25. Geβner G .; , Methe S .; , Rink T .; And Boheim G .; (1996) The ionophore and the anthelmintic activity of PF1022A, cyclooctadepsipeptide are not relevant. Pestic. Sci. 48, 399-407.<br class="style-scope patent-text">
26. {Grynkiewicz G. , Poenier M .; M. And Tsien R .; Y. (1985) Ca with greatly improved fluorescence properties<sup class="style-scope patent-text">2+</sup>New occurrence of indicator. J. Biol. Chem. 260, 3440-3450.<br class="style-scope patent-text">
27. Gyuris J. Golemis E., et al. , Chertkov H .; And Brent R.A. (1993) Cdi1, human G1 and S-phase protein phosphatases that bind Cdk2. <figure-callout id="75" label="Cell" filenames="2004508052-15.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Cell</a></figure-callout> 75, 791-803.<br class="style-scope patent-text">
28. Harder A. , Londershausen M .; And Mehlhorn H .; (1997) The 4 larval stages and adults of Heterakis spumosa are impaired by the anthelmintic cyclodepsipeptide PF 1022A. Zbl. Bakteriol. 286, 212.<br class="style-scope patent-text">
29. Henkel A. W. And Sankaranarayanan S.A. (1999) α-Latrotoxin action mechanism. Cell Tissue Res. 296, 229-233.<br class="style-scope patent-text">
30. Holz G. G. FIG. And Habener J. et al. F. (1998) Black widow spider α-latrotoxin: a presynaptic neurotoxin that shares structural homology with the glucagon-like peptide-1 family of secretagogues, Comp. Biochem. Physiol. B. Biochem. Mol. Biol. 121, 177-184.<br class="style-scope patent-text">
31. Hunkapiller M. W. Hewick R .; M. , Dreyer W .; J. And Good L .; E. FIG. (1983) Highly sensitive sequencing using a gas phase sequencer. Meth. Enzymol. 91, 399-413.<br class="style-scope patent-text">
32. Ichtchenko, K .; , Bittner, M.A. A. , Krasnoperov, V .; , Little, A .; R. Chepurny, O .; Holz, R .; W. And Petrenko, A .; G. FIG. (1999) A novel broadly expressed α-latrotoxin receptor is a member of the CIRL family of G protein-coupled receptors. J. Biological Chem. 274, 5491-5498.<br class="style-scope patent-text">
33. Jackson R. J. , Howell M .; T. And Kaminski A .; (1990) New mechanism of inhibition of picornavirus RNA translation. Trends Biochem. Sci. 15, 477-483.<br class="style-scope patent-text">
34. Jang S. K. , Krausslich H .; G. FIG. , Nicklin M .; J. , Duke G .; M. , Palmenberg, A .; C. And Wimmer E .; (1988) The 5 'untranslated region segment of encephalomyocarditis virus RNA causes internal entry of the ribosome during in vitro translation. J. Virol. 62, 2636-2643.<br class="style-scope patent-text">
35. Kachi S.M. , Ishih A .; And Terada M .; (1994) Effect of PF1022A of Angiostrongylus cantonensis resident in the central nervous system of rats and mice. Jpn. J. Parasitol. 43, 483-488.<br class="style-scope patent-text">
36. Kachi S. , Ishih A .; And Terada M .; (1995) Effect of PF1022A, an adult S. cerevisiae in the pulmonary artery and liver migrating into the central nervous system of rats. Parasitol. Res. 81, 631-637.<br class="style-scope patent-text">
37. Kachi S. , Terada M .; And Hashimoto H .; (1997) Effect of PF1022A on motility of S. cerevisiae in vitro. Parasitol. Res. 83, 578-582.<br class="style-scope patent-text">
38. Kachi S. , Terada M .; And Hashimoto H .; (1998)<br class="style-scope patent-text">
Effect of PF1022A, a novel anti-nematode drug armorfou and polymorphism on Angiostrongylus costaricensis in mice. Jpn. J. Pharmacol. 77, 235-245.<br class="style-scope patent-text">
39. Klein R. D. And Geary T .; G. FIG. (1997) Recombinant microorganisms as tools for high-throughput screening for non-antibacterial compounds, Biomol. <figure-callout id="2" label="Screening" filenames="2004508052-10.png,2004508052-15.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Screening</a></figure-callout> 2, 41-49.<br class="style-scope patent-text">
40. {Krasnoperov V. , Bittner M .; A. Holz R .; W. , Chepurny O .; And Petrenko A. et al. G. FIG. (1999) Structural requirements for α-Latrotoxin binding and α-Latrotoxin stimulated secretion. J. Biological Chem. 274, 3590-3596.<br class="style-scope patent-text">
41. Kozak M. (1989) Scanning model for translation: An update. J. Cell Biol. 108, 229-241.<br class="style-scope patent-text">
42. Kurachi S.M. , Sze L .; And Kurachi K .; (1998) <figure-callout id="6" label="FuGENE" filenames="2004508052-10.png,2004508052-12.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">FuGENE<sup class="style-scope patent-text"></sup></a></figure-callout><sup class="style-scope patent-text">TM</sup>&nbsp;6 Improved transfection of Hep G2 cells using transfection reagent. <figure-callout id="3" label="Biochemica" filenames="2004508052-10.png,2004508052-12.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Biochemica</a></figure-callout> 3, 43-44.<br class="style-scope patent-text">
43. Laemmli @ U. K. (1970) Cleavage of structural proteins during association of the head of bacteriophage T4. Nature 227, 680-685.<br class="style-scope patent-text">
44. Lowry O. H. , Rosebrough N .; J. , Farr A .; L. And Randall R .; J. (1951) Protein measurement using Folin phenol reagent. J. Biol. Chem. 193, 265-275.<br class="style-scope patent-text">
45. Martin R. J. (1997) Model of action of anthelmintic drugs. Veterinary J. 154, 11-34.<br class="style-scope patent-text">
46. Martin R. J. , Robertson A., et al. P. And Bjorn H .; (1997) Target sites for anthelmintic drugs. Parasitol. 114, 111-124.<br class="style-scope patent-text">
47. Martin R. J. , Harthe A .; , Londershausen M .; And Jeskeke P.S. (1996) Anthelmintic effect of the cyclodepsipeptide PF1022A and electrophysiological effects on muscle cells of the roundworm suum. Pestic. Sci. 48, 343-349.<br class="style-scope patent-text">
48. {McCormack J. G. FIG. And Cobbold P. et al. H. (1991) Cellular calcium: a practical approach. The practical approach series, IRL press, Oxford, 30-42.<br class="style-scope patent-text">
49. McMaster G. K. And Carmichael G .; G. FIG. (1977) Analysis of single- and double-stranded nucleic acids on polyacrylamide and agarose gels using glyoxal and acridine orange. Proc. Natl. Acad. Sci. 74, 4835-4838.<br class="style-scope patent-text">
50. Nakada M. T. , Haskell K .; M. , Ecker D .; J. , Stadel J. et al. M. And Crooke S.A. T. (1989) β in 3T3-L1 fibroblasts<sub class="style-scope patent-text">2</sub>-Genetic eradication of adrenergic receptors. Biochem. J. 260, 53-59.<br class="style-scope patent-text">
51. Pearson W. R. And Lipman D.A. J. (1988) An improved tool for biological sequence comparison. Proc. Natl. Acad. Sci. , U.S. S. A. 85, 2444-2448.<br class="style-scope patent-text">
52. Petrenko A. G. FIG. (1993) α-Latrotoxin receptor. Meaning in nerve terminal function. FEBS Lett. 325, 81-85.<br class="style-scope patent-text">
53. Plasterk @ R. H. (1996) Tc1 / mariner transposon family. Curr. Top Microbiol. Immunol. 204, 125-43.<br class="style-scope patent-text">
54. Rahman M .; A. , Ashton A .; C. , Meunier F .; A. , Davletov B .; A. , Dolly J .; O. And Ushkariov Y. A. (1999) Noelpinephrine exocytosis stimulated by α-latrotoxin requires both external and stored <figure-callout id="2" label="Ca" filenames="2004508052-10.png,2004508052-15.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Ca</a></figure-callout> 2+ and is mediated by latrophilin, G proteins and phospholipase C. Phil. Trans. R. Soc. London. B 354, 379-386.<br class="style-scope patent-text">
55. Rees S.A. , Coote J .; , Stables J. et al. , Goodson S .; , Harris S.M. And Lee M. G. FIG. (1996) A bicistronic vector for creating a stable mammalian cell line that renders all antibiotic resistant cells expressing the recombinant protein sick. <figure-callout id="20" label="BioTechniques" filenames="2004508052-12.png,2004508052-13.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">BioTechniques</a></figure-callout> 20, 102-112.<br class="style-scope patent-text">
56. @Sambrook J. Fritsch E., et al. F. And Maniatis T .; (1989) Molecular cloning. A laboratory handbook. Cold Spring Harbor Laboratory Press, New York, 7.43-7.45.<br class="style-scope patent-text">
57. {Samson-Himmelstjerana G .; von, Harder A. , Schnieder T .; , Kalbe J .; And Mencke N .; (2000) In vivo activity of the novel anthelmintic depsipeptide PF1022A. Parasitol. Res. 86, 194-199.<br class="style-scope patent-text">
58. {Sasaki T. , Takagi M .; , Yaguchi T .; , Miyadoh S .; , Okada T .; And Koyama M .; (1992) A new anthelmintic cyclodepsipeptide, PF1022A. J. Antibiotics 45, 692-697.<br class="style-scope patent-text">
59. Schlack P.S. And Kumpf W.S. (1926) Uber eine new Method zur Ermittlung der Konsituation von Peptiden. Z. Physiol. Chemie Hoppe-Seyler 154, 125-170.<br class="style-scope patent-text">
60. {Schmitt-Wrede H .; -P. , Waldaff A .; , Kruecken J .; , Harder A .; And Wunderlich F .; (1999) Characterization of the hexokinase-encoding cDNA of the parasitic nematode Hemoncus contortus. Biochim. Biophys. Acta 1444, 439-444.<br class="style-scope patent-text">
61. Seagar M. , L. Babaue, C.I. , Charvin N .; , Marquuee B .; , Martin-Moutot N .; , Boudie J .; A. , Boudie J .; -L. , Shoji-Kasai Y .; , Sato K .; And Takahashi M .; (1999) Interaction between proteins involved in exocytosis and voltage-gated calcium channels. Phil. Trans. R. Soc. London. B @ 354, 289-297.<br class="style-scope patent-text">
62. Smith T. F. And Waterman M .; S. (1981) Identification of a consensus molecular sequence. J. Mol. Biol. 147, 195-197.<br class="style-scope patent-text">
63. Sugita S.A. , Ichtchenko K .; , Khvotchev M .; And Suedhof T .; C. (1998) The α-Latrotoxin receptor CIRL / Latrophilin 1 (CL1) defines an abnormal family of ubiquitous G protein-coupled receptors. J. Biological Chem. 273, 32715-32724.<br class="style-scope patent-text">
64. Tagaki M.S. , Sasaki T .; , Yaguchi T .; , Kodama Y .; , Okada T .; , Miyadoh S .; And Koyama M .; (1991) Regarding a novel cyclodepsipeptide having an anthelmintic effect, PF1022A. Nippon Nogeikagaku Kaishi 65, 326 (Abstr.).<br class="style-scope patent-text">
65. Terada M. (1992) Neuropharmacological mechanism of action of an anti-nematode anthelmintic, PF1022A, having a novel structure of cyclodepsipeptide in S. canton nematodes and isolated frog rectus muscle. Jpn. J. Parasitol. 41, 1-18.<br class="style-scope patent-text">
66. Terada M. , Ishih A .; , Tungtrongchitr A .; , Sano M .; And Shomura T .; (1993) Effect of PF1022A on developing S. canton nematodes larvae in mice using special criteria for route, dose and drug system. Jpn. J. Parasitol. 42, 199-210.<br class="style-scope patent-text">
67. {Thomas A. P. And Delaville F .; (1991) Use of fluorescent indicators to measure cell-substrate-free calcium concentration in cell populations and single cells. IRL Press, 1-54.<br class="style-scope patent-text">
68. Waller P. J. (1997) Anthelmintic drug resistance. Veterinary Parasitology 72, 391-412.<br class="style-scope patent-text">
69. Waller P. J. (1998) An international approach to the concept of integrating and eliminating nematode parasites in livestock. Veterinary Parasitology 73, 155-164.<br class="style-scope patent-text">
70. Yang F. , Moss L .; G. FIG. And Phillips G. et al. N. Jr. (1996a.) Molecular structure of green fluorescent protein. <figure-callout id="14" label="Nature Biotechnology" filenames="2004508052-21.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Nature Biotechnology</a></figure-callout> 14, 1246-1251.<br class="style-scope patent-text">
71. Yang T. T. , Cheng L .; Z. And Kain S .; R. (1996b) Optimal codon usage and chromophore mutations provide green fluorescent proteins with enhanced sensitivity. Nucleic Acid Res. 24, 4592-4593.<br class="style-scope patent-text">
[Brief description of the drawings]<br class="style-scope patent-text">
FIG. 1. HC110-R mRNA and protein<br class="style-scope patent-text">
(A) Northern blot analysis using 3.6 kbp cDNA of total RNA and HC110-R from Hemoncus contortus.<br class="style-scope patent-text">
(B) In <figure-callout id="10" label="vitro translation" filenames="2004508052-12.png,2004508052-13.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">vitro translation<sup class="style-scope patent-text"></sup></a></figure-callout><sup class="style-scope patent-text">35</sup>10% SDS-PAGE fluorogram of S-labeled HC110-R protein. In vitro transcription of 1 μg of in vitro transcribed HC110-R mRNA (HC110-R), negative control without HC110-R mRNA (control), 1 μg of luciferase mRNA (luciferase) as a positive control.<br class="style-scope patent-text">
FIG. 2: Full length cDNA sequence and derived amino acid sequence of HC110-R<br class="style-scope patent-text">
The Kozak motif of HC110-R (Kozak, 1989) and the polyadenylation signal (Genebank Accession No .: AJ272270) are underlined; the start codon at <figure-callout id="100" label="position" filenames="2004508052-10.png,2004508052-13.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">position</a></figure-callout> 100 is in bold. Signal peptide (residues 1-21, bold), lectin-like sequence (residues 22-125, dot), Thr stretch (residues 128-147, shaded gray); Structure CX<sub class="style-scope patent-text">9</sub>WX<sub class="style-scope patent-text">12</sub>CX<sub class="style-scope patent-text">9</sub>WXCX<sub class="style-scope patent-text">5</sub>WX<sub class="style-scope patent-text">9</sub>CX<sub class="style-scope patent-text">3</sub>Cysteine-rich (rich) region of W (residues 166-221, dashed line, Cys and Trp residues are even bolder); Structure CXWWX<sub class="style-scope patent-text">6</sub>WX<sub class="style-scope patent-text">4</sub>CX<sub class="style-scope patent-text">11</sub>CXC 4-Cys region (residues 78-524, dashed line, Cys and Trp residues are more bold); 7 transmembrane regions (between residues 563-772, shaded gray) PEST region (residues 915 933, gray shading); N-glycosylation sites (residues 26, 499 and 862, bold); highly conserved estimate of the Cys-Cys pair between secretin GPCRs (sites 595 and 666, bold and double underlined). Disulfide bond.<br class="style-scope patent-text">
FIG. alignment of the derived amino acid sequences of C. contortus HC110-R and C. elegans cosmid clone B0457 (CE-B0457; GenBank Accession No .: Z54306)<br class="style-scope patent-text">
Signal peptide (SP, residues 1-21, bold), lectin-like sequence (lectin, residues 22-125, dot); Thr stretch (T-rich, residues 128-147, shaded gray); Structure CX<sub class="style-scope patent-text">9</sub>WX<sub class="style-scope patent-text">12</sub>CX<sub class="style-scope patent-text">9</sub>WXCX<sub class="style-scope patent-text">5</sub>WX<sub class="style-scope patent-text">9</sub>CX<sub class="style-scope patent-text">3</sub>Cys-rich region of W (C signature, residues 166-221, dashed line, Cys and Trp residues are more bold); Structure CXWWX<sub class="style-scope patent-text">6</sub>WX<sub class="style-scope patent-text">4</sub>CX<sub class="style-scope patent-text">11</sub>CXC 4-Cys motif (4C region, residues 478-524, dashed line, Cys and Trp residues are more bold); 7 transmembrane regions (between residues 536-772, bold and underlined) Pro-rich stretch (P-rich, residues 845-861, shaded gray); PEST region (PEST, residues 915-933, shaded gray); N-glycosylation site (residues 26, 499 and 862, bold) A highly conserved putative disulfide bond of the Cys-Cys pair between secretin GPCRs (595 and 666 sites, bold and double underlined). Identical amino acids are indicated by an asterisk, highly related amino acids by a colon, and related amino acids by a single dot.<br class="style-scope patent-text">
FIG. 4. Alignment of the seven transmembrane receptor HC110-R and various other receptors of the secretin subfamily.<br class="style-scope patent-text">
HC110-R: Hemmox Contortus 7-fold spiral orphan transmembrane receptor (Accession no .: AJ272270); BTLAT3: Bos taurus Latrophilin-3 (Various splicing variant Accession no .: G4164053-G4166405); RNLAT1: Lattus (Rattus) norvegicus latrophilin-1 (accession no .: U78105, U72487); MMEMR1: Mus muscle EMR1 hormone receptor precursor (accession no .: Q61549); HSCD97: Homo sapiens leukocyte activation antigen CD97 (accession no. MMCADH: M.P. musculus larva seven-time transmembrane receptor precursor (Accession no .: G3800738); XLXRF1: Xenopus laevis corticotropin-related receptor precursor (Accession no .: O42602); RNVIP1: R.V. norvegicus vasoactive intestinal polypeptide receptor precursor 2 (Accession no .: Q02643). The seven transmembrane domains are shown in gray shading (I-VII) and the highly conserved putative disulfide bonds are shown in bold.<br class="style-scope patent-text">
FIG. contortus HC 110-R and R. alignment of the derived amino acid sequence of norvegicus latrophilin-1 (GenBank Acc. No. U78105, U72487)<br class="style-scope patent-text">
Signal peptide (SP, residues 1-21, bold), lectin-like sequence (lectin, residues 22-125, dot); Thr stretch (T-rich, residues 128-147, shaded gray); Structure CX<sub class="style-scope patent-text">9</sub>WX<sub class="style-scope patent-text">12</sub>CX<sub class="style-scope patent-text">9</sub>WXCX<sub class="style-scope patent-text">5</sub>WX<sub class="style-scope patent-text">9</sub>CX<sub class="style-scope patent-text">3</sub>Cys-rich region of W (C signature, residues 166-221, dashed line, Cys and Trp residues are more bold); Structure CXWWX<sub class="style-scope patent-text">6</sub>WX<sub class="style-scope patent-text">4</sub>CX<sub class="style-scope patent-text">11</sub>CXC 4-Cys motif (4C region, residues 478-524, dashed line, Cys and Trp residues are more bold); 7 transmembrane regions (between <figure-callout id="536" label="residues" filenames="2004508052-7.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"><figure-callout id="772" label="residues" filenames="2004508052-8.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">residues</a></figure-callout></a></figure-callout> 536 and 772, bold and underlined); Rich stretch (P-rich, residues 845-861, shaded gray); PEST region (PEST, residues 915-933, shaded gray); N-glycosylation site (residues 26, 499 and 862, Bold); highly conserved putative disulfide bonds of the Cys-Cys pair between secretin GPCRs (sites 595 and 666, bold and double underlined). Identical amino acids are indicated by an asterisk, highly related amino acids by a colon, and related amino acids by a single dot.<br class="style-scope patent-text">
FIG. 6 shows the structure of HC110-R protein and the structure of latrophilin-1.<br class="style-scope patent-text">
(A) Hydrophobic blotting of HC110-R with 7 transmembrane domains.<br class="style-scope patent-text">
(B) Protein structure of HC110-R having the following characteristic motifs: signal sequence (SP), lectin domain (lectin), Thr stretch (T-stretch), Cys motif (signature), 4-Cys region ( 4C region), 7 transmembrane domains (1-7, black), Pro-rich motif (P-rich) and PEST sequence (PEST). The putative glycosylation region sites are the Cys residue and two conserved Cys residues in the 4C region of the putative disulfide bond (fine line without capital letters), shown in the lower diagram (N).<br class="style-scope patent-text">
(C) Protein structure of latrophilin-1. Latrophilin-1 has no Thr stretch but contains additional olfactmedin motifs (olfactmedin), Pro-Thr region (PT region), linker domain (linker) and some repeats Including long areas.<br class="style-scope patent-text">
FIG. 7. Expression of HC110-R-GFP in HEK-293 and COS-7 cells<br class="style-scope patent-text">
(A) HEK-293 and COS-7 cells transiently transfected with ΔGFP (GFP) or HC110-R-GFP (HC110-R), and non-transfected (nt) HEK-293 And all proteins from COS-7 cells were isolated by the <figure-callout id="24" label="Trizol method" filenames="2004508052-10.png,2004508052-19.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Trizol method</a></figure-callout> 24 hours after transfection.<br class="style-scope patent-text">
(B) β<sub class="style-scope patent-text">2</sub>-R-GFP (β<sub class="style-scope patent-text">2</sub>-R) or HEK-293 cells transiently transfected with M1-R-GFP (M1-R), and all proteins from untransfected (nt) HEK-293 cells were transfected. Isolated by the <figure-callout id="24" label="Trizol method" filenames="2004508052-10.png,2004508052-19.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Trizol method</a></figure-callout> 24 hours after the injection. The SDS marker bands are 116, 90, 70 and 55 kDa (marker).<br class="style-scope patent-text">
20 μg of total protein per lane was fractionated on a 10% polyacrylamide gel and blotted on a nitrocellulose membrane. Block overnight in RotiBlock solution and use the ECL system with monoclonal mouse anti-GFP IgG primary antibody (0.4 μg / mL) and monoclonal rabbit anti-mouse IgG-HRP secondary antibody (1: 25000). Immunodetection was performed.<br class="style-scope patent-text">
FIG. 8. HC110-R and β in transfected COS-7 with CLSM<sub class="style-scope patent-text">2</sub>-R cell localization<br class="style-scope patent-text">
COS-7 cells were transfected using HC110-R-GFP and β2-R-GFP each having a C-terminal GFP tag. CLSM was performed 24 hours after transfection. The bar corresponds to 10 μm.<br class="style-scope patent-text">
(A) ΔHC110-R-GFP is expressed on the plasma membrane and in the cell compartment. Cell vesicle compaction is seen near the nucleus.<br class="style-scope patent-text">
(B) CLSM coexistence of acid lysosome and green HC110-R-GFP protein was stained at 37 ° C. for 1 hour using LysoTracker Red DND-99.<br class="style-scope patent-text">
(C) β<sub class="style-scope patent-text">2</sub>-R-GFP-transfected cells show a GFP fluorescence pattern similar to HC110-R-GFP or a GFP fluorescence pattern as described in (A) below. This receptor localizes in the plasma membrane and vesicles and in some cases can co-localize with acid lysosomes (staining was performed at 37 ° C. for 1 hour using LysoTracker Red DND-99). ).<br class="style-scope patent-text">
(D) expressed β<sub class="style-scope patent-text">2</sub>-R-GFP is localized in some cases with the endoplasmic reticulum (staining was performed with a monoclonal anti-KDEL antibody).<br class="style-scope patent-text">
FIG. 9: Binding of α-Latrotoxin to HC110-R<br class="style-scope patent-text">
(A) Isolated 5 μg of total protein from Latrodectus revenivens venom grands (1) and pure 130 kDa α-LTX (2), stable using HC110-R-Myc / His construct of <figure-callout id="40" label="pIRES1neo vector" filenames="2004508052-12.png,2004508052-13.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">pIRES1neo vector</a></figure-callout> 40 μg total protein in each case from HEK-293 cells transfected into (3), untransfected cells (4) and 5E. The 4 kDa N-terminus (6) and 21 kDa C-terminus (7) of HC110-R introduced into E. coli were fractionated on a 10% SDS polyacrylamide gel, and blotted and blocked overnight. The denatured protein was incubated with 20 nM α-LTX for 2 hours and detected using rabbit anti-α-LTX IgG-HRP (1: 5000) and goat anti-rabbit IgG antibody (1: 25000) and the ECL system. -LTX binding becomes possible.<br class="style-scope patent-text">
(B) &lt;&lt; E. E. coli, the total protein of each case derived from the C-terminal (1) and N-terminal (2) of HC110-R introduced into E. coli, and the total protein (3) derived from non-transfected HEK-293 cells, and HC110-R-Myc HEK-293 cells (4) stably transfected with H./His and living H.-His cells. contortus nematodes (5) were fractionated on a 10% SDS polyacrylamide gel and partially regenerated using a regeneration buffer containing 4M urea. The blot was blocked overnight, incubated with 20 nM pure α-LTX, and the α-LTX binding protein was converted to rabbit anti-α-LTX IgG antibody (1: 5000), biotin protein A (1: 100), Detection was performed using streptavidin-peroxidase (1: 3000) and the ECL system.<br class="style-scope patent-text">
FIG. 10. HC110-R mediated Ca<sup class="style-scope patent-text">2+</sup>Dose dependence of α-LTX in signaling<br class="style-scope patent-text">
48 hours after transient transfection with HC110-R-GFP, HEK-293 cells were loaded with 1 μM Fura-2 / AM for 30 minutes. The cells were stimulated for an additional 44 <figure-callout id="6" label="minutes" filenames="2004508052-10.png,2004508052-12.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">minutes</a></figure-callout> 6 minutes after the start of measuring the various α-LTX concentrations. The quotient (ratio) of 340/380 nm was measured as a function of time. The number of selected cells is represented as n.<br class="style-scope patent-text">
(A) ΔHC110-R-GFP-expressing cells were stimulated with 7.5 nM (black line) or 25 nM α-LTX (grey line).<br class="style-scope patent-text">
(B) 50 nM (grey line) or 75 nM α-LTX (black line) was added to HC110-R-GFP-expressing cells.<br class="style-scope patent-text">
(C) ΔHC110-R-GFP-expressing cells were stimulated with 90 nM (grey line) or 120 nM α-LTX (black line).<br class="style-scope patent-text">
(D) [Ca<sup class="style-scope patent-text">2+</sup>]<sub class="style-scope patent-text">i</sub>&nbsp;Are plotted in nM on the horizontal axis, the first rapid peak (first peak, gray line) and the second delayed peak obtained by stimulating HC110-R-GFP expressing HEK-293 cells. The α-LTX concentrations (0, 7.5, 25, 50, 75, 90 and 120 nM) for the (second peak, black line) were plotted on the vertical axis.<br class="style-scope patent-text">
FIG. 11. Ca of HC110-R transfected HEK-293 cells.<sup class="style-scope patent-text">2+</sup>Imaging<br class="style-scope patent-text">
(A) HC110-R with C-terminal GFP tag (HC110-R-GFP): black line. HC110-R with N-terminal GFP tag (GFP-HC110-R): Gray line.<br class="style-scope patent-text">
(B) ７５ Nontransfected HEK-293 cells (nt, black line) and 75 nM α-LTX using GFP transfected cells (GFP, gray line).<br class="style-scope patent-text">
(C) ΔC-terminal targeted human M1 muscarinic acetylcholine receptor (M1-R-GFP, gray line) and C-terminal targeted mouse β<sub class="style-scope patent-text">2</sub>Adrenergic acetylcholine receptor (β<sub class="style-scope patent-text">2</sub>-R-GFP, black line) using 75 nM α-LTX.<br class="style-scope patent-text">
(D) ΔHC110-R-GFP-transfected cells were treated with 2 mM EGTA for 6 minutes, and then α-LTX (75 nM) (+ EGTA, gray line) was added. EGTA was omitted from controls (-EGTA, black line).<br class="style-scope patent-text">
(E) @ 2 mM EGTA was added 10 minutes after α-LTX (75 nM) (+ EGTA, gray line). No EGTA was added to the control mixture (-EGTA, gray line).<br class="style-scope patent-text">
(F) As controls, non-transfected cells (nt, gray line) and HC110-R-GFP-expressing cells (black line) were mixed with 2 nM EGTA for 30 minutes.<br class="style-scope patent-text">
FIG. 12. Interference by BAY44-4400 using signaling caused by α-LTX<br class="style-scope patent-text">
HEK-293 was transiently transfected with GFP-tagged HC110-R protein and stimulated 48 hours after the transfection (arrow). Ca<sup class="style-scope patent-text">2+</sup>Imaging was performed for 50 minutes (FIGS. AD), control experiments with various endogenous natural receptors on untransfected HEK-293 cells were performed for 20 minutes. n indicates the number of cells.<br class="style-scope patent-text">
(A) Add BAY44-4400 (black line) or PF1022-001 (gray line) of 400 ng / mL to the cells. As a control, after adding BAY44-4400 or PF1022-001, the cells are used as a solvent for various substances.<sup class="style-scope patent-text">+</sup>&nbsp;Treated with HBS / HEPES buffer (HBS).<br class="style-scope patent-text">
(B) Signaling caused by α-LTX (75 nM) in the presence of 4 ng / mL BAY44-4400 (black line) and PF1022-001 (grey line).<br class="style-scope patent-text">
(C) Signaling caused by α-LTX in cells pre-incubated for 90 minutes with 4 ng / mL BAY44-4400 (black line) or PF1022-001 (grey line). This material was removed before adding α-LTX.<br class="style-scope patent-text">
(D) Signaling produced by HEK-293-GFP transfected cells pre-incubated for 90 minutes with 400 ng / mL BAY44-4400 (black line) or PF1022-001 (grey line). This material was removed before adding α-LTX.<br class="style-scope patent-text">
(E) Untransfected HEK-293 cells were prepared using 1 mM carbamylcholine chloride (carbacol) in the presence (400 ng / mL BAY44-4400, black line) or in the absence (gray) of 400 ng / mL BAY44-4400. Line, -BAY44-4400) for 100 seconds.<br class="style-scope patent-text">
(F) Untransfected HEK-293 cells were incubated with 1 mM isoproterenol and 1 mM arecoline in the presence (400 ng / mL BAY44-4400, black line) or absence (grey line) of 400 ng / mL BAY44-4400. , -BAY44-4400) in each case for 100 seconds.<br class="style-scope patent-text">
FIG. 13. Detection of PF1022A binding to HC110-R transfected HEK-293 cells by FACScan.<br class="style-scope patent-text">
Untransfected GFP, HC110-R-GFP, GFP-HC110-R, β<sub class="style-scope patent-text">2</sub>5 × 10 5 transiently transfected with -R-GFP and M1-R-GFP and transiently co-transfected with HC110-R-Myc / His<sup class="style-scope patent-text">5</sup>&nbsp;In each case of HEK-293 cells, after transfection, they were incubated with 0.5 μg / mL PF1022A-biotin and streptavidin-phycoerythrin (1: 300) for 24 hours and fixed. As a negative control, HC110-R-GFP transfected cells were incubated with only streptavidin-phycoerythrin without PF1022A-biotin. Autofluorescence subtraction: 4.6% of untransfected cells (nt) in the green channel of all green fluorescent cells and 4.4% of nonspecific staining caused by streptavidin-phycoerythrin in the red channel. After the subtraction, GFP fluorescent cells bound to PF1022A (GFP, HC110-R-GFP, GFP-HC110-R, β<sub class="style-scope patent-text">2</sub>-R-GFP, M1-R-GFP and HC110-R-Myc / His + GFP) ratios were found (PF1022A binding in%). The average of triplicate mixtures was determined and the standard deviation was determined.<br class="style-scope patent-text">
FIG. 14. HC110-R mediated Ca<sup class="style-scope patent-text">2+</sup>Effect of BAY44-4400 and optical antipode PF1022-001 on signal transduction<br class="style-scope patent-text">
Loading of cells with 1 μM Fura-2 / AM was performed 48 hours after untransfected HEK-293 cells and transiently transfected with HEK-293-GFP or M1-R-GFP. The quotient (ratio) of 340/380 nm was measured as a function of time. The number of selected cells is indicated by n.<br class="style-scope patent-text">
(A) non-transfected (nt, gray line) and HC110-R-GFP-transfected (HC110-R-GFP, black line)<sup class="style-scope patent-text">+</sup>&nbsp;Mixing was performed after 6 minutes as a control using 0.1% solvent DMSO in HBS buffer.<br class="style-scope patent-text">
(B) ΔHC110-R-GFP- (black line) and M1-R-GFP- (grey line) Transfected cells were stimulated with 400 ng / mL BAY44-4400 after 6 minutes.<br class="style-scope patent-text">
(C) Similar to (B), HC110-R-GFP- (black line) and M1-R-GFP- (grey line) transfected cells were stimulated after 6 minutes with 400 ng / mL PF1022-001. .<br class="style-scope patent-text">
(D) ΔHC110-R-GFP-expressing cells were pre-incubated with 400 ng / mL BAY44-4400 (black line) or PF1022-001 (gray line) for 90 minutes, and unbound substances were washed away before measurement.<br class="style-scope patent-text">
(E) @ 10 μM piperazine was added to non-transfected cells (nt, gray line) and HC110-R-GFP-expressing cells (HC110-R-GFP, black line) after 6 minutes.<br class="style-scope patent-text">
(F) A mixture of 10 μM piperazine and 400 ng / mL BAY44-4400 was applied to untransfected cells (nt, gray line) and HC110-R-GFP-expressing cells (HC110-R-GFP, black line) for 6 hours. Performed as in (E), except added after min.<br class="style-scope patent-text">
FIG. 15. Interaction of HC110-R-mediated α-LTX signaling through PF1022A derivative<br class="style-scope patent-text">
Loading of cells with 1 μM Fura-2 / AM was performed 48 hours after transient transfection with untransfected HEK-293 and HC110-R-GFP or M1-R-GFP. The amount of α-LTX used was always 75 nM. For experiments with control substances, cells were run at a flow rate of 1.6 ml Na.<sup class="style-scope patent-text">+</sup>&nbsp;Flowed at HBS / min. The quotient (ratio) of 340/380 nm was measured as a function of time. The number of selected cells is indicated by n.<br class="style-scope patent-text">
(A) [Ca<sup class="style-scope patent-text">2+</sup>]<sub class="style-scope patent-text">i</sub>. 6 min before α-LTX stimulation, HC110-R-GFP- (black line) and M1-R-GFP- (grey line) to eliminate DMSO which has an effect on α-LTX-induced changes in Expressing cells were mixed with 0.1% DMSO.<br class="style-scope patent-text">
(B) ΔHC110-R-GFP-transfected cells were mixed with 4 ng / mL BAY44-4400 (black line) or PF1022-001 (gray line) 6 minutes before adding α-LTX.<br class="style-scope patent-text">
(C) Except that 400 ng / mL BAY44-4400 (black line) or PF1022-001 (grey line) was added to HC110-R-GFP-expressing <figure-callout id="6" label="cells" filenames="2004508052-10.png,2004508052-12.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">cells</a></figure-callout> 6 minutes before stimulation with α-LTX. Performed in the same manner as in (B).<br class="style-scope patent-text">
(D) ΔHC110-R-GFP-transfected cells were pre-incubated with 4 ng / mL BAY44-4400 (black line) or PF1022-001 (grey line) for 90 minutes to remove unbound substances before measurement. The cells were stimulated 6 minutes later using α-LTX.<br class="style-scope patent-text">
(E) ΔHC110-R-GFP-transfected cells were pre-incubated with 400 ng / mL BAY44-4400 (black line) or PF1022-001 (gray line) for 90 minutes to remove unbound substances before measurement, Was performed as in (D), except that was stimulated with α-LTX after 6 minutes.<br class="style-scope patent-text">
(F) Cells stably expressing ΔHC110-R-Myc / His were mixed with 400 ng / mL BAY44-4400 (black line) or PF1022-001 (gray line) 6 minutes before the addition of α-LTX. .<br class="style-scope patent-text">
(G) と し て As a control, 1 mM carbamylcholine chloride (carbacol) was added for 6 seconds and then again for 100 minutes.<sup class="style-scope patent-text">+</sup>&nbsp;After washing with HBS, untransfected cells in the presence (400 ng / mL BAY44-4400, black line) and in the absence (-BAY44-4400, gray line) of 400 ng / mL BAY44-4400, Again Na<sup class="style-scope patent-text">+</sup>&nbsp;Washed using HBS.<br class="style-scope patent-text">
(H) ΔM1-R-GFP-transfected cells were cultured in the presence of 400 ng / mL BAY44-4400 (400 ng / mL BAY44-4400, black line) or in the absence (-BAY44-4400, gray line) for 6 minutes. Later, the cells were stimulated with 1 mM carbachol for 100 seconds, and<sup class="style-scope patent-text">+</sup>&nbsp;The procedure was as in (G), except that washing was carried out with HBS.<br class="style-scope patent-text">
(I) As a control, in the presence (400 ng / mL BAY44-4400, black line) or absence (−BAY44-4400, gray line) of 400 ng / mL BAY44-4400, 100 mM with 1 mM isoproterenol after 3 minutes. After 12 minutes, the cells were stimulated with 1 mM arecoline for 100 seconds. After 100 seconds, the material is<sup class="style-scope patent-text">+</sup>&nbsp;Washed again with HBS.
  <p class="style-scope patent-text"></p>
</description>
  </section>
      <div id="margin" class="style-scope patent-text">
        <div id="createHighlight" style="top: 0px;" class="style-scope patent-text" hidden="">
          <iron-icon id="comment" icon="editor:insert-comment" class="style-scope patent-text x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 2H4c-1.1 0-2 .9-2 2v12c0 1.1.9 2 2 2h14l4 4V4c0-1.1-.9-2-2-2zm-2 12H6v-2h12v2zm0-3H6V9h12v2zm0-3H6V6h12v2z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        </div>
      </div>
    </div>
  </patent-text>
              </section>
            </div>
            <div class="flex flex-width style-scope patent-result">
              <section id="claims" class="style-scope patent-result">
                <h3 class="style-scope patent-result">
                  <div class="layout horizontal style-scope patent-result">
                    <div class="flex style-scope patent-result">Claims <span class="style-scope patent-result">(45)</span></div>
                    <div class="collapse style-scope patent-result">
                      Hide Dependent <iron-icon style="height: 15px; width: 15px;" icon="expand-less" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M12 8l-6 6 1.41 1.41L12 10.83l4.59 4.58L18 14z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon><template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </div>
                  </div>
                  <div class="layout horizontal style-scope patent-result">
                    <div class="flex style-scope patent-result"></div>
                    <div class="righthead style-scope patent-result">translated from Japanese</div>
                  </div>
                </h3>
                <patent-text name="claims" enable-text-selection="" class="style-scope patent-result" style="padding-top: 0px;">
    
    
    <template is="dom-if" restamp="" class="style-scope patent-text"></template>
    <overlay-tooltip id="tooltip" class="style-scope patent-text" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
    </div>
  </overlay-tooltip>
    <div class="layout horizontal style-scope patent-text">
      <section id="text" class="flex style-scope patent-text"><claims mxw-id="PCLM13701888" lang="EN" load-source="google" class="style-scope patent-text">
  <claim num="1" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">駆虫活性を有する物質を同定するたの、蠕虫由来のカルシウムチャネル膜貫通受容体の使用。</span>Use of a helminth-derived calcium channel transmembrane receptor to identify substances with anthelmintic activity.</span>
    </claim-text>
  </claim>
  <claim num="2" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">殺節足動物活性を有する物質を同定するための、節足動物由来のカルシウムチャネル膜貫通受容体の使用。</span>Use of an arthropod-derived calcium channel transmembrane receptor for identifying a substance having arthropodicidal activity.</span>
    </claim-text>
  </claim>
  <claim num="3" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">７回膜貫通ドメインを有するＧタンパク共役膜貫通受容体であることを特徴とする、請求項１又は２に記載の膜貫通受容体の使用。</span>The use of the transmembrane receptor according to claim 1 or 2, which is a G protein-coupled transmembrane receptor having a seven transmembrane domain.</span>
    </claim-text>
  </claim>
  <claim num="4" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">セクレチンサブファミリーの膜貫通受容体であることを特徴とする、請求項１〜３のいずれかに記載の膜貫通受容体の使用。</span>Use of the transmembrane receptor according to any one of claims 1 to 3, which is a transmembrane receptor of the secretin subfamily.</span>
    </claim-text>
  </claim>
  <claim num="5" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">線虫由来の膜貫通受容体であることを特徴とする、請求項１、３又は４のいずれかに記載の膜貫通受容体の使用。</span>The use of the transmembrane receptor according to any one of claims 1, 3 and 4, wherein the transmembrane receptor is a nematode-derived transmembrane receptor.</span>
    </claim-text>
  </claim>
  <claim num="6" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ダニ類由来の膜貫通受容体であることを特徴とする、請求項２〜４のいずれかに記載の膜貫通受容体の使用。</span>Use of the transmembrane receptor according to any one of claims 2 to 4, wherein the transmembrane receptor is a tick-derived transmembrane receptor.</span>
    </claim-text>
  </claim>
  <claim num="7" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ヘモンクス コントルタス由来の膜貫通受容体ＨＣ１１０−Ｒが関与することを特徴とする、請求項１及び３〜５のいずれかに記載の膜貫通受容体の使用。</span>The use of the transmembrane receptor according to any one of claims 1 and 3 to 5, wherein the transmembrane receptor HC110-R derived from Hemoncus contortus is involved.</span>
    </claim-text>
  </claim>
  <claim num="8" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">膜貫通受容体ＨＣ１１０−Ｒと相同的であることを特徴とする、請求項１〜６のいずれかに記載の膜貫通受容体の使用。</span>Use of a transmembrane receptor according to any of claims 1 to 6, characterized in that it is homologous to the transmembrane receptor HC110-R.</span>
    </claim-text>
  </claim>
  <claim num="9" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">カルシウムチャネル遮断物質を同定するための、請求項１〜８のいずれかに記載の膜貫通受容体の使用。</span>Use of a transmembrane receptor according to any of claims 1 to 8 for identifying calcium channel blockers.</span>
    </claim-text>
  </claim>
  <claim num="10" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">α−ラトロトキシン−結合膜貫通受容体であることを特徴とする、カルシウムチャネル遮断物質を同定するための、請求項１〜８のいずれかに記載の膜貫通受容体の使用。</span>Use of a transmembrane receptor according to any of claims 1 to 8 for identifying a calcium channel blocker, characterized in that it is an α-latrotoxin-binding transmembrane receptor.</span>
    </claim-text>
  </claim>
  <claim num="11" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">請求項１、３〜５、及び７のいずれかに記載の膜貫通受容体のアゴニストとしての、α−ラトロトキシンの使用。</span>Use of α-latrotoxin as an agonist of the transmembrane receptor according to any one of claims 1, 3 to 5, and 7.</span>
    </claim-text>
  </claim>
  <claim num="12" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">殺線虫剤としてのα−ラトロトキシンの使用。</span>Use of α-Latrotoxin as a nematicide.</span>
    </claim-text>
  </claim>
  <claim num="13" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">殺線虫活性及び／又は殺節足動物活性を有する化合物を同定するための方法における、α−ラトロトキシンの使用。</span>Use of α-latrotoxin in a method for identifying a compound having nematicidal activity and / or arthropodidic activity.</span>
    </claim-text>
  </claim>
  <claim num="14" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ＨＣ１１０−Ｒ受容体及びそれと相同的なタンパク質を得るための方法であって、原核生物又は真核生物発現系において該ポリペプチド又はその断片を発現させることを含む方法。</span>A method for obtaining the HC110-R receptor and a protein homologous thereto, comprising expressing the polypeptide or a fragment thereof in a prokaryotic or eukaryotic expression system.</span>
    </claim-text>
  </claim>
  <claim num="15" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">真核生物発現系が関与することを特徴とする、請求項１４に記載の方法。</span>15. The method according to claim 14, wherein a eukaryotic expression system is involved.</span>
    </claim-text>
  </claim>
  <claim num="16" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ＨＥＫ２９３又はＣＯＳ７細胞を、その発現に用いることを特徴とする、請求項１５に記載の方法。</span>The method according to claim 15, wherein HEK293 or COS7 cells are used for their expression.</span>
    </claim-text>
  </claim>
  <claim num="17" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">受容体ＨＣ１１０−Ｒ及びそれと相同的な、可能性のあるタンパク質を一過的に発現する宿主細胞。</span>A host cell that transiently expresses the receptor HC110-R and a potential protein homologous thereto.</span>
    </claim-text>
  </claim>
  <claim num="18" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">受容体ＨＣ１１０−Ｒ及びそれと相同的な、可能性のあるタンパク質を安定に発現する宿主細胞。</span>A host cell stably expressing the receptor HC110-R and a potential protein homologous thereto.</span>
    </claim-text>
  </claim>
  <claim num="19" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">エクオリンを発現することを特徴とする、請求項１８に記載の宿主細胞。</span>19. The host cell according to claim 18, which expresses aequorin.</span>
    </claim-text>
  </claim>
  <claim num="20" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">寄託番号ＤＳＭ ＡＣＣ２４６４を付与された安定に形質転換された細胞系であることを特徴とする、請求項１８に記載の宿主細胞。</span>19. The host cell according to claim 18, characterized in that it is a stably transformed cell line given the deposit number DSM ACC2464.</span>
    </claim-text>
  </claim>
  <claim num="21" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">寄託番号ＤＳＭ ＡＣＣ２４６５を付与された安定に形質転換された細胞系であることを特徴とする、請求項１８又は１９に記載の宿主細胞。</span>20. The host cell according to claim 18 or 19, characterized in that it is a stably transformed cell line given the deposit number DSM ACC2465.</span>
    </claim-text>
  </claim>
  <claim num="22" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">請求項１８〜２１のいずれかに記載の宿主細胞の安定な形質転換のための、及び請求項１７に記載の宿主細胞の一過性形質転換のためのベクター。</span>A vector for stable transformation of a host cell according to any of claims 18 to 21 and for transient transformation of a host cell according to claim 17.</span>
    </claim-text>
  </claim>
  <claim num="23" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ベクターｐＭｙｃ６ｘＨｉｓが関与することを特徴とする、請求項１８又は２０に記載の宿主細胞を安定に形質転換するためのベクター。</span>21. The vector for stably transforming a host cell according to claim 18 or 20, wherein the vector pMyc6xHis is involved.</span>
    </claim-text>
  </claim>
  <claim num="24" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">蠕虫及び／又は節足動物由来のカルシウムチャネル膜貫通受容体のアゴニスト及び／又はアンタゴニストを同定するための方法であって、<br class="style-scope patent-text">
ａ）請求項１７〜２１のいずれかに記載の宿主細胞又はそれらの膜と、化合物または化合物の混合物とを、蠕虫及び／又は節足動物由来のカルシウムチャネル膜貫通受容体のポリペプチドと化合物との相互作用が可能な条件下で接触させる工程、及び、<br class="style-scope patent-text">
ｂ）該ポリペプチドと特異的に結合する化合物を決定する工程、<br class="style-scope patent-text">
を含む方法。</span>A method for identifying agonists and / or antagonists of a helminth and / or arthropod-derived calcium channel transmembrane receptor, comprising: <br class="style-scope patent-text"> a) combining a host cell or a membrane thereof according to any of claims 17 to 21 with a compound or a mixture of compounds with a polypeptide of a helminth and / or arthropod-derived calcium channel transmembrane receptor and a compound. Contacting under conditions that allow the interaction of <br class="style-scope patent-text"> b) determining a compound that specifically binds to the polypeptide; <br class="style-scope patent-text"> A method that includes</span>
    </claim-text>
  </claim>
  <claim num="25" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">蠕虫又は節足動物由来のカルシウムチャネル膜貫通受容体の発現を変化させる化合物の同定方法であって、<br class="style-scope patent-text">
ａ）請求項１７〜２１のいずれかに記載の宿主細胞を、化合物又は化合物の混合物と接触させる工程、<br class="style-scope patent-text">
ｂ）カルシウムチャネル膜貫通受容体濃度を測定する工程、及び<br class="style-scope patent-text">
ｃ）蠕虫又は節足動物由来のカルシウムチャネル膜貫通受容体のポリペプチドの発現に特異的に影響を及ぼす化合物を決定する工程、<br class="style-scope patent-text">
を含む方法。</span>A method for identifying a compound that alters expression of a calcium channel transmembrane receptor from a helminth or arthropod, <br class="style-scope patent-text"> a) contacting the host cell according to any of claims 17 to 21 with a compound or a mixture of compounds. <br class="style-scope patent-text"> b) measuring the calcium channel transmembrane receptor concentration, and c) determining a compound that specifically affects the expression of the helminth or arthropod derived calcium channel transmembrane receptor polypeptide; <br class="style-scope patent-text"> A method that includes</span>
    </claim-text>
  </claim>
  <claim num="26" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">セクレチンサブファミリーのＧタンパク共役膜貫通受容体又はその断片が関与することを特徴とする、請求項２４又は２５に記載の方法。</span>The method according to claim 24 or 25, wherein a G protein-coupled transmembrane receptor of the secretin subfamily or a fragment thereof is involved.</span>
    </claim-text>
  </claim>
  <claim num="27" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">膜貫通受容体ＨＣ１１０−Ｒ又はその断片、及びそれらと相同的なタンパク質が関与することを特徴とする、請求項２４又は２５に記載の方法。</span>The method according to claim 24 or 25, wherein the transmembrane receptor HC110-R or a fragment thereof and a protein homologous thereto are involved.</span>
    </claim-text>
  </claim>
  <claim num="28" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">被験物質と膜貫通受容体とを、該受容体分子と該被験物質との相互作用が可能な条件下で接触させ、次いで<br class="style-scope patent-text">
ａ）生じた被験物質の結合を検出し、そして<br class="style-scope patent-text">
ｂ）被験物質存在下の受容体分子の活性と被験物質の非存在下の該活性とを比較すること<br class="style-scope patent-text">
を特徴とする、請求項２４、２６及び２７のいずれかに記載の方法。</span>Contacting the test substance with the transmembrane receptor under conditions that allow the receptor molecule to interact with the test substance, then a) detecting the resulting binding of the test substance, and b) detecting the presence of the test substance 28. The method according to any one of claims 24, 26 and 27, wherein the activity of the lower receptor molecule is compared with the activity in the absence of the test substance.</span>
    </claim-text>
  </claim>
  <claim num="29" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">細胞ベースの試験システムを用いることを特徴とする、請求項２４〜２８のいずれかに記載の方法。</span>The method according to any one of claims 24 to 28, wherein a cell-based test system is used.</span>
    </claim-text>
  </claim>
  <claim num="30" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">請求項１７〜２１のいずれかに記載の細胞を用いることを特徴とする、請求項２９に記載の方法。</span>The method according to claim 29, wherein the cell according to any one of claims 17 to 21 is used.</span>
    </claim-text>
  </claim>
  <claim num="31" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">無細胞試験システムを用いることを特徴とする、請求項２４及び２６〜２８のいずれかに記載の方法。</span>The method according to any one of claims 24 and 26 to 28, wherein a cell-free test system is used.</span>
    </claim-text>
  </claim>
  <claim num="32" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">被験物質と膜貫通受容体との相互作用を、それに結合したα−ラトロトキシンの置換によって検出することを特徴とする、請求項２４及び２６〜３１のいずれかに記載の方法。</span>The method according to any one of claims 24 and 26 to 31, wherein an interaction between the test substance and the transmembrane receptor is detected by displacement of α-latrotoxin bound thereto.</span>
    </claim-text>
  </claim>
  <claim num="33" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">被験物質と膜貫通受容体との相互作用を、それに結合したニフェジピンの置換によって検出することを特徴とする、請求項２４及び２６〜３１のいずれかに記載の方法。</span>The method according to any one of claims 24 and 26 to 31, wherein the interaction between the test substance and the transmembrane receptor is detected by displacement of nifedipine bound thereto.</span>
    </claim-text>
  </claim>
  <claim num="34" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">請求項２４及び２６〜３１のいずれかに記載の方法におけるニフェジピンの使用。</span>Use of nifedipine in the method of any of claims 24 and 26-31.</span>
    </claim-text>
  </claim>
  <claim num="35" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">請求項２４〜３４のいずれかに記載の方法において同定される物質。</span>A substance identified in the method according to any one of claims 24 to 34.</span>
    </claim-text>
  </claim>
  <claim num="36" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">蠕虫及び／又は節足動物を抑制するための組成物を製造するための請求項３５に記載の物質の使用。</span>Use of a substance according to claim 35 for the manufacture of a composition for controlling helminths and / or arthropods.</span>
    </claim-text>
  </claim>
  <claim num="37" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">駆虫剤及び／又は殺節足動物剤としての、ＨＣ１１０−Ｒ受容体及びそれと相同的なタンパク質の調節物質の使用。</span>Use of a modulator of the HC110-R receptor and proteins homologous thereto as an anthelmintic and / or arthropodicide.</span>
    </claim-text>
  </claim>
  <claim num="38" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">遺伝子組換え無脊椎動物を作製するための、ＨＣ１１０−Ｒ受容体をコードするＤＮＡ及びそれと相同的なＤＮＡの使用。</span>Use of DNA encoding the HC110-R receptor and DNA homologous thereto to produce transgenic invertebrates.</span>
    </claim-text>
  </claim>
  <claim num="39" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ＨＣ１１０−Ｒ受容体又はそれと相同的なタンパク質を含む遺伝子組換え無脊椎動物。</span>A transgenic invertebrate comprising the HC110-R receptor or a protein homologous thereto.</span>
    </claim-text>
  </claim>
  <claim num="40" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Ｄｒｏｓｏｐｈｉｌａ ｍｅｌａｎｏｇａｓｔｅｒ及びＣａｅｎｏｒｈａｂｄｉｔｉｓ ｅｌｅｇａｎｓであることを特徴とする、請求項３９に記載の遺伝子組換え無脊椎動物。</span>40. The transgenic invertebrate of claim 39, which is Drosophila melanogaster and Caenorhabditis elegans.</span>
    </claim-text>
  </claim>
  <claim num="41" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">蠕虫由来のＤＮＡを検出するための、ＨＣ１１０−Ｒ受容体をコードするＤＮＡと特異的にハイブリダイズするＤＮＡオリゴヌクレオチドの使用。</span>Use of a DNA oligonucleotide that specifically hybridizes to DNA encoding the HC110-R receptor to detect helminth-derived DNA.</span>
    </claim-text>
  </claim>
  <claim num="42" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">蠕虫由来のＤＮＡを検出するための方法であって、<br class="style-scope patent-text">
ａ）ＨＣ１１０−Ｒ受容体をコードするＤＮＡまたはその相補鎖、又はその５’−若しくは３’−隣接領域とハイブリダイズするＤＮＡオリゴヌクレオチドを入手し、<br class="style-scope patent-text">
ｂ）該ＤＮＡオリゴヌクレオチドをＤＮＡ含有試料と接触させ、<br class="style-scope patent-text">
ｃ）該ＤＮＡオリゴヌクレオチドのハイブリダイゼーションを検出し、<br class="style-scope patent-text">
ｄ）検出した配列の配列を決定し、そして<br class="style-scope patent-text">
ｅ）該配列を、ＨＣ１１０−Ｒ受容体をコードするＤＮＡ配列と比較すること<br class="style-scope patent-text">
を特徴とする方法。</span>A method for detecting helminth-derived DNA, <br class="style-scope patent-text"> a) Obtaining a DNA encoding the HC110-R receptor or its complementary strand, or a DNA oligonucleotide that hybridizes to the 5′- or 3′-adjacent region thereof, <br class="style-scope patent-text"> b) contacting the DNA oligonucleotide with a DNA-containing sample; <br class="style-scope patent-text"> c) detecting hybridization of the DNA oligonucleotide; <br class="style-scope patent-text"> d) determining the sequence of the detected sequence and e) comparing the sequence to a DNA sequence encoding the HC110-R receptor.</span>
    </claim-text>
  </claim>
  <claim num="43" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ＨＣ１１０−Ｒ受容体をコードするＤＮＡ配列又はその断片あるいはそれらと相同的なＤＮＡ配列を含む診断用試験キット。</span>A diagnostic test kit comprising a DNA sequence encoding the HC110-R receptor, a fragment thereof, or a DNA sequence homologous thereto.</span>
    </claim-text>
  </claim>
  <claim num="44" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ＤＮＡ配列が検出可能な指標と共に提供されていることを特徴とする、請求項４３に記載の診断用試験キット。</span>44. The diagnostic test kit of claim 43, wherein the DNA sequence is provided with a detectable indicator.</span>
    </claim-text>
  </claim>
  <claim num="45" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ワクチン生産のための、ＨＣ１１０−Ｒ受容体又はその断片及びそれらと相同的なタンパク質の使用。</span>Use of the HC110-R receptor or fragments thereof and proteins homologous thereto for vaccine production.</span>
    </claim-text>
  </claim>
</claims>
  </section>
      <div id="margin" class="style-scope patent-text">
        <div id="createHighlight" style="top: 0px;" class="style-scope patent-text" hidden="">
          <iron-icon id="comment" icon="editor:insert-comment" class="style-scope patent-text x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 2H4c-1.1 0-2 .9-2 2v12c0 1.1.9 2 2 2h14l4 4V4c0-1.1-.9-2-2-2zm-2 12H6v-2h12v2zm0-3H6V9h12v2zm0-3H6V6h12v2z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        </div>
      </div>
    </div>
  </patent-text>
              </section>
            </div>
          </div>

          <div class="footer style-scope patent-result">

            
            <h3 id="patentCitations" class="scroll-target style-scope patent-result">
              Patent Citations (2)
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Publication number</span>
                    <span class="th style-scope patent-result">Priority date</span>
                    <span class="th style-scope patent-result">Publication date</span>
                    <span class="th style-scope patent-result">Assignee</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  <template is="dom-repeat" class="style-scope patent-result"></template>

                  <div class="tr style-scope patent-result">
                    <span class="td famheader style-scope patent-result">Family To Family Citations</span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                  </div>

                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US4925664A/en"><a id="link" href="#" class="style-scope state-modifier">US4925664A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1986-10-20</span>
                    <span class="td style-scope patent-result">1990-05-15</span>
                    <span class="td style-scope patent-result">University Of Utah</span>
                    <span class="td style-scope patent-result">Spider toxins and methods for their use as blockers of calcium channels and amino acid receptor function 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/DE19704024A1/en"><a id="link" href="#" class="style-scope state-modifier">DE19704024A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1996-10-10</span>
                    <span class="td style-scope patent-result">1998-04-16</span>
                    <span class="td style-scope patent-result">Bayer Ag</span>
                    <span class="td style-scope patent-result">
  Proteins, DNA sequences coding for them, on the other hand specific antibodies and their use to find nematicidal active substances
 
     </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>

                </div>
              </div>
            </div>
            <div style="padding: 10px 12px; font-size: 11px;" class="style-scope patent-result">* Cited by examiner, † Cited by third party</div>
            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="citedBy" class="scroll-target style-scope patent-result">
              Cited By (5)
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Publication number</span>
                    <span class="th style-scope patent-result">Priority date</span>
                    <span class="th style-scope patent-result">Publication date</span>
                    <span class="th style-scope patent-result">Assignee</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  <template is="dom-repeat" class="style-scope patent-result"></template>

                  <div class="tr style-scope patent-result">
                    <span class="td famheader style-scope patent-result">Family To Family Citations</span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                  </div>

                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2004027042A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2004027042A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-09-23</span>
                    <span class="td style-scope patent-result">2004-04-01</span>
                    <span class="td style-scope patent-result">E. I. Du Pont De Nemours And Company</span>
                    <span class="td style-scope patent-result">Isolation and use of ryanodine receptors 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN102839193A/en"><a id="link" href="#" class="style-scope state-modifier">CN102839193A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-08-22</span>
                    <span class="td style-scope patent-result">2012-12-26</span>
                    <span class="td style-scope patent-result">海狸（广州）生物科技有限公司</span>
                    <span class="td style-scope patent-result">Detection method for compound specificity through G protein-coupled receptor (GPCR) 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN108779449A/en"><a id="link" href="#" class="style-scope state-modifier">CN108779449A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2016-02-06</span>
                    <span class="td style-scope patent-result">2018-11-09</span>
                    <span class="td style-scope patent-result">诺维信公司</span>
                    <span class="td style-scope patent-result">Polypeptide with proteinase activity and encode its polynucleotides 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN111903618B/en"><a id="link" href="#" class="style-scope state-modifier">CN111903618B</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2020-08-11</span>
                    <span class="td style-scope patent-result">2023-04-25</span>
                    <span class="td style-scope patent-result">福建省农业科学院水稻研究所</span>
                    <span class="td style-scope patent-result">Artificial cultivation method of rice lice thysanoptera (Anagrus nilaparvatae) 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN112715487B/en"><a id="link" href="#" class="style-scope state-modifier">CN112715487B</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2020-12-23</span>
                    <span class="td style-scope patent-result">2022-08-05</span>
                    <span class="td style-scope patent-result">广西壮族自治区林业科学研究院</span>
                    <span class="td style-scope patent-result">Breeding method of erythema plexum schottii 
       </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>

              </div>
            </div>
            <div style="padding: 10px 12px; font-size: 11px;" class="style-scope patent-result">* Cited by examiner, † Cited by third party, ‡ Family to family citation</div>
            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="similarDocuments" class="scroll-target style-scope patent-result">
              Similar Documents
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Publication</span>
                    <span class="th style-scope patent-result">Publication Date</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="scholar/17181081501203085915"><a id="link" href="#" class="style-scope state-modifier">Denac et al.</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000</span>
                    <span class="td style-scope patent-result">Structure, function and pharmacology of voltage-gated sodium channels</span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="scholar/11915410370448882321"><a id="link" href="#" class="style-scope state-modifier">Blackhall et al.</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2003</span>
                    <span class="td style-scope patent-result">Selection at a γ-aminobutyric acid receptor gene in Haemonchus contortus resistant to avermectins/milbemycins</span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/RU2340629C2/en"><a id="link" href="#" class="style-scope state-modifier">RU2340629C2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2008-12-10</span>
                    <span class="td style-scope patent-result">Photoprotein with increased bioluminescence 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/DE602004013361T2/en"><a id="link" href="#" class="style-scope state-modifier">DE602004013361T2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2009-05-20</span>
                    <span class="td style-scope patent-result">
  MEDIUM AND METHOD FOR IN VITRO DETERMINATION OF CAMP
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20020052018A1/en"><a id="link" href="#" class="style-scope state-modifier">US20020052018A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-05-02</span>
                    <span class="td style-scope patent-result">Inward rectifier, g-protein activated, mammalian, potassium channels and uses thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/DE69839347T2/en"><a id="link" href="#" class="style-scope state-modifier">DE69839347T2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2009-05-07</span>
                    <span class="td style-scope patent-result">
  KCNQ2 KALIUM CHANNEL FROM THE HUMAN BRAIN
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6008046A/en"><a id="link" href="#" class="style-scope state-modifier">US6008046A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-12-28</span>
                    <span class="td style-scope patent-result">Drug and pesticide screening 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/DE69533796T2/en"><a id="link" href="#" class="style-scope state-modifier">DE69533796T2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2005-11-10</span>
                    <span class="td style-scope patent-result">
  DNA encoding the glutamate-dependent choroid ducts
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2007056043A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2007056043A2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2007-05-18</span>
                    <span class="td style-scope patent-result">Use of potassium channels for identifying compounds that have an insecticidal effect 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP2004508052A/en"><a id="link" href="#" class="style-scope state-modifier">JP2004508052A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2004-03-18</span>
                    <span class="td style-scope patent-result">
  Test system for identifying and characterizing compounds and uses thereof
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20050037436A1/en"><a id="link" href="#" class="style-scope state-modifier">US20050037436A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2005-02-17</span>
                    <span class="td style-scope patent-result">Test systems and the use thereof for identifying and characterizing compounds 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/DE102010018878B4/en"><a id="link" href="#" class="style-scope state-modifier">DE102010018878B4</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2013-09-26</span>
                    <span class="td style-scope patent-result">
  New cell line for the fluorescence-based detection of functionally active antibodies and autoantibodies against the beta1-adrenergic receptor
 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/DE10053785A1/en"><a id="link" href="#" class="style-scope state-modifier">DE10053785A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-03-28</span>
                    <span class="td style-scope patent-result">
  Test systems and their use to identify and characterize compounds
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP1414850B1/en"><a id="link" href="#" class="style-scope state-modifier">EP1414850B1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2013-06-19</span>
                    <span class="td style-scope patent-result">Genetically modified cyclic-nucleotide controlled ion channels  and the use thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="scholar/6086669540176009458"><a id="link" href="#" class="style-scope state-modifier">McHugh</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2021</span>
                    <span class="td style-scope patent-result">Ligand-gated ion channels: Putative target sites for anthelmintic therapy in muscle and intestine cells of parasitic nematodes</span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/DE60123943T2/en"><a id="link" href="#" class="style-scope state-modifier">DE60123943T2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2007-06-14</span>
                    <span class="td style-scope patent-result">
  LIGAND-CONTROLLED ION CHANNELS FROM DERMACENTOR VARIABILIS CODING DNA MOLECULES
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="scholar/6330777712150461919"><a id="link" href="#" class="style-scope state-modifier">Lajevardi</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2020</span>
                    <span class="td style-scope patent-result">Functional Characterization of Pyrokinins and their Receptors in the Adult Mosquito, Aedes aegypti</span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JPH10508751A/en"><a id="link" href="#" class="style-scope state-modifier">JPH10508751A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1998-09-02</span>
                    <span class="td style-scope patent-result">
  Methods for identifying para cation channel modulators
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2006063075A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2006063075A2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2006-06-15</span>
                    <span class="td style-scope patent-result">Hemipteran octopamine receptor 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA2567877A1/en"><a id="link" href="#" class="style-scope state-modifier">CA2567877A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2005-12-22</span>
                    <span class="td style-scope patent-result">Polynucleotides encoding acetylcholine-gated chloride channel subunits of caenorhabditis elegans 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="scholar/13858173471828673493"><a id="link" href="#" class="style-scope state-modifier">Rocco et al.</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2019</span>
                    <span class="td style-scope patent-result">Expression Profiling, Downstream Signalling and Inter-Subunit Interactions of GPA2/GPB5 in the Adult Mosquito Aedes aegypti</span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="scholar/5444685063247285348"><a id="link" href="#" class="style-scope state-modifier">Jenson</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2013</span>
                    <span class="td style-scope patent-result">Characterization of neuronal structure and insecticide target site expression in Spodoptera frugiperda (Sf21) and Anopheles gambiae (Sua1B) insect cells</span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="scholar/4536374928271025044"><a id="link" href="#" class="style-scope state-modifier">Horoszok</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000</span>
                    <span class="td style-scope patent-result">Characterisation of glutamate-gated chloride channels from caenorhabditis elegans</span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2006101830A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2006101830A2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2006-09-28</span>
                    <span class="td style-scope patent-result">Hemipteran glutamate ligand gated ion channel 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="scholar/6496843861175528112"><a id="link" href="#" class="style-scope state-modifier">Dürrnagel</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2013</span>
                    <span class="td style-scope patent-result">Characterization of HyNaCs: peptide-gated DEG/ENaCs from Hydra magnipapillata</span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>
              </div>
            </div>
            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="relatedApplications" class="scroll-target style-scope patent-result">Priority And Related Applications</h3>

            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="appsClaimingPriority" class="scroll-target style-scope patent-result">
              Applications Claiming Priority (3)
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Application</span>
                    <span class="th style-scope patent-result">Filing date</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <template is="dom-if" class="style-scope patent-result"></template>
                        DE10044098<template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">2000-09-07</span>
                    <span class="td style-scope patent-result"></span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/DE10053785A1/en"><a id="link" href="#" class="style-scope state-modifier">DE10053785A</a></state-modifier><template is="dom-if" class="style-scope patent-result"></template>
                        <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">2000-10-30</span>
                    <span class="td style-scope patent-result">
  Test systems and their use to identify and characterize compounds
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2002020830A2/en"><a id="link" href="#" class="style-scope state-modifier">PCT/EP2001/009771</a></state-modifier><template is="dom-if" class="style-scope patent-result"></template>
                        <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">2001-08-24</span>
                    <span class="td style-scope patent-result">Test systems based on transmembrane receptors from helminths and the use thereof for identifying and characterizing compounds 
       </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>
              </div>
            </div>
            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="legalEvents" class="scroll-target style-scope patent-result">
              Legal Events
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Date</span>
                    <span class="th style-scope patent-result">Code</span>
                    <span class="th style-scope patent-result">Title</span>
                    <span class="th style-scope patent-result">Description</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2008-07-10</span>
                    <span class="td nowrap style-scope patent-result">A621</span>
                    <span class="td nowrap style-scope patent-result">Written request for application examination</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: JAPANESE INTERMEDIATE CODE: A621</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20080709</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2008-09-12</span>
                    <span class="td nowrap style-scope patent-result">RD04</span>
                    <span class="td nowrap style-scope patent-result">Notification of resignation of power of attorney</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: JAPANESE INTERMEDIATE CODE: A7424</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20080911</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2009-04-17</span>
                    <span class="td nowrap style-scope patent-result">A711</span>
                    <span class="td nowrap style-scope patent-result">Notification of change in applicant</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: JAPANESE INTERMEDIATE CODE: A711</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20090416</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2009-05-14</span>
                    <span class="td nowrap style-scope patent-result">A521</span>
                    <span class="td nowrap style-scope patent-result">Written amendment</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: JAPANESE INTERMEDIATE CODE: A821</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20090416</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2010-03-31</span>
                    <span class="td nowrap style-scope patent-result">A761</span>
                    <span class="td nowrap style-scope patent-result">Written withdrawal of application</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: JAPANESE INTERMEDIATE CODE: A761</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20100330</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2010-03-31</span>
                    <span class="td nowrap style-scope patent-result">RD03</span>
                    <span class="td nowrap style-scope patent-result">Notification of appointment of power of attorney</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: JAPANESE INTERMEDIATE CODE: A7423</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Effective date</strong>: 20100330</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>
              </div>
            </div>
            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            <div id="notices" class="vertical layout center style-scope patent-result">
              
                <span class="style-scope patent-result">Data provided by IFI CLAIMS Patent Services</span>
              <template is="dom-if" class="style-scope patent-result"></template>
            </div>
          </div>
          <div class="bottombar style-scope patent-result">
            <bottom-bar class="style-scope patent-result"><template is="dom-if" class="style-scope bottom-bar"></template>
</bottom-bar>
          </div>
        </div>
      </div>
      <template is="dom-if" class="style-scope patent-result"></template>
    </div>
  </patent-result>
    <template is="dom-if" restamp="" class="style-scope result-container"></template>
    <template is="dom-if" restamp="" class="style-scope result-container"></template>
    <template is="dom-if" restamp="" class="style-scope result-container"></template>
  </result-container>
        </div>
      </div>
    
        </div>
      </div>
      <search-footer class="style-scope search-ui">
    
    

    <div id="footer" class="vertical layout center style-scope search-footer">
        <span class="links style-scope search-footer">
          <overlay-tooltip positioning-target="#footerAbout" direction="top" class="style-scope search-footer" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Learn more about data coverage, search syntax and other features.
    </div>
  </overlay-tooltip>
          <a id="footerAbout" data-proto="ABOUT" href="https://support.google.com/faqs/answer/6390996" target="_blank" class="style-scope search-footer">About</a>
          <overlay-tooltip positioning-target="#footerFeedback" direction="top" class="style-scope search-footer" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Send feedback about technical issues or feature requests for Google Patents.
    </div>
  </overlay-tooltip>
          <a id="footerFeedback" data-proto="SEND_FEEDBACK" href="#" onclick="sendFeedback();" class="style-scope search-footer">Send Feedback</a>
          <a data-proto="PUBLIC_DATASETS" href="https://console.cloud.google.com/marketplace/product/google_patents_public_datasets/google-patents-public-data" target="_blank" class="style-scope search-footer">Public Datasets</a>
          <a data-proto="TERMS" href="https://www.google.com/policies/terms/" target="_blank" class="style-scope search-footer">Terms</a>
          <a data-proto="PRIVACY_POLICY" href="https://www.google.com/privacy/privacy-policy.html" target="blank" class="style-scope search-footer">Privacy Policy</a>
          <a data-proto="SEARCH_HELP" href="https://support.google.com/websearch/" target="_blank" class="style-scope search-footer">Help</a>
        </span>
    </div>
  </search-footer>
    </div>

  </search-ui>
  </search-result>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <paper-toast id="toast" duration="3000" class="style-scope search-app x-scope paper-toast-0" aria-hidden="true" style="outline: none; display: none;">
    

    <span id="label" class="style-scope paper-toast"></span>
    
      <div id="noticeContent" class="style-scope search-app"></div>
    
  </paper-toast>
  </search-app>
    <script type="text/javascript" src="//www.gstatic.com/feedback/api.js"></script>
    <script type="text/javascript" src="//www.gstatic.com/feedback/js/help/prod/service/lazy.min.js"></script>
    <script type="text/javascript">
      if (window.help && window.help.service) {
        helpApi = window.help.service.Lazy.create(0, {apiKey: 'AIzaSyDTEI_0tLX4varJ7bwK8aT-eOI5qr3BmyI', locale: 'en-US'});
        window.requestedSurveys = new Set();
        window.requestSurvey = function(triggerId) {
          if (window.requestedSurveys.has(triggerId)) {
            return;
          }
          window.requestedSurveys.add(triggerId);
          helpApi.requestSurvey({
            triggerId: triggerId,
            enableTestingMode: false,
            callback: (requestSurveyCallbackParam) => {
              if (!requestSurveyCallbackParam.surveyData) {
                return;
              }
              helpApi.presentSurvey({
                productData: {
                  productVersion: window.version,
                  customData: {
                    "experiments": "",
                  },
                },
                surveyData: requestSurveyCallbackParam.surveyData,
                colorScheme: 1,
                customZIndex: 10000,
              });
            }
          });
        };

        window.requestSurvey('YXTwAsvoW0kedxbuTdH0RArc9VhT');
      }
    </script>
    <script src="/sw/null_loader.js"></script>
  

<iframe id="apiproxyddf475d63cd8173a637a287407211e3c7614fb050.4075004239" name="apiproxyddf475d63cd8173a637a287407211e3c7614fb050.4075004239" style="width: 1px; height: 1px; position: absolute; top: -100px; display: none;" src="https://scone-pa.clients6.google.com/static/proxy.html?usegapi=1&amp;jsh=m%3B%2F_%2Fscs%2Fabc-static%2F_%2Fjs%2Fk%3Dgapi.lb.en.IKZeRvoAYNY.O%2Fam%3DAAAQ%2Fd%3D1%2Frs%3DAHpOoo-SMWTzMRJrTty6iE5dL_aWGYOnuw%2Fm%3D__features__#parent=https%3A%2F%2Fpatents.google.com&amp;rpctoken=351209429" tabindex="-1" aria-hidden="true"></iframe><iron-a11y-announcer>
    
    <div class="style-scope iron-a11y-announcer" aria-live="polite"></div>
  </iron-a11y-announcer></body></html>